Defunct Company
Total Trials
4845
As Lead Sponsor
3565
As Collaborator
1280
Total Enrollment
8,376,559
NCT06638177
Obesity and Obesity-Related Factors and Risk of Herpes Zoster (Shingles) and Postherpetic Neuralgia
Phase: N/A
Role: Collaborator
Start: Jun 30, 1976
Completion: Dec 31, 2027
NCT01536561
Study of Radiolabeled Monoclonal Antibody Anti-B1 for the Treatment of B-Cell Lymphomas and Extended Study to Determine the Safety and Efficacy of Coulter Clone® 131Iodine-B1 Radioimmunotherapy of Advanced Non-Hodgkin's Lymphoma
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 24, 1990
Completion: Oct 16, 2009
NCT00699231
Evaluation of Immunogenicity, Reactogenicity and Safety of HBV-MPL Vaccine vs Engerix™-B, in Haemodialysis Patients
Start: Feb 29, 1992
Completion: Dec 31, 1992
NCT00698893
Evaluation of Safety of Candidate gD Vaccine, With or Without MPL in Healthy Herpes Simplex Virus-positive Adults
Start: May 1, 1992
Completion: Jul 1, 1992
NCT00697229
Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerix™-B in Healthy Adults Following 2 Different Schedules
Phase: Phase 2
Start: Sep 30, 1992
Completion: Dec 31, 1998
NCT00697567
Evaluation of Immunogenicity, Reactogenicity and Safety of Herpes Simplex (gD) Candidate Vaccine With/Without Adjuvant
Completion: Dec 31, 1997
NCT00697125
Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants
Start: Jun 30, 1993
Completion: Jul 31, 1994
NCT00697970
Evaluation of Immunogenicity and Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine
Phase: Phase 3
Start: Nov 30, 1993
Completion: Apr 30, 1995
NCT00697242
Comparison of Immuno, Reacto and Safety of Recombinant Hepatitis B Vaccine With or Without MPL in Healthy Older Adults
Start: Jan 31, 1994
Completion: Nov 30, 1995
NCT00530400
Study of the Efficacy of Preoperative Cefuroxime Prophylaxis to Prevent Surgical Site Infection in Herniated Disk Surgery
Phase: Phase 4
Start: Apr 30, 1994
Completion: Mar 31, 2000
NCT00698087
Comparison of Safety, Immuno- and Reactogenicity of MPL-Adjuvanted Recombinant Hepatitis B Vaccine to That of Engerix™-B
Start: Jan 31, 1995
Completion: Feb 29, 1996
NCT00697840
Safety, Immunogenicity and Reactogenicity of Recombinant Hepatitis B Vaccine (Adjuvanted & New Formulation) and Engerix™-B
Start: Jun 30, 1995
Completion: Jan 31, 1996
NCT00698490
Humoral and Cellular Immune Response of Herpes Simplex (gD) Candidate Vaccines From 2 Different Cell Lines
Phase: Phase 1/2
Start: Aug 31, 1995
Completion: Jan 31, 1997
NCT01224821
Dosimetry/Validation Study of 131Iodine-Anti B1 (Murine) Radioimmunotherapy for Chemotherapy Refractory Low Grade B Cell Lymphomas and Low Grade Lymphomas That Have Transformed to Higher Grade Histologies
Start: Dec 31, 1995
Completion: May 31, 2008
NCT00002767
Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma
Start: Jan 31, 1996
Completion: Not specified
NCT00699764
Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease
Start: Mar 31, 1996
Completion: Oct 31, 1999
NCT00996996
Iodine-131 Anti-B1 Antibody (Tositumomab and Iodine I 131 Tositumomab) for Previously Untreated, Advanced-stage, Low Grade Non-Hodgkin's Lymphoma
Start: Jun 30, 1996
Completion: Oct 31, 2011
NCT00139113
Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young Children
Start: Sep 30, 1996
Completion: Jun 30, 2001
NCT00698568
Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects
Start: Oct 31, 1996
Completion: Apr 30, 1999
NCT00989664
Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-refractory Low-grade or Transformed Low-grade B-cell Non-Hodgkin's Lymphoma
Start: Nov 30, 1996
Completion: Sep 30, 2008
NCT01657097
Allergic Inflammation in Rhinitis Patients Following Nasal Allergen Challenge
Start: Feb 28, 1997
Completion: Apr 30, 1997
NCT00697216
Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs).
Start: Mar 31, 1997
NCT00698555
Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 18-40 y
NCT00697931
Immunogenicity and Reactogenicity of MPL Adjuvanted Recombinant Hepatitis B- Vaccine and Engerix™-B in Adult Non-Responders
Start: May 31, 1997
Completion: Jun 30, 1998
NCT00696891
Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in Adults
Start: Jun 30, 1997
NCT00698906
Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 y
NCT01267058
Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy Adults
Start: Sep 30, 1997
Completion: Feb 28, 1998
NCT01262924
Study of Reduced-antigen-content Acellular Pertussis Vaccine and Diphtheria-Tetanus-Acellular Pertussis Vaccine
Start: Oct 31, 1997
NCT01559753
Early-onset Ventilator-associated Pneumonia in Adults: Comparison of 8 Versus 15 Days of Antibiotic Treatment
Start: Jan 31, 1998
Completion: Nov 30, 2002
NCT00697775
Safety and Immunogenicity of GSK Bio's Candidate HBV-MPL Vaccines Compared to Engerix™-B, in Healthy Adolescents
Start: Mar 31, 1998
NCT00938041
Retreatment of Patients With Non-Hodgkin's Lymphoma Who Have Previously Responded to Iodine-131 Anti B1 Antibody
Start: Apr 30, 1998
Completion: Jun 30, 2013
NCT00950755
Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology
Start: Jun 30, 1998
Completion: Apr 30, 2011
NCT00996593
Study of Iodine-131 Anti-B1 Antibody for Patients With Non Hodgkin's Lymphoma Who Have Previously Received Rituximab
Start: Jul 31, 1998
Completion: Aug 31, 2009
NCT00933335
Study of Safety and Efficacy of a Sequential Regimen Consisting of Three Cycles of Fludarabine Followed by Tositumomab and Iodine I 131 Tositumomab
Start: Aug 31, 1998
Completion: Aug 31, 2010
NCT00268203
Expanded Access Study Of BEXXAR® For Low Grade And Transformed Low-Grade Non-Hodgkin's Lymphoma
Start: Sep 30, 1998
Completion: Feb 28, 2013
NCT01457495
Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly
Completion: Sep 30, 1999
NCT01573000
A Randomized Study of Iodine-131 Anti-b1 Antibody Versus Anti-b1 Antibody in Chemotherapy-relapsed/Refractory Low-grade or Transformed Low-grade Non-Hodgkin's Lymphoma (NHL)
Completion: Apr 30, 2010
NCT00022958
Expanded Access Study of Iodine-131 Anti-B1 Antibody
NCT00178048
Paroxetine in the Treatment of Chronic Primary Insomnia
Completion: Dec 31, 2003
NCT00201474
Acute, Affective, Organic Disorders.
Start: Oct 31, 1998
Completion: Jun 30, 2010
NCT00697853
Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy Adults
Start: Nov 30, 1998
NCT00184977
COPD on Primary Care Treatment (COOPT)
Start: Dec 31, 1998
Completion: Jan 31, 2003
NCT00003635
506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents
Start: Jan 31, 1999
Completion: Mar 31, 2004
NCT01457508
Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately
NCT00696917
Safety and Immunogenicity of 3 Lots of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Volunteers ≥ 15y
Start: Apr 30, 1999
NCT00697749
Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Healthy Volunteers Positive for the HLA-DQ2 Genotype
Completion: Jan 31, 2000
NCT00992758
Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Non Hodgkin's Lymphoma (NHL) Patients With Greater Than 25% Bone Marrow Involvement
Start: May 28, 1999
Completion: Jun 7, 2012
NCT00022906
Safety and Efficacy of Iodine-131 Anti-B1 Antibody for NHL Patients With Greater Than 25% Bone Marrow Involvement
Start: May 31, 1999
NCT00022880
Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic Leukemia
Start: Jul 31, 1999
NCT01387191
Drug Use Investigation for FLOLAN (Epoprostenol) Injection 0.5mg・1.5mg
Start: Aug 31, 1999
Completion: Jul 31, 2009
NCT00693966
Dose-Comparison Study to Evaluate the Safety and Immunogenicity of MEDI-517 (GSK 580299) in Healthy Adult Females
Start: Oct 31, 1999
Completion: Sep 30, 2004
NCT00179426
Effect of Antiseizure Medication on Hormone Levels and Sexual Function in Men With Epilepsy
Completion: Jun 30, 2006
NCT00181818
Bupropion for Hospitalized Smokers With Acute Cardiovascular Disease
NCT00158834
Pediatric Asthma Study Using Stepwise Treatment With Two Food And Drug Administration Approved Asthma Medications
Start: Nov 30, 1999
NCT00698061
Immunogenicity and Safety of an Adjuvanted HBV Vaccine Compared to Engerix™-B, in a Non-responder Population ≥ 15y
Completion: May 31, 2001
NCT00263744
Study to Evaluate the Safety and Immunogenicity of MEDI-517P in Healthy Adult Female Volunteers Who Are HPV-16 or HPV-18 DNA Positive
NCT00383227
Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years
Start: Dec 31, 1999
Completion: Nov 30, 2000
NCT00383383
NCT00279045
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
Start: Jan 3, 2000
Completion: Jun 19, 2006
NCT00697554
Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Pre-liver Transplant Patients 18 Years of Age
Start: Jan 31, 2000
NCT00606242
Dose Response Effects of Inhaled Fluticasone on Airway Effects of Hypertonic-saline in Asthma
Completion: Dec 31, 2007
NCT01457560
Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine
Start: Feb 29, 2000
Completion: Apr 30, 2001
NCT01663714
Open Label Multicenter Study of CVP Followed by Iodine-131 Anti-B1 Antibody for Subjects With Untreated Low-Grade Non Hodgkin's Lymphoma.
Completion: Feb 29, 2012
NCT00194896
Preferred Treatment of Type 1.5 Diabetes
Completion: Dec 31, 2008
NCT00508833
Safety and Efficacy of SmithKline Beecham (GlaxoSmithKline [GSK]) Biologicals' Candidate Adjuvanted Vaccines (287615)
Start: Mar 31, 2000
NCT00628225
Smoking Cessation in Patients With COPD (SMOCC) in General Practice
NCT00005865
Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Start: Apr 30, 2000
Completion: Jun 30, 2007
NCT00140725
Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV)
NCT00500955
Rosiglitazone on Microalbuminuria in Type 2 Diabetics
Completion: Jun 30, 2004
NCT00158847
Modification Of Disease Outcome In COPD
Completion: May 31, 2005
NCT00043875
Pediatric Epilepsy Trial in Subjects 1-24 Months
Start: May 31, 2000
Completion: Nov 30, 2003
NCT01868035
Iodine-131 Anti-B1 Antibody Consolidation for Patients With Non-Hodgkin's Lymphoma Following First-line CHOP
Completion: Oct 31, 2012
NCT00352170
Calcium and Vitamin D Malnutrition in Elderly Women
Completion: Jul 31, 2005
NCT00333723
AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide Alone
Start: Jul 28, 2000
Completion: Jan 6, 2003
NCT00425737
Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine in Healthy Infants
Start: Aug 31, 2000
Completion: Jul 31, 2001
NCT00697866
Consistency of 3 Consecutive Lots of a Novel HBV Vaccine With Single-blind Safety Evaluation Using Engerix™-B as Control
NCT00044278
Pediatric Epilepsy Study in Subjects 1-24 Months
Start: Sep 30, 2000
NCT00268216
Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Completion: Nov 30, 2005
NCT00879827
Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy Infants
NCT01798992
Effect of Beta-blockers on Structural Remodeling and Gene Expression in the Failing Human Heart
Completion: Mar 31, 2009
NCT00119743
A Efficacy Against Otitis Media in Children With 11 Valent Pneumococcal Vaccine
Start: Oct 31, 2000
NCT00693615
Safety and Immunogenicity Study of MEDI-517 (GSK 580299) With or Without Adjuvant in Healthy Adult Females
Completion: Jan 31, 2005
NCT00516113
A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual Dysphoria
NCT00276276
Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung Cancer
Start: Nov 30, 2000
NCT00388440
Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.
NCT00729001
Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants.
Completion: Sep 30, 2002
NCT00193245
Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung Cancer
Completion: Jan 31, 2009
NCT00338780
Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia)
NCT00043901
Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug
Start: Dec 1, 2000
Completion: Mar 1, 2005
NCT00157560
Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma
Start: Dec 31, 2000
NCT00429481
Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine at Different Viral Concentrations in Healthy Infants
Start: Jan 31, 2001
Completion: Apr 30, 2003
NCT00689741
Efficacy Study of HPV-16/18 Vaccine (GSK 580299) to Prevent HPV-16 and/or -18 Cervical Infection in Young Healthy Women
NCT00880477
Immunogenicity and Safety of Primary and Booster Vaccination With DTPa-HBV-IPV/Hib Vaccine
NCT00292838
Relative Potency of Inhaled Corticosteroids
Completion: Feb 28, 2007
NCT00304993
Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia
Completion: Feb 28, 2005
NCT00440687
Withdrawal of Inhaled Corticosteroids in Patients With COPD in Primary Care
NCT00011895
Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
Start: Feb 28, 2001
NCT00262717
Can Resistance Enhance Selection of Treatment? (CREST)
Start: Mar 1, 2001
Completion: Jul 31, 2006
NCT00388258
Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus
Completion: Dec 1, 2002
NCT00041470
Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial
Start: Mar 31, 2001
Completion: Aug 31, 2008
NCT00226135
Prophylactic Effect of Lamotrigine Compared With Lithium in Bipolar Disorder
Completion: Dec 31, 2006
NCT00043927
Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults
Start: Apr 30, 2001
NCT00379769
RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes
NCT01371435
Drug Use Investigation for PAXIL Tablet
Completion: Dec 31, 2005
NCT00193089
Docetaxel, Vinorelbine and Trastuzumab in the Treatment of Patients With Metastatic Her-2 Positive Breast Cancer
Completion: Sep 30, 2009
NCT01556945
Safety and Preliminary Efficacy of the Malaria Vaccine Candidates Falciparum Merozoite Protein-1 (FMP1) and SmithKlineBeecham (SKBB) Candidate Malaria Vaccine RTS,S
NCT03619590
Twinrix Pregnancy Registry
Start: May 18, 2001
Completion: Sep 15, 2017
NCT04807712
Pediatric Pertussis in Ambulatory Settings
Start: May 30, 2001
Completion: Jan 1, 2030
NCT00025727
Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure
Start: May 31, 2001
NCT00385320
Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months
NCT01371448
Special Drug Use Investigation for PAXIL Tablet (Long-term)
Completion: Sep 30, 2005
NCT00220259
Cystic Fibrosis Withdrawal of Inhaled Steroids Evaluation Study (CF WISE Study)
NCT00510263
Scandinavian Bell's Palsy Study
Completion: Sep 30, 2007
NCT00501020
Comparison of the Efficacy and Tolerability of the Addition of AVANDIA to Submaximal Doses of Metformin
Start: Jun 5, 2001
Completion: Feb 13, 2003
NCT00992992
Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma
Start: Jun 28, 2001
NCT00060918
Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And Hypertension
Start: Jun 30, 2001
Completion: Apr 30, 2004
NCT00060931
Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension
NCT00287469
A Safety and Efficacy Study of the Hepatitis E Vaccine in Nepal.
Start: Jul 9, 2001
NCT00095654
The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial
Start: Jul 31, 2001
Completion: Oct 31, 2006
NCT00910689
Drug and Non-Drug Treatment Of Severe Migraine
NCT00143702
D4T or Abacavir Plus Vitamin Enhancement in HIV-Infected Patients (DAVE)
Phase: Phase 2/3
Start: Aug 31, 2001
Completion: Aug 31, 2006
NCT00146549
Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer
NCT00046111
A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors
Start: Sep 30, 2001
NCT00366366
To Evaluate Immunogenicity & Safety of GSK Bio's DTPa-HBV-IPV/Hib (Mixed Vaccine) and DTPa-IPV/Hib + HBV Vaccines
NCT01376141
Drug Use Investigation for IMIGRAN Tablet
NCT00540098
Paroxetine vs Placebo Combined With Aerobic Exercise or Relaxation in Panic Disorder
Completion: Jun 30, 2005
NCT00049998
Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer
Start: Oct 31, 2001
NCT00034840
Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose
Completion: Aug 31, 2002
NCT00125047
Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood
Completion: Aug 31, 2007
NCT00299793
Observational Study of Lamotrigine
NCT00333385
Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis
NCT00158886
Oral Topotecan As A Radiosensitizing Agent In Rectal Cancer
Start: Nov 8, 2001
Completion: Aug 11, 2006
NCT00325416
Study of Melphalan and Topotecan (MT) Followed by Autologous Stem Cell Rescue in Patients With Multiple Myeloma.
Start: Nov 19, 2001
Completion: Jan 30, 2018
NCT00038961
A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO).
Start: Nov 30, 2001
Completion: Oct 31, 2004
NCT00041496
Prevention Of Recurrence Of Atrial Fibrillation
NCT00346892
To Evaluate 2 Doses of GSK Biologicals' Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV or IPV
NCT00920959
Advair Pediatric Once-Daily
Completion: Jan 31, 2004
NCT01064297
Lamotrigine Pregnancy Registry (LAM05)
Completion: Jul 31, 2010
NCT00215956
A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma
Completion: Jan 31, 2008
NCT00296504
A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected Subjects
Completion: Oct 31, 2010
NCT00631878
Safety and Pharmacokinetics Study in VLBW Neonates With BSYX-A110
Completion: Aug 31, 2003
NCT01059604
Sumatriptan and Naratriptan Pregnancy Registry
Start: Dec 31, 2001
Completion: Apr 30, 2013
NCT00131820
Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam
Completion: Jan 31, 2007
NCT00151086
Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer
NCT00388479
Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/ Postoperative Ileus
NCT00043914
Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy
Start: Jan 14, 2002
Completion: Jan 29, 2003
NCT00041509
ThromboEmbolism Prevention Efficacy and Safety Trial (TEMPEST)
Start: Jan 31, 2002
Completion: May 31, 2003
NCT00043888
Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR
NCT01277705
Comparison of GSK Biologicals' Reduced Antigen Diphtheria and Tetanus Toxoids and Acellular Pertussis- Inactivated Poliovirus Vaccine, to BoostrixTM and Inactivated Poliovirus Vaccine Administered Separately and With Revaxis®
Completion: Apr 30, 2002
NCT00129363
Study to Evaluate the Safety of Twice Daily Oral Carvedilol
Completion: Jan 31, 2006
NCT00175565
Inhaled Steroid Reduces Systemic Inflammation in COPD
Completion: Jul 31, 2003
NCT00388401
Completion: Jun 30, 2003
NCT00610610
Paroxetine-CR (Paxil-CR) in the Treatment of Patients With Fibromyalgia Syndrome
Completion: Dec 31, 2002
NCT00610909
Paroxetine - Controlled Release in the Treatment of Irritable Bowel Syndrome (IBS)
NCT02522754
Development of an Intranasal Proteosome Influenza Vaccine
NCT00193297
Topotecan Plus Paclitaxel and Carboplatin in the Initial Treatment of Advanced Ovarian and Primary Peritoneal Carcinoma
Start: Feb 28, 2002
NCT00193570
Topotecan in Combination With Docetaxel in Refractory and/or Advanced Solid Tumors
NCT00407264
Randomized Trial of Fluticasone in Bronchial Premalignancy
NCT00457665
Mechanisms of Lipodystrophy in HIV-Infected Pateints
Completion: Oct 31, 2014
NCT00549874
Effect of Rosiglitazone on Myocardial Blood Flow Regulation in Type 2 Diabetes
Completion: Nov 30, 2006
NCT00135486
Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT Vaccine and Hib-MenC-TT Vaccine in Infants
Start: Mar 31, 2002
NCT00383591
NCT00290355
Study to Test the Efficacy of the Vaccine GSK 249553 in Treating Non-small-cell Lung Cancer After Tumour Removal by Surgery
Start: May 28, 2002
Completion: Jul 19, 2011
NCT00044460
Efficacy and Safety In Poorly Controlled Type 2 Diabetics
Start: May 31, 2002
Completion: Apr 10, 2003
NCT00197249
Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & Immunogenicity
NCT00306644
Effect Of Rosiglitazone On Carotid Intima Media Thickness In Patients With Insulin Resistance Syndrome And/Or Type 2 Diabetes
Completion: Nov 30, 2004
NCT00650104
Long-term Extension Study Evaluating Extended Release Ropinirole XL (Formerly Referred to as Ropinirole CR) in Patients Who Already Completed Either Study 167 or 164
NCT00839397
BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder
NCT01177839
Study to Assess the Incidence of Intussusception in Children < 2 Years of Age in Singapore
NCT00476346
Calcium and Vitamin D Supplementation Decreases Incidence of Stress Fractures in Female Navy Recruits
Completion: Mar 31, 2006
NCT00046332
A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients
Start: Jun 30, 2002
NCT00137917
Immunogenicity & Safety Study of a Meningococcal Serogroup B Vaccine Given in a 3 Dose Schedule to Healthy Adolescents Aged 12-18 Yrs
Start: Jul 31, 2002
NCT00043862
The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC)
Start: Aug 31, 2002
NCT00224510
A Study To Investigate The Antidepressant Effect Of Lamotrigine In Patients With Bipolar Disorder Using Lithium
Completion: Sep 30, 2006
NCT00320359
Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung Cancer
NCT01390766
Drug Use Investigation for IMURAN (Azathioprine) Tablet (Hepatic Transplantation)
Completion: May 31, 2011
NCT00238888
Randomised Controlled Trial of a Multi-faceted Community-based Intervention to Improve Asthma in Children
Completion: Dec 31, 2011
NCT00044343
GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin
Start: Sep 30, 2002
Completion: Oct 31, 2003
NCT00046241
Prevention of Seasonal Affective Disorder
NCT00046449
NCT00049972
Major Depressive Disorder Study In Adults
Completion: Sep 30, 2003
NCT00231387
Rosiglitazone And Plaque Study for Type 2 Diabetes Mellitus
NCT00329225
Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin
NCT00731029
Reacto & Immunogenicity of TF Formulation of Influsplit SSW® 2002/03 v/s Std Formulation of Influsplit SSW® 2002/03
NCT00065065
A Trial of Rosiglitazone for Ulcerative Colitis
NCT00193388
Weekly Topotecan in the Second-Line Treatment of Small Cell Lung Cancer
NCT00285584
Bupropion For Reducing High-Risk Behaviors in Depressed Men Who Have Sex With Men (MSM)
NCT00353886
Study of Antiepileptic Drug Effects on Child Development
NCT00802230
Pharmacodynamic Study of Carvedilol Versus Metoprolol in Heart Failure
Completion: Dec 31, 2004
NCT00048360
Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults
Start: Oct 31, 2002
NCT00049946
Schizophrenia Study In Adults
NCT00051103
Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin.
NCT00197132
Study In Patients With Insulin Resistance
NCT00268177
Airway Inflammation In Patients With Chronic Obstructive Pulmonary Disease
NCT00306696
Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone.
NCT00123227
Rosiglitazone Plaque Study
NCT00133081
Study to Improve the Treatment of Epilepsy (SITE)
NCT00225225
Rosiglitazone-Induced Weight Gain
NCT00654680
Evaluating the Efficacy and Safety of Vardenafil in Patients Erectile Dysfunction Solely Secondary to Spinal Cord Injury
NCT00656188
Placebo-controlled Study Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction
NCT00048204
A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder
Start: Nov 4, 2002
NCT00109330
A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine
Start: Nov 30, 2002
NCT00263692
Comparison of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP and IPV Separately Administered Vaccines in Terms of Immune Response and Safety
NCT00291967
Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants
NCT00376454
The Study of GW493838, an Adenosine A1 Agonist, in Peripheral Neuropathic Pain
NCT00453778
A Study To Investigate The Effect Of Inhaled Fluticasone Propionate On The Bronchial Responsiveness To Leukotriene D4 In Asthmatics Patients
Completion: May 31, 2004
NCT00479739
CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca.
Completion: Jul 31, 2004
NCT00156377
Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections
NCT00187031
A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor
Completion: Oct 31, 2007
NCT00344513
Organized Program To Initiate Lifesaving Treatment In Hospitalized Patients With Heart Failure (OPTIMIZE-HF)
Start: Dec 16, 2002
NCT00061308
Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer
Start: Dec 31, 2002
NCT00370591
Study Of Airway Physiology In Adults. SERETIDE DISKUS® Inhaler and FLIXOTIDE® Inhaler Are Trademarks of GSK Croup of Companies.
NCT00857675
A Efficacy and Safety Study of Adefovir Dipivoxil to Treat Chinese Patients With HBeAg+ve Chronic Hepatitis B
Completion: Mar 31, 2008
NCT00215163
Paroxetine-CR to Treat Post-Traumatic Stress Disorder (PTSD) Symptomatic After Initial Exposure Therapy
NCT00226447
Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients
NCT00057330
HerpeVac Trial for Young Women
Start: Jan 14, 2003
Completion: Aug 22, 2009
NCT00297206
A Safety And Tolerability Study Of Valaciclovir Oral Suspension In Infants And Children
Start: Jan 25, 2003
NCT00051259
Effects of Antidepressants on Sexual Functioning
Start: Jan 31, 2003
NCT00051272
Effects Of Antidepressants On Sexual Functioning In Adults
NCT00085878
Dose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid Tumors
NCT00135564
Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT and Hib-MenC-TT or Meningitec™ in Healthy Toddlers
NCT00169546
Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies.
NCT01324362
GSK BHR Study (Sont - Second Study)
NCT01916720
Study to Determine the Effect of 14 Days Dosing With Darapladib (SB-480848) on Carotid Plague Composition in Patients With Planned Carotid Endarterectomy
NCT00330239
Paroxetine Treatment in Outpatients With Comorbid PTSD and Substance Dependence
NCT00056277
Bipolar Disorder Study for Men and Women
Start: Feb 27, 2003
Completion: Dec 14, 2005
NCT00053638
A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy
Start: Feb 28, 2003
NCT00920543
GSK BHR Study (Sont)
NCT00308932
Effect of Age and Device on Delivery of Fluticasone
NCT00668005
Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction and Hypertension
NCT00127855
Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine
Start: Mar 1, 2003
Completion: Feb 12, 2004
NCT00129116
3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age
Completion: Dec 16, 2003
NCT00058526
A Dose-escalation Vaccine Trial in HER2-overexpressing Patients With High-risk Breast Cancer
Start: Mar 20, 2003
Completion: Sep 6, 2006
NCT00056407
"REDUCE - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk"
Start: Mar 31, 2003
Completion: Apr 30, 2009
NCT00057213
An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder
Completion: Apr 30, 2007
NCT00057226
An 8 Week Study Of Adults Diagnosed With Major Depressive Disorder
NCT00057239
An 8 Week Depression Study In Adults Diagnosed With Major Depressive Disorder
NCT00315731
A Study Of Pharmacokinetics, Whole Body And Organ Dosimetry, And Biodistribution Of Fission-Derived Iodine I 131 Tositumomab (BEXXAR®) For Patients With Previously Untreated Or Relapsed Follicular Or Transformed Non-Hodgkin's Lymphoma
NCT00161434
A Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected Persons
NCT00256815
Combination of Weekly Chest Radiotherapy and Oral Navelbine for the Palliation of Advanced Non Small Cell Lung Cancer: A Phase I Study
NCT00405925
FREE Study: Efficacy and Toxicity of Trizivir
NCT00681772
Evaluation of the Safety and Efficacy of Vardenafil in Subjects With Erectile Dysfunction
NCT00148902
Effects Of GW572016 In Combination With Docetaxel (TAXOTERE)
Start: Apr 28, 2003
Completion: Jan 21, 2006
NCT00062894
Study of Untreated or Transformed Follicular Non-Hodgkin's Lymphoma With Fission-Derived Iodine I 131 Tositumomab
Start: Apr 30, 2003
NCT00139815
Michelangelo - Oasis 5
NCT00146835
Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine
NCT01294605
Immunogenicity and Reactogenicity Study of BoostrixTM (dTpa) and Boostrix-IPV (dTpa-IPV)
NCT00230477
Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALT
NCT00233051
Evaluating Genes in Sputum to Measure Drug Response in COPD
NCT00307970
Impact of Anti-static Chamber/Mask
NCT00135525
Study Of Generalized Anxiety Disorder
Start: May 31, 2003
Completion: May 31, 2006
NCT00544271
Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines.
NCT00123643
Vascular Effects of Rosiglitazone Versus Glyburide in Type 2 Diabetic Patients
NCT00125008
Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever
NCT00193583
Weekly Topotecan in Combination With Carboplatin in Two Different Schedules for Refractory and/or Advanced Solid Tumors
NCT00631800
Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity Study in VLBW Neonates of BSYX-A110
NCT00241605
AVANDAMET Versus Metformin For Type 2 Diabetes Mellitus
Start: Jun 25, 2003
Completion: Dec 16, 2005
NCT00064467
Lethargic Depression Study
Start: Jun 30, 2003
NCT00067444
Depression Study In Elderly Patients
NCT00067457
Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy
NCT00067561
Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy
NCT00361959
SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease
Completion: Feb 28, 2006
NCT00381472
Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa
NCT00519467
Safety and Efficacy Dose of Artesunate Used in Combination With LAPDAP Treatment of Uncomplicated Falciparum Malaria
NCT00062738
Treatment of Depression in Parkinson's Disease Trial
NCT00156819
The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial
NCT00169832
Vein-Coronary Atherosclerosis And Rosiglitazone After Bypass Surgery: The VICTORY Trial
Completion: Jul 31, 2007
NCT00190242
Immunogenicity and Tolerance of Two Strategies of Anti-HAV Vaccination in HIV-infected Patients
Completion: Oct 31, 2009
NCT00317473
Phase 1 Trial of a Malaria Vaccine in Young Kenyan Children
NCT00658177
Study Evaluating the Efficacy and Safety of Flexible-dose Vardenafil in Subjects With Erectile Dysfunction
Completion: Feb 29, 2004
NCT00661297
Study Evaluating the Efficacy, Safety, and Reliability of Vardenafil
NCT00197041
A Study to Evaluate the Safety, Immunogenicity and Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Malaria Vaccine RTS,S/AS02A, When Administered to Children Aged 1 to 4 Years Living in a Malaria-endemic Region of Mozambique.
Start: Jul 31, 2003
Completion: Apr 30, 2005
NCT00317174
A Study to Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects.
NCT00240552
Fosamprenavir Expanded Access
Completion: Aug 31, 2005
NCT00308061
Safety Study of Candidate Malaria Vaccine FMP1/AS02A in Healthy Adults in Bandiagara, Mali
NCT00908115
Post Market Surveillance for Infanrix™
Start: Aug 1, 2003
Completion: Jun 23, 2008
NCT00140673
A Study to Test 2 Doses of the HRV Vaccine in Healthy Infants.
Start: Aug 5, 2003
Completion: Oct 20, 2005
NCT00065182
Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer
Start: Aug 14, 2003
Completion: Aug 30, 2007
NCT00064428
OASIS-6 : The Safety and Efficacy of Fondaparinux Versus Control Therapy in Patients With ST Segment Elevation Acute Myocardial Infarction
Start: Aug 31, 2003
NCT00067938
Bipolar Study in Adults at Least 18 Years of Age
Completion: Aug 31, 2004
NCT00071747
Clinical Study Of Schizophrenia in Both Men and Women
NCT00363857
A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome
NCT00757770
Assessment of Clinical Consistency of Three Production Lots of GSK Biologicals' HRV Vaccine
NCT00969072
Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia
NCT01061541
Immunogenicity, Safety & Reactogenicity of GSK Vaccine Tritanrix™-HepB/Hib2.5 Compared to GSK Vaccine Tritanrix™-HepB/Hiberix™
NCT00153062
PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes
NCT00378976
HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.
NCT00384670
A Phase I/II Trial of a Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naïve Children
NCT00792623
Immunogenicity and Safety of GSK Biologicals' Live Attenuated Varicella Vaccine (VARILRIXTM).
Start: Sep 8, 2003
Completion: Sep 10, 2007
NCT00197002
Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age
Start: Sep 11, 2003
Completion: Jan 16, 2006
NCT01290601
Study to Evaluate the Efficacy and Safety of Tafenoquine for the Treatment of Plasmodium Vivax in Adults
Start: Sep 15, 2003
Completion: Jan 10, 2005
NCT01855711
Safety and Efficacy Study of GR68755 (Alosetron Hydrochloride) to Treat Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS)
Start: Sep 18, 2003
Completion: May 10, 2005
NCT00069459
Seasonal Affective Depression (SAD) Study
Start: Sep 23, 2003
Completion: Jun 3, 2004
NCT00196950
Study to Evaluate Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 18-25 Years
Start: Sep 30, 2003
NCT00197171
Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine
NCT00279032
GW406381 In Patients With Peripheral Nerve Injury
NCT00352963
Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).
Completion: Jul 16, 2004
NCT00383903
Evaluate Safety & Immunogenicity of 2 or 3 Doses of GSK HRV Vaccine in Healthy Infants in South Africa
NCT00950794
Study of Salmeterol (SN408D) for Adult Asthma
NCT01499446
A Study of GW685698X 100mcg Administered Once Daily Either in the Morning or the Evening and GW685698X 250mcg Administered Once Daily in the Evening Via DISKHALER for 28 Days in Subjects With Persistent Bronchial Asthma.
NCT00039858
Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin
NCT00159302
Biomarkers of iNOS Activity in COPD, Asthma, Healthy Control
NCT00169728
Vaccination of Children Following Allogeneic Stem Cell Transplantation
NCT00203632
Glitazones and Endothelial Function (GATE)
NCT00662441
Evaluating of the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction
NCT00801879
Mupirocin Ointment to Eliminate Nasal Carriage of Staphylococcus Aureus in HIV Infection
Completion: Apr 30, 2006
NCT00264680
Spanish Validation Of Quality of Life Questionnaire (QOLIE-10) For Epilepsy
Start: Oct 1, 2003
Completion: Mar 1, 2006
NCT00101998
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
Completion: May 1, 2006
NCT00750360
Study to Monitor the Safety and Reactogenicity of Fluarix™ in Korean Subjects Aged > 6 Months of Age.
Start: Oct 3, 2003
Completion: Dec 28, 2007
NCT00197015
Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children
Start: Oct 6, 2003
Completion: Jun 9, 2009
NCT00499707
Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects
Start: Oct 8, 2003
Completion: Dec 16, 2004
NCT00067951
A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II Diabetics
Start: Oct 17, 2003
NCT00071760
Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects
Start: Oct 23, 2003
Completion: Mar 29, 2022
NCT00062790
Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels
Start: Oct 31, 2003
NCT00069836
Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies.
NCT00240500
Follow-up Study 16-20 Years After Primary Vaccination Against Hepatitis B of Newborns From HBeAg+ & HBsAg+ Mothers
Completion: Nov 30, 2007
NCT00240526
LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ Mothers
Completion: Mar 31, 2010
NCT00240539
Long Term Follow-Up Study 16-20 Years After Hepatitis B Vaccination in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg) & Hepatitis B Surface Antigen (HBsAg)
Completion: Jul 31, 2008
NCT00240591
Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Tositumomab and/or Iodine I 131 Tositumomab
NCT00307008
Study to Evaluate the Response Rate to the Licensed Pneumovax 23™ in Elderly Population.
NCT00731393
Immuno & Reacto of TF Trivalent Influenza Split Vaccine 2003/04 or of Std Formulation Influsplit SSW®/Fluarix™ 2003/04
NCT01457547
Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course
NCT01767402
Study to Evaluate Safety, Reactogenicity and Immunogenicity of the Pneumococcal Protein PhtD Vaccine in Healthy Adults
NCT00221390
Trial of Ropinirole in Motor Recovery After Stroke
Completion: May 31, 2007
NCT00429832
A RCT of Ondansetron and Promethazine in the Treatment of Nausea and Vomiting in the Emergency Department
NCT00657033
Study to Investigate the Efficacy and Safety of Vardenafil Flexible Dose Versus Placebo in Males With Erectile Dysfunction
NCT00197184
Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared
Start: Nov 1, 2003
Completion: Mar 10, 2004
NCT00197236
Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months
Start: Nov 11, 2003
Completion: Dec 3, 2007
NCT00289731
Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc
Start: Nov 24, 2003
Completion: Dec 21, 2004
NCT00062686
GW572016 For Treatment Of Refractory Metastatic Breast Cancer
Start: Nov 30, 2003
NCT00073008
A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer
NCT00090103
Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment
NCT00120848
Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults
NCT00169559
"Dyslipidemia Study Investigating The Increase In Good Cholesterol"
NCT00240578
Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Iodine I 131 Tositumomab
NCT00263679
Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine.
NCT00274677
Depression And Bipolar Disorder
NCT00422955
Fluid Retention in Rosiglitazone Treated Subjects With Autonomic Neuropathy.
Completion: Oct 31, 2005
NCT00549146
Treatment Of Partial Reversible Chronic Obstructive Pulmonary Disease
NCT00211263
Bipolar Disorder Research Study for Ages 12 and Older
NCT00214019
The Effect of Salmeterol on Eosinophil (EOS) Function
NCT02989727
Melancholic Symptoms in Bipolar Depression and Responsiveness to Lamotrigine
Completion: Dec 31, 2017
NCT00325143
Safety of DTPa-IPV/Hib & DTPa-HBV-IPV/Hib, Followed by DTPa-IPV/Hib Vaccine in Infants Who Received Hepatitis B Vaccine
Start: Dec 1, 2003
Completion: Feb 1, 2007
NCT00317135
Safety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.
Start: Dec 11, 2003
Completion: Oct 23, 2004
NCT00118716
A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise
Start: Dec 23, 2003
Completion: Apr 23, 2006
NCT00085813
Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer
Start: Dec 31, 2003
NCT00118690
NCT00139347
Study of 2 Doses of HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants
Completion: Mar 31, 2007
NCT00197210
A Study to Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants
NCT00224471
Study to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex Vaccine
NCT00363727
Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's
NCT01045590
Glibenclamide (Dose to be Titrated From Starting Dose of 5mg om) Plus Rosiglitazone 4mg om (Increased to 8mg om After 6 Months) and vs Glibenclamide (Dose to be Titrated With Starting Dose of 5mg om) Plus Placebo, Administered to Patients With Type 2 Diabetes Mellitus
NCT00075049
Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent Malaria
NCT00682019
Study Evaluation the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction for 10 Weeks
NCT00901407
Lamotrigine Augmentation in Resistant Depression
NCT00289757
Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine, Injected According to 0, 6-month Schedule
Start: Jan 1, 2004
Completion: Mar 1, 2013
NCT00291876
Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine Injected According to a 0, 12-month Schedule
NCT00307528
Safety and Efficacy Study of Investigational Pneumococcal Vaccine in Elderly Population
Start: Jan 20, 2004
Completion: Mar 30, 2005
NCT00075270
Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer
Start: Jan 31, 2004
Completion: Mar 31, 2012
NCT00327353
Influence Of Different Airflow Resistances On Drug Effect Of 50μg Salmeterol And 6 μg Formoterol
NCT00480649
Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS)
NCT00730795
Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine Given to PPD-Negative Adults
NCT01371461
Special Drug Use Investigation for PAXIL Tablet (20mg-Clinical Symptom Progression)
NCT00107081
Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting
NCT00120744
Oral Disintegrating Ondansetron Tablet to Reduce Vomiting From Gastroenteritis in a Pediatric Emergency Department
NCT00159185
Epidemiology Study in Major Orthopaedic Surgery
NCT00193167
Weekly Topotecan in Patients Treated for Metastatic Colorectal Cancer
NCT00257816
Weekly IV Topotecan and Cisplatin With Radiation in Cervical Carcinoma
Completion: Dec 17, 2007
NCT00490620
Study of Combivir for Patients With Primary Biliary Cirrhosis
NCT01406704
Effects of Rosiglitazone and Alpha-lipoic Acid on the Patients With Pathologically Proved NASH
Completion: Dec 31, 2013
NCT00289744
Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule
Start: Feb 16, 2004
Completion: Apr 15, 2009
NCT00330889
Effects Of Prednisolone On Rheumatoid Arthritis Patients
Start: Feb 29, 2004
NCT00359112
AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes
NCT00632736
An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease
NCT00080171
Osteoarthritis Initiative (OAI): A Knee Health Study
Completion: Oct 31, 2015
NCT00158743
Efficacy Study of Digibind for Treatment of Severe Preeclampsia
NCT00176228
Lamotrigine Monotherapy in Pediatric Bipolar Disorder
NCT00322049
A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive Infants
Completion: Jun 30, 2009
NCT00746174
Insulin Resistance and Intramyocellular Lipid Content in Glucose Intolerant Subjects Receiving Rosiglitazone
Completion: Feb 29, 2008
NCT00079911
A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons
Start: Mar 12, 2004
Completion: Oct 15, 2004
NCT00197067
A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Candidate Vaccines RTS,S/AS02D (0.5 mL Dose) and RTS,S/AS02A (0.25 mL Dose) Administered IM According to a 0, 1, 2 Month Vaccination Schedule in Children Aged 3 to 5 Years Living in a Malaria-endemic Region of Mozambique.
Start: Mar 15, 2004
Completion: Apr 26, 2005
NCT00086658
Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)
Start: Mar 23, 2004
NCT00078572
Capecitabine (XELODA) With Or Without Lapatinib (GW572016) For Women With Refractory Advanced or Metastatic Breast Cancer
Start: Mar 31, 2004
Completion: Feb 28, 2010
NCT00648284
Cardiovascular (CV) Risk Evaluation In Type 2 Diabetes Subjects
NCT00085020
GW572016 and Trastuzumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/Neu
NCT00229528
Effect of Paroxetine on COAT-Platelet Production in Normal Volunteers and Patients With Cardiovascular Disease
NCT00733174
Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose Tolerance
NCT00738023
Free Fatty Acid-Induced Hypertension in Obese Subjects With Type 2 Diabetes
Completion: Dec 31, 2009
NCT00224484
Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old
Start: Apr 7, 2004
Completion: Jul 24, 2007
NCT00343915
Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs
Start: Apr 21, 2004
Completion: Jan 10, 2008
NCT00082394
A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV
Start: Apr 26, 2004
NCT00355342
Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease. DISKUS® Inhaler is a Trademark of the GSK Group of Companies.
Start: Apr 28, 2004
Completion: Sep 6, 2007
NCT00085904
Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or Lymphomas
Start: Apr 30, 2004
NCT00090077
Monotherapy Versus Placebo Over 7 Days-Non-Nucleoside Reverse Transcriptase Inhibitor-Experienced HIV1 Infected Adults
NCT00136513
SB-743921 In Patients With Solid Tumors
NCT00240565
Tositumomab And Iodine I 131-Tositumomab In Patients With Relapsed Indolent Non-Hodgkin's Lymphoma
Completion: Sep 30, 2011
NCT00610571
Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas
Completion: Apr 30, 2012
NCT00663130
Evaluating the Efficacy Vardenafil 10 mg vs Tadalafil 10 mg in in Subjects With Erectile Dysfunction (ED)
NCT00122681
Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18
Start: May 6, 2004
Completion: Nov 26, 2009
NCT00265148
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
Start: May 18, 2004
Completion: Jul 10, 2008
NCT00085943
KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks
Start: May 31, 2004
NCT00086593
Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia
NCT00197119
Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years
NCT00290303
Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy Infants
Completion: Mar 31, 2005
NCT00328939
ARIXTRA Local Study For Registration In China.
NCT01476059
Pediatric Study to Evaluate Treatment of Persistent Moderate or Severe Asthma With the Association Fluticasone 250 mcg/Dose and Salmeterol 50 mcg/Dose - ADERE PROJECT
NCT00248209
Female Orgasmic Disorder (FOD) and Wellbutrin XL
NCT00252889
Doxil Topotecan Doublet Cancer Study
Completion: Jun 30, 2008
NCT00317187
Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.
Start: Jun 8, 2004
Completion: Jan 16, 2005
NCT00158860
A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.
Start: Jun 21, 2004
Completion: Jul 26, 2006
NCT00359190
Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast Cancer
Start: Jun 29, 2004
Completion: Jan 9, 2008
NCT00089973
Study Of Ispinesib In Subjects With Breast Cancer
Start: Jun 30, 2004
Completion: Aug 25, 2006
NCT00089999
Lapatinib In Chemotherapy-Naive Or Metastatic Breast Cancer
NCT00093288
Major Depressive Disorder In The Elderly
NCT00128661
Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants
Completion: Dec 31, 2010
NCT00169520
SB-715992 In Combination With Docetaxel In Patients With Solid Tumors
NCT00196924
Human Papilloma Virus Vaccine Safety and Immunogenicity Trial in Young Adolescent Women With GSK Bio HPV-16/18.
NCT00384306
Effects Of Oral Prednisolone On Bone Metabolism In Patients With Chronic Obstructive Pulmonary Disease
NCT00462956
GW572016 In Patients With Advanced Or Metastatic Breast Cancer
Completion: Dec 20, 2006
NCT00662805
Pharmacovigilance Study to Evaluate Safety of SERETIDE in Participants With Chronic Obstructive Pulmonary Disease (COPD)
NCT01294553
An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance to Monitor the Safety and/or Efficacy of AVANDAMET Between June 2004 and January 2010
Completion: Jan 31, 2010
NCT00123604
Vascular Effects of Carvedilol Versus Metoprolol in Hypertensive Patients With Type 2 Diabetes
NCT00186446
Treatment of Nicotine Dependence and Acute Depression
NCT00193362
Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung Cancer
NCT00205842
NCT00851630
Tuberculosis and Human Immunodeficiency Virus (HIV) Immune Reconstitution Syndrome Trial (THIRST)
NCT00650871
A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary Insomnia
Start: Jul 30, 2004
Completion: Aug 30, 2005
NCT00094367
A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study)
Start: Jul 31, 2004
NCT00289796
Assess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPV/Hib Vaccine
NCT00291889
Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02 in Healthy PPD-negative Adults.
NCT00406211
Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine
NCT00089583
48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection
Completion: Jul 31, 2013
NCT02712203
MMR and MMRV Vaccines: Effect of Age at First Dose on Safety and Immunogenicity of the Measles Component.
Completion: Dec 31, 2016
NCT00129129
Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine
Start: Aug 1, 2004
Completion: Mar 29, 2006
NCT00169533
Rollover Study Of Lapatinib In Cancer Patients
Start: Aug 19, 2004
Completion: May 5, 2009
NCT00158899
GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol
Start: Aug 31, 2004
NCT00317161
Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose.
NCT00354042
Effects Of Repeat Inhaled Doses Of GW597901X On Patient Safety And Lung Function In Asthmatic Subjects
NCT01329419
HEPSERA Post Marketing Surveillance
NCT00206427
Neoadjuvant GW572016 to Treat Breast Cancer
NCT00665054
BAY38-9456, 5/10/20mg, vs.Placebo in Erectile Dysfunction
NCT00089986
GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults
Start: Sep 1, 2004
Completion: Apr 15, 2007
NCT00317772
Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer
Start: Sep 2, 2004
Completion: Nov 4, 2020
NCT00158782
Study Of Safety And Tolerability Of GW786034 Given With Lapatinib In Cancer Patients
Start: Sep 28, 2004
Completion: Aug 21, 2007
NCT00092274
Study of HuMax-CD20, a New Drug to Treat Early Stage Non-Hodgkin´s Follicular Lymphoma
Start: Sep 30, 2004
NCT00097331
Three Months Treatment With SB683699 In Patients With Relapsing Multiple Sclerosis
NCT00097370
Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome
Completion: Sep 29, 2010
NCT00140686
To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines
NCT00144846
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
NCT00158873
Pharmaco-Economic Study Of Ultiva In Intensive Care Unit(ICU)Subjects
NCT00169494
Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18
NCT00197093
In-Patient Study In Schizophrenic Patients
NCT00316160
Sexual Functioning Study With Antidepressants
NCT00354666
Single Doses GSK159797 On Patient Safety And Lung Function In Patients With Mild To Moderate Asthma
NCT01571661
A First-time-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of GSK189075A in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus
NCT01750827
A Study to Assess the Effect of SB 659032 on Platelet Function
NCT00135577
Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
NCT00216229
Twinrix Alternative Schedule Study
NCT00225914
Study of Paxil Use in Menopausal Women
NCT00295243
Phase I Study of GW572016 With Topotecan to Treat Advanced Solid Malignancies
NCT00297011
Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis
NCT00490009
Phase 2 Study of Bexxar in Relapsed/Refractory DLCL
NCT00663728
Assessment of Duration of Erection With Vardenafil 10 mg
NCT00667979
Evaluating the Efficacy of Vardenafil in Subjects With Erectile Dysfunction (ED) Administered 12, 18 or 24 Hours Prior to Intercourse
NCT00259935
A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors
Start: Oct 4, 2004
Completion: Jul 5, 2007
NCT00196937
Human Papilloma Virus (HPV) Vaccine Immunogenicity and Safety Trial in Young and Adult Women With GSK Biologicals' HPV-16/18
Start: Oct 7, 2004
Completion: Dec 15, 2005
NCT00136578
Ispinesib In Combination With Carboplatin In Patients With Solid Tumors
Start: Oct 20, 2004
Completion: Oct 25, 2006
NCT00316732
Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS
Start: Oct 25, 2004
Completion: Dec 19, 2006
NCT00093314
HuMax-CD20 in Chronic Lymphocytic Leukemia
Start: Oct 31, 2004
NCT00101946
Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's Disease
NCT00101985
Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS)
NCT00102492
Study Of GW679769 In Major Depressive Disorder
NCT00102882
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
NCT00108095
A Study To Evaluate An NK-1 Antiemetic For The Prevention Of Post Operative Nausea And Vomiting
NCT00113165
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
NCT00144911
ADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Trademarks of the GSK Group of Companies.
NCT00169481
A Study in Children With Different Formulations of GSK Biologicals' 11 Valent Pneumococcal Conjugate Vaccine
NCT00242853
A Study To Investigate Markers Of Inflammation In Rheumatoid Arthritis
NCT00268983
Comparison Of Rituximab Versus Tositumomab and Iodine I 131 Tositumomab (BEXXAR® Therapeutic Regimen) For Patients With Relapsed Follicular Non-Hodgkins Lymphoma
NCT00317122
Assess the Immune Response Following Primary Vaccination With GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ Given at 6,10 & 14 Wks of Age to Infants Who Received Hepatitis B Vaccine at Birth
NCT00367055
Rosiglitazone-Metformin Combination Versus Metformin-Sulfonylurea Combination On Beta-Cell Function In Type 2 Diabetes
Completion: Oct 31, 2008
NCT01387165
Epidemiologic Survey to Describe the Current Medical Practice of General Practitioners Treating Subjects With Type 2 Diabetes Mellitus in Latina
NCT00144872
LAMICTAL (Lamotrigine) For The Treatment Of Absence Seizures
Start: Nov 1, 2004
Completion: Apr 22, 2006
NCT00289718
Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule
Completion: Mar 2, 2005
NCT00289770
Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults
Completion: Dec 20, 2004
NCT00325156
Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants
Start: Nov 2, 2004
Completion: Aug 23, 2007
NCT00315744
Viapaed Study In Children And Adolescents With Asthma
Start: Nov 4, 2004
Completion: Apr 12, 2007
NCT00273026
Study In Asthma Control
Start: Nov 8, 2004
Completion: Mar 28, 2006
NCT00107718
Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma
Start: Nov 15, 2004
Completion: May 19, 2006
NCT00273013
Study With GW274150 In Patients With Mild Asthma
Completion: Oct 28, 2005
NCT00102765
Study Of Asthma In Patients Of African Descent
Start: Nov 30, 2004
NCT00103922
Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease)
NCT00119171
Ispinesib In Combination With Capecitabine In Patients With Solid Tumors
NCT00256893
Fibromyalgia Study In Adults
NCT00323050
Study of a Booster Dose of Hib-MenC Conjugate Vaccine vs Infanrix Hexa When Given to 14 Month Old Subjects
NCT00328965
Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea
NCT00343707
PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety Patients
NCT00343941
Tucaresol As Add-On To HAART (Highly Active Antiretroviral Therapy) In Chronic HIV-1 Infected Adults
NCT00379600
The Anti-Inflammatory And Metabolic Effects Of Rosiglitazone In Subjects With Rheumatoid Arthritis
NCT00403962
A Combination Therapy In Patients With Social Anxiety Disorder
NCT00225251
Wellbutrin XL for Dysthymic Disorder
NCT00231855
Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers
NCT00283322
Heparin Antibodies in Intensive Care Unit Patients (HAICU)
NCT00315211
Weekly Topotecan With Docetaxel in Recurrent Small Cell Lung Cancer
Completion: Nov 8, 2007
NCT00349713
FMP2.1/AS02A: Rabies Vaccine Malaria-Experienced Adults in Bandiagara, Mali
NCT00135512
Study Of 323U66 SR In Major Depressive Disorder
Start: Dec 1, 2004
Completion: May 28, 2007
NCT00214890
Viral Dynamics and Pharmacokinetics of Abacavir and Tenofovir
Start: Dec 7, 2004
Completion: Apr 27, 2010
NCT00094523
Fosamprenavir Versus Other Protease Inhibitors
Start: Dec 14, 2004
Completion: Jun 29, 2007
NCT01205165
An Open Label, Multi Centre Phase IV Study of Adefovir Dipivoxil in Korean Patients With Chronic Hepatitis B (CHB)
Start: Dec 17, 2004
Completion: Apr 28, 2006
NCT00097409
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
Start: Dec 31, 2004
NCT00103727
Study Of Talnetant Versus Placebo And Risperidone In Schizophrenia
NCT00104403
Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy
NCT00104416
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures
NCT00114049
Dental Pain (Following Third Molar Tooth Extraction) Study
NCT00115492
Advair® DISKUS® Versus Serevent® DISKUS® For Chronic Obstructive Pulmonary Disease Exacerbations
NCT00115622
Study In Adults And Adolescents With Seasonal Allergic Rhinitis
NCT00300963
Effect Of Talnetant Versus Risperidone Versus Placebo On Psychotic Symptoms In Schizophrenic Patients
NCT00334568
Effects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers Disease
NCT00343135
AUGMENTIN 1gm In Skin And Soft Tissue Infection
NCT00388180
An Exploratory Study To Look At The Effect Of Two Investigational Drugs On Body Fat And Inflammation
NCT00457171
GI-270384 Study In Patients With Mild To Moderate Ulcerative Colitis
NCT00593593
Pharmacovigilance Study To Evaluate Safety Of AVODART In Subjects With Benign Prostate Hyperplasia
NCT00600990
Study Of An NK-1 Anti-Emetic Medication For The Prevention Of Post-Operative Nausea And Vomiting In Female Patients
NCT01299571
AVODART(Dutasteride) Post-marketing Surveillance(PMS)
NCT01381432
Special Drug Use Investigation for IMURAN (Azathioprine) Tablet (Pulmones Transplantation)
NCT00120978
Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled Trial
NCT00160394
Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris
NCT00634062
Study of Lamotrigine Treatment of Affective Instability in Borderline Personality Disorder
NCT00148941
Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines
Start: Jan 6, 2005
Completion: Dec 4, 2006
NCT00358371
Bioavailability Of Flucloxacillin Capsules (250 mg and 500 mg)
Completion: Feb 8, 2005
NCT00449436
Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults
Start: Jan 10, 2005
Completion: Dec 13, 2007
NCT00419237
Investigating The Pharmacokinetics Of An Inhaled Dose Of A New Corticosteroid In Patients With Impaired Liver Function
Start: Jan 13, 2005
Completion: Apr 15, 2005
NCT00269087
GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema)
Start: Jan 28, 2005
NCT00364442
Repeat Dose Study of Fluticasone Propionate/Salmeterol Versus Fluticasone Propionate + Salmeterol In Asthmatics
Completion: Apr 13, 2005
NCT00103454
A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).
Start: Jan 31, 2005
NCT00108082
The CLEVER Study - Coreg And Left Ventricular Mass Regression
NCT00116818
A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults
NCT00116831
Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes
NCT00158795
Assess Safety & Reactogenicity of GSK Biologicals' Hib Vaccine Co-administered With or Without Chinese DTPw Vaccine
NCT00158808
Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 Mths
NCT00225862
A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)
NCT00256880
Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma
NCT00354874
Investigation Of A New Medication (GW642444) In Asthmatic Patients
NCT00400855
Study on the Effects of an AMP Challenge on Asthmatic Patients Following Treatment With Fluticasone Propionate
NCT01389479
Study to Evaluate the Safety, Tolerance and Immunogenicity of Fluviral™ in Healthy Adults
NCT00116402
A Pilot Study of the Mechanism of Synergism Between FP and Salmeterol in Preventing COPD Exacerbations
NCT00204815
Bone Mineral Density in Pediatric Epilepsy
NCT00289588
An Attempt to Reduce Community-Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection in Soldiers
NCT00292877
The Prednisone-sparing Effect of Anti-IL-5 Antibody (SB-240563)
NCT00465205
HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons
NCT00169442
Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants
Start: Feb 10, 2005
Completion: Mar 10, 2006
NCT00363740
Study of GW685698X In Patients With Seasonal Allergic Rhinitis
Start: Feb 19, 2005
NCT00102726
SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy
Start: Feb 28, 2005
NCT00102739
SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP)
NCT00108914
Perennial Allergic Rhinitis Study In Pediatric Subjects
NCT00116883
A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics
NCT00169572
Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy
NCT00258700
Primary & Booster Immunogenicity Study of GSK Biologicals' Hib-MenC Versus a Licensed Men-C Vaccine
NCT00269126
Clinical Evaluation Of GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema)
NCT00274690
Post-Operative Nausea And Vomiting Study In Female Patients
NCT00291928
HuMax-CD20 in Active Rheumatoid Arthritis, Phase I/II
NCT00481182
Co-Administration Of Fosamprenavir With Methadone: A Drug Interaction Study.
NCT01863589
Drug Use Investigation for HEPSERA (Adefovir) Tablet
Completion: Jul 31, 2012
NCT00287911
Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer
NCT00295776
Lamictal in the Treatment of Post-Herpetic Neuralgia
NCT00316654
Persistence of Antibody Response to N. Meningitidis Group C in Children
NCT00424762
Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocardial Triglyceride
NCT00461565
FDA Phase IV - Commitment - Retinal Function Study
NCT01843621
A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive Children
Completion: Feb 28, 2009
NCT00148928
Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA
Start: Mar 1, 2005
Completion: Nov 7, 2006
NCT00231413
Human Papilloma Virus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Bio's Novel HPV Vaccine.
Start: Mar 4, 2005
Completion: Mar 27, 2006
NCT00140738
Safety and Immunogenicity Study of the New dHER2 Vaccine to Treat HER2-positive Metastatic Breast Cancer
Start: Mar 10, 2005
Completion: Sep 29, 2009
NCT00263666
A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa
Start: Mar 16, 2005
Completion: Feb 13, 2008
NCT00742131
A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally to Subjects With Solid Tumors
Start: Mar 17, 2005
Completion: Aug 29, 2011
NCT00196976
Safety & Immunogenicity of 1 Dose of GSK134612 in Children 12-14 Months and 3-5 Years Old
Start: Mar 24, 2005
Completion: Mar 3, 2006
NCT00116844
VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.
Start: Mar 29, 2005
Completion: Jan 10, 2006
NCT00105950
Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast Cancer
Start: Mar 31, 2005
Completion: May 31, 2010
NCT00107757
Seasonal Allergic Rhinitis In Pediatric Subjects
NCT00144833
Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV Subjects
NCT00158769
A Study To Compare The Effects Of The Infusion Of A Sepsis Drug Between Healthy Adults And Adults With Damaged Livers
Completion: Oct 26, 2005
NCT00169416
Evaluation Of Valaciclovir In Patients With Chickenpox
NCT00169455
Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy Infants
NCT00169507
Study of Immunological Memory Induced in Children by a Full 4 Dose Vaccination Schedule of 11 Valent Pneumococcal Conjugate Vaccine by Giving 1 Dose of Aventis Pasteur's 23-valent Pneumococcal Polysaccharide Vaccine (Pneumo 23)
NCT00169585
Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA)
NCT00196963
Evaluate 4 Different Formulations of Meningococcal Serogroups A, C, W-135, Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs
NCT00197158
Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune Response
NCT00263653
Safety, Reactogenicity & Immunogenicity Study to Evaluate a Booster Dose of GSK Biologicals' Hib-MenC Given With Priorix™ in Toddlers (13-14 m) Primed With 3 Doses of Hib and MenC-CRM197
NCT00316173
Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian Cancer
NCT00369993
Spacer Comparison In Adult Asthmatics
NCT00117832
Nasal Ocular Reflexes Contribute to Eye Symptoms
NCT00136383
Comparing Paroxetine and Duloxetine on Cardiovascular Measures
NCT00161421
Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone
NCT00194675
TRADE-Testosterone Replacement and Dutasteride Effectiveness
NCT00562081
The Virtual Asthma Clinic
NCT01097720
Developmental Delay in Children Exposed During Pregnancy to Either Lamotrigine,Sodium Valproate, or Carbamazepine
Completion: Sep 30, 2010
NCT00223990
Double-blind, Randomized, Controlled Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine
Start: Apr 8, 2005
NCT00111787
Study Of Lapatinib In Combination With Paclitaxel In The Treatment Of Newly Diagnosed Inflammatory Breast Cancer
Start: Apr 11, 2005
Completion: Nov 1, 2006
NCT00134719
Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines
Completion: Feb 21, 2007
NCT00111800
A New Oral Treatment For Type II Diabetes Mellitus
Start: Apr 28, 2005
Completion: Jul 21, 2006
NCT00109486
Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray
Start: Apr 30, 2005
NCT00110799
SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C
NCT00118729
Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of Action
NCT00133848
Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment
NCT00133874
Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo
NCT00323622
Long-Term Follow-up of Children for a 2-Year Period to Confirm the Safety and Immunogenicity of GSK 257049 Vaccine
NCT00327990
Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly Alendronate
NCT00348361
Exploration Of Key Targets And Biomarkers Involved In An Allergic Response In Subjects With Allergic Rhinitis (Hay Fever)
NCT00375765
Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer
NCT00455923
SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII)
Start: May 3, 2005
NCT00583362
A Continuation Trial for Subjects With Systemic Lupus Erythematosus That Have Completed Protocol LBSL02
Start: May 4, 2005
Completion: Feb 23, 2016
NCT00306995
Safety Study of Pandemic Candidate Influenza Vaccines in the Elderly Population
Start: May 11, 2005
Completion: Jul 4, 2006
NCT00120900
Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee
Start: May 31, 2005
NCT00126997
Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases
NCT00127023
Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases
NCT00225823
Study In Adults And Adolescents With Seasonal Allergic Rhinitis.
NCT00347009
Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis
NCT00419809
SB-681323-Methotrexate Interaction Study
NCT00126373
A Trial of Wellbutrin for Crohn's Disease
NCT00127608
Detection and Characterisation of Varicella Zoster Virus From Dermal Lesions of Chickenpox-infected Patients
Start: Jun 7, 2005
Completion: Jul 13, 2006
NCT00140712
Ropinirole Tablets In Young Patients With Restless Legs Syndrome
Start: Jun 10, 2005
Completion: Feb 28, 2008
NCT00356642
Study Of Single And Ten Day Repeat Atopical Applications Of GW842470X Cream On The Skin Of Patients With Atopic Dermatitis
Completion: Dec 21, 2005
NCT00228917
Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children
Start: Jun 16, 2005
Completion: Jan 20, 2006
NCT00577629
Chemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell Non-Hodgkins Lymphoma
Start: Jun 18, 2005
Completion: Nov 3, 2016
NCT00134693
A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid Arthritis
Start: Jun 21, 2005
Completion: Aug 3, 2006
NCT00269035
SPECT Study With SB-773812 In Schizophrenic Patients
Completion: May 26, 2007
NCT00358475
Study Of Perennial Allergic Rhinitis
Completion: Oct 12, 2005
NCT00113308
COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis
Start: Jun 30, 2005
NCT00123890
Screening Protocol To Determine Eligibility For Studies Of The Chemokine Coreceptor 5 (CCR5) Antagonist GW873140
NCT00139334
A Study to Test 2 Doses of the HRV Vaccine Given With or Without OPV in Healthy Infants in Bangladesh
NCT00197080
Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome
NCT00197106
Treatment Of Symptomatic Asthma In Children
NCT00227422
Assess the Non-inferiority of GSK Biologicals' Mencevax™ ACWY (Manufactured by a New Process) vs Mencevax™ ACWY (the Already Existing Vaccine in the Market) When Given as a Single Dose to Subjects Aged 2-30 Yrs
NCT00237991
Safety of GlaxoSmithKline (GSK) Biologicals Hepatitis A Vaccine in Korean Population
NCT00259883
Combination Of PAXIL Tablet And Benzodiazepines
NCT00316186
First-line Treatment Of Subjects With Extensive Disease Small Cell Lung Cancer With Weekly Hycamtin And Paraplatin
Completion: May 31, 2009
NCT00380133
Study of SB681323 and Prednisolone on Biomarkers in COPD (Chronic Obstructive Pulmonary Disease) Patients
NCT00413023
Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)
NCT00110630
Smoking Treatment of Prisoners
NCT00117429
Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)
NCT00159354
Measurement of Smoking-Induced Neutrophil Activation
NCT03324633
Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV
Completion: Dec 31, 2022
NCT00118703
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis
Start: Jul 1, 2005
Completion: Feb 9, 2006
NCT00117325
Study Of Adults And Adolescents With Vasomotor Rhinitis
Start: Jul 11, 2005
NCT00197145
Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects
Start: Jul 21, 2005
Completion: Sep 11, 2007
NCT00318630
The Effect Of AVANDIA On The Late Asthmatic Response
Start: Jul 22, 2005
NCT00351143
A Comparative Study To Determine If Motivating Asthma Education (Compliance Enhancement) Has An Effect On Asthma Control
Start: Jul 26, 2005
Completion: Jun 13, 2007
NCT00123903
COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria
Start: Jul 31, 2005
NCT00126984
Study in Children to Evaluate the Immunogenicity and Safety of 4 Formulations of GSK Bio MenACWY-TT Conjugate Vaccine
NCT00134732
Study of 2 Doses of Oral Live Attenuated Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis
NCT00144859
Safety And Anti-Inflammatory Effect Of SB681323 In Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00146744
Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02A in Healthy PPD-positive Adults
NCT00197197
Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5/X4-Tropic Treatment-Experienced HIV-Infected Subjects
NCT00244712
Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV
Completion: Apr 30, 2008
NCT00253058
Study Of Perennial Allergic Rhinitis In Pediatrics
NCT00297076
Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects
NCT00306943
Annual Study for Fluarix Registration
NCT00321438
Observational Study of HIV-Infected Subjects With X4-Tropic or Non-Phenotypeable Virus
NCT00343278
Pharmacokinetic Study Of Valaciclovir Hydrochloride Tablets
NCT00364429
SPECT Investigation Of The NMDA Receptor System In Healthy Volunteers And Patients With Schizophrenia
NCT01745458
SB-659032 Platelet Aggregation Study
NCT00119496
Rosiglitazone Versus Theophylline in Asthmatic Smokers
NCT00197054
Safety, Immunogenicity of RTS,S/AS02A, and RTS,S/AS01B Malaria Vaccines in Malaria-experienced Adults.
NCT00322920
Efficacy Study of Weekly Topotecan With Cisplatin in Advanced Stage or Recurrent Cervical Cancer
NCT00241722
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Start: Aug 1, 2005
NCT00327197
Assessment Of Disease Pathology And Key Therapeutic Targets In Severe Asthma
Start: Aug 2, 2005
Completion: Jun 6, 2011
NCT00334646
Cyclophosphamide Drug Interaction Study In Cancer Patients
Start: Aug 10, 2005
Completion: Oct 14, 2009
NCT00256867
A Study In Patients With Type 2 Diabetes Mellitus
Start: Aug 18, 2005
NCT00197028
Examine Safety and Immune Responses of GSK 257049 Vaccine When Administered to Infants Living in a Malaria-endemic Region
Start: Aug 23, 2005
Completion: Dec 27, 2007
NCT00364273
GSK159802 In Healthy Male Subjects And Asthmatics
Start: Aug 24, 2005
Completion: Jul 6, 2006
NCT00126945
Evaluate 4 Different Formulations of Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs
Start: Aug 31, 2005
NCT00137930
Study of Immunogenicity & Safety of 2 Different Formulations of Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis
NCT00197262
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)
NCT00257569
Study Of Atopic Dermatitis In Pediatrics
NCT00257582
Study Of Cutaneous Disease Accompanied With Pruritus In Pediatrics
NCT00257595
Perennial Allergic Rhinitis In Pediatric Subjects
NCT00273039
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
NCT00370435
Study Of 90mg Of GW274150 In Subjects Over 50 Years, Who Have Rheumatoid Arthritis (RA)
NCT00372801
Effectiveness Of Single Doses Of Ibuprofen In Patients With Osteoarthritis Of The Knee
NCT02948881
A Study To Assess The Quality Of Bone In Patients Taking Oral Ibandronate Versus Placebo
NCT00120796
Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2)
NCT00135200
Clinical Trial of Consolidation Treatment With Iodine I 131 Tositumomab for Multiple Myeloma
Completion: Sep 4, 2024
NCT00223509
Lamictal As Add on Treatment in Mixed States of Bipolar Disorder
NCT00256932
Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
NCT00259922
Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
NCT00316407
Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients
Completion: Nov 30, 2009
NCT00226499
Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox
Start: Sep 1, 2005
Completion: Oct 12, 2006
NCT02153320
Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers
Start: Sep 5, 2005
NCT00158756
Immune Response Post Pry Vaccination of 2 Formulations of DTPw-HBV Vaccine Given With Rotavirus Vaccine to Infants
Start: Sep 12, 2005
Completion: Nov 23, 2006
NCT00358384
Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034
Start: Sep 26, 2005
Completion: Feb 24, 2006
NCT00196989
Study In People With Type 2 Diabetes
Start: Sep 30, 2005
NCT00197223
Post-marketing Study to Evaluate the Efficacy of Influenza Vaccine
NCT00224497
A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's Disease
NCT00224523
Long Term Safety Of GW685698X Via Nasal Biopsy
NCT00232596
Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy
NCT00244725
Odiparcil For The Prevention Of Venous Thromboembolism
NCT00259870
SB-773812 Administered In Adults With Schizophrenia
NCT00296491
Study Of Allergic Rhinitis In Patients Who Also Have Asthma
NCT00296530
Study Of Patients With Allergic Rhinitis And Asthma
NCT00319332
A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic Regimen
Completion: Feb 28, 2021
NCT00320307
Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected Subjects
NCT01299584
ULTIVA Post Marketing Surveillance
NCT00131664
Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study)
NCT00145990
The Impact of Dosimeter on Measurement of Airway Responsiveness to Methacholine
NCT00180843
Assessment of Ventilation-perfusion Abnormalities in Patients With Stable Smoking-related Airways Disease
NCT00234195
Wellbutrin XL, Major Depressive Disorder and Breast Cancer
NCT00262587
Elite Sport and Development of Asthma
NCT00314678
Cisplatin Induction With Paclitaxel Consolidation for Stage III-IV Epithelial Ovarian and Primary Peritoneal Cancer
NCT00314821
Ropinirole in the Treatment of Bipolar Depression
Completion: Mar 17, 2008
NCT00701779
Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia
NCT00736801
Effect of Salmeterol on Brain-Derived Neurotrophic Factor (BDNF) Concentrations in Asthma
NCT00318058
Safety Study of an Adjuvanted Candidate Influenza Vaccine to Prevent Influenza Disease in the Elderly Population
Start: Oct 3, 2005
Completion: Nov 4, 2005
NCT00483899
Examine the Effect of Repeat Inhaled Doses of GW870086X on Lung Function in Mild Asthmatic Male Subjects
Start: Oct 7, 2005
Completion: Dec 15, 2006
NCT00318149
Safety Study of Four Candidate Influenza Vaccines to Prevent Influenza Disease in the Elderly Population
Start: Oct 10, 2005
Completion: May 14, 2006
NCT00373243
A Study Of GW406381 In Volunteers With Moderate Hepatic Impairment
Start: Oct 19, 2005
Completion: Sep 26, 2006
NCT00307541
Assess the Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine
Start: Oct 27, 2005
Completion: Apr 7, 2006
NCT00250276
Evaluation of the Immune Responses of GSK Biologicals' HPV Vaccine Following Manufacturing Process Adaptation.
Start: Oct 28, 2005
Completion: Mar 1, 2007
NCT00197288
Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines
Start: Oct 31, 2005
NCT00240617
Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks
NCT00240630
Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks
NCT00241644
Vaccine Efficacy Against Rotavirus Diarrhea; Vaccine Given With Routine Childhood Vaccinations in Healthy African Infants
NCT00242866
Use Of GW274150 In The Prophylactic Treatment Of Migraine
NCT00244764
GW786034 In Subjects With Locally Recurrent Or Metastatic Clear Cell Renal Cell Carcinoma
Completion: Sep 30, 2013
NCT00246636
Evaluation of Efficacy and Safety of Omacor (Omega-3-acid Ethyl Esters) as Add-on Therapy in Hypertriglyceridemic Subjects Treated With Antara (Fenofibrate) Followed by an 8-week Extension
NCT00259896
In-patient Study in Patients With Type 2 Diabetes Mellitus
NCT00264615
Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
NCT00264628
GW679769 In Fibromyalgia
NCT00264654
Long-term Study Of Paroxetine in Women and Men
NCT00267488
Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer
NCT00316706
Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine
NCT00328718
Pediatric ADVAIR DISKUS Versus Oral Montelukast Chewable Tablets
NCT00349427
A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus Patients
NCT00355641
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
NCT00360126
An Open-Label Extension Study Of Lamotrigine In Subjects With Bipolar Disorder
NCT00243152
Evaluation of Lamotrigine on Neuropathic Facial Pain Using fMRI
NCT00246753
Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
Completion: May 31, 2013
NCT00272805
Drug Compliance and Quality of Life in Patients With Heart Failure Dosed With Either Once-daily or Twice-daily Coreg
NCT00563134
A Randomised Trial on the Saftely and Efficacy of GR270774 in the Treatment of Gram-negative Sepsis in Adult
NCT00674674
Phase 1 Intrathecal Topotecan for Neoplastic Meningitis
NCT01197729
OPTAMI (Optimized Therapy of Acute Myocardial Infarction) - Registry
NCT00246701
Evaluation of Efficacy and Safety of Combined Omacor (Omega-3-acid Ethyl Esters) and Simvastatin Therapy in Hypertriglyceridemic Subjects
Start: Nov 1, 2005
Completion: Jun 1, 2006
NCT00244751
Antifibrotic Activity Of GI262570 In Chronic Hepatitis C Subjects
Start: Nov 2, 2005
Completion: Mar 13, 2008
NCT00259909
Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00338338
The Efficacy And Safety Of Lacidipine And Amlodipine Once-Daily Treatment In Hypertensive Adult Patients
Start: Nov 7, 2005
Completion: Sep 14, 2007
NCT00887406
Study of GSK961081 in Healthy Volunteer Subjects
Completion: Oct 4, 2006
NCT00268996
Integrated Biomarker And Imaging Study - 2
Start: Nov 10, 2005
Completion: Aug 28, 2007
NCT00256854
Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome)
Start: Nov 14, 2005
Completion: Sep 21, 2006
NCT00903409
Open-Label Extension of a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lovaza® and Simvastatin Therapy in Hypertriglyceridemic Subjects
Start: Nov 15, 2005
Completion: Jun 27, 2008
NCT00372255
Study on the Immunogenicity and Tolerability of Influsplit SSW® 2005/2006 in Children Aged 6 - 13 Years
Start: Nov 17, 2005
NCT00353873
Seretide Versus Flixotide In Asthmatic Children Not Controlled By Inhaled Corticosteroids
Start: Nov 18, 2005
Completion: Oct 26, 2006
NCT00258050
To Examine The Effects Of Lapatinib On Orally And Intravenously Administered Midazolam In Cancer Patients
Start: Nov 21, 2005
Completion: Feb 8, 2007
NCT00400660
A First Time In Human Study To Assess The Compound GSK615915
Start: Nov 23, 2005
Completion: Jul 3, 2006
NCT00320411
GW572016 In Patients With ErbB2 Over - Expressing Advanced Or Metastatic Breast Cancer
Start: Nov 28, 2005
Completion: Apr 1, 2009
NCT00127010
Start: Nov 30, 2005
NCT00240643
Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke
NCT00256919
Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA)
NCT00259987
Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The Esophagus
NCT00269048
SB-480848 In Subjects With Coronary Heart Disease
NCT00290277
Evaluate the Immunogenicity & Safety of GSK Biologicals' HPV Vaccine in Female Subjects Aged 10-14 Years
NCT00291382
Airway Hyper-responsiveness Study In Asthma Using Salmeterol/Fluticasone Propionate Combination Product
NCT00297258
Pazopanib In Patients With Relapsed Or Refractory Soft Tissue Sarcoma
Completion: Feb 28, 2014
NCT00307554
A Lot-to-lot Consistency (3 Lots of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine) & Non-inferiority Study
NCT00307567
Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488
NCT00318656
24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes
NCT00320385
Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer
NCT00320450
SB-681323 In Subjects With Rheumatoid Arthritis
NCT00523913
A Study Of BRL49653C For The Treatment Of Type 2 Diabetes
NCT00126308
Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy
NCT00244309
Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer
NCT00260793
Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's Disease
NCT00317434
Maximum Tolerated Dose of Lapatinib When Given With Carboplatin for Recurrent Ovarian Cancer
NCT00730782
Assessment of Three Formulations of the Candidate Vaccine AMA 1 in Healthy Dutch Adult Volunteers
NCT00359177
Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment
Start: Dec 1, 2005
NCT00281684
SB-705498 Dental Pain Study After Tooth Extraction
Start: Dec 7, 2005
Completion: Oct 3, 2007
NCT00279019
Safety Study Using GSK233705 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease
Start: Dec 12, 2005
Completion: Jun 13, 2006
NCT00235755
Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy
Start: Dec 31, 2005
NCT00264667
Study In Patients With Dyslipidaemia
NCT00274703
An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult Patients
NCT00292552
Evaluation of COPD (Chronic Obstructive Pulmonary Disease) to Longitudinally Identify Predictive Surrogate Endpoints
NCT00316147
Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules
NCT00318617
Effect Of GW501516X On How The Heart Obtains And Uses Energy
NCT00318669
Social Anxiety Disorder Study Of Paroxetine
NCT00319137
An Adaptive Design Trial Of GW274150 In The Treatment Of Acute Migraine
NCT00321477
A Study Of GW679769 Compared To Placebo In Women With Overactive Bladder
NCT00325169
SERETIDE Plus Tiotropium Versus Individual Components
NCT00122603
Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127)
NCT00285831
Mild Depression 2 Week Observational Study
NCT00296933
Memory Functioning and Antidepressant Treatment
NCT00309855
Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men
NCT00290342
Evaluation of the Immunogenicity, Safety and Reactogenicity of the Combined DTPa-IPV Vaccine in Healthy Infants
Start: Jan 1, 2006
Completion: Jan 23, 2007
NCT00307034
Safety & Immunogenicity Study of 10-Valent Pneumococcal Conjugate Vaccine When Administered as a 2-Dose Schedule
Completion: Jan 25, 2007
NCT00273052
COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension
Start: Jan 5, 2006
NCT00297063
BRL49653C In Type 2 Diabetes -Comparison Study With Pioglitazone And Placebo By Monotherapy-
Start: Jan 11, 2006
NCT00290329
Safety of Purified Meningococcal Vaccine With Serogroups ACWY, in 3,000 Filipino Subjects Aged > 2 Years
Start: Jan 14, 2006
Completion: Oct 17, 2006
NCT00296517
Study In Patients With Depression Not Responding to Selective Serotonin Re-uptake Inhibitors
Start: Jan 19, 2006
Completion: Mar 28, 2008
NCT00354965
Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients
Completion: Apr 2, 2007
NCT00136604
Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m
Start: Jan 22, 2006
NCT00282295
US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease
Start: Jan 25, 2006
Completion: Aug 8, 2006
NCT00320398
Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium)
Start: Jan 30, 2006
Completion: Jul 18, 2006
NCT00269022
Use Of SB-705498 In The Acute Treatment Of Migraine
Start: Jan 31, 2006
NCT00269061
Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or Insulin
NCT00280423
Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia
NCT00280436
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
NCT00291356
GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients
NCT00297180
Weight Loss In Obese Subjects Taking Either GW869682 Or Placebo 3 Times Per Day For 12 Weeks
NCT00316719
Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients
NCT00324961
Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B
NCT00332046
fMRI Study Comparing BOLD Activation Patterns Using GW679769 In Subjects With Social Anxiety Disorder
NCT00332319
Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients
NCT00358410
An Exploratory Study Examining The Effects Of Taking GW679769 Once-Daily For 4 Days In Patients With Functional Dyspepsia
NCT00379990
A Study To Investigate GW274150 Or Prednisolone In Rheumatoid Arthritis Taken Repeatedly For 28 Days.
NCT00460005
Clinical Study Of Migraine Evolution
NCT00274417
Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP)
NCT00275275
Pramipexole Conversion to Ropinirole Controlled Release (CR)
NCT00284791
Lamotrigine in Treatment Resistant Depression in Adolescents
NCT00285727
Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression
NCT00298805
A Quality of Life Study in Patients With Migraines
NCT00465296
Ppar-Gamma EliminAtes Restenosis Longevity Study: PEARLS
NCT00291343
Immune Response & Safety of GSK Biologicals' Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study
Start: Feb 1, 2006
Completion: Mar 15, 2007
NCT00289198
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)
Start: Feb 7, 2006
NCT00453791
The Safety and Tolerability of GW805858 in Healthy Volunteers and Mild Asthmatics
Completion: Apr 10, 2006
NCT00289172
Assess the Immunogenicity & Safety of 2 Doses of Oral Live Attenuated Human Rota(HRV)Vaccine in Healthy Infants in India
Start: Feb 10, 2006
Completion: Sep 8, 2006
NCT00294047
Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older
Start: Feb 16, 2006
Completion: Jan 29, 2014
NCT00320424
Hip Fracture Study of GSK576428 (Fondaparinux Sodium)
NCT00368979
Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects
Start: Feb 17, 2006
Completion: Dec 6, 2007
NCT00331058
Comparison Of Molecular Targets In Mild To Severe Asthmatics And Healthy Subjects
Start: Feb 18, 2006
Completion: Jul 7, 2011
NCT00306293
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
Start: Feb 20, 2006
Completion: Nov 27, 2006
NCT00289783
Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine
Start: Feb 22, 2006
Completion: Feb 26, 2008
NCT00197275
Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Infants
Start: Feb 28, 2006
NCT00314860
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
NCT00354536
In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus
NCT00225355
Rosiglitazone Versus Placebo in Chronic Stable Angina
NCT00291941
A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B.
NCT00294190
Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer
NCT00583232
Protein and Energy Metabolism in Pediatric Crohn's Disease
NCT00379730
Prednisolone Novel Endpoint Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Start: Mar 21, 2006
Completion: May 3, 2007
NCT00372957
Study Of GW823093 In Japanese Subjects With Type 2 Diabetes Mellitus
Start: Mar 22, 2006
Completion: Jun 28, 2006
NCT00406003
Single Dose Pharmacokinetic (PK) Study Of Paroxetine CR(12.5-37.5mg) In Healthy Chinese Subjects
Start: Mar 24, 2006
Completion: Apr 26, 2006
NCT00309634
Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged Between 18 and 60 Years
Start: Mar 27, 2006
Completion: Oct 28, 2006
NCT00309647
Study to Evaluate the Safety and Immunogenicity of Pandemic Monovalent (H5N1) Influenza Vaccines (Whole Virus Formulation) in Adults 18 and 60 Years of Age
Start: Mar 29, 2006
Completion: Nov 16, 2006
NCT00281632
A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer
Start: Mar 31, 2006
NCT00291902
A Pharmacokinetic Study Of SB-681323 In Subjects With Coronary Heart Disease Undergoing Percutaneous Intervention
NCT00297856
Post-marketing Safety Study of GSK Biologicals' Boostrix® Vaccine
NCT00306241
A Study to Evaluate the Immunogenicity and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years
NCT00306982
Incidence of Influenza, Downstream Complications of Influenza & Hospitalizations in Elderly Vaccinated With Fluarix™
NCT00316680
Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age.
NCT00326248
Casopitant (Oral) And ZOFRAN To Prevent Postoperative Nausea And Vomiting In Women
NCT00329602
Long-term Study Of Ropinirole In Restless Legs Syndrome
NCT00334152
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
NCT00351923
Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes
NCT00353288
Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™
NCT00354510
Topical GW842470X In Adults Patients With Moderate Atopic Dermatitis
NCT00358358
Chronic Obstructive Pulmonary Disease Endpoints Study
NCT00371566
A Study Of Lapatinib Versus Placebo Followed By Chemoradiation In Patients With Locally Advanced Head And Neck Cancer
NCT00377728
Trial With Rhinitic Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber
NCT00891293
A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (Formerly Known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated With Antara™
NCT00277641
Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity
NCT00291954
Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination
NCT00291980
A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Responded to Previous Hepatitis B Vaccination But Lost Antibody.
NCT00299650
Systematic Early Use of Neuromuscular Blocking Agents in ARDS Patients
NCT00305942
Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer
NCT00315861
Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies
NCT00323037
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
NCT00335270
A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination
NCT00370942
GW823093C For The Treatment Of Type 2 Diabetes Mellitus
Start: Apr 1, 2006
Completion: Nov 25, 2006
NCT01327339
REQUIP RLS Post Marketing Surveillance
NCT00239577
A Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US Adults
Start: Apr 5, 2006
Completion: Jun 19, 2007
NCT00309166
Evaluation of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine in Young Males.
NCT00350337
Safety and Immunogenicity of Various Formulations of Live Attenuated Tetravalent Dengue Vaccine in Healthy US Adults
NCT00371488
GW572016 Combined With Trastuzumab For The Treatment Of Previously Trastuzumab-Treated Breast Cancer
Start: Apr 6, 2006
Completion: Dec 10, 2007
NCT00307021
Double-blind Study of Safety and Immunogenicity of Two Candidate Malaria Vaccines in Gabonese Children
Start: Apr 7, 2006
Completion: Aug 22, 2007
NCT00359463
Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment
Start: Apr 18, 2006
Completion: Mar 7, 2007
NCT00317109
Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACW at 24 to 30 m in Primed Subjects
Start: Apr 19, 2006
Completion: May 17, 2007
NCT00316693
Human Papillomavirus (HPV) Vaccine (Cervarix TM) Efficacy, Immunogenicity & Safety Trial in Adult Japanese Women With GSK Biologicals HPV-16/18 Vaccine
Start: Apr 26, 2006
Completion: Feb 10, 2009
NCT00321763
Study to Demonstrate the Lot-to-lot Consistency and to Evaluate the Safety of an Adjuvanted Influenza Vaccine Candidate
Start: Apr 27, 2006
Completion: Jul 7, 2006
NCT00388076
Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB)
Start: Apr 28, 2006
Completion: Jul 21, 2009
NCT00320463
Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants
Start: Apr 30, 2006
NCT00327184
Primary & Booster Study in Infants to Demonstrate Non-inferiority, Persistence & Immunogenicity of Hib-MenC Vaccine
NCT00334282
Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma
Completion: Dec 31, 2014
NCT00338351
Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine.
NCT00340080
Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir Hypersensitivity
NCT00352898
NCT00358488
Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic Patients
NCT00371735
Chlorproguanil-Dapsone-Artesunate (CDA) Versus Chlorproguanil-Dapsone (LAPDAP) For Uncomplicated Malaria
NCT00422994
A Study To Investigate The Effects Of End Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of Ropinirole
NCT01371474
Special Drug Use Investigation for PAXIL Tablet (Investigation in Case of Administered From 20mg/Day)
NCT00312169
Evolution of L74V or K65R Mutations in VIremic Subjects on Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) (EVITA)
NCT00312663
Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America
NCT00312702
NCT00315380
Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis
Completion: Dec 31, 2028
NCT00331045
Clinical Evaluation Of Alvimopan (SB767905) On Constipation And Related Symptoms Associated With Opioid
NCT00385463
Adolescent and Adult Subjects With Asthma and Seasonal Allergic Rhinitis Receiving Advair Diskus or Placebo
NCT00413504
Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism
NCT00486187
Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study
NCT00310375
Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial
Start: May 1, 2006
Completion: Mar 15, 2017
NCT00319098
Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above
NCT00327665
Study to Evaluate the Safety and Immunogenicity of an Investigational Pneumococcal Vaccine in the Elderly Population
Completion: Jan 8, 2007
NCT00346775
Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q)
Completion: Jun 29, 2006
NCT00331630
Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer
Phase: Early Phase 1
Start: May 4, 2006
Completion: Aug 5, 2010
NCT00406432
A Repeat Dose Pharmacokinetic Study Of Paroxetine CR Tablet In Healthy Chinese Subjects
Start: May 9, 2006
Completion: Jun 2, 2006
NCT00321373
Study to Evaluate an Influenza Vaccine Candidate
Start: May 11, 2006
NCT00363480
Results Of Patient Rated Asthma Control Test In Comparison To Diary Card Data
Start: May 17, 2006
NCT00379756
A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia
Start: May 22, 2006
NCT00347139
Repeat Doses Of A New Medication (GW642444) In Asthmatic Patients
Start: May 23, 2006
Completion: Jan 10, 2007
NCT01059578
First Study in Humans With GSK206136
Completion: Dec 18, 2006
NCT00432679
A Study Of BRL49653C For The Treatment Of Type 2 Diabetes (Combination Therapy With Sulfonyl Urea) -With Placebo Study
Start: May 24, 2006
Completion: Mar 28, 2007
NCT01059591
First Study in Humans With GSK424887
Start: May 25, 2006
NCT00312013
Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer
Start: May 31, 2006
NCT00322335
Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenC
NCT00329355
Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA)
NCT00329459
Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea
NCT00329576
Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine
NCT00330616
Study Of Bupropion SR (323U66) In Patients With Major Depressive Disorder In Japan
NCT00333021
Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients
NCT00343486
Dose Ranging Study Of Solabegron Versus Placebo In Female Patients With Overactive Bladder Symptoms
NCT00348192
SB-742457 And Donepezil In Alzheimer's Disease
NCT00354809
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
NCT00355082
Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy
Completion: Nov 30, 2008
NCT00356811
Lapatinib Combined With Paclitaxel For Patients With First-Line ErbB2-Amplified Metastatic Breast Cancer
NCT00363142
A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects
NCT00387972
Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM)
NCT00405119
A Study To Investigate The Effectiveness Of AH234844 (Lavoltidine) Compared With NEXIUM And Ranitidine.
NCT00344994
SWITCH:Restless Legs Patients Switched to Ropinirole From Pramipexole
NCT00472251
One-year Prospective Observational Study of BMI Change Effect of 5-alpha Reductase Inhibitor in Korean BPH Patients
NCT00484666
Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
NCT00525564
Effects of Salmeterol on Walking Capacity in Patients With COPD
NCT00545051
A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis.
NCT00663845
Assessing Efficacy and Safety of Flexible Dosing With Vardenafil in Subjects With Erectile Dysfunction and Hyperlipidemia
NCT00896987
Lamotrigine Cognitive Function Study in Adult Untreated Epilepsies
NCT00326118
Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years.
Start: Jun 1, 2006
Completion: Nov 6, 2007
NCT00358540
Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide
Completion: Oct 22, 2010
NCT00716144
Dose Ranging Study of the Safety and Efficacy of R115966 in Plaque Psoriasis
Completion: May 1, 2007
NCT00331149
A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's
Start: Jun 20, 2006
Completion: Aug 29, 2007
NCT00356603
Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan
Completion: Aug 7, 2006
NCT00381238
Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease
Completion: Feb 3, 2009
NCT00327522
Safety and Immune Response Study of an Investigational Pneumococcal Vaccine.
Start: Jun 30, 2006
NCT00332566
Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/Hib
NCT00334334
NCT00334607
Study of 2 Doses of HRV Vaccine Given Concomitantly or Separately With Routine Vaccinations in Healthy Infants in USA
NCT00335881
Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib
NCT00337818
Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women
NCT00344006
Chlorproguanil-Dapsone-Artesunate Versus COARTEM For Uncomplicated Malaria
NCT00349349
HuMax-CD20 in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Failing Fludarabine and Alemtuzumab
Completion: Jun 30, 2012
NCT00357097
The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome
NCT00445510
This Study Will Examine the Effects of GSK256066 to Protect Mild Steroid-naive Asthmatics Against an Antigen Challenge
NCT00726323
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
Completion: Aug 18, 2010
NCT01376154
Special Drug Use Investigation for ZEFIX (Lamivudine) Tablet (HBV Cirrhosis)
Completion: Feb 28, 2011
NCT00242593
Rosiglitazone Effects on Cognition for Adults in Later Life
NCT00334048
Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI) Medication: a Study Comparing Requip CR to Placebo
NCT00343044
Ph II Study of Wkly Topotecan + Bevacizumab in Plat. Resistant/Recurrent Gyn Cancers
Completion: Aug 31, 2011
NCT00343395
Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable Coronary Syndromes (Romance) Pilot Study
NCT00611468
Phase I, Dosage-finding and PK Study of IV Topotecan and Erlotinib With Refractory Solid Tumors
NCT00827814
Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic Obstruction
NCT00310388
Open-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial. 115097
Start: Jul 5, 2006
Completion: May 24, 2018
NCT00348309
Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease
Start: Jul 6, 2006
Completion: Jan 28, 2009
NCT00348140
Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease
Start: Jul 12, 2006
Completion: Mar 20, 2009
NCT00346073
Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years
Start: Jul 13, 2006
NCT00344032
Evaluation of the Immune and Safety Response of GlaxoSmithKline (GSK) Biologicals' HPV Vaccine in Healthy Indian Women
Start: Jul 28, 2006
Completion: Dec 4, 2007
NCT00401583
A Study To Test The Effect Of GW786034 (Pazopanib) On P450 Enzymes
Completion: Feb 20, 2008
NCT00337922
Pharmacokinetic Study Of EPZICOM Tablet
Start: Jul 31, 2006
NCT00345904
Study to Evaluate the Safety and Immunogenicity of Fluarix™ 2006/2007 in Adults Aged 18 Years or Above
NCT00347360
The COREG And Lisinopril Combination Therapy In Hypertensive Subjects (COSMOS) Trial
NCT00347919
Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast Cancer
Completion: Mar 31, 2015
NCT00356564
Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib
NCT00363311
Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men
NCT00366834
Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting
NCT00368589
Effects Of Atorvastatin On Macrophage Activity And Plaque Inflammation Using Magnetic Resonance Imaging
NCT00403585
Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814
NCT00451321
TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
Completion: Dec 1, 2011
NCT00567424
GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
NCT00298155
Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer
Completion: Jan 31, 2014
NCT00334698
Study to Assess the Effect of a Combination of Cetirizine With Pseudoephedrine Versus Cetirizine Alone on Symptoms in Patients With Allergic Rhinitis
NCT00356915
Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail.
NCT00367744
Rosiglitazone Effect on Mitochondria and Lipoatrophy
NCT00439179
A Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic Pancreaticobiliary Cancer Schema
NCT00545480
SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis.
NCT00381394
A Study Evaluating Sitamaquine Compared With Amphotericin B In The Treatment Of Visceral Leishmaniasis.
Start: Aug 4, 2006
NCT00344318
Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine
Start: Aug 7, 2006
Completion: Oct 17, 2007
NCT00395694
Clinical Evaluation of BW430C in Epilepsy
Completion: Mar 26, 2009
NCT00743067
A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects With Solid Tumors
Start: Aug 9, 2006
Completion: Nov 9, 2009
NCT00376714
Safety And Tolerability Study In Patients With Chronic Obstructive Pulmonary Disease
Start: Aug 16, 2006
Completion: Apr 3, 2007
NCT00419692
Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food
Start: Aug 24, 2006
Completion: Dec 12, 2006
NCT00360230
Partially-blind (Observer-blind) Study of Safety and Immunogenicity of Two Malaria Vaccines in Ghanaian Children
Start: Aug 30, 2006
Completion: May 30, 2008
NCT00370097
FLOVENT Hydrofluoroalkane (HFA) In 6-12 Month Old Subjects
NCT00390845
P38 Mitogen-activated Protein (Map) Kinase Inhibitor (SB-681323)Study In Patients With Neuropathic Pain
Completion: Aug 11, 2008
NCT00406757
Clinical Evaluation of Nelarabine (506U78)in Japanese Patients With Leukemia or Lymphoma
Completion: Jul 15, 2009
NCT00331292
A Methodology Study To Look At Genes In Lung Cells And Tissue From Asthmatic Patients
Start: Aug 31, 2006
NCT00333450
Immune Memory Evaluation in Children Following a Primary Vaccination With Pneumococcal Conjugate Vaccines.
NCT00368576
A Study To Determine The Effect Of SB-480848 On Asthma
NCT00373945
HLA-B*5701 And Hypersensitivity To Abacavir
NCT00374322
Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer
NCT00376038
Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes
NCT00381667
Study to Assess GW642444 in Asthma Patients
NCT00392587
A Study To Investigate The Effects Of GW856553 On Patients With COPD (Chronic Obstructive Pulmonary Disease)
NCT00394186
A Study To Investigate GW427353 In Subjects With Irritable Bowel Syndrome (IBS)
NCT00429299
Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer
NCT00471588
Characterize The Modulatory Effects Of Dopamine D2/D3 Receptor Agonist And Antagonist Drugs On Compulsive Behaviors
NCT00218465
Effectiveness of GW468816, an NMDA Glycine Site Antagonist, for Prevention of Relapse to Smoking
NCT00365482
Bipolar Disorder in Epilepsy
NCT00378027
Arixtra PE Study- Outpatient Management of Stable Acute Pulmonary Embolism: Once Daily Subcutaneous Fondaparinux
NCT00426296
SHARE: Simple HAART With Abacavir, Reyataz, and Epivir
NCT00363545
To Assess Immunogenicity, Reactogenicity & Safety of 2 Formulations of GSK's HRV Vaccine as 2-dose Vaccination (Infants)
Start: Sep 1, 2006
NCT00358813
Observational Pharmacokinetic Study Of GW679769 In Subjects With Renal Impairment
Start: Sep 8, 2006
Completion: Aug 22, 2008
NCT00358449
Intravenous Mepolizumab In Children With Eosinophilic Esophagitis
Start: Sep 11, 2006
Completion: Nov 25, 2008
NCT00404586
Effects Of Single Doses Of GW784568X On Allergic Rhinitis Symptoms In Male Subjects Whilst In An Environmental Chamber
Completion: Jan 16, 2007
NCT00359619
Human Papillomavirus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Biologicals Novel HPV Vaccine
Start: Sep 12, 2006
Completion: Jan 30, 2007
NCT00361803
Topotecan Pharmacokinetic Characterization Study
Completion: Aug 9, 2007
NCT00385008
TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine
Start: Sep 13, 2006
Completion: Nov 24, 2006
NCT00345358
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine
Start: Sep 18, 2006
Completion: Nov 15, 2007
NCT00363194
A Two-way Crossover Study Of The Effect Of Food On The Pharmacokinetics Of Pazopanib In Cancer Patients
Start: Sep 21, 2006
Completion: Jun 19, 2009
NCT00377585
Demonstrate the Superiority of the Immune Response of Adjuvanted Influenza Vaccine Induced in an Adult Population
Start: Sep 22, 2006
NCT00345878
Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years
Start: Sep 25, 2006
Completion: Dec 21, 2007
NCT00370396
Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine.
NCT00369824
Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female Subjects
Start: Sep 26, 2006
NCT00289185
Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants
Start: Sep 27, 2006
Completion: Jan 15, 2009
NCT00442871
Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment
Start: Sep 28, 2006
Completion: Jan 3, 2008
NCT00494767
Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active Drugs
Start: Sep 29, 2006
Completion: Jun 7, 2007
NCT00345579
Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age
Start: Sep 30, 2006
NCT00345956
To Evaluate Immunogenicity, Reactogenicity & Safety of 2 Doses of GSK Bio HRV Liquid Vaccine Given to Infants (Vietnam)
NCT00359983
Long-Term Antibody Persistence at 1, 3 and 5 Years After a Fourth Dose of GSK Biologicals' Hib-MenCY-TT Vaccine Compared to ActHIB
NCT00363870
A Study to Demonstrate the Efficacy of GSK Biologicals' Influenza Vaccine in Adults
NCT00370318
Prophylactic Antipyretic Treatment in Children Receiving Pneumococcal Conjugate and Standard Infant Vaccines
NCT00379977
Study to Assess the Safety & Reactogenicity of GSK Biologicals' DTPa/Hib Vaccine When Given at 3, 4 and 5 Months of Age
NCT00380211
Safety and Immunogenicity of FluLaval™ TR and Fluarix® (Influenza Vaccines) in Young and Older Adults
NCT00380354
Study To Evaluate GSK256066 In Subjects With Mild Bronchial Asthma
NCT00387764
Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer
NCT00387881
TREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1)
NCT00437164
A Study To Assess GW677954 Used In Combination With Insulin In Subjects Who Have Type 2 Diabetes Mellitus
NCT02075632
Study to Evaluate Product Duration of Use Experience With Alclometasone Dipropionate Cream
NCT00186693
How Airway Remodeling and Hyperresponsiveness Contribute to Airflow Obstruction in Asthma
NCT00385047
A Study to Determine Whether 2 Investigational Malaria Vaccines Are Safe, Protective Against Malaria in Adults
NCT00388765
Normal Control Cohort Sample Bank
NCT00831129
A Study for Pre-diabetic Patients With Cholesterol Lowering Drugs
NCT01216956
Metabolic Effects of an 8 Week Niaspan Treatment in Patients With Abdominal Obesity and Mixed Dyslipidemia
NCT01405235
Study on Paclitaxel Plus Topotecan in Comparison With Topotecan Plus Cisplatin in Recurrent or Persistent Cervical Carcinoma
Completion: Jan 31, 2015
NCT00390910
Study to Evaluate the Safety and Immunogenicity of a 10-valent Pneumococcal Conjugate Vaccine in Preterm Infants
Start: Oct 1, 2006
Completion: May 2, 2008
NCT00363077
Study to Evaluate the Immunogenicity and the Safety of an Adjuvanted Influenza Vaccine Candidate
Start: Oct 2, 2006
Completion: Nov 17, 2006
NCT00387413
A Study Of GSK189254 And Duloxetine In The Electrical Hyperalgesia Model Of Healthy Volunteers
NCT00374842
Study to Evaluate the Immunogenicity and Safety of 2 Formulations of GlaxoSmithKline (GSK) Biologicals' GSK1247446A Low Dose Influenza Vaccine Candidate
Start: Oct 3, 2006
NCT00377611
Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™
Start: Oct 5, 2006
Completion: Jun 20, 2007
NCT00426608
To Investigate Effects GSK561679 on Part of the Body's System That Controls the Balance of Many of the Hormones.
Start: Oct 6, 2006
NCT00411866
Effects Of The Drug Ketoconazole On How The Body Handles The Drug SB773812
Start: Oct 13, 2006
Completion: Oct 10, 2007
NCT00421707
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
Start: Oct 14, 2006
Completion: Jun 25, 2008
NCT00386113
Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly
Start: Oct 16, 2006
Completion: Nov 14, 2006
NCT00394030
Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers
Completion: Mar 20, 2007
NCT00411190
Study To Determine The Effects Of Doses Of Relacatib On The Metabolism Of Acetaminophen, Ibuprofen And Atorvastatin
Start: Oct 19, 2006
NCT00385840
Study to Evaluate the Immunogenicity and Safety of a Second Vaccination With the Adjuvanted Influenza Vaccine Candidate
Start: Oct 20, 2006
Completion: Feb 5, 2007
NCT00387387
Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin)
Completion: Aug 14, 2009
NCT00404378
Study Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The Body Will React To Casopitant [GW679769]
Completion: Jan 5, 2007
NCT00385255
Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults
Start: Oct 23, 2006
NCT00554255
A Study of SB751689 in Japanese Postmenopausal Women
NCT00370227
Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine
Start: Oct 31, 2006
NCT00373542
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
NCT00376779
Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age
NCT00386100
A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. Metformin
NCT00386347
A Study To Evaluate Formulations And Food Effect On GSK364735 In Healthy Subjects.
NCT00386698
Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly Adults
NCT00387257
Effect Of Rilapladib (SB-659032) On Platelet Aggregation
NCT00388596
A Study Of SB-751689, Atorvastatin, Ketoconazole, And Rosuvastatin In Health Postmenopausal Women.
NCT00393146
A Study To Investigate The Effect Of 28 Days Of Dosing With GW856553 On Patients With Rheumatoid Arthritis
NCT00398580
28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men
NCT00400335
Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride
NCT00400608
A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS
NCT00401479
A Study To Investigate The Effect Of Solabegron (GW427353) On Gastrointestinal Transit In Healthy Volunteers
NCT00404963
A Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects
NCT00422604
Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT00426751
Efficacy Of Eptifibatide Compared To Abciximab In Primary Percutaneous Coronary Intervention (PCI) For Acute ST Elevation Myocardial Infarction (STEMI)
NCT00427141
A Three-Part Study Of GSK580416 In Healthy Subjects
NCT00437242
Odiparcil QT Definitive Study
NCT00439881
A Study To Look At The Safety Of SB-681323 In Healthy Adult Subjects After Intravenous Administration Of A Single Dose
NCT00439959
Monotherapy Versus Placebo Over 14 or 17 Days in Healthy and Hepatitis C Infected Adults
NCT00444769
Dental Pain 3rd Molar Tooth Extraction GW842166
NCT00457925
Absorption, Distribution, Metabolism And Excretion Study For GSK221149A
NCT00346697
Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients
NCT00395239
Asthma/Steroid Withdrawal Study
NCT00404066
Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer
Completion: Mar 31, 2011
NCT00431626
A Clinical Trial Comparing Laser TURP With and Without Dutasteride.
NCT00487578
Naratriptan for the Treatment of Post Traumatic Headache Associated With Cognitive Dysfunction
NCT00404274
A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers
Start: Nov 1, 2006
Completion: Mar 18, 2007
NCT00408785
A Study Of BOTOX For The Treatment Of Glabellar Lines
Completion: May 9, 2007
NCT00383123
Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children
Start: Nov 2, 2006
Completion: Oct 19, 2007
NCT00372112
A Study To Assess The Safety And Tolerability Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Start: Nov 3, 2006
Completion: May 10, 2007
NCT00431236
A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy
Start: Nov 6, 2006
Completion: Oct 9, 2007
NCT00397722
Treatment Of Patients With Social Anxiety Disorder
Start: Nov 9, 2006
Completion: Sep 5, 2007
NCT00405080
A Study in Healthy Subjects to Assess How Dosing of Rifampin Affects What the Body Does to a Dose of GW679769 (Casopitant).
Start: Nov 11, 2006
NCT00397943
Safety and Immunogenicity of 2 Formulations of Tuberculosis Vaccine GSK692342 Given at 0,1 Months to Healthy Adults
Start: Nov 15, 2006
Completion: Dec 1, 2009
NCT00398645
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma.
NCT00353366
To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination
Start: Nov 16, 2006
Completion: Jul 17, 2010
NCT00397215
Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Adults Over 60 Years of Age
Start: Nov 17, 2006
Completion: Sep 14, 2009
NCT00366080
Effectiveness Of The Drug GSK189254 In Treating Patients With Narcolepsy
Start: Nov 30, 2006
NCT00367679
Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer
NCT00370331
RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag
NCT00376896
Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy Volunteers
NCT00382772
A Study in Infants to Test Two Preparations (Freeze-dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine).
NCT00383162
A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2)
NCT00387127
Lapatinib Versus Placebo Given Concurrently With Cisplatin And Radiotherapy In Patients With Unresected Head And Neck Cancer
NCT00398125
Monotherapy Versus Placebo Over 10 Days in Integrase Naive HIV-1 Infected Adults
NCT00402363
Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation
NCT00411372
Shortness Of Breath Questionnaire Validation Study
NCT00411814
A Study Of GSK679586A When Infused Into Healthy And Mild Asthmatic Volunteers
NCT00429728
A Study To Investigate The Metabolism Of GW876008 In Smokers Compared To Non-Smokers.
NCT00430781
Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer
Completion: Jul 31, 2011
NCT00435695
Study Of Safety, Blood Levels, And Brain Receptor Occupancy Of GSK163090 Using PET Imaging In Healthy Males
NCT00436228
To Study And Compare Bioavailability And Safety Of Four Different Formulations Of The Study Drug
NCT00443170
A Placebo-controlled Study to Investigate the Safety, and Pharmacokinetics of Oral GSK626616AC in Healthy Subjects
NCT00448890
Evaluation of Single and Repeat Doses of GSK729327 in Healthy Volunteers
NCT00501683
A Single Dose Of GSK189075 Taken By Mouth Containing Small Amounts Of Radioactivity Studied In Healthy Male Volunteers
NCT01390805
Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)
NCT00358332
Phase I Pediatric FMP2.1/AS02A Trial in Mali
NCT00382733
Oral Topotecan to Treat Recurrent or Persistent Solid Tumors
NCT00399165
Oral Androgens in Man-4: (Short Title: Oral T-4)
NCT00399243
Sumatriptan 4 mg Statdose in the Acute Treatment of Cluster Headache
NCT00419601
Rapip Study: Clinical Trial on Remifentanyl for Analgesia and Sedation of Ventilated Neonates and Infants
NCT00800553
fMRI-behavioral Study of Cholinergic Augmentation With Donepezil in Healthy Sleep Deprived Adults
NCT00807014
Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne
NCT01029015
Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects
NCT01077557
Fractures Stratified by HIV and Antiretroviral Therapy (ART) Status
Completion: Nov 30, 2011
NCT01150981
Effect of Rosiglitazone on the Vascular Biology of Human Fat Tissue
NCT00398476
Fluticasone Nasal Spray Patient Preference Study
Start: Dec 1, 2006
NCT00370513
A Phase I Study of Pazopanib in Adult Patients With Liver Cancer
Start: Dec 6, 2006
Completion: Apr 8, 2009
NCT00385099
Effects Of GW876008 On The Bowel In Patients With Irritable Bowel Syndrome
Start: Dec 8, 2006
Completion: Oct 15, 2007
NCT00441116
A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia
Start: Dec 15, 2006
Completion: Jan 21, 2008
NCT00420641
MDD POC Study GSK372475 Subjects Depressive Disease
Start: Dec 19, 2006
Completion: Oct 15, 2008
NCT00435461
Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
Start: Dec 20, 2006
NCT00356369
Study in Adolescents/Adults to Evaluate Non-inferiority&Persistence up to 5 Years of GSK Bio MenACWY Conjugate Vaccine
Start: Dec 23, 2006
NCT00410371
Study to Compare Two Formulations of Lamotrigine in Healthy Subjects
Start: Dec 28, 2006
NCT00346749
ADVAIR DISKUS® (Fluticasone Propionate/Salmeterol) Inhaler Versus SEREVENT DISKUS® (Salmeterol) Inhlaer On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease. ADVAIR DISKUS® and SEREVENT DISKUS® Inhalers Are Trademarks of the GSK Group of Companies.
Start: Dec 31, 2006
NCT00350727
Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma
NCT00368303
A Local Register Study For Major Depression Of Paroxetine Controlled Release
NCT00370032
Study to Assess the Effect Of Alosetron On Mucosal Blood Flow
NCT00382993
A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)
NCT00390806
Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer
NCT00392743
A Study to Compare Two Different Brain Imaging Techniques in Healthy Volunteers and in Schizophrenic Patients
NCT00394056
Vestipitant Or Vestipitant/Paroxetine Combination In Subjects With Tinnitus And Hearing Loss.
NCT00395317
Study Of SB-683699 Compared To Placebo In Subjects With Relapsing-Remitting Multiple Sclerosis (MS)
NCT00411073
Study Of The Effects Of SB 480848 (Darapladib) On The Electrical Conduction Of The Heart
NCT00411697
Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge
NCT00423761
An Investigation To Determine The Potential Interaction Effect Between GW876008 And Midazolam.
NCT00424255
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Completion: Nov 30, 2013
NCT00426816
To Evaluate The Effects Of SB-649868 (10, 30 Mg And 60 Mg) On Subjects With Primary Insomnia
NCT00441974
Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)Patients
NCT00537459
A Study On Concentrations Of 16448 In Blood And The Safety Of This Compound In Healthy Males With Premature Ejaculation
NCT00410384
A Study of Belimumab in Subjects With Systemic Lupus Erythematosus
NCT00380393
Efficacy of RTS,S/AS01 Vaccine Against Episodes of Malaria Due to P. Falciparum Infection in Children.
Start: Jan 3, 2007
Completion: Nov 11, 2008
NCT00412854
Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib.
Completion: Jun 25, 2007
NCT00440323
Disturbed Sleep Model Study.
Start: Jan 5, 2007
Completion: Jul 3, 2007
NCT00470483
A Study To Compare Emotional Changes In Subjects With Social Anxiety Disorder
Start: Jan 22, 2007
Completion: Jan 7, 2009
NCT00396630
A Study to Explore the Existence of Horizontal Transmission of the RIX4414 Vaccine Strain Between Twins Within a Family.
Start: Jan 23, 2007
NCT00500331
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
Completion: Feb 14, 2008
NCT00423046
Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age
Start: Jan 24, 2007
Completion: May 14, 2012
NCT00420745
To Assess Safety, Reactogenicity & Immunogenicity of 2 Doses of GSK's Oral Human Rotavirus Vaccine in Pre-Term Infants
Start: Jan 25, 2007
Completion: Mar 25, 2008
NCT00461682
Sb-705498 Rectal Pain Study
Start: Jan 26, 2007
Completion: Sep 1, 2007
NCT00329745
Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210)
Start: Jan 31, 2007
NCT00404261
Evaluation Of Patient Satisfaction Of Metered Dose Inhaler (MDI) With Counter In Asthmatics And Chronic Obstructive Pulmonary Disease Patients (COPD).
NCT00406562
Study to Assess the Safety & Reactogenicity of GSK Biologicals' dTpa Vaccine (Boostrix) When Given at 6-8 Years of Age.
NCT00410163
Ofatumumab With Fludarabine and Cyclophosphamide in B-CLL Patients
NCT00421720
A Study Comparing Two Analgesia/Sedation Regimens, Remifentanil/Propofol Versus Sufentanil/Propofol In Mechanically Ventilated Intensive Care Patients Requiring Analgesia And Sedation.
NCT00424034
A Study of GSK1325760A in Healthy Japanese Subjects
NCT00427596
A Two-Part Study to Determine: Best Medication Formulation and Food Effect
NCT00430157
Trial With Allergic Rhinitis Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber
NCT00441675
A Long Term Prospective Follow Up Study For The CATO Study (SAS30018/SER9702)
NCT01390792
Special Drug Use Investigation for Relenza® (Zanamivir) (Prophylaxis)
NCT00397839
The Effect Of Oral Ibandronate In Male Osteoporosis
NCT00423683
Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With a Venous Thromboembolism
Completion: Nov 30, 2010
NCT00460070
Study of Hormonal Sideeffects in Patients Taking Levetiracetam, Carbamazepine or Lamotrigine for Epilepsy
NCT00460915
Efficacy and Safety of Lacidipine and Amlodipine on Blood Pressure in Korean ISH Patients Aged 60 to 80 Years
NCT00490490
Study of Bexxar <Tositumomab> Combined With External Beam Radiation Therapy
NCT00499824
GIANT: General Practitioner Implementation in Asia of Normoglycaemic Targets
NCT00579436
Effects of Fish Oils on Inflammation and Insulin Resistance
Completion: Jan 15, 2015
NCT00916149
Cognitive Effects of Treatment of Interictal Discharges
NCT00430521
Safety & Immunogenicity of an Alternative Immunization Schedule of GSK Bio's Pandemic Influenza Vaccine (GSK1119711A)
Start: Feb 5, 2007
Completion: Oct 20, 2008
NCT00412191
Bioequivalence And Lack Of Food Effects Of 300mg Lamotrigine XR
Start: Feb 6, 2007
Completion: Apr 27, 2007
NCT00427908
Study in Children to Evaluate Non-Inferiority and Persistence up to 5 Years of GSK Bio Meningococcal Vaccine 134612
Start: Feb 7, 2007
NCT00420316
Long-term Efficacy and Safety of Subjects Approximately 3 Years After Priming With 2 Doses of GSK Bio's HRV Vaccine.
Start: Feb 12, 2007
Completion: Aug 8, 2007
NCT00426361
Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus (HPV) Vaccine With Other Vaccines in Healthy Female Subjects
Start: Feb 13, 2007
Completion: Jul 25, 2008
NCT00434577
Safety and Immunogenicity of the Zoster Vaccine GSK1437173A in Elderly Subjects
Start: Feb 14, 2007
Completion: Jul 14, 2010
NCT00522678
Repeat Dose GW685698X With Magnesium Stearate, Excipient Bridging Study, In Healthy Volunteers
Start: Feb 15, 2007
Completion: Apr 25, 2007
NCT00439868
A Study To Evaluate The Effect Of WELLBUTRIN XL On Intraocular Pressure
Start: Feb 16, 2007
Completion: Jun 8, 2007
NCT00444509
Single Dose GW685698X Magnesium Stearate Study In Asthmatic Patients.
Start: Feb 17, 2007
Completion: Apr 9, 2007
NCT00437229
A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy Adults
Start: Feb 19, 2007
Completion: May 15, 2007
NCT00434512
Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers
Start: Feb 20, 2007
Completion: Jun 13, 2008
NCT00435396
Study to Evaluate Safety and Immunogenicity of the GSK Bio CMV Vaccine in CMV-seronegative Healthy Male Adult Subjects
Start: Feb 22, 2007
Completion: Aug 27, 2008
NCT00428090
Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
Start: Feb 27, 2007
Completion: Sep 5, 2008
NCT00390143
Study in Adolescents/Adults to Evaluate the Persistence up to 3.5 Yrs of GSK Biologicals Meningococcal Vaccine 134612
Start: Feb 28, 2007
NCT00435045
Evaluation of Efficacy and Safety of Omacor, Co-Administered With Atorvastatin, in Subjects With Hypertriglyceridemia
NCT00441441
A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With Asthma
NCT00469040
Safety, Blood Levels and Effects of GW642444
Completion: Apr 16, 2007
NCT00501397
A Study of the Effects of Ketoconazole Taken Orally Has on the PK Profiles of a Dose of GSK189075 in Healthy Volunteers
NCT00541320
Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR)
NCT00643929
LENS - Long-term Eltrombopag Observational Study
Completion: Mar 31, 2013
NCT00421343
Secondary Prevention of Osteoporosis
NCT00424281
Effectiveness of Blood Clot Medication With Concomitant Blood Pressure Medication
NCT00430040
Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI.
NCT00434629
Safety and Efficacy of Bexxar Therapy in the Treatment of Relapsed/Residual B-Cell Lymphoma After Autologous Transplant
Completion: May 31, 2015
NCT00436787
Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers
NCT00446966
Fish Oil for Reduction of Atrial Fibrillation After Cardiac Surgery
NCT00450892
Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer
NCT00548418
Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer
Completion: Dec 31, 2012
NCT00752167
Diagnosis of Exercise-induced Bronchospasm (EIB) and Asthma in National Collegiate Athletic Association (NCAA) Division I Athletes
NCT00437632
Study To Investigate If Repeat Doses Of GSK598809 Are Safe And Well Tolerated And To Evaluate Blood Levels Of GSK598809
Start: Mar 1, 2007
NCT00483535
Oral Contraceptive Interaction Study for GW273225
Start: Mar 7, 2007
Completion: Nov 16, 2007
NCT00432380
A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants.
Start: Mar 9, 2007
Completion: Sep 4, 2007
NCT00453687
A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK233705 In Healthy Volunteers.
Completion: May 16, 2007
NCT00459550
A Clinical Study to Assess Single and Repeat Doses of a New Medication (GSK933776) in Patients With Alzheimer's Disease
Start: Mar 12, 2007
Completion: May 30, 2011
NCT00441688
Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients
Start: Mar 15, 2007
Completion: Jun 1, 2007
NCT00437840
A Study To Investigate The Safety, Tolerability And Blood Levels Of GSK598809
Start: Mar 20, 2007
NCT00453440
Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701
Completion: Aug 10, 2007
NCT00468897
A Study To Demonstrate The Bioequivalence Of Rosiglitazone XR (BRL-049653) 8mgs XR Manufactured At Two Different Sites.
Start: Mar 21, 2007
Completion: May 2, 2007
NCT00405392
Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis
Start: Mar 22, 2007
Completion: May 27, 2008
NCT00449670
Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults
Start: Mar 24, 2007
Completion: Jun 10, 2008
NCT00443131
Characterisation of the Immune Responses of 2 Experimental Malaria Vaccines
Start: Mar 26, 2007
Completion: Jul 13, 2007
NCT00555139
A Study To Compare The Putative Anxiolytic Effect Of 2 New Drugs In Subjects With Social Anxiety Disorder
Start: Mar 27, 2007
NCT00453479
A Dose Ascending, Study To Examine The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of GSK233705B.
Start: Mar 28, 2007
Completion: Oct 11, 2007
NCT00464568
A 5-way Treatment Period Trial of Single Doses of Intranasal GSK256066 in Patients With Rhinitis
NCT00421421
Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without Catheter
Start: Mar 31, 2007
NCT00424177
Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)
NCT00424697
A Study to Investigate the Effects of GW876008 on Brain Activation During Emotional Processing in Healthy Subjects.
NCT00435838
A Study of Patient Management in HIV-1 Infected Patients Found to Have the Genetic Marker HLA-B*5701
NCT00443053
Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)
NCT00449046
Clinical Assessment Of GW815SF Salmeterol/Fluticasone Propionate(HFA MDI) In Pediatric Patients With Bronchial Asthma -A Long Term (24-week) Study-
NCT00449709
A Study To Assess The Pharmacokinetics Of Different Modified Release Formulations Of GSK221149 In Healthy Adult Subjects
NCT00452686
Study to Assess Safety & Immunogenicity of GSK Biologicals' Boostrix (dTpa) Vaccine vs. Chinese DT Vaccine
NCT00460226
Lamictal Bipolar Observational Study
NCT00461500
SERETIDE 100/50 bd (Twice Daily) Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In Adults
NCT00463320
A Study To Evaluate The Safety, Tolerability And Pk Of Pazopanib Eye Drops In Healthy Adult And Elderly Subjects.
NCT00474513
An Imaging Study to Investigate the Distribution of GSK239512 in the Brain.
NCT00517946
A Study To Investigate If MRI Scanning Is Effective At Seeing What Hayfever Drugs Do In Nasal Passage.
NCT00725712
Study of GSK1363089 in Metastatic Gastric Cancer
NCT00440947
Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection
NCT00450580
HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults
NCT00454675
Pulmonary Function Changes in 10 Pack Year Smokers With Chronic Bronchitis
NCT00482391
Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast Cancer
NCT00553878
Comparing 0.5 mg Dutasteride vs Placebo Daily in Men Receiving Androgen Ablation Therapy for Prostate Cancer
NCT02028676
Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in Africa
NCT00777114
Phase 1 Study of Radiosensitization Using Bortezomib in Relapsed Non-Hodgkin's Lymphoma Patients Receiving Radioimmunotherapy
Start: Apr 1, 2007
Completion: Dec 18, 2012
NCT00463697
A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In Asthmatic Patients
Start: Apr 2, 2007
Completion: Aug 4, 2007
NCT00434304
Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD)
Start: Apr 9, 2007
Completion: Mar 10, 2009
NCT00453986
Lot Consistency, Immuno, Safety of Meningococcal Vaccine GSK134612 Given With Fluarix™ to 18-55 Year-Old Adults
Completion: May 21, 2008
NCT00465816
Primary Study to Demonstrate Non-inferiority and Immunogenicity of GSK Biologicals' Meningococcal Vaccine 134612
Start: Apr 11, 2007
Completion: Apr 28, 2008
NCT00460707
A Study to Assess the Safety and Interaction Between Casopitant and Ketoconazole When Taken By Healthy Adults
Start: Apr 16, 2007
Completion: Aug 27, 2007
NCT00495729
15-Day Repeated-Dose Study With SB-649868 And Its Interaction With CYP3A4 Isoenzyme In Healthy Male Subjects.
Start: Apr 18, 2007
NCT00548769
Firategrast (SB683699) Surface Area Study in Multiple Sclerosis Patients
Start: Apr 21, 2007
Completion: Nov 26, 2007
NCT00454909
Immunogenicity and Safety of Meningococcal Vaccine GSK134612 vs. Menactra® in Healthy Adolescent/Adults Aged 10-25 Years.
Start: Apr 23, 2007
Completion: Apr 11, 2008
NCT00463437
Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines
Start: Apr 25, 2007
Completion: Jun 14, 2008
NCT00422903
Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer
Start: Apr 30, 2007
NCT00436007
Safety and Immunogenicity Study of GSK Biologicals' Malaria Vaccine 257049, When Incorporated Into an EPI Regimen
Completion: Oct 7, 2009
NCT00436358
Implementing Hospital-based Active Surveillance Procedures for Vaccine Safety Monitoring at IMSS Hospitals in Mexico
NCT00442468
Airway Limitation Study: Study In Primary Care Centers Of Chronic Bronchitis In Long-Term Cigarette Smokers Of At Least 40 Years Of Age With Symptoms Of Cough And Shortness Of Breath
NCT00447486
A Study of GW842166 in Adults With Osteoarthritis Pain
NCT00448058
A Study Of New Medicine (GSK 372475) For The Treatment Of Depression
NCT00448435
Clinical Assessment Of GW815SF HFA MDI In Pediatric Patients With Bronchial Asthma
NCT00456625
Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine.
NCT00456807
Complementary Testing to Evaluate Immunogenicity of Human Papillomavirus (HPV) Vaccine (580299) in Healthy Female Subjects Aged >/= 26 Years
NCT00460148
Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole
NCT00468689
Evaluation Of SB-751689 Administered At Supratherapeutic Dose Levels In Healthy Adult Subjects.
NCT00468806
Study of Safety, Blood Levels and Brain Receptor Occupancy of GSK598809 Using PET Imaging in Health Males.
NCT00470145
Comparison Of Two Tablet Formulations Of SB-568859
NCT00493818
Open-label Study to Investigate the Safety, Tolerability, PK, and Pharmacodynamics of the AKT Inhibitor GSK690693
NCT00499928
A Study To Investigate The Metabolism And Excretion Of 14C SB-751689 Given To Healthy Males And Postmenopausal Women
NCT00501930
A Study to Evaluate and Study Drug Levels in Blood Plasma When Giving High Doses of GSK189075 to Healthy Volunteers
NCT00504816
A Study of the Effects of GSK189075 on PK Profiles of an Oral Contraceptive Pill When Given to Healthy Female Volunteers
NCT00518115
Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only
NCT00540878
A Study to Estimate the Effect of Formulation on the Relative Absorption of SB-751689 Administered to Healthy Women
NCT00370682
A Phase II Trial of a Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in Thailand
NCT00405015
The Effect of Rosiglitazone on Ischemia-reperfusion-injury Using Annexin A5 Scintigraphy.
NCT00459056
The Vascular Effects of Carvedilol Controlled Release (CR) in Abdominally Obese Hypertensive Patients
NCT00470847
Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer
NCT00473915
Intranasal Steroids and the Nasal Ocular Response
NCT00512954
Causes, Characteristics and Mechanisms of Infective Exacerbations in Subjects With Asthma and Chronic Obstructive Pulmonary Disease (COPD)
NCT00531167
Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis B
NCT00539942
Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy
NCT00464815
Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 11-17 Year-Old Subjects
Start: May 2, 2007
Completion: Sep 10, 2008
NCT00440128
The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer
Start: May 4, 2007
Completion: Jul 17, 2008
NCT00449774
Bioequivalence And Effect Of Food And Water On Lamotrigine in Healthy Volunteers
Start: May 7, 2007
NCT00455572
Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung Cancer
Start: May 11, 2007
Completion: Aug 8, 2013
NCT00471237
A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.
Start: May 14, 2007
Completion: Dec 26, 2008
NCT00475436
A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK573719 In Healthy Volunteers
Completion: Sep 18, 2007
NCT00470704
Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer
Completion: Aug 20, 2024
NCT00454987
Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine
Start: May 16, 2007
Completion: Oct 12, 2007
NCT00500201
A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of SB773812 Tablets.
Start: May 24, 2007
Completion: Jul 25, 2007
NCT00478621
Human Papillomavirus Vaccine Safety & Immunogenicity Trial in Healthy Young Adult Women With HPV Vaccine (GSK1674330A)
Start: May 25, 2007
Completion: Oct 13, 2008
NCT00394836
HuMax-CD20 i(Ofatumumab) n Follicular Lymphoma (FL) Patients Refractory to Rituximab
Start: May 31, 2007
NCT00437073
Brain Metastases In ErbB2-Positive Breast Cancer
NCT00447226
Randomized Discontinuation Study of Lapatinib Versus Placebo in Subjects With Documented Tumor Progression After Chemotherapy, or Where no Approved Therapy Exists
NCT00452348
A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg Twice Daily In Symptomatic Patients With Asthma
NCT00452699
A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg BID In Symptomatic Subjects With Asthma
NCT00460564
Study Of GSK1358820 In Patients With Post-Stroke Upper Limb Spasticity
NCT00460655
Study of GSK1358820 In Patients With Post-Stroke Lower Limb Spasticity
NCT00470834
Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy
NCT00487968
Eltrombopag Taste Testing in Healthy Adult Volunteers
NCT00551473
Open-label Comparison of 24hr Gastric pH on Days 1, 2, 7 With Once-daily Administration of Lavoltidine 40 mg.
NCT00424476
A Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)
NCT00460525
Phase II AMA-1 Malaria Vaccine FMP2.1/AS02A Trial in Mali
NCT00471861
Inflammatory Markers in Patients With Active Migraine Headaches
NCT00479167
A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma
NCT00481429
Predictive Markers of Glitazone Efficacy in Diabetic Patients - Pilot Study
NCT00551655
Impact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected Patients
NCT00702507
Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants
NCT01231230
Interactive Acute Smooth Muscle Effects of Salmeterol and Fluticasone in the Airway
NCT00473668
Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib
Start: Jun 1, 2007
Completion: Jan 30, 2008
NCT00489970
Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9
Completion: Mar 1, 2016
NCT00500461
Study To Examine Safety, Tolerability And Pharmacokinetics Of Intravenous Doses And Oral Dose Of GSK233705
Start: Jun 4, 2007
NCT00504439
A Study To Evaluate The Safety And Tolerability Of SB-656933-AAA Following Repeated Doses In Healthy Adult Subjects
NCT00474266
Safety & Immunogenicity Study of Meningococcal Vaccine GSK134612 Given With Priorix-Tetra™ to 12-23 Month-Old Children
Start: Jun 5, 2007
Completion: Mar 26, 2008
NCT00508911
A Study To Evaluate The Effect Of GW876008 On The Pharmacokinetics Of Oral Contraceptive Pills
Start: Jun 8, 2007
Completion: Oct 22, 2007
NCT00520663
Radiolabel Study In Healthy Volunteers For Insomnia-Targeting Drug
NCT00485732
A Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine/Cervarix TM Vaccine in Healthy Females Aged 15-25 Years
Start: Jun 11, 2007
Completion: Mar 30, 2008
NCT00511654
28-day Repeat Dose and Drug Interaction Study With Orvepitant (GW823296)
Start: Jun 12, 2007
Completion: Jan 11, 2008
NCT00480324
Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants
Start: Jun 19, 2007
Completion: Nov 21, 2009
NCT00483860
A Phase I Topotecan Study in Subjects With Cancer and Impaired Renal Function
Start: Jun 20, 2007
Completion: Feb 6, 2012
NCT00515502
Safety Study Using GSK573719 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease
Start: Jun 21, 2007
NCT00492648
Month 30 & 42 Extension Studies of CRD-004 Primary Study
Start: Jun 25, 2007
NCT00504790
Phase I Study to Assess the Safety, Pharmacokinetics, & Pharmacodynamics of GSK923295 in Subjects w/ Refractory Cancer
Completion: May 8, 2012
NCT00511524
An Imaging Study to Investigate the Distribution of GW842166X in the Brain.
Start: Jun 26, 2007
Completion: Jul 4, 2007
NCT00466947
COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate Vaccine
Start: Jun 28, 2007
Completion: Jul 28, 2011
NCT00513279
To Investigate If Single Doses Of GSK618334 Are Safe And To Investigate Blood Levels Of GSK618334
Completion: Oct 4, 2007
NCT00476307
Immunogenicity and Reactogenicity of Fluarix™ (Influsplit SSW®) 2007/2008 in People 18 Years Old or Above
Start: Jun 30, 2007
NCT00477464
Lapatinib in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer
NCT00478738
A 2 Part Study Examining Doses Of GSK961081 In Healthy Volunteers And Then In COPD Patients
NCT00481390
Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 In HIV-1 Infected Patients
NCT00485069
REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 Study
NCT00488449
Study Of Pharmacokinetics and Pharmacodynamics Effects Of GSK256073A On Healthy Volunteers
NCT00494780
Ofatumumab (Humax-CD20) With CHOP (Cyclophosphamide,Doxorubicin, Vincristine, Predisolone) in Follicular Lymphoma (FL) Patients
NCT00495014
Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects
NCT00501267
A Study To Test The Interaction of Two Medications for Treatment of Overactive Bladder
NCT00549198
KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects
NCT00680485
Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK580416
NCT01381393
BONVIVA(Ibandronate) PMS(Post-marketing Surveillance )
NCT00299286
Short-term Presurgical Study to Assess Molecular Predictors of Lapatinib's Effects in Primary Breast Cancer
NCT00377091
Is Using Fondaparinux (Blood Thinner) to Treat Lung Clot Cheaper Than Traditional Therapy
NCT00464087
Switching From Fondaparinux to Bivalirudin or Unfractionated Heparin in ACS Patients Undergoing PCI
NCT00484874
Safety and Efficacy Study of I-131 Tositumomab in Patients With Relapsed/Refractory Hodgkin's Lymphoma
Completion: Nov 30, 2015
NCT00555438
Prospective, Multicentre, Open-label Study Evaluating 1.5 mg/Day of Fondaparinux.
NCT00584987
Intranasal Steroids and Oxymetazoline in Allergic Rhinitis
NCT00834457
A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe
NCT00492544
Immunogenicity and Safety of GSK Biologicals' HPV Vaccine 580299 in Healthy Japanese Females 10-15 Years of Age
Start: Jul 2, 2007
NCT00495274
Bioequivalence and Food Effect Study in Healthy Volunteers
Completion: Sep 26, 2007
NCT00496015
Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A
Completion: Feb 17, 2009
NCT00489554
Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age
Start: Jul 3, 2007
NCT00471081
Immunogenicity and Safety of Meningococcal Vaccine GSK134612 Given as 1 or 2 Doses to Healthy 9-12 Months Old Toddlers.
Start: Jul 5, 2007
Completion: Nov 26, 2008
NCT00479427
A Study Of The Effects Of CB2 Compound Of GW842166 In Patients With Osteoarthritis
Start: Jul 6, 2007
NCT00488514
Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents
Start: Jul 13, 2007
Completion: Aug 20, 2009
NCT00540943
Study of Pazopanib, Irinotecan and Cetuximab in Combination to Treat 2nd Line Metastatic Colorectal Cancer
Completion: May 3, 2010
NCT00604825
Treatment Of Hot Flashes/Flushes In Postmenopausal Women (WARM Study)
Start: Jul 17, 2007
Completion: Jul 23, 2008
NCT00478725
Part A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034
Start: Jul 18, 2007
Completion: Jul 1, 2008
NCT00502593
Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Children
Start: Jul 23, 2007
Completion: Dec 4, 2009
NCT00511823
The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects
Completion: Sep 21, 2007
NCT00490204
Cetirizine Placebo Controlled Study For Perennial Allergic Rhinitis
Start: Jul 27, 2007
NCT00510874
Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in Adults
Start: Jul 28, 2007
Completion: Oct 24, 2008
NCT00345683
Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 12 to 15 Months of Age.
Start: Jul 31, 2007
NCT00469378
Study Of White Blood Cells In The Cerebrospinal Fluid And Blood Of Patients With Relapsing Forms Of Multiple Sclerosis
NCT00474864
Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia.
NCT00486954
Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer
NCT00488098
GSK372475 Bioequivalence Study
NCT00500058
A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18
Completion: Mar 4, 2010
NCT00501462
A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function
NCT00505453
A Phase III, Open-Label, Single-Dose Study to Evaluate the Safety and Immunogenicity of Fluviral® Vaccine
NCT00508534
A Study To Evaluate The Effects Of Repeat Dosing Of Esomeprazole On The Pharmacokinetics Of SB-751689 In Healthy People
NCT00514033
A Post-marketing Safety Study of GSK Bio IPV Vaccine (PoliorixTM) in Korean Children
NCT00517673
To Evaluate Safety, Tolerability, Pharmacokinetics, And Food Effect Of Single Doses Of GSK945237 In Healthy Subjects
NCT00551317
A Study Investigating the Concentrations of Darapladib in Blood and the Safety of This Compound in Healthy Japanese Men
NCT00551564
Study to Determine the Utility of Novel Technologies and Biomarkers to Measure Human Response to Rosiglitazone Maleate
Completion: Sep 8, 2008
NCT00981409
The Treatment of Acute Pulmonary Thromboembolism (PE) of GSK576428 (Fondaparinux Sodium) in Japanese Patients
NCT00468858
A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children
NCT00486668
A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer
Completion: Mar 31, 2017
NCT00490061
Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy
Completion: Jun 30, 2016
NCT00493896
Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients
NCT00509275
A Study to Evaluate Efficacy and Safety of Three W0027 Regimens in the Treatment of Moccasin Type Tinea Pedis (MTTP)
NCT00815685
A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia
NCT00506350
Evaluate Reactogenicity & Immunogenicity of an Influenza Pandemic Candidate Vaccine (GSK1562902A) in Primed Adults
Start: Aug 1, 2007
Completion: Oct 12, 2009
NCT00508261
Co-Administration of Meningococcal Vaccine GSK134612 With Infanrix Hexa™ Versus Individual Administration of Each Vaccine
Completion: Oct 27, 2008
NCT00530309
Clinical Assessment of GSK716155 for Type 2 Diabetes Mellitus
Completion: Apr 17, 2008
NCT00622609
Anti-MAG First Administration to Human
Completion: Apr 9, 2009
NCT00501865
Study to Assess the Effect of Food on the Concentration of GW273225 in the Body of Healthy Male and Female Volunteers
Start: Aug 6, 2007
NCT00490568
Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers
Start: Aug 8, 2007
Completion: Jun 1, 2009
NCT00527020
First Time in Human Study With GSK1018921
Start: Aug 10, 2007
Completion: Jul 12, 2008
NCT00549120
Optimising the Propranolol Block Model
Start: Aug 15, 2007
Completion: Oct 26, 2007
NCT00536835
Study to Assess the Pharmacokinetics and Pharmacodynamics of GSK461364 in Subjects With Non-Hodgkins Lymphoma
Start: Aug 16, 2007
NCT00495469
Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive
Start: Aug 17, 2007
Completion: Jun 5, 2008
NCT00513409
Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule
Start: Aug 22, 2007
Completion: Aug 28, 2008
NCT00530790
Clinical Evaluation of Ropinirole CR-RLS ( SK&F101468)Tablets in Restless Legs Syndrome
Start: Aug 23, 2007
Completion: Feb 1, 2008
NCT00725764
Phase 2 Study of GSK1363089 (Formerly XL880) in Adults With Squamous Cell Cancer of the Head and Neck
Start: Aug 27, 2007
Completion: May 2, 2009
NCT00501670
VZV PCR Sampling Validation Study
Start: Aug 31, 2007
NCT00502775
NCT00511563
A Study In Patients With Irritable Bowel Syndrome To Measure Hormone Response After Dosing With GW876008 And Gsk561679
NCT00516139
Lamotrigine Extended-Release In Elderly Patients With Epilepsy
NCT00517543
A Study to Examine the Effect of Particle Size on Bioequivalence and Bioavailability
NCT00517634
Study Of Fluticasone Propionate/Salmeterol In Asthmatic Subjects
NCT00519376
A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In COPD Patients.
NCT00519636
Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS
NCT00519649
Long-term Persistence of Immunity Against Hepatitis B in 7-8 Years Old Children After Hepatitis B Vaccination.
NCT00524303
Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.
Completion: Aug 31, 2015
NCT00532077
A Study to Evaluate the Effects of SB-751689 or rhPTH(1-34) on Excretion of Calcium and Phosphate in Women
NCT00539006
Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS
NCT00540436
Evaluate the Efficacy, Safety and Pharmacokinetics of GSK1325760A in the Treatment of Pulmonary Arterial Hypertension
NCT00540553
Study to Test Safety, Tolerability and Blood Levels of GSK971086 After 1 Dose & 7 Days of Dosing in Healthy Adult Males
NCT00551772
A Study To Assess The Pharmacokinetics Of SB-742457 Formulated As A Capsule And A Tablet In Healthy Elderly Volunteers.
NCT00553657
The Study To Test The Effect of Standardization Of Fluid Intake In Female Patients With Overactive Bladder
NCT01837511
Analysis of the Incidence of Expression of Tumor Antigens in Pathologically Proven Stage I, II and III Non-Small Cell Lung Cancer(NSCLC) in Asiatic Patients
NCT00483600
Pharmacokinetic Study of Fondaparinux in Outpatients With Renal Dysfunction
NCT00716430
European Quality Improvement Programme for Acute Coronary Syndromes
NCT00837213
Comparative Efficacy and Safety of Benzoyl Peroxide Used in Combination With Clindamycin vs. Benzoyl Peroxide Used in Combination With Clindamycin and Doxycycline in the Treatment of Moderate Acne
NCT00841776
Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial Acne
NCT00539760
A Phase I Rheumatoid Arthritis Study in Healthy Volunteers
Start: Sep 5, 2007
Completion: Apr 5, 2008
NCT00516672
Phase I Study of Pazopanib Alone and In Combination With Lapatinib in Japanese Patients With Solid Tumors
Start: Sep 10, 2007
Completion: Oct 14, 2015
NCT00562848
A Study to Evaluate Safety, Side Effects, Muscle Activity and Speed of Gastric Emptying of GSK962040
NCT00519480
A Study To Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of >/ 2000mg of Metformin
Start: Sep 11, 2007
Completion: Apr 1, 2008
NCT00569062
A Study of GW856553X For the Treatment of Depression
Start: Sep 12, 2007
NCT00513565
A Study To Investigate Effects Of GSK561679 On Brain Activation During Emotional Processing In Healthy Volunteers
Start: Sep 13, 2007
Completion: May 14, 2009
NCT00514904
Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 2-10 Year Old Subjects
Start: Sep 18, 2007
Completion: Jan 6, 2009
NCT00533507
Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Weeks of Age
Completion: Jun 6, 2008
NCT00528281
A Phase II Trial of Lapatinib (TYKERB) + Pemetrexed (ALIMTA) in Advanced Non Small Cell Lung Cancer With an Initial Dose Finding Phase
Start: Sep 20, 2007
Completion: May 27, 2009
NCT00532298
Non-Inferiority of Various GSK Bio's Influenza Vaccine Presentations in Adults Aged 65 Years and Over
Completion: Nov 2, 2007
NCT00536679
Relative Bioavailability and Food Effect Study for GSK163090 in Healthy Male and Female Volunteers
Completion: Nov 5, 2007
NCT00548496
A Phase IIa Study Of Men And Post-Menopausal Women With A Fractured Distal Radius
NCT00564746
To Assess the Excretion Balance and Pharmacokinetics of a Single Oral Dose of [14C]SB-681323 in Healthy Adult Males
NCT00508365
Evaluation of Potential for Orthostatic Hypotension in Elderly Hypertensives
Start: Sep 25, 2007
Completion: Jun 3, 2008
NCT00536809
Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer
Start: Sep 26, 2007
NCT00515268
Endotoxin Challenge Study For Healthy Men and Women
Start: Sep 27, 2007
Completion: Apr 23, 2008
NCT00523770
Exploratory Study in Healthy Elderly Subjects to Collect Urine for Development of Assays to Detect S. Pneumoniae
Start: Sep 30, 2007
NCT00532610
A Study to Compare the Effect on Heart Rhythm of 3 Days of GSK189075, Placebo, or Moxifloxacin in Healthy Adults
NCT00536497
Relative Bioavailability Study on a Single Dose of GW842166X in Healthy Male and Female Subjects.
NCT00539201
GSK706769 A First Time in Human Study For Males and Females
NCT00539825
Effect of GSK704838 In Healthy Volunteers
NCT00539994
Retapamulin Ointment in Healthy Adults Nasally Colonized With Staphylococcus Aureus
NCT00540423
Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP)
NCT00549497
A Randomized Study Evaluating Steroid Hormone Levels, Safety And Tolerability Of GW870086X In Healthy Volunteers
NCT00552708
A Study Investigating the Bioequivalence of the Fixed Dose Combination of COREG CR to COREG CR and ZESTRIL.
NCT00555061
Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections.
NCT00561795
Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors
NCT00657020
Functional Magnetic Resonance Imaging (fMRI) Investigation of Nicotine Withdrawal Symptoms
NCT00682461
Oral Tolerability Of Two Nicotine Dosage Forms
NCT00752089
Experimental Dentifrice Remineralization/Fluoride Uptake in an in Situ Model
NCT01420809
Special Drug Use Investigation for ARIXTRA® (Fondaparinux) Injection
NCT00475332
Study to Treat Relapsed Follicular Non-Hodgkin's Lymphoma With Radiation and Bexxar
NCT00521885
Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients
NCT00527566
Mepolizumab As a Steroid-sparing Treatment Option in the Churg Strauss Syndrome
NCT00574171
Phase II Trial of Lapatinib & Capecitabine for Patients With Refractory Advanced Colorectal Adenocarcinoma
NCT00481767
Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age.
Start: Oct 1, 2007
Completion: Jul 26, 2010
NCT00550420
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
Completion: Feb 12, 2009
NCT00538057
Comparing Two Respiratory Drugs When Used In Combination And Separately From A Novel Inhaler Device In Healthy Subjects
Start: Oct 2, 2007
Completion: Dec 1, 2007
NCT00480025
GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer
Start: Oct 4, 2007
Completion: Sep 23, 2014
NCT00534638
Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix) Administered in Healthy Adolescents
Completion: Dec 17, 2014
NCT00549679
Study To Evaluate Safety And Tolerability Of GSK256066 In Chronic Obstructive Pulmonary Disease (COPD) Patients
Completion: Dec 15, 2008
NCT00540228
Start: Oct 5, 2007
Completion: May 8, 2008
NCT00540592
Immunogenicity and Safety Study to Evaluate Different Formulations of GSK Biologicals' Influenza Vaccine GSK576389A
Start: Oct 8, 2007
NCT00551811
Evaluate the Effects of the Drug (SB-656933-AAA) on the Body After a Single Dose in Subjects Who Have Inhaled Ozone
Completion: Jul 22, 2008
NCT00404768
The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor
Start: Oct 12, 2007
NCT00529516
Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
Start: Oct 15, 2007
Completion: Jun 4, 2008
NCT00538213
Evaluation of Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
Completion: Nov 28, 2007
NCT00545025
Revaccination With Influenza Vaccine GSK1247446A
Completion: Dec 12, 2007
NCT00541970
Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs
Start: Oct 17, 2007
Completion: Mar 18, 2013
NCT00537654
A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State
Start: Oct 18, 2007
Completion: Feb 22, 2008
NCT00547248
Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines
Start: Oct 22, 2007
Completion: Oct 7, 2008
NCT00538473
Evaluate Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
Start: Oct 23, 2007
NCT00605852
Investigation Of a New Oral Anti-Histamine in Healthy Male Subjects
Start: Oct 29, 2007
Completion: May 3, 2008
NCT00489567
Hospital-based Surveillance to Collect Prospective Data to Estimate the Disease Burden of Severe RV GE in Sweden
Start: Oct 31, 2007
NCT00503009
Study Of RV-39 In Patients Who Also Have Asthma
NCT00516321
Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease
NCT00527605
Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)
NCT00529568
Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease
NCT00534872
A Clinical Study to Evaluate the Pharmacokinetic Profile of SB-649868 in Elderly and Female Population
NCT00537043
A Study to Compare COREG CR to COREG CR Fixed-dose Combination in Patients With High Blood Pressure
NCT00539136
A Study to Examine the Absorption of GSK561679 in Healthy Male Volunteers
NCT00540501
A Study to Evaluate Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Subjects
NCT00549211
A First Time in Human Study in Healthy Male Volunteers for Compound GSK557296.
NCT00549510
Study to Investigate Dose Proportionality of the Fixed Dose Combination of COREG CR and Lisinopril.
NCT00549653
A Study Investigating Blood Concentrations Of Rosuvastatin When Co-administered With GW856553 In Healthy Men
NCT00551694
A Second Study to Determine the Effect of GSK256073A on HVTs
NCT00556920
Study to Demonstrate the Bioequivalence of the Fixed Dose Combination of COREG CR™ and Lisinopril to Its Components
NCT00596245
Open-Label, Placebo-Controlled, Parallel Group Study in Healthy Volunteers to Evaluate the Effects of Two Single MT 400 or Naproxen Sodium Tablets
NCT00848965
A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study Assessing the Dose-response Curve of Fluticasone Propionate in an Antigen Challenge Chamber
NCT01207999
Type Distribution of Human Papillomavirus in Adult African Women Diagnosed With Invasive Cervical Cancer
NCT01395849
Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)
NCT00450203
Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric Cancer
NCT00568334
Study of Two Formulations of GSK Biologicals' Varicella Vaccine
Start: Nov 1, 2007
Completion: Apr 29, 2008
NCT00548171
Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination in Study NCT01267058
Start: Nov 5, 2007
NCT00552279
Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age
Start: Nov 12, 2007
Completion: Jul 20, 2009
NCT00619424
A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors
Start: Nov 15, 2007
Completion: Sep 4, 2009
NCT00549744
Clinical Endpoint Trial Investigating Once Daily and Bronchodilator Dosing
Start: Nov 16, 2007
NCT00607906
First-Time-in-Humans Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of SB756050
Completion: Mar 10, 2008
NCT00578175
Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age
Start: Nov 20, 2007
Completion: Mar 17, 2009
NCT00570492
Phase 4 Fluticasone Furoate Nasal Spray (VERAMYST) Long Term Pediatric Growth Study.
Start: Nov 26, 2007
Completion: Mar 17, 2011
NCT00524576
Challenge Dose of Hepatitis B Vaccine in Subjects Who Previously Received Engerix™-B Vaccine
Start: Nov 28, 2007
Completion: May 14, 2008
NCT00550225
Succinate Salt Version of GSK961081 for Healthy Volunteers
Start: Nov 29, 2007
Completion: Jan 8, 2008
NCT00436345
Pharmacoeconomic Consequences Of Analgesia in the Intensive Care Unit (ICU)
Start: Nov 30, 2007
NCT00479856
Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast Cancer
NCT00518336
Follow-up Study to Evaluate the Long-term Efficacy of the HPV Vaccine (580299) in Healthy Young Adult Women in Brazil
NCT00527826
Influence Of Salmeterol Xinafoate/Fluticasone Propionate (50/500 µg BID) On The Course Of The Disease And Exacerbation Frequency In COPD Patients Gold Stage III And IV
NCT00550407
An Evaluation Of BW430C (Lamotrigine) Versus Placebo In The Prevention Of Mood Episodes In Bipolar I Disorder Patients
NCT00554762
Dose Response and Efficacy of GW842166 in Pain
NCT00555035
GSK1349572 First Time in Human Study
NCT00557128
Study to Examine the Effect of Food on the Pharmacokinetics of the Fixed Dose Combination of COREG CR and Lisinopril.
NCT00558363
ARTS - AVODART After Radical Therapy For Prostate Cancer Study
NCT00559299
Patient Tolerability Study of GSK163090
NCT00559884
A Study to Compare the Safety and Drug Levels in Blood When Using Various Forms of GSK189075 Given to Healthy Subjects
NCT00708123
In Situ Caries of Fluoride Toothpastes
NCT01376102
BONVIVA(Ibandronate) Injection PMS(Post-marketing Surveillance)
NCT01390857
Special Drug Use Investigation for VALTREX (Valaciclovir) (Pediatrics Chickenpox)
NCT01395862
Special Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)
Completion: Sep 30, 2012
NCT00531791
Effects of Advair® in Outpatients With Chronic Obstructive Pulmonary Disease (COPD) Acute Exacerbation
NCT00552084
Evaluating the Effectiveness of Fish Oil Supplements at Reducing the Recurrence of Atrial Fibrillation
Completion: Apr 30, 2014
NCT00553969
Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease
NCT00842153
Evaluation of the Efficacy and Tolerability of Clobetasol Propionate Foam Compared to Vehicle Foam
NCT00586612
Primary & Booster Study to Evaluate the Immunogenicity and Safety of Menitorix Vaccine in Preterm Infants
Start: Dec 1, 2007
Completion: Dec 30, 2008
NCT00603382
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy.
Completion: Oct 2, 2008
NCT00603746
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.
Completion: Sep 20, 2008
NCT00549900
A Single Centre Study to Evaluate the Safety and Immunogenicity of the Human Papillomavirus Vaccine (GSK-580299) in Chinese Females
Start: Dec 2, 2007
NCT00537719
Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo.
Start: Dec 7, 2007
Completion: Apr 4, 2008
NCT00555022
Effect of GSK1160724 In Healthy Volunteers
Start: Dec 12, 2007
Completion: Apr 7, 2008
NCT00586469
A Randomized Study to Compare the Safety and Immunogenicity of Fluviral® Made With New Versus Aged Bulk
Start: Dec 14, 2007
Completion: Jan 14, 2008
NCT00578227
Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus Vaccine With Another Vaccine in Healthy Female Subjects
Start: Dec 15, 2007
Completion: Apr 28, 2009
NCT00694993
Single and Repeat Dose First Time in Human Study for an Intranasal H1/H3 Dual Antagonist in Healthy Male Subjects
Start: Dec 17, 2007
Completion: May 26, 2008
NCT00606697
A Study With GW597599 And GR205171: Potential New Drugs For The Treatment Of Primary Insomnia
Start: Dec 19, 2007
Completion: May 7, 2008
NCT00456313
No Resistance After Long Term Treatment SERETIDE
Start: Dec 31, 2007
NCT00558103
Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer
NCT00600171
Efficacy And Safety Of GW642444M Comparing Placebo In Adolescent And Adult Subjects With Persistent Asthma.
NCT00603278
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy.
NCT00608699
A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers
NCT00622388
Ofatumumab in Patients With Relapsed/Progressive Diffused Large B-Cell Lymphoma (DLBCL) Ineligible for or Relapse/Progression After Transplant
Completion: Aug 31, 2014
NCT00527618
Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV
NCT00531843
The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients
NCT00559312
The Effect of Fluticasone/Salmeterol Combination on Exertional Breathlessness in Patients With Mild COPD
NCT00610168
Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.
Start: Jan 1, 2008
NCT00611455
Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to MTX Therapy
Completion: Jul 15, 2013
NCT00655824
Long-term Efficacy and Safety of Repeated Ofatumumab Treatment Courses in RA Patients Who Previously Received Ofatumumab or Placebo in Trial Hx-CD20-403
Completion: Mar 19, 2013
NCT00615212
Effect of GSK376501 on CYP450 Activity in Healthy Adult Subjects
Start: Jan 2, 2008
Completion: Feb 15, 2008
NCT00609492
Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants.
Start: Jan 3, 2008
Completion: Mar 30, 2009
NCT00546078
Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America
Start: Jan 14, 2008
NCT00605371
Bioequivalence and Food Effect of 250mg of Lamotrigine XR
Start: Jan 15, 2008
Completion: Mar 6, 2008
NCT01706185
Incidence of Expression of Tumor Antigens in Cancer Tissue From Patients With Pathologically Demonstrated Bladder Cancer
Completion: Jan 15, 2008
NCT00625859
A Study to Assess the Safety of Repeated Doses of GSK189075 and WELLBUTRIN SR in Healthy Male Subjects
Start: Jan 16, 2008
Completion: Apr 10, 2008
NCT00586339
Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix) in HIV Infected Females
Start: Jan 17, 2008
Completion: Jul 18, 2011
NCT00599612
To Assess the Excretion Balance and Pharmacokinetics of a Single Oral Dose of [14C]GW856553 in Healthy Adult Males
Completion: Feb 18, 2008
NCT00616928
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
Start: Jan 23, 2008
Completion: Mar 19, 2009
NCT00557622
Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD)
Start: Jan 25, 2008
Completion: Dec 11, 2008
NCT01002118
Feasibility Study of Omega-3 Fatty Acids in Dialysis Patients
Completion: Feb 23, 2011
NCT00703547
A First Time in Human Study of GSK586529 in Healthy Volunteers
Start: Jan 28, 2008
NCT00579982
An Open-Label Trial Measuring Satisfaction And Convenience Of Two Formulations Of Lamotrigine In Subjects With A Mood Disorder
Start: Jan 31, 2008
NCT00595205
Intussusception Surveillance After Rotarix Introduction in Mexico
NCT00603252
Study to Show That the Combined Hepatitis A and B Vaccine is Non-inferior to Monovalent Vaccines in Adults
NCT00603525
Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to TNF-α Antagonist Therapy
NCT00605449
A Drug Interaction Study Between Simvastatin and GSK376501
NCT00609674
A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis
NCT00612820
A Phase II Study Evaluating Intranasal GSK256066 and Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis (SAR)
NCT00622830
Phase I Study of SB-480848(Darapladib) -Repeat Dose Study in Healthy Japanese Male Subjects-
NCT01077609
Flixonase Safety in Patients With Allergic Rhinitis (AR)
NCT01406275
Special Drug Use Investigation for CLAVAMOX® (Amoxicillin/Clavulanate) Pediatrics Dry Syrup (Every Indication Excluded Otitis Media)
NCT00600743
Effect of a CCK-1R Agonist on Food Intake in Humans
NCT00603044
Mechanism of Action of Fluticasone Furoate in Childhood Obstructive Sleep Apnea Syndrome
NCT00607945
Dietary Fatty Acids As Complementary Therapy in Type 2 Diabetes Mellitus
Completion: May 31, 2012
NCT00614978
Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast Cancer
Completion: Jun 30, 2011
NCT00614991
An Interaction Study to Assess Drug Levels in Healthy Adult Subjects
NCT00621842
Lamotrigine for Symptoms of Geriatric Bipolar Depression
NCT00659399
Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of Progression
NCT00880672
Effect of Dutasteride on HIF-1alpha and VEGF in the Prostate
NCT02016963
An Open-label, Nonrandomized Study to Evaluate the Safety and Immunogenicity of Raxibacumab With Reinjection
NCT00627458
Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine
Start: Feb 1, 2008
Completion: Aug 18, 2008
NCT00635128
Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine
Completion: Jul 8, 2008
NCT00627575
AED/Statin Interaction Study
Start: Feb 4, 2008
Completion: Sep 12, 2008
NCT00600782
Immunogenicity and Safety of a Candidate Tuberculosis (TB) Vaccine Given to Healthy Adults in a TB-endemic Region
Start: Feb 5, 2008
Completion: Dec 19, 2008
NCT00614614
Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014
Start: Feb 13, 2008
Completion: Sep 17, 2009
NCT00611559
Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children
Start: Feb 14, 2008
NCT00642148
A 12 Week Study To Assess Efficacy And Safety Of GW856553 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Completion: Jul 27, 2009
NCT00675090
Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease
Start: Feb 21, 2008
Completion: Jun 16, 2009
NCT01177826
Effectiveness Study of GSK Biologicals' Rotarix TM Vaccine in Hospitalized Children
Start: Feb 23, 2008
Completion: Jun 11, 2010
NCT00605241
A Study To Assess The Effects Of A Single Dose Of GSK598809 In Modulating Nicotine Reward
Start: Feb 25, 2008
NCT00609596
A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State.
Start: Feb 26, 2008
NCT00625196
Comparing Two Respiratory Drugs in Combination and Separately From a Novel Inhaler Device in Healthy Japanese Subjects
Start: Feb 27, 2008
Completion: May 6, 2008
NCT01567995
Randomised, Double-blind, Placebo-controlled Study of Topical Clobetasone Butyrate 0.05% Cream in Subjects With Eczema for Two Weeks to Evaluate the Efficacy and Safety
Start: Feb 28, 2008
NCT00549263
Bioequivalence Study of SB797620 in Healthy Japanese Volunteers
Start: Feb 29, 2008
NCT00549328
Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer
NCT00554619
A Study to Evaluate GSK1325760A - a Long-Term Extension Study
Completion: Jan 31, 2011
NCT00573170
TREXIMET® Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults
NCT00605761
SD Cystic Fibrosis Study
NCT00606684
A Study To Assess Efficacy And Safety Of Different Doses Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT00612118
A Phase II Study Evaluating Intranasal GSK256066 and Azelastine Hydrochloride in Subjects With Seasonal Allergic Rhinitis
NCT00651079
GSK1247303 First Time in Human Study
NCT00651352
A Single Dose Bioequivalence Study OfTwo Formulations Of Nicotine Lozenges
NCT00651534
To Estimate Relative Bioavailability of 5 Formulations of Ronacaleret Given to Healthy Postmenopausal Females
NCT00659191
A Healthy Volunteer And Patient Study To Assess The Safety, Tolerability And Pharmacokinetics Of GSK1265744
NCT00679796
The Effectiveness of Varicella Vaccination in Children in Germany
NCT01253967
Surveillance Study to Estimate the Proportion of Rotavirus Gastroenteritis in Children < 5 Years of Age in Romania
NCT00624819
Assessment of Antibody Persistence in Children Previously Vaccinated With Pneumococcal Conjugate Vaccine
Start: Mar 3, 2008
Completion: Jun 2, 2008
NCT00633074
Non-inferiority Study of GSK Biologicals' Influenza Vaccine GSK576389A Using Different Formulations
NCT00612456
To Evaluate the Pharmacodynamics, Safety, and Pharmacokinetics of Pazopanib Drops in Adult Subjects With Neovascular AMD
Start: Mar 5, 2008
Completion: Jun 17, 2009
NCT00601172
A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.
Start: Mar 10, 2008
Completion: Apr 13, 2009
NCT00687700
A Study to Investigate the Pharmacology of a Dual Pharmacophore in Healthy Volunteers
NCT00637195
Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)
Start: Mar 11, 2008
Completion: Jun 18, 2009
NCT00621894
Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation
Start: Mar 15, 2008
Completion: May 15, 2009
NCT02447393
Phase 1 Study of Levocetirizine
Start: Mar 18, 2008
NCT00653198
Effectiveness of Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants in Panama
Start: Mar 19, 2008
Completion: Mar 18, 2011
NCT00652743
Immunogenicity of GSK Biologicals' Pandemic Influenza Vaccine (GSK1562902A) at Different Boosting Vaccination Schedules
Start: Mar 23, 2008
Completion: Jun 8, 2011
NCT00615576
Repeat Dose Study in Male Healthy Volunteer Smokers
Start: Mar 26, 2008
Completion: Jul 24, 2008
NCT00526669
Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib
Start: Mar 31, 2008
NCT00575159
A Study to Assess the Safety of Single Doses of GSK189075 in Subjects With Type 1 Diabetes Mellitus
Completion: Dec 18, 2008
NCT00624065
Research Study To Test Carvedilol CR + Lisinopril Versus Lisinopril + Placebo In Patients With High Blood Pressure
NCT00633217
Advair HFA For Chronic Obstructive Pulmonary Disease(COPD)
NCT00637351
A Study in Elderly Subjects With Pneumonia to Support the Development of Bacteriological Diagnostic Assays
NCT00671424
A Study To Compare Effects Of GSK189075 In Combination With Either Furosemide Or Hydrochlorothiazide
NCT00730756
A Pilot Study In Adults And Adolescents With Irritant (Non-Allergic) Rhinitis
NCT01376128
Special Drug Use Investigation for PAXIL Tablet (Pediatric Panic Disorder)
NCT01406301
Fondaparinux EU-RMP (Adherence)
NCT00639678
A Study to Evaluate the Safety and Tolerability of Raxibacumab in Healthy Subjects
NCT00657709
Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
NCT00688519
Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies
NCT00689481
Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis Two of Two Phase 3 Studies
NCT00888810
Efficacy of Topotecan and Lapatinib in Early Recurrent Ovarian or Peritoneal Cancer
NCT00652951
Co-administration of Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/Hib
Start: Apr 1, 2008
Completion: Dec 1, 2010
NCT00674817
An Investigation Of The Interaction Of GSK961081 With Inhaled Beta-Agonist And Anti-Muscarinic Drugs.
Completion: Oct 19, 2008
NCT00621322
Safety and Immunogenicity Study of GSK Biologicals Tuberculosis Vaccines (692342) to Healthy Adults
Start: Apr 3, 2008
Completion: Apr 3, 2009
NCT00678977
A Phase I, Open-label, Study of Pazopanib in Combination With Gemcitabine and Gemcitabine Plus Cisplatin for Advanced Solid Tumors
NCT00659555
Study Of The Repeat Dosing Of Ketoconazole On The Pharmacokinetics Of A Single Dose Of Pazopanib (GW786034) Eye Drops
Start: Apr 4, 2008
Completion: May 10, 2008
NCT00652938
Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine Co-administered With Another Vaccine in Healthy Female Subjects
Start: Apr 9, 2008
Completion: Jan 8, 2010
NCT00711776
Bioequivalence Study of Aciclovir 5% Cream in Japanese Healthy Volunteers
Start: Apr 10, 2008
Completion: Aug 17, 2008
NCT00664365
FTIH Study With GSK958108
Start: Apr 12, 2008
NCT00679939
Study In Postmenopausal Women With Type 2 Diabetes Looking At Approved Diabetes Drugs And How They Affect Bone Health
Start: Apr 21, 2008
Completion: Sep 16, 2010
NCT00650910
Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Positive Breast Cancer
Start: Apr 23, 2008
Completion: Jul 10, 2009
NCT00702910
A Study to Investigate the Effect of Inhaling Single Doses of Different Formulations of GW642444M in Asthmatic Patients
Start: Apr 27, 2008
Completion: Oct 4, 2008
NCT00685750
Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma
Start: Apr 28, 2008
Completion: Dec 17, 2013
NCT00513253
A Phase I Study to Test Alternate Oral Formulations vs the Current Tablet Formulation of Lapatinib
Start: Apr 30, 2008
NCT00615524
Phase II Study Evaluating Exemestane Alone Or In Combination With Pazopanib In Postmenopausal Women With Hormone Receptor Positive Breast Cancer
Completion: Nov 30, 2012
NCT00655187
Effectiveness of Human Rotavirus Vaccine, Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants
NCT00657657
Safety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine
NCT00666081
Study to Investigate AKT Inhibitor GSK690693 in Subjects With Relapsed or Refractory Hematologic Malignancies
NCT00674635
Phase II Study Evaluating the Safety and Efficacy of GSK315234A in Patients With Rheumatoid Arthritis
NCT00675116
GW823296 Repeat Dose Study In Healthy Male And Female Subjects
NCT00688207
Mild Alzheimer''s Disease to Assess the of Extended Release Formulation of Rosiglitazone (RSG XR)
NCT00708097
In Situ Caries Efficacy of Fluoride Toothpastes
NCT02602002
Experimental Medicine Study to Validate Pharmacodynamic Pain Assessments in Healthy Volunteers With an Opioid Analgesic (Remifentanil)
NCT00631969
Vardenafil ODT Versus Placebo in Males With Erectile Dysfunction
NCT00655629
Vardenafil Orodispersible Tablet (ODT) Versus Placebo in Males With Erectile Dysfunction, 50% of Whom Are to be 65 Years or Older.
NCT00657241
Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril
NCT00666380
A Study to Determine the Effects of an Investigational Malaria Vaccine Given to Adults Living in the United States and Thereafter to Adults Living in Kenya
NCT00669279
Effect of Carvedilol Controlled-Release (CR) and Atenolol on Central Blood Pressure
NCT00672633
Trial of Lovaza in Adolescents With Mild to Moderately Elevated Triglycerides
NCT00689117
A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel
NCT00709878
Histological Characterization and Differentiation of Rash From Other Epidermal Growth Factor Receptor (EGFR) Inhibitors
NCT02458092
Evaluate the Safety and Efficacy of Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered With Adjuvant AS01B
NCT00675064
Single-Blind, Placebo-Controlled, Randomized Study Testing Single Ascending Doses Of GSK369796 In Healthy Subjects
Start: May 2, 2008
Completion: Oct 12, 2008
NCT00743405
Safety, Tolerability and Pharmacokinetics of GSK1034702 in Healthy Subjects
NCT00803673
A Healthy Volunteer Study With Inhaled GSK573719 and Placebo
Start: May 5, 2008
Completion: Oct 16, 2008
NCT00875784
An Open-label, Randomized, 3-period Crossover Study to Evaluate Sumatriptan Pharmacokinetics for a TREXIMA™ (Sumatriptan Succinate / Naproxen Sodium) Tablet Followed by IMITREX® (Sumatriptan Succinate)
Start: May 6, 2008
NCT00674583
Comparison of GSK Biologicals' Meningococcal Vaccine (GSK134612) and Licensed MenC-CRM197 Vaccine in Healthy Children
Start: May 9, 2008
Completion: Jan 8, 2009
NCT00808093
Repeat Dose Food Effect Study of GSK256073F in Healthy Adult Subjects
Start: May 12, 2008
NCT00676052
Dose-Ranging Study Of GSK233705B In Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Start: May 16, 2008
Completion: Dec 22, 2008
NCT00711386
GSK706769 Repeat Dose Study
NCT00661557
Comparison of GSK134612 in Subjects Previously Vaccinated Against Meningococcal Disease Versus Non-vaccinated Subjects
Start: May 19, 2008
NCT00945503
Positron Emission Tomography (PET) Study to Describe the Relationship Between Plasma Concentrations and Brain Gly-T1 Occupancy of GSK1018921 Over Time.
NCT00671216
A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects.
Start: May 20, 2008
Completion: Jul 7, 2008
NCT01597609
A Study to Characterise the Physiology of Weight Loss and Regain Under Dietary, Behavioural and Pharmacological Interventions in Healthy Obese Subjects
Start: May 22, 2008
NCT00684671
Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary Vaccination
Start: May 26, 2008
Completion: Nov 3, 2008
NCT00694902
Single Dose Escalation Study FTIM in Order to Assess Safety and Tolerability of GSK610677
Completion: Sep 23, 2008
NCT00712933
A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057
Start: May 30, 2008
Completion: Dec 9, 2016
NCT00566020
A Clinical Evaluation Of BW430C (Lamotrigine) In Bipolar I Disorder- Long-term Extension Of Study SCA104779 (NCT00550407) -
Start: May 31, 2008
NCT00640328
Ofatumumab Dose-finding in Relapsing Remitting Multiple Sclerosis (RRMS) Patients
NCT00684177
Retapamulin Versus Placebo in Secondarily-Infected Traumatic Lesions (SITL)
NCT00704431
A Study With Darapladib to Collect Tolerability Information
NCT00828750
Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP)
NCT01177657
Study to Evaluate the Effectiveness of Rotarix™ Against Severe Gastroenteritis Among Hospitalized Children in Brazil
NCT00548184
Lapatinib and Trastuzumab With or Without Endocrine Therapy
NCT00638222
Carvedilol and Micro T-Wave Alternans in Hypertensives With Chronic Kidney Disease
NCT00740064
Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects
NCT00933530
A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Normal Healthy Male Volunteers
NCT00633022
A Study to Evaluate the Effects of 3 Months Dosing With GW856553, as Assessed FDG-PET/CT Imaging
Start: Jun 2, 2008
Completion: Dec 3, 2009
NCT00688272
Study In Healthy Subjects To Evaluate The Photo-Irritant Potential Of Eltrombopag
Completion: Sep 25, 2008
NCT00693706
Safety and Immune Response Study of GSK Biologicals' Influenza Virus Vaccine 1388442A Compared With Fluarix
NCT00695669
A Trial to Test the Response to Different Vaccination Regimens With an H5N1 Vaccine With AS03 in Adults Aged 18-64
Start: Jun 5, 2008
NCT00696423
Immunogenicity and Safety of GSK Biologicals' Infanrix/Hib in Children
Start: Jun 7, 2008
Completion: Jul 26, 2008
NCT00728052
A Human Volunteer Study Investigating Single Oral Doses of GSK598809 in Otherwise Healthy Smokers
Start: Jun 9, 2008
Completion: Aug 19, 2008
NCT00680914
Primary Vaccination Course in Children Receiving Pneumococcal Conjugate Vaccine GSK 1024850A or Prevenar™ and Hiberix™
Start: Jun 10, 2008
Completion: May 8, 2009
NCT00686868
Study to Evaluate SC Route of Administration of Ofatumumab in RA Patients
Start: Jun 13, 2008
Completion: May 2, 2011
NCT00659178
Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian Cancer
Start: Jun 18, 2008
Completion: Feb 18, 2011
NCT00678301
Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Zilbrix™ Hib and Polio Sabin™
Completion: Dec 10, 2009
NCT00695448
Phase I Open-Label, Dose-Escalation Study of GSK1059615 in Patients With Solid Tumors or Lymphoma
Start: Jun 24, 2008
NCT00733304
An Extension to Study MD7108240
Start: Jun 25, 2008
Completion: Sep 9, 2009
NCT00678587
Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures
Start: Jun 30, 2008
NCT00679224
An Observational Study For Ambrisentan
NCT00682643
A Clinical Study With Fluticasone Furoate Nasal Spray And Vehicle Placebo For The Treatment Of Perennial (Year-round) Allergic Rhinitis
NCT00707798
Evaluation of Pneumococcal Vaccine Formulations in Young Adults
NCT00707967
Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults.
NCT00708305
Evaluation of Plaque Fluid Fluoride Retention From Fluoride Toothpastes
NCT00709618
Lapatinib + Vinorelbine in ErbB2 Overexpressing, First or Second Line Metastatic Breast Cancer Subjects
NCT00820924
Study of Lapatinib in Breast Cancer Patients With HER-2 Non-amplified Primary Tumors and HER-2 Positive or EGFR Positive Circulating Tumor Cells
NCT00824356
Allergen Challenge Chamber Study With Single Dose Intranasal GSK1004723 Compared With Placebo
NCT00911157
The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients
NCT01077596
Carcinogenicity Study of Bupropion
NCT01227369
Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate Treatment
NCT00634088
Phase I Study of Ixabepilone Plus Lapatinib With or Without Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
NCT00694746
Study of Fish Oil to Reduce ALT Levels in Adolescents
Completion: Mar 31, 2014
NCT00695071
Study to Assess Blood Levels of Itraconazole During a Two-Week Period
NCT00703846
STUDY TO ASSESS THE LONG-TERM SAFETY OF EXTINA (KETOCONAZOLE) FOAM, 2%
NCT00708110
Phase IIa Dose-ranging Study of GSK1349572 in HIV-1 Infected Adults
NCT00712855
A Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma
Completion: Aug 31, 2012
NCT00713609
Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne
NCT00812318
Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal.
NCT00911651
Study to Assess the Effect of Salbutamol and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00710684
A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease
Start: Jul 1, 2008
Completion: Nov 16, 2010
NCT00728897
A Healthy Volunteer Study to Investigate the Relative Bioavailability of Two Forms of GSK598809 Capsules.
Start: Jul 2, 2008
Completion: Jul 29, 2008
NCT00706199
The Expression of Antigens in Bone Marrow Samples From Volunteering Donors.
Start: Jul 3, 2008
Completion: Jan 23, 2009
NCT00708552
Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease
Start: Jul 4, 2008
Completion: Mar 9, 2010
NCT00706563
A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix™ / Influsplit SSW® 2008/2009 in Adults
Start: Jul 7, 2008
Completion: Jul 30, 2008
NCT00749359
PAXIL CR Bioequivalence Study
Completion: Sep 16, 2008
NCT00750256
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK1278863A in Healthy Subjects
Completion: Dec 12, 2008
NCT00876018
Nutrition, Physical Performance & Fitness in Indian School Children
NCT00722293
A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors
Start: Jul 8, 2008
Completion: Feb 25, 2014
NCT00719043
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged ≥18 Years
Start: Jul 11, 2008
NCT01607086
Compare the Properties and Characteristics of an Investigational Formulation of Lamotrigine With Placebo
Completion: Jul 18, 2008
NCT00714285
Immunogenicity and Safety Study of a GSK Influenza Vaccine Candidate in Adults.
Start: Jul 14, 2008
NCT00730405
Efficacy and Safety Study of 4 Dose Regimens of Oral Albaconazole in Subjects With Distal Subungual Onychomycosis
Start: Jul 16, 2008
Completion: Feb 19, 2010
NCT00718120
Immunogenicity and Safety Study of GSK Biologicals' Fluviral® (2008 - 2009 Season) in Adults Over 18 Years
Start: Jul 18, 2008
Completion: Aug 9, 2008
NCT00731250
A Study To Assess The Effect Of SB-705498 In A Capsaicin Challenge Model
Start: Jul 22, 2008
NCT00723775
GSK706769/KALETRA Drug-drug Interaction Study
Start: Jul 24, 2008
Completion: Nov 8, 2008
NCT00687622
Open-label Study to Investigate the Safety, PK, and Pharmacodynamics of GSK1120212 in Subjects With Solid Tumors or Lymphoma
Start: Jul 28, 2008
Completion: Nov 8, 2011
NCT00728208
GSK372475 PK Study in Healthy Volunteers
Completion: Dec 29, 2008
NCT00678886
Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1
Start: Jul 29, 2008
Completion: Jan 31, 2012
NCT00698516
Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer
Start: Jul 31, 2008
NCT00699608
An Evaluation of Potential Next-day Residual Effects of Eszopiclone in Healthy Volunteers.
NCT00715910
The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Adolescents/Adults
Completion: Oct 31, 2013
NCT00723450
Lamictal as Add-on Treatment for Bipolar I Disorder in Pediatric Patients
Completion: Aug 31, 2013
NCT00751686
Estimation of the Burden of Rotavirus Gastroenteritis (RV GE) in Children Less Than 5 Years in Greece
NCT00929370
A Repeat Dose Study With GSK1018921 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteers and Patients With Schizophrenia and to Evaluate Its Effect on PK of Midazolam.
NCT01381406
Impact of Initiating Tiotropium Alone Versus Initiating Tiotropium in Combination With Fluticasone Propionate/Salmeterol Xinafoate Combination (FSC) on Chronic Obstructive Pulmonary Disease-related Outcomes in Patients With Pre-existing Exacerbations
NCT01387178
Outcomes From Initial Maintenance Therapy With Fluticasone Propionate 250/Salmeterol 50 (FSC) or Tiotropium in Chronic Obstructive Pulmonary Disease
NCT00716651
Safety and Efficacy Study of Mepolizumab in Churg Strauss Syndrome
NCT00721630
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Completion: Jul 31, 2016
NCT00727597
A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT
NCT02136875
Strategy for Early Treatment of Exacerbations in COPD: Standing Prescriptions of Advair With a Written Action Plan in the Event of an Exacerbation
NCT00727428
Immunogenicity and Safety of GSK Biologicals' FluLaval® TF
Start: Aug 5, 2008
NCT00733577
A Study to Test How SB756050 Affects Subjects With Type 2 Diabetes Mellitus After 6 Days of Dosing.
Start: Aug 11, 2008
Completion: Mar 3, 2009
NCT00742261
A Bioavailability Study of GSK1363089 in Subjects With Solid Tumors
Completion: Jun 24, 2009
NCT00733785
PK, Dose Proportionality, Food Effect And Repeat Dose Study Of Rosiglitazone XR In Healthy Volunteers
Start: Aug 13, 2008
Completion: Nov 28, 2008
NCT00920803
A Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects With Colorectal Cancer and Hepatic Metastases
Start: Aug 19, 2008
Completion: Nov 11, 2009
NCT00734032
A Phase II Clinical Study of SB-480848 in Dyslipidemic Patients
Start: Aug 26, 2008
Completion: Jan 16, 2009
NCT00742508
A Phase I/II Clinical Study of SK&F-105517-D in Japanese Patients With Chronic Heart Failure
Start: Aug 28, 2008
Completion: Aug 21, 2009
NCT00843011
Food and Relative Bioavailability Study
Completion: Oct 23, 2008
NCT00726336
GSK1349572 Drug Interaction With Tenofovir
Start: Aug 31, 2008
NCT00731822
A Study To Assess Single Dosage Strength Of GW685698/GW642444 Chronic Obstructive Pulmonary Disease (COPD)
NCT01498627
Cervarix Long-term Safety Surveillance
NCT00724867
A Continuation Trial for Subjects With Lupus Who Completed Protocol HGS1006-C1056 in the United States
NCT00729430
Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging
Completion: Jul 31, 2014
NCT00741767
The Impact of Salmeterol-Fluticasone on Sleep in Patients With COPD
NCT00742209
Prevention Study in Adult Patients Suffering From Migraine Headaches
NCT02712177
Bexsero™and Routine Infant Vaccines: Effect of Coadministration on the Safety of Immunization
Completion: Apr 30, 2019
NCT00742885
Immunogenicity and Safety of GSK Biologicals' (Pre-) Pandemic Influenza Candidate Vaccine
Start: Sep 1, 2008
Completion: Mar 7, 2009
NCT00750893
Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix (Human Rotavirus Vaccine) in Infants
Start: Sep 2, 2008
Completion: Jun 15, 2013
NCT00783549
A Study in Healthy Volunteers of Single Doses of Orally Administered Investigational Product to Investigate Safety, Tolerability, and Pharmacokinecs.
Start: Sep 4, 2008
NCT00757523
Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris
Start: Sep 10, 2008
NCT00753272
Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older
Start: Sep 15, 2008
Completion: Jan 5, 2011
NCT00730847
A Study to Assess the Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (Cervarix) in Healthy Female Filipino Subjects Vaccinated According to the Prescribing Information From the Age of 10 Years Onwards.
Start: Sep 17, 2008
Completion: Jan 16, 2012
NCT00742144
Ofatumumab in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic Leukemia
Start: Sep 19, 2008
Completion: Nov 18, 2009
NCT00756067
Evaluation of Pneumococcal Vaccine Formulations in Elderly
Completion: May 28, 2009
NCT01424384
Emotional Processing in Healthy Volunteers in the Presence of an Investigational Anxiolytic
NCT00964249
Phase I Study of GW642444M in Healthy Japanese Male Subjects
Start: Sep 20, 2008
Completion: Dec 1, 2008
NCT00964405
Phase I Study of GSK233705 in Healthy Japanese Male Subjects
Completion: Dec 20, 2008
NCT00733551
Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects.
Start: Sep 23, 2008
NCT00753649
Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants
Completion: Mar 12, 2013
NCT00732420
Open-label Study of Topotecan and Pazopanib in Advanced Solid Tumors
Start: Sep 24, 2008
Completion: Jun 12, 2013
NCT00972673
A Study of GW685698X in Healthy Japanese Male Subjects
NCT00721812
A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686
Start: Sep 25, 2008
NCT00706238
MAGE-A3 Antigen-Specific Cancer Immunotherapeutic in Patients With Progressive Metastatic Cutaneous Melanoma
Start: Sep 29, 2008
Completion: Jan 19, 2011
NCT00887367
EtOH Interaction Study
Completion: Dec 3, 2008
NCT00682279
A Phase I Study Of Oral Topotecan And Lapatinib In Subjects With Advanced Solid Tumors
Start: Sep 30, 2008
NCT00743860
A Healthy Volunteer Pharmacokinetic Study of Single and Repeat Doses of SB-480848
NCT00752726
Effect of Orlistat in Body Composition
NCT00851344
Allergen Challenge Chamber Study With Single Dose Oral GSK835726 Compared With Placebo
NCT01231490
Acute Osteoarthritis Experimental Model Study.
NCT00731211
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
NCT00752869
Efficacy Study for Use of Dutasteride (Avodart) With Testosterone Replacement
NCT00819910
Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL)
NCT00867737
Onset of Action of Advair Hydrofluoroalkane (HFA) 115/21 in Comparison to Symbicort Pressurised Metered-Dose Inhalers (pMDI) 160/4.5 Measured by Impulse Oscillometry (IOS)
NCT01216735
Effect of an Inhaled Glucocorticosteroid (ICS) on Endothelial Dysfunction in Cigarette Smokers
NCT00725283
Evaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia (AML)
Start: Oct 1, 2008
Completion: Jun 22, 2016
NCT00751348
Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136
Completion: May 27, 2010
NCT00764790
Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children
NCT00733980
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
Start: Oct 2, 2008
Completion: Jun 18, 2010
NCT00760617
Evaluation of Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Years and Older
Start: Oct 6, 2008
NCT00772889
Evaluation of the Safety and Immunogenicity of the Influenza Vaccine GSK2186877A in the Elderly
Start: Oct 9, 2008
Completion: Dec 15, 2009
NCT00765076
Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older
Start: Oct 16, 2008
NCT00771615
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years
NCT00718666
The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Toddlers
Start: Oct 20, 2008
Completion: Mar 28, 2014
NCT01381419
First Time in Human Study (FTIH) With Positron Emission Tomography (PET)
NCT00711126
A Study To Investigate Safety, Blood Levels And Effects Of Giving GW642444, By Mouth, By Inhalation & By Injection
Start: Oct 21, 2008
Completion: Dec 17, 2008
NCT00779766
Efficacy, Immunogenicity and Safety of GSK Biologicals' HPV GSK 580299 Vaccine in Healthy Chinese Female Subjects
Start: Oct 22, 2008
Completion: Feb 28, 2016
NCT00758264
Co-administration of Meningococcal Vaccine GSK134612 and Pneumococcal Vaccine GSK1024850A vs Individual Administration
Start: Oct 30, 2008
Completion: Nov 2, 2009
NCT00732472
A Study to Assess the Safety and Tolerability of Once Daily Inhaled Doses of GSK573719 Made With Magnesium Stearate in Subjects With Chronic Obstructive Pulmonary Disease(COPD)for 7 Days
Start: Oct 31, 2008
NCT00753688
Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy
NCT00766090
Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of Asthma
NCT00774111
GSK1349572 Drug Interaction Study With Etravirine
NCT00774735
GSK1349572 Drug Interaction Study With Protease Inhibitors
NCT00995995
Evaluation of the Duration of Oral Combination Therapy in Type 2 Diabetes, Prior to the Initiation of Insulin in the UK
NCT00732940
Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)
NCT00756470
Phase II Neoadjuvant in Inflammatory Breast Cancer
NCT00764465
NCT00776919
Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne
NCT00828464
Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand Dermatitis
NCT01077635
PENTA Fosamprenavir Study
NCT00989625
A Pharmacokinetic Study to Evaluate TREXIMET in Adolescents With Migraine and Healthy Subjects Administered at Three Doses.
Start: Nov 4, 2008
Completion: Sep 10, 2009
NCT00778895
Clinical Study in Children, 6 Months to 3 Years of Age, to Assess Two Dose Levels of an Experimental Flu Vaccine, Using a Licensed Influenza Virus Vaccine, Vaxigrip® as the Control
Start: Nov 10, 2008
Completion: Aug 19, 2009
NCT00783003
A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects
Completion: Feb 6, 2009
NCT00907933
Intranasal SB-705498 in Healthy Volunteers
Completion: Feb 11, 2009
NCT00749411
Safety and Tolerability of Repeat Dosing of GSK233705/GW642444 in COPD
Start: Nov 13, 2008
NCT00828867
Single Dose Escalation First Time in Human PK Study
Start: Nov 14, 2008
Completion: Dec 7, 2009
NCT00812981
A Study for Evaluation of GSK Biologicals' Pandemic Influenza Vaccine.
Start: Nov 15, 2008
Completion: Jun 7, 2009
NCT00849134
First Time in Human Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and the Effect of Food of Single Assending Doses of GSK1482160.
Start: Nov 17, 2008
Completion: Apr 6, 2009
NCT00857883
A First-Time-In-Human Study in Healthy Subjects
Completion: Aug 1, 2009
NCT01915758
W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers
Start: Nov 21, 2008
Completion: Feb 20, 2009
NCT00779779
Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Infants
Start: Nov 22, 2008
Completion: Aug 26, 2009
NCT00937872
A Clinical Study to Evaluate the Pharmacokinetics and the Absolute Bioavailability of SRT2104 Given as a 250mg Oral Suspension and Intravenous Microdose of 100 µg Carbon-14 Radio-labeled SRT2104 in Healthy Male Subjects
NCT00912275
Lapatinib in Combination With Oral Vinorelbine for Metastatic Breast Cancer
Start: Nov 24, 2008
Completion: Jul 7, 2017
NCT00861484
Proof of Mechanism in ELT
Start: Nov 26, 2008
Completion: Dec 11, 2009
NCT00695305
An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks
Start: Nov 30, 2008
NCT00774995
Immune Response of Healthy Subjects Who Received Neonatal Vaccination Course With Engerix™-B Vaccine.
NCT00792636
A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period
NCT00911196
Analysis of Expression of Specific Markers and Their Prognostic Significance in Hepatocellular Carcinoma
NCT01005966
In Situ Caries Model of Fluoride Toothpastes
NCT01153828
EU PV for Retapamulin-Prescribing
NCT00771914
The Effects of Omega-3 Fatty Acids on Aspirin Resistance
NCT00784784
Zanamivir Versus Trivalent Split Virus Influenza Vaccine
NCT00789113
Determination of Absorption and Elimination of Lamotrigine-XR
NCT00791089
Effects of Fish Oil on Post Ablation Arrhythmias
NCT00791973
Effect of Veramyst on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With Allergen
NCT00825994
Omega-3 for Peri- and Postmenopausal Depression
NCT01044485
Lapatinib in Combination With Docetaxel in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer
NCT01346475
Randomized Trial to Evaluate Suppressive Effect of High-Dose Valacyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2
NCT00796445
A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor
Start: Dec 1, 2008
Completion: Jan 27, 2016
NCT00799903
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Completion: Oct 17, 2013
NCT00812929
A Clinical Trial to Test a Study Drug in Volunteers Who Develop Asthma Following Exercise
NCT00792909
Vaccination Course in Primed Children and Age-matched Unprimed Children With Pneumococcal Vaccine GSK1024850A
Start: Dec 2, 2008
Completion: Jul 2, 2009
NCT00814957
An Open Label Positron Emission Tomography (PET) Study of GSK618334 in Healthy Male Subjects Using 11C-PHNO as PET Ligand
Start: Dec 8, 2008
Completion: Jun 11, 2009
NCT01929278
W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers
NCT00843193
Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma
Start: Dec 9, 2008
Completion: Jul 25, 2010
NCT00811356
A First Time in Human Study in Healthy Volunteers to Investigate a New Medicine to Treat Malaria
Start: Dec 11, 2008
NCT00805389
Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B Vaccine
Start: Dec 15, 2008
Completion: Jul 14, 2011
NCT01039454
Effects of the D3 Antagonist GSK598809 on Food Reward and Reinforcement
Start: Dec 18, 2008
Completion: Apr 26, 2010
NCT00866515
Drug Interaction Study to Investigate Co-administration of GW642444M With Ketoconazole
Start: Dec 22, 2008
Completion: Mar 27, 2009
NCT00748306
Study in Mild Asthmatic Patients
Start: Dec 31, 2008
NCT00784550
A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).
NCT00791518
Evaluation of Lung Function and Symptoms in Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator Monotherapy
NCT00793468
Relapse Prevention Study in Newly Abstinent Smokers
NCT00812773
Study to Evaluate GSK2190915 in Subjects With Mild Asthma
NCT00843024
Migraine Study in Adolescent Patients
NCT00843492
A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery
NCT01075256
Dose Response of a Tubule Occlusion Agent
NCT01153880
United States Pharmacovigilence Retapamulin-Prescribing
NCT01175252
Trends Over Time (1990-2010) of Diarrhoea-related Hospitalizations and Deaths in Children < 5 Years of Age in Brazil
NCT01376180
Drug Use Investigation for LAMICTAL
Completion: Aug 31, 2016
NCT01390883
Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal (Urology,Obstetrics,Gynecology)
NCT01568749
A Study Investigating the Pharmacokinetic Profiles of Four Extended Release Paracetamol Formulations
NCT00524134
P-glycoprotein Inhibition as Adjunct Treatment for Medically Refractory Epilepsy.
NCT00799760
Evaluation of Efficacity and Safety of Oseltamivir and Zanamivir
NCT00802074
An Interaction Study to Assess Drug Levels in Fasting Healthy Adult Subjects
NCT00799825
Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US
Start: Jan 1, 2009
Completion: Aug 2, 2012
NCT01563172
Effect of Dentifrice Usage Regime on Delivery and Efficacy of Fluoride
NCT00808444
Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6-12wks of Age
Start: Jan 5, 2009
NCT00814489
Evaluation of Non-typable Haemophilus Influenzae and Pneumococcal Protein Vaccine Formulations in Young Adults
Start: Jan 8, 2009
Completion: Jun 10, 2010
NCT00802464
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years
Start: Jan 12, 2009
Completion: Jul 2, 2010
NCT00823940
A Phase 1 Study to Evaluate the Safety and Tolerability of GSK1362885 in Healthy Normal Subjects
Start: Jan 13, 2009
Completion: Apr 27, 2009
NCT00833378
Drug Interaction Study Between Eltrombopag and Lopinavir/Ritonavir in Healthy Adult Subjects.
Start: Jan 19, 2009
Completion: Mar 11, 2009
NCT00938275
A Clinical Study to Assess the Effect of Food and Gender on the Pharmacokinetics of SRT2104 Administered as an Oral Suspension or Capsule Formulation to Normal Healthy Volunteers
Start: Jan 20, 2009
NCT00748410
Study to Evaluate the Pharmacodynamics of SB-656933 in Patients With Ulcerative Colitis
Start: Jan 22, 2009
Completion: Dec 12, 2009
NCT00802737
Efficacy and Safety of Ofatumumab Retreatment and Maintenance Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL)
Start: Jan 31, 2009
NCT00849017
Safety and Efficacy Study of Albiglutide in Type 2 Diabetes
NCT00849056
Safety and Efficacy of Albiglutide in Type 2 Diabetes
Completion: Jan 31, 2013
NCT00858455
A Study to Evaluate the Effect of Antacid and Multivitamin and Mineral Tablet on the Study Drug GSK1349572
NCT00861601
Phase 2, Pharmacokinetics Study of Eltrombopag in Japanese Thrombocytopenic Subjects With Chronic Liver Disease
NCT01054586
Fosamprenavir in Pts With Hepatic Impairment
NCT01159951
Analysis of Trends Over Time of Hepatitis Related Incidence in Panama
NCT01171144
Trends Over Time (1990-2010) of Diarrhoea-related Incidence, Hospitalizations and Deaths in Children of Panama
NCT00731770
Comparing Fluticasone-salmeterol in Chronic Obstructive Pulmonary Disease (COPD) and Sleep
NCT00803543
Effect of Valacyclovir in the Reduction of HSV-2 Recurrence and Shedding
NCT00805701
Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation
NCT00807469
Responses Induced by Smoking in Individuals Being Susceptible and Non-Susceptible for Development of COPD
NCT00817765
Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir
NCT00902018
Eltrombopag and the Bcl-extra-large (xL) Pathway in Idiopathic Thrombocytopenic Purpura (ITP)
Completion: Sep 7, 2015
NCT01133860
Efficacy of Eltrombopag to Improve Thrombocytopenia of MYH9-related Disease
NCT00814762
Safety of the HIV Vaccine 732462 in HIV Infected Subjects Aged 18 to 55 Years Old
Start: Feb 3, 2009
NCT00857857
A Study to Evaluate the Effect of GW870086X on Allergen Challenge in Mild Asthmatics
Start: Feb 16, 2009
Completion: Nov 3, 2009
NCT00829010
Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age.
Start: Feb 17, 2009
Completion: Jun 27, 2012
NCT00835237
Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine.
Completion: Oct 15, 2009
NCT00839254
Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A
Start: Feb 18, 2009
NCT00790907
Fondaparinux Trial With Unfractionated Heparin (UFH) During Revascularization in Acute Coronary Syndromes (ACS)
Start: Feb 28, 2009
NCT00828763
GSK1349572 Mass Balance Study
NCT00838903
Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes
NCT00838916
A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes
NCT00839527
A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes
NCT00858286
A Follow-up Survey to Compare Stable Dosing (SERETIDE) With SYMBICORT, SMART, Maintenance and Reliever Therapy in One Inhaler in Moderate and Severe Asthmatics.
NCT00866671
Observational Study of Nelarabine in Children and Young Adults
Completion: Sep 30, 2014
NCT01013948
Prevalence of Chronic Airway Obstruction in Subjects With a History of Cigarette Smoking in a Primary Care Setting
NCT01098500
Liver Function Test (LFT) Elevations in Cancer Patients and Users of Tyrosine Kinase Inhibitor (TKI) Drugs
NCT01304238
Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II
NCT01550926
A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage Forms
NCT01587950
The Effects of Potassium Nitrate in Reducing Dentinal Hypersensitivity
NCT00837044
Treximet in Acute Migraine Headache: Assessing Cognitive Function
NCT00841828
Trastuzumab Versus Lapatinib as Neoadjuvant Treatment for Her2+ Patients
NCT00850863
Systemic Inflammation in Chronic Obstructive Pulmonary Disease (COPD)
NCT00856297
Evaluation of Persistence of Anti-meningococcal Bactericidal Antibodies Among Adolescents Who Previously Received MenACWY Conjugate Vaccine
NCT00872963
An Extended Follow up of a RTS,S/AS01E Malaria Vaccine Trial
NCT00887484
A Comparative Study of the Tolerability of Two Combination Therapies for the Treatment of Acne
NCT00811733
A Phase II Trial of Ofatumumab in Subjects With Waldenstrom's Macroglobulinemia
Start: Mar 1, 2009
Completion: Feb 1, 2014
NCT00880399
A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Completion: Jun 16, 2010
NCT00821054
A Study to Examine the Effects of Low and High-fat Meals on Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer Patients
Start: Mar 6, 2009
Completion: Mar 22, 2011
NCT00814710
Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age
Start: Mar 7, 2009
Completion: Nov 13, 2009
NCT00849329
A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast Cancer
Start: Mar 10, 2009
Completion: Nov 24, 2009
NCT00880048
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Start: Mar 11, 2009
Completion: Jun 21, 2010
NCT00849069
Study to Assess the Safety of a New GSK Biologicals' GSK2231395A Candidate Vaccine
Start: Mar 12, 2009
Completion: Apr 7, 2009
NCT00840320
Repeat Dose Safety Study for Compound to Treat Anemia
Start: Mar 13, 2009
Completion: Sep 2, 2009
NCT00861029
VEG111485: A QTc Study of Pazopanib
Start: Mar 19, 2009
Completion: Feb 15, 2010
NCT00933062
Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of SRT2104 Administered to Normal Healthy Male Volunteers
Start: Mar 23, 2009
Completion: May 12, 2009
NCT00871156
Tafenoquine/Chloroquine DDI Study
Start: Mar 24, 2009
NCT00866619
Efficacy of GSK Biologicals' Candidate Malaria Vaccine 257049 Against Malaria Disease in Infants and Children in Africa
Start: Mar 27, 2009
NCT00920556
A Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination With Bortezomib in Patients With Multiple Myeloma
Start: Mar 30, 2009
Completion: Nov 4, 2010
NCT00812812
Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study)
Start: Mar 31, 2009
NCT00823836
Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's Disease
NCT00857766
A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT00871117
Immunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 Years
Completion: Jun 15, 2010
NCT00891553
CR9112792, a Follow-up of Study CR9108963
NCT01386983
Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database Assessment
NCT00805870
The Effects of High Dose Fish Oil Supplementation on Delayed Onset Muscle Soreness and Inflammatory Markers
NCT00852761
A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis
NCT00853697
Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer
NCT00864812
Clinical Outcomes of Tiotropium Plus Fluticasone Propionate/Salmeterol Compared With Tiotropium for Chronic Obstructive Pulmonary Disease (COPD) in Korea
NCT00866554
Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy
Completion: Dec 31, 2019
NCT00949455
A Double Blind Randomised Study of Lapatinib and Placebo in Metastatic TCC of the Urothelium
NCT01054638
HIV Treatment and CVD Events
NCT01133912
Preoperative Chemotherapy With Paclitaxel, Gemcitabine, and Lapatinib (Tykerb®) (PGT)
NCT01541475
Neuroimaging Study of Bupropion Treatment in Patients With Major Depressive Disorder
NCT00871000
Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.
Start: Apr 1, 2009
NCT00871741
Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.
Completion: Jun 25, 2009
NCT00891982
A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash
Completion: Jun 5, 2009
NCT01153802
An Open Label Positron Emission Tomography Study in Healthy Male Subjects to Investigate Brain DAT and SERT Occupancy,Pharmacokinetics and Safety of Single Oral Doses of GSK1360707, Using 11C- PE2I and 11C-DASB as PET Ligands
Start: Apr 3, 2009
NCT00920660
Clinical Study to Assess the Effects of SRT2104 and Prednisolone on Biomarkers in Blood in Healthy Volunteers
Start: Apr 6, 2009
Completion: Jun 12, 2009
NCT01767584
Bioequivalence Study of Cephalexin Tablets 1g
Completion: Apr 14, 2009
NCT00883909
ARI103094-Follow-Up Study for REDUCE Study Subjects
Start: Apr 9, 2009
Completion: Dec 29, 2010
NCT00867048
Strategic Timing of Antiretroviral Treatment
Start: Apr 15, 2009
Completion: Jul 27, 2022
NCT00875641
Safety Study of GSK Biologicals' Rotavirus Vaccine (Rotarix®) Administered to Children Aged <1 Year in the United States
Start: Apr 20, 2009
Completion: Nov 4, 2016
NCT02224521
GSK2190915A - Bioavailability Study
Completion: Jun 8, 2010
NCT00896363
Safety and Efficacy Study in Patients With Major Depressive Disorder
Start: Apr 23, 2009
Completion: Feb 9, 2010
NCT00924911
Relative Bioavailability Study in Healthy Subjects
Start: Apr 27, 2009
Completion: Jul 9, 2009
NCT00849381
Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Brazil, Taiwan or Thailand
Start: Apr 30, 2009
NCT00866294
Controlled-release Paroxetine in Major Depressive Disorder (Double-blind, Placebo-controlled Study)
NCT00883935
GSK1349572 Drug Interaction Study With Atazanavir/Ritonavir and Atazanavir
NCT01128543
Lapatinib in Combination With Vinorelbine
NCT01328028
Human Papillomavirus (HPV) Type Distribution in Adult Women Diagnosed With Invasive Cervical Cancer in New Zealand
NCT01376193
Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet
NCT01587638
Use of Beta-blockers and Risk of New Onset Diabetes
NCT01863602
Special Drug Use Investigation for LAMICTAL® (Long Term)
NCT00800345
Phase I Trial of Oral Metronomic Topotecan and Oral Pazopanib to Treat Recurrent/Persistent Gynecologic Tumors
Completion: Sep 30, 2015
NCT00852540
Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA
NCT00857714
Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast
NCT00891436
Study of the Effect of Fluticasone Furoate Nasal Spray on Spring Allergy Eye Symptoms
NCT00931086
Expanded Access Trial of Belimumab Antibody in RA Patients Who Were Previously Treated Under HGS Protocol LBRA99
NCT01001767
Pilot Placebo Controlled Study With Lovaza in Cardiovascular Disease
NCT00875485
Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™
Start: May 1, 2009
Completion: Jul 1, 2014
NCT00861380
Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease
Start: May 4, 2009
Completion: Oct 5, 2013
NCT01064349
Breast Cancer With Over-expression of erbB2-BRAINSTORM
Start: May 6, 2009
Completion: Jun 3, 2011
NCT00877877
Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.
Start: May 7, 2009
Completion: Jan 6, 2015
NCT00896558
A Repeat Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Subjects
Start: May 11, 2009
Completion: Sep 25, 2009
NCT01362244
Mepolizumab in Nasal Polyposis
Start: May 12, 2009
Completion: Dec 5, 2014
NCT00875446
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
Start: May 13, 2009
Completion: Sep 9, 2011
NCT00891176
Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines
Start: May 14, 2009
Completion: Nov 21, 2012
NCT00903422
Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
Completion: Dec 5, 2013
NCT00907985
A Study to Evaluate the Effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and in Combination on Resting Motor Threshold in Healthy Subjects
Start: May 15, 2009
NCT00896064
Evaluation of a Booster Dose of Pneumococcal Vaccine Formulations in Young Adults
Start: May 18, 2009
Completion: Aug 5, 2009
NCT00896480
Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in Patients With Inoperable Metastatic Cutaneous Melanoma
Start: May 19, 2009
Completion: Nov 3, 2014
NCT00849875
A Study of Safety and Clinical Activity of Immunotherapy Plus Chemotherapy in Metastatic Melanoma Patients
Start: May 26, 2009
Completion: Nov 17, 2014
NCT01171157
Effectiveness of Flu Vaccination and Burden of Illness Among Community-dwelling Elderly With Influenza Like Illness in Brazil
Completion: Jun 29, 2009
NCT00866697
Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Completion: Aug 24, 2017
NCT00811798
Safety Study of GSK Biologicals' HPV Vaccine (GSK-580299) in Healthy Female Subjects.
Start: May 31, 2009
NCT00823719
Phase II Study of Ofatumumab Plus Ifosfamide, Carboplatin, Etoposide (ICE) or Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Regimen in Relapsed/ Refractory Diffuse Large B Cell Lymphoma (DLBCL)
NCT00879970
Thiazolidinedione Intervention With Vitamin D Evaluation
NCT00908206
Effects of GSK598809 on Brain Activation in Abstinent Alcoholics
NCT00985985
Efficacy and Safety Study of Nicotine Mint Lozenge (2mg and 4mg) in Smoking Cessation
NCT00992160
Vestipitant 28-day Tolerance Study
NCT01031082
Study to Identify and Characterize Bacteria Causing Acute Otitis Media in South African Children
NCT01055223
Fracture Risk With Thiazolidinediones
NCT01055327
Birth Defects Associated With Exposure to Lamotrigine in Pregnancy (EUROCAT)
NCT01332383
Special Drug Use Investigation for AMERGE® Tablet (Long-term)
NCT01366599
CV Events in Emetogenic Chemotherapy
NCT01390870
Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to Adherence
NCT01782794
Acceptability of Hepatitis B Vaccination in General Population
NCT00856089
Efficacy Study of Altabax to Clear Methicillin-resistant Staphylococcus Aureus (MRSA) Nasal Colonization
NCT00871208
Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapy
NCT00888901
Platelet Function in Idiopathic Thrombocytopenic Purpura (ITP) Patients With Eltrombopag
NCT00894010
Photosensitivity Proof of Concept Trial
NCT00903656
Lapatinib Plus Caelyx in Patients With Advanced Metastatic Breast Cancer Following Failure of Trastuzumab Therapy
NCT00908362
Impact of Fluticasone and Salmeterol on Airway Dendritic Cells (DCs) in Smokers
NCT00926367
Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications
NCT01213693
Effects of Inhaled Corticosteroids on Sputum Bacterial Load in COPD
NCT00920439
Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' IPV Vaccine (PoliorixTM) in Toddlers
Start: Jun 1, 2009
Completion: Aug 3, 2009
NCT00972504
723/726 Proof of Concept Study in Allergen Challenge Chamber in Hannover
NCT00861744
Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age
Start: Jun 3, 2009
Completion: Jun 18, 2012
NCT00892775
Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds
Completion: Dec 13, 2010
NCT00880321
A Phase I Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2118436 in Subjects With Solid Tumors
Start: Jun 4, 2009
Completion: Mar 20, 2012
NCT01026064
Cantharidin-induced Skin Blister for Testing Anti-inflammatory Effects of Macrolides
Completion: Nov 27, 2009
NCT01119846
A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics
Start: Jun 5, 2009
Completion: Mar 19, 2010
NCT00920426
Study to Compare the Safety and Anti-HIV Effect of GSK1265744 Versus Placebo in HIV-1 Infected Adults (ITZ112929)
Start: Jun 9, 2009
Completion: Aug 13, 2009
NCT00911144
Booster Vaccination Study With a Pneumococcal Vaccine in Children Primed With the Same Vaccine
Start: Jun 11, 2009
Completion: Jan 11, 2010
NCT00903617
Study to Test GSK256073 in Patients With Dyslipidemia
Start: Jun 15, 2009
Completion: Feb 16, 2010
NCT00976066
[11C]Carfentanil PET Study of GSK1521498
NCT00920257
A Phase I, Open-Label, First-Time-In-Human Study of the Oral AKT Inhibitor GSK2141795
Start: Jun 16, 2009
Completion: Apr 17, 2013
NCT00920374
A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults
Completion: Jul 8, 2009
NCT00907777
Vaccination With GSK 1024850A in Children Primed With GSK 1024850A & Boosted With Pneumovax 23™
Start: Jun 23, 2009
Completion: Oct 5, 2009
NCT00871338
Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants
Start: Jun 24, 2009
Completion: Dec 9, 2010
NCT00850642
GSK2190915 Moderate to Severe Asthma Study
Start: Jun 26, 2009
Completion: Jun 2, 2010
NCT00861809
The Effect of Single Doses of the Motilin Receptor Agonist GSK962040 in Type I Diabetic Patients With Gastroparesis
Start: Jun 30, 2009
NCT00884533
QTc Study of Rosi XR in Healthy Volunteers
NCT00920088
Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs
NCT00929526
Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study
NCT01160185
Meta-analysis of Efficacy of Topotecan
NCT01204385
Study to Identify and Characterize the Bacteria Causing Acute Otitis Media Episodes in Young Children in Saudi Arabia
NCT01328964
Comparison of Asthma-related Outcomes and Costs in Pediatric Subjects That Received Fluticasone Propionate, Budesonide or Montelukast in a Large Managed Care Population
NCT01332344
Outcomes in Patients Taking Fluticasone Propionate/Salmeterol Combination or Other Inhaled Corticosteroids
NCT01332357
Use of Fluticasone Propionate/Salmeterol Combination Post Emergency Department Visit
NCT01345279
Indirect Comparison Topotecan Cervical Carcinoma
NCT01551836
At What Time Therapeutic Plasma Concentrations of Paracetamol Are Achieved in Two Marketed Formulations
NCT00440115
Disease Management for Smoking Cessation
NCT00863122
Concentration and Activity of Lapatinib in Vestibular Schwannomas
NCT00893737
"Completeness of Response Following Treatment With Treximet™ for Migraine"
NCT00894283
Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients
NCT00921466
Pilot Study to Assess Feasibility, Reliability and Validity of the e-SSRS-IVR
NCT00930527
Omega-3-Fatty Acid on Joint Symptoms Inducted by Aromatase Inhibitors
NCT01209039
A Repeat Dose Positron Emission Tomography Study With GSK1144814
Start: Jul 1, 2009
Completion: Oct 25, 2009
NCT01205178
G6PD (Glucose-6-phosphate Dehydrogenase) Study to Evaluate Hemolysis Potential of TFQ (Tafenoquine)
Start: Jul 2, 2009
Completion: Apr 1, 2013
NCT00833989
Safety Escalating Repeat IV, in Stroke Patients
Start: Jul 8, 2009
NCT00946257
Subcutaneous Administration of Otelixizumab to T1DM Patients
Completion: Jun 25, 2013
NCT00866528
Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung Cancer
Start: Jul 9, 2009
Completion: Oct 25, 2012
NCT01199757
A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome Measures
Start: Jul 10, 2009
NCT00929331
Immunogenicity & Safety Study of Fluviral® (2009 - 2010 Season) in Adults Aged 18 to 60 Years and Over 60 Years
Start: Jul 11, 2009
NCT00920218
Safety & Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A
Start: Jul 14, 2009
Completion: Mar 21, 2012
NCT00938184
Single Dose Study of Controlled-Release Paroxetine Tablets in Healthy Japanese Male Subjects
NCT00937846
Brain Uptake of GSK1034702: a Positron Emission Tomography (PET) Scan Study
Start: Jul 15, 2009
Completion: Aug 28, 2009
NCT00976144
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of GSK573719 (LAMA) and GW642444 (LABA)Administered Individually and Concurrently in Healthy Japanese Subjects
Start: Jul 29, 2009
Completion: Sep 22, 2009
NCT00938392
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine for the Elderly
Start: Jul 30, 2009
NCT00951015
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
Completion: Dec 22, 2016
NCT00849472
Treatment With Pazopanib for Neoadjuvant Breast Cancer
Start: Jul 31, 2009
NCT00858000
Analysis of Expression of Specific Markers in Hepatocellular Carcinoma
NCT00871403
Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer
NCT00920296
DDI Study of Etravirine and GSK1265744
NCT00942136
GSK1349572 Proton Pump Inhibitor Drug Interaction and Supratherapeutic Dose Study
NCT00945932
A Study to Evaluate the Effect of Repeat Doses of GW870086X in Mild to Moderate Asthmatics
NCT01156701
Prophylactic Efficacy of Relenza Against Influenza A and B
NCT01159925
Surveillance Study to Determine the Trends in Acute Hepatitis A Among Panamanian Children
NCT01201252
Study to Estimate the Disease Burden of Acute Rotavirus Gastroenteritis in Children < 5 Years in United Arab Emirates
NCT01331694
Outcomes and Costs Associated With Initiating Maintenance Treatment With Fluticasone Propionate 250mcg/Salmeterol Xinafoate 50mcg Combination (FSC) Versus Anticholinergics Including Tiotropium (TIO) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT01332500
Treximet ™ Pharmacy Budget Impact Model Database Validation Study
NCT01346852
Predictive Ability of Therapeutic Risk Factors in Pediatric and Adult Asthma Patients
NCT01347060
Outcomes for Medicare Asthma Patients Taking Fluticasone Propionate/Salmeterol Xinafoate Combination Versus Inhaled Corticosteroids or Other Combination Therapy
NCT01476176
A Pharmacokinetic Study of an Experimental Paracetamol Formulation
NCT01755702
Paracetamol With Caffeine to Treat Episodic Tension Type Headache
NCT01914770
Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76
NCT00833976
Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
NCT00915902
Fish Oil Study for High Triglyceride Levels in Children
NCT00934219
Triglyceride Lowering Study
NCT00939120
Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS)
NCT00944034
Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered as Booster Dose at 12, 18 or 24 Months of Age in Toddlers (12-24 Months) Primed With a Three-Dose Immunization Series as Infants in Study V72P12
NCT00952692
Study to Assess dHER2+AS15 Cancer Vaccine Given in Combination With Lapatinib to Patients With Metastatic Breast Cancer
NCT00964223
A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne
NCT00964366
Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications
NCT01871038
Rotarix Vaccine Effectiveness
NCT01706263
U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With Acne
Start: Aug 1, 2009
Completion: Nov 20, 2009
NCT00938327
Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Indian Infants
Start: Aug 3, 2009
Completion: Apr 23, 2010
NCT00937404
Safety and Reactogenicity of GSK Biologicals' Inactivated Poliomyelitis Vaccine (IPV) (Poliorix) in Infants
Start: Aug 4, 2009
NCT00937950
Gynaecological Follow-up of a Subset of 580299/008 (NCT00122681) Study Subjects
Start: Aug 5, 2009
Completion: Jan 20, 2014
NCT00938158
A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.
Completion: Apr 12, 2011
NCT00950833
Long-term Follow-up Study of Children Previously Primed With GSK Pneumococcal Vaccine (GSK1024850A) and of Unprimed Children
Start: Aug 10, 2009
Completion: Oct 27, 2010
NCT00951041
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults
Start: Aug 11, 2009
Completion: Aug 30, 2010
NCT00920192
Safety Study of Foretinib (GSK1363089) in Adults With Liver Cancer
Start: Aug 12, 2009
Completion: Mar 24, 2015
NCT00935831
Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment
NCT01428427
Combination Study of GSK1120212 With Gemcitabine in Subjects With Solid Tumors
NCT00970307
Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age
Start: Aug 13, 2009
Completion: Jan 27, 2010
NCT01013766
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK1362885 in Type 2 Diabetics
NCT00942162
A Study to Test the Benefit of a New Anti-cancer Treatment in Patients With Unresectable Advanced Melanoma
Start: Aug 14, 2009
Completion: Apr 1, 2015
NCT00955383
GSK2190915 Safety and Pharmacokinetic Study in Healthy Japanese Subjects
NCT00955773
A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects
Start: Aug 17, 2009
NCT00937326
Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Type 2 Diabetic Human Subjects
Start: Aug 19, 2009
Completion: Sep 18, 2010
NCT00950586
Safety, Blood Levels, Drug Interaction and Effects of Repeated Doses of GSK1034702
Start: Aug 24, 2009
Completion: Dec 24, 2009
NCT01014962
A Study of the Effects of Increasing Doses of a Drug for the Treatment of Nail Fungus
NCT00955682
Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK134612
Start: Aug 25, 2009
Completion: Sep 10, 2012
NCT00969228
Study to Evaluate Immunogenicity, Reactogenicity and Safety of Rotarix™ Vaccine in Korean Infants
Completion: Jul 23, 2010
NCT00964106
Validation Study of Multiple Probe Compounds for Drug Interaction Evaluation
Start: Aug 26, 2009
NCT01030939
Study to Investigate Safety, Tolerability, Pharmacokinetics and Cardiac Function After Repeat Doses of SB-649868 in Healthy-volunteers
Start: Aug 27, 2009
Completion: Jan 6, 2010
NCT00911300
Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart Rhythm
Start: Aug 31, 2009
NCT00969059
Study in Neuropathic Pain Patients With Peripheral Nerve Injury
NCT00972686
Dose-Escalation Study of GSK2126458
NCT01128972
Evaluation of a Test Mouthwash and Dentifrice Regimen in an In-situ Model of Dental Erosion
NCT01209091
Utility and Work Productivity Data for Economic Evaluation of Breast Cancer Therapies in the Netherlands and Sweden
NCT01235988
Meta-analysis - Eltrombopag
NCT01236014
Indirect Comparison Between Eltrombopag & Romiplostim
NCT01270958
A Phase-IV, Open-label Study to Evaluate Safety/Tolerability of Once-daily AVAMYS (TM) Aqueous Nasal Spray 110mcg Among Vietnamese Adult Patients With Established Perennial Allergic Rhinitis
NCT01332409
Special Drug Use Investigation for ADOAIR DISKUS COPD (Salmeterol and Fluticasone)
NCT01381471
Fluticasone Propionate-salmeterol Combination Adherence in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00881621
Lapatinib and Capecitabine for Second Line Treatment of Pancreas Cancer
NCT00946400
Validating 4Ts for Heparin Induced Thrombocytopenia (HIT)
NCT00950859
A Pilot Study Assessing the Integrase Inhibitor GSK1349572 in HIV-infected Persons With Virus Resistant to Raltegravir
NCT00980707
Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of Asthma
NCT01015638
Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications
NCT00950807
GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease
Start: Sep 1, 2009
Completion: Mar 15, 2010
NCT01077622
A Phase I/II, a Single Arm, Open-label Study of Ofatumumab (GSK1841157) in Patients With Previously Treated Chronic Lymphocytic Leukemia
Completion: Apr 1, 2011
NCT01090440
Pharmacokinetics, Effect of Food, Safety and Tolerability of a New Tablet Formulation of GSK1144814 in Healthy Subjects
Completion: Oct 9, 2009
NCT00968526
Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults
Start: Sep 8, 2009
Completion: Sep 23, 2010
NCT00968539
Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults
Completion: Sep 28, 2010
NCT00971425
Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1)
Completion: Oct 8, 2010
NCT01316926
Paxil CR Bioequivalence Study Brazil
Start: Sep 9, 2009
NCT00964158
Safety and Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A)
Start: Sep 10, 2009
Completion: Nov 27, 2010
NCT00971321
Safety, Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A)
Completion: Nov 24, 2010
NCT00968890
Immunogenicity and Safety of Vaccine GSK2340272A (H1N1) and GSK Biologicals Fluarix™ Vaccine When Co-administered in Elderly
Start: Sep 12, 2009
NCT00975884
Study to Evaluate Immunogenicity & Safety of an Investigational Influenza Vaccine in Adults
Start: Sep 14, 2009
NCT01036022
Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative Colitis
Start: Sep 15, 2009
Completion: Jan 10, 2013
NCT01000597
Study to Look at and Compare How Inhaled and Intravenous Fluticasone Furoate is Processed by the Body in Healthy Caucasian, Japanese, Korean and Chinese Subjects
Start: Sep 17, 2009
Completion: Dec 23, 2009
NCT01039974
GSK962040 Drug-drug Interaction Study With Ketoconazole
Start: Sep 18, 2009
NCT01371682
A Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole Prolonged Release Tablets Manufactured at Crawley and Aranda
Completion: Dec 2, 2009
NCT00975936
Phase 0 Microdose Study
Start: Sep 21, 2009
Completion: Nov 12, 2009
NCT00947115
Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects
Start: Sep 22, 2009
Completion: Feb 3, 2015
NCT00976105
Effects of Repeat Dosing of GSK1521498
NCT00976560
Clinical Study to Test a New Drug to Treat Major Depression
Start: Sep 25, 2009
Completion: Jul 7, 2010
NCT01009463
A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT01017952
A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Completion: Oct 17, 2011
NCT03105297
To Characterize the Performance of the Nasal Dilator Strip in Lowering Nasal Resistance During Sleep, Promoting Nasal Route Breathing and Reducing the Signs and Symptoms of Sleep Disordered Breathing in a Group of Chronic Nocturnal Nasal Congestion Sufferers Who Report Trouble With Their Sleep.
Completion: Aug 10, 2010
NCT00903201
28 Day Repeat Dose in Cystic Fibrosis Patients
Start: Sep 28, 2009
NCT00963937
Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents
Completion: Dec 3, 2010
NCT01036061
GSK618334 Repeat Dose Study
Completion: Feb 17, 2010
NCT00972517
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children
Start: Sep 29, 2009
Completion: Nov 22, 2010
NCT00953576
Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer
Completion: Apr 11, 2013
NCT00891761
A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy
Start: Sep 30, 2009
NCT00908037
Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)
NCT00974363
Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK 134612
NCT00976391
A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine
NCT00980200
Efficacy and Safety Study in Subjects With Asthma
NCT00996021
Study to Assess Cardiac Conduction of GSK1349572
NCT00996216
Clinical Trial for Non-responders Who Previously Participated in Eltrombopag Studies TPL 103922 or TPL 108390
NCT01105949
An Evaluation of Two Novel Nasal Strip Prototypes on Nasal Patency
NCT01115452
Efficacy of Potassium Nitrate Solution in Reducing Dentinal Hypersensitivity
NCT01154244
Insulin Resistance as Primary Pathogenesis in Newly Diagnosed, Drug naïve Type 2 Diabetes Patients in Korea
NCT01231464
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic Rhinitis
NCT01390896
Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal General Surgery
NCT01435941
Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine
NCT00935766
Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries
NCT00941642
Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease
NCT00959842
Effects of Lovaza on Lipoprotein Composition and Function in Mild Hypertriglyceridemia
NCT00973739
Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
NCT00985738
Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate Cancer
NCT01010399
Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects
NCT01086358
Does Treximet Improve Productivity and Patient Satisfaction Due to Sustained Response and Consistency of Response?
NCT01766544
Asthma & COPD Guideline Implementation
NCT00964340
A Clinical Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral SRT2104 Capsules Administered to Healthy Elderly Subjects for 28 Days
Start: Oct 1, 2009
NCT00985673
Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults
NCT00989612
Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1)
Completion: Apr 19, 2010
NCT01001169
Safety and Immunogenocity Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Japanese Children
Completion: May 17, 2010
NCT01122849
Exploratory Subjective Sleep Study of a Prototype Nasal Dilator
Completion: Feb 1, 2010
NCT01017120
A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne
Completion: Nov 9, 2010
NCT01013974
A Study of GSK573719 in Healthy Japanese Male Subjects
Start: Oct 5, 2009
Completion: Dec 18, 2009
NCT01053988
A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Completion: Apr 14, 2011
NCT00989287
Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults
Start: Oct 7, 2009
Completion: Oct 26, 2010
NCT00910962
A Study to Evaluate the Safety of 12 Weeks of Dosing With GW856553 and Its Effects on Inflammatory Markers, Infarct Size, and Cardiac Function in Subjects With Myocardial Infarction Without ST-segment Elevation
Start: Oct 8, 2009
Completion: Mar 6, 2012
NCT00985790
Immunogenicity and Safety Study of a GlaxoSmithKline Biologicals' Candidate Influenza Vaccine in Healthy Children
Completion: May 21, 2010
NCT00985088
Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older
Start: Oct 11, 2009
Completion: Dec 16, 2010
NCT00979407
Study to Evaluate Immunological Equivalence Between Two Investigational Influenza Vaccines in Adults (H1N1)
Start: Oct 12, 2009
NCT00984139
Persistence of Immunity Against Hepatitis B in 12-13 Year Old Adolescents After Infant Hepatitis B Vaccination
Completion: Apr 7, 2010
NCT00989404
Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Repeat Dose Zanamivir/Placebo Via Devices Administered Twice Daily for 5 Days
NCT01019603
A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne Vulgaris
Completion: Dec 20, 2009
NCT00980005
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Start: Oct 13, 2009
Completion: Jun 17, 2010
NCT00992511
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults, Using Two Different Manufacturing Processes
Start: Oct 14, 2009
NCT00992784
Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine in Elderly People
Start: Oct 15, 2009
NCT00996268
An Open-label Single Dose Randomized, Parallel Group Study Followed by Single-blind Repeat Dosing, to Compare the Relative Bioavailability of GSK2212836.
Completion: Jan 4, 2010
NCT01209052
First Time in Human Study With GSK1325756
Completion: Mar 2, 2010
NCT00996840
SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS
Start: Oct 16, 2009
Completion: Feb 9, 2013
NCT00976261
A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes
Start: Oct 17, 2009
Completion: Sep 5, 2010
NCT01018186
Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety Study
Start: Oct 19, 2009
Completion: May 12, 2011
NCT01054885
Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Completion: Feb 8, 2011
NCT00976820
Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age
Start: Oct 20, 2009
Completion: Mar 21, 2011
NCT01339247
Paxil CR Bioequivalence Study Brazil - Fed Administration
Completion: Nov 16, 2009
NCT00945282
Safety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults.
Completion: Nov 28, 2009
NCT00996125
Immunogenicity and Safety Study of GSK Biologicals' Human Papillomavirus 580299 Vaccine in Healthy Female Subjects
Start: Oct 24, 2009
Completion: Dec 8, 2010
NCT00984659
Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary Disease
Start: Oct 29, 2009
Completion: Jul 1, 2010
NCT00996853
Post-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United Kingdom
Start: Oct 31, 2009
Completion: Apr 6, 2011
NCT01077661
Regulatory Nebilet PMS
NCT01082081
Post-operative Dental Pain Study Comparing Analgesic Efficacy
NCT01195259
Malignancy Meta Analysis for BRL49653
NCT01221987
Cross-sectional Study on Human Papillomavirus Type Distribution in Adult Women Diagnosed With Cervical Cancer
NCT01366508
A Study to Characterize Event Related Potential Markers of Attentional Bias Towards Words and Images of Food
NCT00832364
Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis
NCT00931879
Lovaza® and Microvascular Function in Type 2 Diabetes
NCT00991523
Overnight Post-Exercise Recovery After Protein Ingestion Prior to Sleep
NCT01001325
Does Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza?
NCT01008813
Clinical Trial to Evaluate the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine and a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac)
NCT01016977
A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris
NCT01017146
A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - W0260-301
NCT01289418
Surveillance for Adverse Events Following Pandemic H1N1 Immunization
NCT01429376
Pulmonary Function, Chronic Obstructive Pulmonary Disease (COPD) Prevalence, and Systemic Inflammation in Chronic Heart Failure With or Without COPD
NCT01485237
Severe Pandemic H1N1 Infection in ICU: Comparative Resource Utilization
NCT01000506
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
Start: Nov 1, 2009
Completion: Mar 23, 2012
NCT01000493
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
Start: Nov 2, 2009
Completion: Jun 28, 2010
NCT01009255
Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease
Completion: Nov 10, 2010
NCT01000857
Repeat Dose Study of Controlled-Release Paroxetine Tablets and Immediate-Release Paroxetine Tablets in Healthy Japanese Male Subjects
Start: Nov 5, 2009
Completion: Feb 25, 2010
NCT00996671
Phase I Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of GSK2256098 in Healthy Volunteers
Start: Nov 6, 2009
Completion: Mar 17, 2010
NCT01000324
Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix Adult
Completion: Jul 25, 2014
NCT00969436
Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM
Start: Nov 9, 2009
Completion: Feb 21, 2011
NCT00979602
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
Completion: Feb 1, 2011
NCT01181908
Alcohol Interaction Study
Start: Nov 11, 2009
Completion: Dec 30, 2009
NCT00985465
Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Mali
Start: Nov 12, 2009
NCT00996762
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Completion: Sep 18, 2012
NCT04912297
Immunity to Serotype 19A Streptococcus Pneumoniae in Children Vaccinated With PCV10
Completion: May 7, 2013
NCT01003418
Study to Evaluate Safety and Immunogenicity of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children
Start: Nov 17, 2009
Completion: Nov 25, 2010
NCT00992121
An Open-Label Pharmacodynamic Study of Bevacivumab and Pazopanib in Renal Cell Carcinoma
Start: Nov 18, 2009
Completion: Nov 1, 2013
NCT01031186
First Time in Human Study
Start: Nov 23, 2009
NCT01128621
A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263
Completion: Apr 12, 2010
NCT01009814
Pharmacodynamics, Safety and Pharmacokinetics of BMS-663068, an HIV Attachment Inhibitor, in HIV-1
Completion: Jun 25, 2010
NCT01039883
A Study to Compare the Blood Levels of Albaconazole in Healthy Subjects Who Have Received a Single Dose of 400 mg Albaconazole as a Tablet Versus Albaconazole as a Capsule
Completion: Jan 20, 2010
NCT00985751
Safety & Immunogenicity of Pneumococcal Vaccine 2189242A in Children Aged 12-23 Months at the Time of First Vaccination
Start: Nov 24, 2009
Completion: Mar 2, 2011
NCT01332071
Avandamet Bioequivalence Study Brazil - Fed Administration
Completion: Dec 6, 2009
NCT01021293
Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Poliorix™ Vaccine
Start: Nov 28, 2009
Completion: Jul 5, 2010
NCT00996944
Clinical Evaluation of Ropinirole IR (Immediate Release) Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome (RLS) Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemodiafiltration)
Start: Nov 30, 2009
Completion: Jun 29, 2010
NCT00997061
SCOT Registry: Small Cell Lung Cancer Treatment and Outcome
NCT01014988
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Completion: Feb 28, 2015
NCT01037127
Study to Determine the Effectiveness of GSK1120212 in BRAF Mutation-positive Melanoma Previously Treated With or Without a BRAF Inhibitor
NCT01039610
A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose and Repeat Escalating Oral Doses of GSK945237; the Effect of Linezolid on Hematology Safety Parameters; and the Effects of GSK945237 and Moxifloxacin on QTc.
NCT01075243
Post-operative Dental Pain Study Comparing Two Different Dosage of Analgesic Efficacy
NCT01128946
Enamel Remineralization Potential of Dentifrices in Situ
NCT01199744
Relenza® Sentinel Site Monitoring Program in Japan
NCT01332422
Special Drug Use Investigation for ADOAIR Metered-dose Inhaler (Pediatric)
NCT01332435
Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor Use
NCT01332461
Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance Therapies
NCT01476189
A Study to Compare to the Pharmacokinetic Profile of Two Paracetamol Formulations
NCT01476215
A Pharmacokinetic Study Investigating the Rate and Extent of Paracetamol Absorption of Three Experimental Sustained Release Pediatric Suspensions
NCT01495494
A Multiple Use Tolerability Study of a Breathe Right Nasal Strip Prototype
NCT01777074
Acceptability of Hepatitis B Vaccination in General Practitioners and Paediatricians
NCT00977301
Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)
NCT01007253
Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy Symptoms
NCT01013701
Compare the Effects of Fluticasone Furoate Nasal Spray vs Placebo in Patients With Nasal Polypoid Disease
Completion: Jul 29, 2010
NCT01050322
Safety Study in Subjects With Metastatic Breast Cancer Who Progressed After Taxanes Treatment.
NCT00964028
Safety Study of GSK Biologicals' DTPa-IPV/Hib (Infanrix™-IPV/Hib)
Start: Dec 1, 2009
NCT00972725
Evaluation of the Immune Response of a HIV Candidate Vaccine After Administration of One Chloroquine Dose
Completion: Oct 4, 2010
NCT01000727
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Completion: Apr 24, 2014
NCT01009060
Study to Evaluate the Efficacy and Safety of GSK239512 in Schizophrenia
Completion: Aug 10, 2011
NCT01014091
Study to Evaluate the Safety and Immunogenicity of GSK Biological Pandemic Candidate Influenza Vaccine (H1N1) in Children
Completion: Jan 14, 2011
NCT01018628
A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2379 in Normal Healthy Male Volunteers
Start: Dec 7, 2009
Completion: Aug 6, 2010
NCT00950612
Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Healthy HIV Negative Adolescents
Start: Dec 8, 2009
NCT01027845
Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A in Healthy Japanese Children
Completion: Sep 17, 2011
NCT01330303
SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin
Completion: Dec 22, 2009
NCT01014117
Effect of SRT2104 on Endotoxin-induced Inflammation
Start: Dec 9, 2009
Completion: May 10, 2010
NCT01051063
Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy
Completion: Apr 26, 2016
NCT01079910
To Investigate the Clinical Efficacy of an Experimental Toothpaste
NCT01030965
28-day Repeat Dose Study of GSK573719
Start: Dec 15, 2009
Completion: Jul 4, 2010
NCT01371799
A Study to Examine the Pharmacodynamic Effects of GSK1034702 on Neurophysiological Biomarkers of Cognition in Nicotine Abstained Otherwise Healthy Smokers
Start: Dec 17, 2009
NCT01031472
A Study to Assess Relative Bioavailability and Food Effect of New Formulations of GSK2248761
Start: Dec 21, 2009
Completion: Mar 11, 2010
NCT01021553
A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation
Start: Dec 23, 2009
Completion: May 5, 2011
NCT01004874
Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma
Start: Dec 30, 2009
Completion: Nov 2, 2021
NCT01039805
Evaluation of Single Doses of GSK962040 in Critically Ill Patients With Enteral Feed Intolerance
Start: Dec 31, 2009
NCT01332370
Prescription Patterns, Resource Utilization & Costs - Add-on Therapy With Anti Dipeptidyl Peptidase-IVs vs Rosiglitazone
NCT01376206
Drug Use Investigation for ALLERMIST
NCT01428440
PET Study to Study Tumour Apoptosis
NCT01439308
Intranasal SB-705498 in Non-allergic Rhinitis Patients
NCT01540721
Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol® Extend
NCT01540734
Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol®
NCT01592227
A Study to Compare Two Paracetamol Formulations.
NCT01012362
Study of Pazopanib and Ixabepilone in Patients With Solid Tumors
NCT01016444
Acute Asthma Responsiveness and B2 Adrenergic Receptors Polymorphisms
Completion: Jul 29, 2011
NCT01052701
Drug Interaction Study With Ribavirin and Abacavir in Male Subjects With Hepatitis C Who Have Failed Ribavirin Treatment
NCT01196273
Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follow-up
NCT01262469
Evaluating Lapatinib + Capecitabine in Patients Aged 70 and Over With HER2 Metastatic Breast Cancer.
NCT01450995
Migraine Treatment Satisfaction With Treximet Versus Concomitant 2 Aleve and Imitrex
NCT01916395
Comparison of Treximet & Imitrex as They Affect the Levels of Inflammatory Markers When the Patient is Actively Having a Migraine Headache
NCT01039675
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Combination of GSK573719 and GW642444 in Subjects With COPD
Start: Jan 1, 2010
Completion: Apr 20, 2010
NCT01072149
A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic (PD) Profiles of 3 Doses of Fluticasone Furoate (FF)/GW642444 Inhalation Powder at the End of a 28-day Treatment Period in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Compared to Placebo
NCT01262989
SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast Admin
Start: Jan 4, 2010
Completion: Jan 26, 2010
NCT01035645
First Time in Human Study of Intravenous Interleukin-18 Antibody
Start: Jan 5, 2010
Completion: Jul 11, 2012
NCT01018030
Dose Finding Study of Fluticasone Furoate Nasal Spray for Uncomplicated Acute Rhinosinusitis
Start: Jan 6, 2010
Completion: Jul 16, 2010
NCT01110057
Efficacy Study in Lumbosacral Radiculopathy
Start: Jan 7, 2010
Completion: Aug 23, 2010
NCT01051700
A Safety Study in Healthy Volunteers to Evaluate Safety, How Fast the Drug is Absorbed, and the Side Effects of the Drug in Humans
Start: Jan 12, 2010
NCT01072162
Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation and Food Effect
NCT01299597
A Single-centre Open Label Study to Investigate the Effect of Repeat Doses of SB-649868 on the Pharmacokinetics of Simvastatin and Atorvastatin in Healthy Male Volunteers.
Start: Jan 18, 2010
Completion: Feb 26, 2010
NCT01086462
Intravenous Microdose Pharmacokinetic (PK) Study With [14C]-GSK2239633
Start: Jan 21, 2010
Completion: Feb 22, 2010
NCT01068587
MET/VEGFR2 Inhibitor GSK1363089 and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone in Locally Advanced or Metastatic NSCLC That Has Not Responded to Previous Chemotherapy
Completion: Feb 13, 2015
NCT01037114
Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix Adult
Start: Jan 27, 2010
NCT00975988
Regulatory TYKERB® Tablets PMS
Start: Jan 31, 2010
NCT01051622
PBMC (Peripheral Blood Mononuclear Cells) /Lymphocyte SPECT (Single Photon Emission Computerized Tomography) Imaging in Crohn's Disease
NCT01064362
Hemorrhage Risk Prescribed Arixtra
NCT01128569
Randomised Study Comparing the Effects of Inhaled Fluticasone Furoate (FF)/Vilanterol (VI; GW642444M) Combination and FF on an Allergen Induced Asthmatic Response
NCT01337258
Economic Analyses of the REDUCE Trial
NCT01376219
European Cost of Asthma Treatment
NCT01376271
Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)
NCT01387243
Survey on the Pharmacy Follow-up of Alli Purchasers
NCT01424449
A PET Study in Healthy Volunteers
NCT00746811
Effects of Prescription Omega-3 on LDL-C in Primary Hypercholesterolemia
NCT00920348
The Canadian Cohort Obstructive Lung Disease
NCT00936195
Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial
NCT00944229
The Effect of Omega-3 Polyunsaturated Fatty Acids in Congestive Heart Failure
NCT01027598
Randomized, Double-Blind Trial of Erlotinib/Pazopanib or Erlotinib/Placebo in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer
Completion: Jun 30, 2014
NCT01028326
PCV10 Reactogenicity and Immunogenicity Study - Malindi
Completion: Dec 31, 2018
NCT01035658
Pazopanib/Doxil in Adv Relapsed Plat Sensitive or Resistant Ovarian, Fallopian or Primary Peritoneal Adenocarcinoma
NCT01044576
Patient Research Cohort: Rapidly Evolving Multiple Sclerosis
NCT01046604
Pilot Study of Lovaza (Omega 3 Fatty Acids) to Improve Cardiac Antioxidant/Anti-inflammatory Profile Before Cardiac Surgery
NCT01048502
Fenofibrate and Omega-3 Fatty Acid Modulation of Endotoxemia
NCT01085461
Assessment of Suicidality in Epilepsy - Rating Tools
NCT00979771
A Study to Investigate the Ability of GSK706769 to Maintain Clinical Remission After Withdrawal of Enbrel in Rheumatoid Arthritis Patients
Start: Feb 1, 2010
Completion: Apr 28, 2011
NCT01035749
Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years
Completion: May 10, 2011
NCT01345266
Characterisation of Healthy Volunteers, Asthma and Chronic Obstructive Pulmonary Disease Patients for Inhalation Profile, Pharyngometry, Spirometric Indices and Lung Morphometry
NCT01039961
PK Study of IV Formulation of GW856553
Start: Feb 2, 2010
Completion: Apr 15, 2010
NCT01067339
Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Progenitor Cells and Coronary Atherosclerosis in Humans
Start: Feb 4, 2010
NCT01059617
Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults
Start: Feb 9, 2010
Completion: Oct 21, 2011
NCT01424423
NOGO-A in Multiple Sclerosis FTIH
Start: Feb 11, 2010
Completion: Aug 26, 2010
NCT01051661
Safety and Efficacy of H1N1 Vaccines in Children Aged 6 Months to Less Than 10 Years of Age
Start: Feb 12, 2010
NCT01154166
A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment With Ropinirole PR as Adjunctive Therapy in Patients With Parkinson's Disease Who Are Not Optimally Controlled on L-Dopa
Start: Feb 15, 2010
Completion: Sep 29, 2011
NCT01068925
Drug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy Volunteers
Completion: Apr 5, 2010
NCT01086384
Asthma Exacerbation Study
Start: Feb 22, 2010
Completion: Sep 15, 2011
NCT01077648
Brain Metastasis in Breast Cancer Patients
Start: Feb 28, 2010
NCT01332448
Meta-analysis of Orlistat Laboratory Data From Placebo-controlled Clinical Trials
NCT01444612
Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery
NCT01702337
Prevalence-based Health and Economic Model of the Bivalent Versus the Quadrivalent Human Papillomavirus (HPV) Vaccine
NCT02069496
Drug Use Investigation for Arepanrix® (H1N1)
NCT00974805
An Investigation of the Mechanism of Action of Seretide in Chronic Obstructive Pulmonary Disease
NCT01002040
Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults With HIV
NCT01064947
Safety and Efficacy Study of Altabax Ointment in the Treatment of Secondarily Infected Atopic Dermatitis
NCT01072890
Temsirolimus and Pazopanib in Patients With Advanced Solid Tumors
NCT01546116
Adefovir and Lamivudine for Entecavir Resistance (ALTER Study)
NCT01811615
Efficacy of New Alcohol Free Mouthrinses
NCT01086423
Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine
Start: Mar 1, 2010
Completion: Nov 19, 2010
NCT01162590
Study to Evaluate the Reactogenicity and Safety of Rotarix™ in Chinese Adults
NCT01018017
A Clinical Study to Assess the Safety, Tolerability, and Activity of Oral SRT2104 Capsules Administered for 28 Days to Subjects With Type 2 Diabetes Mellitus
Start: Mar 3, 2010
Completion: Dec 25, 2010
NCT01086449
Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Ethnic Japanese Adults
Start: Mar 4, 2010
NCT01128634
Pharmacokinetic and Safety of GSK573719 and GW642444 Administered Individually and Concurrently, With Verapamilin in Healthy Subjects
NCT01072214
A Safety Study to Evaluate Pazopanib Eye Drops in Healthy Volunteers
Start: Mar 9, 2010
NCT01086436
Study to Evaluate the Safety of Rotarix™ in Chinese Children
Start: Mar 13, 2010
Completion: Apr 16, 2010
NCT01077505
An Evaluation of the Pharmacokinetics of an Oral Contraceptive (Brevicon) When Co-administered With Albiglutide .
Start: Mar 15, 2010
NCT01098526
GSK1349572 Drug Interaction Study With Efavirenz
Start: Mar 16, 2010
Completion: May 26, 2010
NCT01092611
Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine
Start: Mar 22, 2010
Completion: May 19, 2014
NCT01112787
A Study to Evaluate the Irritation Potential of Tazarotene Foam on Skin in Healthy Volunteers
Start: Mar 26, 2010
NCT01745575
Bioequivalence Trial of Alprazolam 2 mg Tablets
Start: Mar 28, 2010
NCT01060384
Study of Lenalidomide and Ofatumumab for the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma
Start: Mar 29, 2010
Completion: Jan 1, 2018
NCT01004939
Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism
Start: Mar 31, 2010
NCT01014208
Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma
Completion: Nov 30, 2014
NCT01047397
Repeat Dose Safety and Efficacy Study for Compound to Treat Anemia
NCT01064336
Promacta Pregnancy Registry
NCT01086410
Safety Study of the Effects of Inhaled Fluticasone Furoate/GW642444 on the Hypothalamic-Pituitary-Adrenal (HPA) Axis
NCT01138124
Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD)
NCT01160081
Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella Pertussis
NCT01381497
Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy
NCT00997620
Fluticasone Furoate Treatment of Daytime Somnolence and Cognitive Performance in Seasonal Allergic Rhinitis
NCT01016678
Treximet Early Intervention Adolescent Migraine
NCT01034540
Effects of Prescription Omega-3 Acids on Glucose and Lipoprotein Lipids in Subjects With Hypertriglyceridemia
NCT01088009
Efficacy Optimizing Research of Lamivudine Therapy
NCT01092390
Go Fish: Omega-3 Fatty Acid Supplementation in Diabetes-Related Kidney Disease
NCT01114841
A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers
Completion: Jun 26, 2010
NCT01179269
Pazopanib and Paclitaxel for Non-Small Cell Lung Cancer
NCT02686424
Tumor Markers Study in Gastric Cancer for Cancer Immunotherapy (ONCO-RD 010 CRT)
NCT01099488
A Study in Healthy Adults Having Received a Single Vaccine Administration to Support the Development of Immunological Assays
Start: Apr 1, 2010
Completion: Dec 7, 2010
NCT01115322
A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers
Completion: Apr 10, 2010
NCT01030822
Booster and Catch-up Vaccination With Vaccine GSK1024850A
Start: Apr 2, 2010
Completion: Aug 19, 2011
NCT01096056
Trial to Evaluate the Safety and the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Healthy Children
Start: Apr 5, 2010
NCT01107587
Study to Assess the Safety of GSK Biologicals' Liquid Human Rotavirus Vaccine in Healthy Infants
Start: Apr 13, 2010
NCT01101568
A Study to Investigate the Interaction of GSK1292263 With Rosuvastatin and Simvastatin in Healthy Subjects
Start: Apr 14, 2010
Completion: Jun 24, 2010
NCT01209104
Pharmacokinetics and Safety of GSK1325756 in Elderly Subjects and Adult Subjects of in the Fed and Fasted States and in the Presence of a Proton Pump Inhibitors
Completion: May 24, 2010
NCT01424462
Healthy Volunteer Pilot Study Using 3 Types of Modified Release Formulations of Firategrast to Investigate How Quickly Absorption From the Digestive System Takes Place.
Start: Apr 19, 2010
Completion: Jul 6, 2010
NCT01077531
Safety, Pharmacodynamics and Pharmacokinetics of GSK2136525 Repeat Dose in Rheumatoid Arthritis
Start: Apr 28, 2010
NCT01110018
GSK573719 IV Enabling Study
Completion: Jun 9, 2010
NCT01004809
AVODART® Alopecia Post-marketing Surveillance (PMS)
Start: Apr 29, 2010
Completion: Dec 21, 2012
NCT01098006
A Study in Adult Subjects With Chronic Hepatitis B Infection to Support the Development of Immunological Assays
Completion: Feb 20, 2012
NCT01008956
Safety and Immune Response of One-Dose of Candidate H1N1 Influenza Vaccine GSK2340274A in Adults
Start: Apr 30, 2010
NCT01098461
Dose Ranging Study of Albiglutide in Japanese Subjects
NCT01110044
Study of a Birth Dose of GlaxoSmithKline Biologicals' 251154 Vaccine
NCT01110200
Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study
NCT01122862
Effect of a Commercial Cosmetic Mouth Rinse on Plaque Re-growth
NCT01128738
GSK1358820 (Botulinum Toxin A) PhIII DB & OL Study in Patients With Axillary Hyperhidrosis
NCT01138046
Phase I/II Study of Lapatinib in Combination With Paclitaxel as 1L Chemotherapy for ErbB2-positive MBC
NCT01153815
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Upper Limb Spasticity
NCT01213459
Study on the Prevalence of Human Papillomavirus Types in Women >= 15 Years of Age in the Kingdom of Saudi Arabia
NCT01323998
Benign Prostatic Hypertrophy Treatment Patterns & Outcomes: Marketscan
NCT01334723
Demonstrating the Clinical and Economic Benefit of 5 Alpha Reductase Inhibitor Adherence in Benign Prostatic Hyperplasia
NCT01381640
A Study to Compare Two Paracetamol Tablets
NCT01453049
An Efficacy and Safety Study of Fixed-dose Rosiglitazone/Glimepiride to Treat Chinese Type 2 Diabetes Patients
NCT01476072
31P MRS Ischaemic Exercise Optimisation and COPD
NCT01511133
Serological Response to Porcine Circovirus Type 1 (PCV-1) and PCV-1 DNA in Stools of Infants Following Administration of Rotarix™
NCT01767428
Pharmacokinetic Study to Compare Two Formulations of Paracetamol
NCT01010568
Ofatumumab and Bendamustine for Previously Treated Chronic Lymphocytic Leukemia (CLL)
NCT01098513
GSK1349572 Relative Bioavailability Study
NCT01102972
A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE)
NCT01108055
Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer
Completion: Jul 31, 2015
NCT01109537
Altered Brain GABA and Glutamate in Restless Legs Syndrome
Completion: May 31, 2014
NCT01112553
Treximet Migraine Brain Imaging Research Study
NCT01126268
Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection
NCT01150760
Clinical Outcomes After Bowel Resection in Patients Receiving Alvimopan Versus Patients Not Receiving Alvimopan in the Premier Perspective Database
NCT01168388
Movement Disorder Survey in East China
NCT01333644
The Role of Inflammation and Aging in HIV-Associated Cardiovascular Risk
NCT01138085
Safety, Pharmacokinetics (PK) of AKT and MEK Combination
Start: May 4, 2010
Completion: Nov 19, 2014
NCT01745601
Bioequivalence Study of Escitalopram Tablets 10 mg
Completion: May 19, 2010
NCT01114607
A Study to Assess the Relative Bioavailability of Four New Formulations of GSK1605786 in Healthy Subjects
Start: May 5, 2010
NCT01132443
W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With Acne
Start: May 6, 2010
Completion: Jun 12, 2010
NCT01101555
Repeat Dose Subcutaneous Rhumatoid Arthritis Efficacy Study
Start: May 12, 2010
Completion: Nov 29, 2012
NCT01106092
Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers
Start: May 13, 2010
Completion: Sep 2, 2010
NCT01110031
Ofatumumab Cardiac Repolarization (QTc) Study in Fludarabine-Refractory Chronic Lymphocytic Leukemia Subjects
Completion: Jun 26, 2012
NCT01863654
Bioequivalence Study of Montelukast 5 mg Chewable
Start: May 16, 2010
NCT01943942
Bioequivalence Study of Montelukast 10 mg Tablets
NCT01090453
Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants
Start: May 17, 2010
Completion: Oct 11, 2011
NCT01114620
Study of GSK Biologicals' Influenza Vaccine Arepanrix™ in Japanese Adults 65 Years of Age or Older
NCT01123083
Trial of Otelixizumab for Adolescents and Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-2
Completion: Mar 9, 2012
NCT01299558
Study to Look at and Compare How Inhaled and Intravenous Fluticasone Furoate and GW642444 Are Processed by the Body in Healthy Subjects
Completion: Jul 15, 2010
NCT01286831
A Single Dose Study to Determine the Excretion, Balance and Metabolic Disposition of Radiolabelled GW642444.
Start: May 18, 2010
Completion: Jul 9, 2010
NCT01147692
A Drug Interaction Study of Simvastatin and Albiglutide
Start: May 19, 2010
Completion: Aug 27, 2010
NCT01424436
Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient
Completion: Dec 8, 2011
NCT01387217
GSK2018682 FTIH in Healthy Volunteers
Start: May 21, 2010
Completion: Dec 20, 2010
NCT01031108
A Clinical Trial to Assess the Safety of Oral SRT2104 and Its Effects on Vascular Dysfunction in Otherwise Healthy Cigarette Smokers and Subjects With Type 2 Diabetes Mellitus
Start: May 28, 2010
Completion: Oct 12, 2011
NCT00866580
A Study for Evaluation of GSK Biologicals' Pandemic Influenza Vaccine
Start: May 31, 2010
NCT01001130
Regulatory AVAMYS Nasal Spray PMS
NCT01046097
Post-marketing Surveillance Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Philippines
NCT01098487
A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
NCT01098539
A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.
NCT01128595
Randomised Study Comparing the Effects of Inhaled FF/GW642444M Combination, FF and GW642444M on an Allergen Induced Asthmatic Response
NCT01128894
A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.
NCT01332292
Pharmacokinetics and PharmacoDynamics of GW685698 in Paedeatric Asthmatic Patients
NCT01332474
JCP Study of Investigation of Patient Background Characteristics
NCT01371513
Korean Practice Patterns for Screening PCA(Prostate Cancer)
NCT01390909
Clinical and Economic Burden of Uncontrolled Epilepsy: Analyses From a Medicaid Database and a Private Health Plan Database
NCT01551797
A Pharmacokinetic Study to Compare Sustained Release and Standard Paracetamol Formulations.
NCT01651247
Assessment of the Serologic Response to Porcine Circovirus Type 1 (PCV-1) in the Serum of Infants and Toddlers, Following Administration of IPV (Inactivated Poliovirus Vaccine)-Containing Vaccines
NCT01053507
Treximet for Prevention of Post Traumatic Headache Associated With Cognitive Dysfunction
NCT01107834
Heart Function in HIV-Negative Children Exposed to HIV and HAART
NCT01121770
"Pharmacokinetic Study of Fondaparinux in Inpatients With Renal Dysfunction"
NCT01123356
Treatment of Chronic Lymphocytic Leukemia in Patients Previously Exposed to Rituximab
NCT01125787
Clinical Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia With a Combination of Bendamustine and Ofatumumab
NCT01128400
Fat Perception in Humans (09-0873)
NCT01139580
The Purpose of This Study is to Demonstrate the Safety and Effectiveness of Calcipotriene Foam in Subjects With Scalp and Body Psoriasis
NCT01150123
Safety and Immunogenicity of a Group B Streptococcus Vaccine in Healthy Women
NCT01134055
Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration
Start: Jun 1, 2010
Completion: Oct 1, 2012
NCT01266954
An Open Label Study To Investigate the Pharmacokinetics and Pharmacodynamics of Repeat Escalating Doses of the Oral AKT Inhibitor GSK2141795 by 18F FDG PET Analysis in Subjects With Ovarian Cancer
Completion: Sep 1, 2011
NCT01147731
A Drug Interaction Study With Albiglutide and Warfarin
Start: Jun 4, 2010
Completion: Sep 9, 2010
NCT01138098
Evaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated Children
Start: Jun 7, 2010
Completion: Nov 26, 2010
NCT01154101
Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis
Completion: Nov 9, 2011
NCT01094860
Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies
Start: Jun 8, 2010
Completion: Aug 9, 2018
NCT01147718
A Drug Interaction Study of Albiglutide and Digoxin
Start: Jun 11, 2010
Completion: Nov 29, 2010
NCT01267071
A Study to Evaluate the Pharmacokinetics and Absolute Bioavailability of GSK962040 Given as an Oral Dose Simultaneously With an Intravenous Microtracer Dose of [14C]-GSK962040 in Healthy Volunteers
Start: Jun 14, 2010
Completion: Sep 1, 2010
NCT01119651
A Study to Evaluate the Potential of Tazarotene Foam to Cause an Allergic Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers.
NCT01147900
Evaluation of Boostrix™10 Years After Previous Booster Vaccination
Start: Jun 15, 2010
NCT01138007
A Fixed Dose Study of 323U66 SR in the Treatment of Major Depressive Disorder (MDD)
Start: Jun 17, 2010
Completion: Aug 7, 2012
NCT01144299
A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults
Completion: Jul 10, 2010
NCT01000974
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Start: Jun 18, 2010
Completion: Jul 17, 2013
NCT01209026
Corrected QT (QTc) Study With Flucticasone Furoate and GW642444
Start: Jun 23, 2010
Completion: Jan 4, 2011
NCT01147744
Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily
Start: Jun 28, 2010
Completion: Oct 6, 2011
NCT01435915
Ropinirole PR Pharmacokinetics Study Among Chinese Healthy Subjects
NCT00924794
Study of Natural History of Human Papillomavirus (HPV) Infections in Adult Women With Recurrent Conizations in Norway
Start: Jun 30, 2010
NCT01134042
Study HZA106829: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics
NCT01138072
A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.
NCT01147809
Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag
NCT01147848
HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and Adolescents
NCT01159912
Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents
NCT01165255
Bupropion and Specific Cardiovascular Malformations
NCT01236053
Cancer in Patients With Gabapentin (GPRD)
NCT01316952
Coreg and HSRs-Updated Analysis
NCT01381510
Establishing the Benefits of Adherence to Enlarged Prostate Treatment: A Validation Study Linking Adherence to Outcomes Using the Market Scan Database
NCT00964678
Pilot Study of the Safety and Efficacy of Carvedilol in Pulmonary Arterial Hypertension
NCT00981799
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Completion: Jul 18, 2016
NCT01129518
Can we Reduce the Number of Vaccine Injections for Children?
NCT01155336
The Effects of Lovaza® in Acute Myocardial Infarction
NCT01167504
Factors Controlling the Formation of Salivary Films
NCT01184482
Lapatinib and Cetuximab in Patients With Solid Tumors
NCT01253369
Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer
NCT01985295
Combined Modality Treatment of Sarcomas of the Extremities
NCT01101542
Evaluation of Safety of a Vaccine Against Cervical Cancer in Healthy Korean Females
Start: Jul 1, 2010
Completion: Feb 20, 2014
NCT01144663
Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Co-administered With Pneumococcal and DTPa-HBV-IPV/Hib Vaccines
Completion: Sep 10, 2013
NCT01147861
A Phase 1 Study to Evaluate the Effect of GSK256073, an HM74A Receptor Agonist, on Glucose and NEFA Levels in Type 2 Diabetics
Completion: Sep 7, 2010
NCT01154114
Study to Evaluate Darapladib in Moderately Hepatically Impaired Subjects
Completion: Oct 15, 2010
NCT01161160
Safety and Immune Response of Candidate H1N1 Influenza Vaccines GSK2340274A and GSK234072A in Children 3 to Less Than 10 Years Old
NCT01165125
A Drug Interaction Study With Fluticasone Furoate/GW642444 Inhalation Powder and Ketoconazole
Completion: Aug 28, 2010
NCT01145209
Ofatumumab-based Induction Chemoimmunotherapy in Previously Untreated Patients With CLL/SLL
Completion: Sep 15, 2023
NCT01149343
Evaluation of a New Vaccine Treatment for Patients With Metastatic Skin Cancer
Start: Jul 2, 2010
Completion: Dec 19, 2016
NCT01098474
Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Healthy Infants
Start: Jul 7, 2010
Completion: Mar 16, 2012
NCT01114503
A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease
Completion: Aug 29, 2012
NCT01153685
Immunogenicity & Safety Study of Fluviral® (2010 - 2011 Season) in Adults Aged 18 to 60 Years and Over 60 Years
Start: Jul 9, 2010
NCT01119625
Immunological Persistence After Priming With GSK1024850A Vaccine and Safety& Immunogenicity After Booster Dose
Start: Jul 12, 2010
Completion: Feb 17, 2011
NCT01128855
A Double-blind, Escalating Dose, Randomized, Placebo-controlled Study Assessing PK, Safety, Tolerability in Non-ambulant DMD Subjects
Completion: Oct 25, 2011
NCT01357863
Role of Early Versus Late Switch to Lapatinib-Capecitabine
Start: Jul 15, 2010
NCT01745614
Bioequivalence Study of Nimesulide 100 mg Tablets
Start: Jul 18, 2010
NCT01124422
Fluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary Disease
Start: Jul 19, 2010
NCT01160172
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy Adults
Completion: Aug 23, 2012
NCT01159964
Evaluation of a New Anti-cancer Vaccine for Patients With Non-small Cell Lung Cancer, After Tumor Removal by Surgery
Start: Jul 20, 2010
Completion: Sep 10, 2014
NCT01381536
Phase I Study of GSK1550188 in Japanese Subjects With Systemic Lupus Erythematosus (SLE)
NCT01611805
Japanese Phase I of GSK1605786
Start: Jul 22, 2010
Completion: Oct 6, 2010
NCT01138033
Study of a Focal Adhesion Kinase Inhibitor in Subjects With Solid Tumors
Start: Jul 27, 2010
Completion: Dec 21, 2015
NCT01160003
A Blinded, Dose Ascending Study to Assess the Pharmacokinetics, Safety and Tollerability of Repeat Inhaled Doses of Nebulised GW870086X in Healthy Adult Male Volunteers.
Start: Jul 29, 2010
Completion: Nov 5, 2010
NCT01148459
Safety and Immunogenicity of GSK Biologicals' Investigational Malaria Vaccine in HIV Infected Infants and Children
Start: Jul 30, 2010
Completion: May 24, 2013
NCT01072227
Study to Identify and Characterize the Bacteria Causing Acute Otitis Media Episodes in Young Children in Taiwan
Start: Jul 31, 2010
NCT01227902
Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures
NCT01244984
A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 and FF in Japanese Subjects With Asthma
NCT01059656
Phase II Pazopanib Study in Advanced Dermatofibrosarcomas
NCT01107964
Oral Omega-3 Fatty Acids in the Treatment of Dry Eye Syndrome
Completion: Jun 15, 2015
NCT01113632
Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
NCT01134822
Prospective Study of Fibrosis In the Lung Endpoints (PROFILE - Central England)
Completion: Sep 5, 2017
NCT01148017
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
NCT01157897
Study of VMP001 and AS01B (Adjuvant Formulation) in Healthy Malaria-Naïve Adults
NCT01167829
ORAL T-8 Oral Testosterone for Male Hormonal Contraception
NCT01169883
Coping Peer Intervention for Adherence
NCT01178346
Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies
NCT01165177
Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and Older
Start: Aug 2, 2010
Completion: Jul 27, 2015
NCT01165229
Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older
Completion: Jul 24, 2015
NCT02207452
Helium-3 MRI Imaging Study in COPD
Start: Aug 5, 2010
Completion: Jul 4, 2011
NCT01153763
A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma
Start: Aug 9, 2010
Completion: Jun 1, 2016
NCT01154062
A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration
Start: Aug 16, 2010
Completion: Apr 29, 2011
NCT01209078
GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
Start: Aug 17, 2010
Completion: Jan 18, 2011
NCT01248897
Study of Biomarker Profiles in Asia Pacific erb2+/HER2 Breast Cancer Patients Treated With Lapatinib
Completion: Sep 5, 2014
NCT01762787
Phase I Methodology Study to Validate the Cantharidin Blister Model in Healthy Volunteers
NCT01171989
Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose
Start: Aug 18, 2010
NCT01165242
Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine GSK 134612 Versus Menactra® in Healthy Adolescents/Adults
Start: Aug 19, 2010
NCT01165138
Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics
Start: Aug 20, 2010
Completion: Oct 19, 2011
NCT01154088
Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Versus Mencevax™ ACWY in Healthy 18-25 Year Olds
Start: Aug 27, 2010
Completion: Dec 30, 2010
NCT01171963
Study to Assess the Efficacy, Immunogenicity and Safety of Liquid Human Rotavirus Vaccine, in Healthy Chinese Infants
Start: Aug 29, 2010
Completion: May 12, 2012
NCT01160237
Study to Evaluate the Immune Response and the Safety of Fluarix TM/ Influsplit SSW® 2010/2011 or Pandemrix TM
Start: Aug 31, 2010
NCT01192178
Fall Epidemic Viral Pediatric Study
NCT01192191
A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 in Japanese Subjects With COPD
NCT01231581
Study of GSK1120212 Plus Gemcitabine vs Placebo Plus Gemcitabine in Metastatic Pancreatic Cancer
NCT01254032
Predictive Ability of the Chronic Obstructive Pulmonary Disease (COPD) Assessment Test (CAT) for Acute Exacerbations (PACE) in Patients With COPD
NCT01332487
Evaluating the Impact of Early Versus Delayed 5 Alpha Reductase Inhibitor Treatment on the Risk of Emergent Surgery in Men With Benign Prostatic Hyperplasia
NCT01362283
Epidemiologic Study to Evaluate the Proportion of Cardiovascular Disease Risk Factors in Korean Hypertensive Patients
NCT01366560
Effect of GSK962040 on Oesophageal Function
NCT01435954
Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy
NCT01453296
Pharmacokinetics and Pharacodynamics of GW642444 in Paedetric Subjects
NCT01107665
Pazopanib and Paclitaxel as First-Line Treatment for Subjects With Unresectable Stage III and Stage IV Melanoma
Completion: Feb 28, 2018
NCT01128686
Lamivudine(LAM) Good Responder Study
NCT01140009
Safety and Protectiveness of the Seasonal Influenza Vaccine for 2010-2011
NCT01180764
Effects of Lovaza on High Density Lipoprotein (HDL) Composition and Function in Hypertriglyceridemia
NCT01188967
Effectiveness of GSK598809, a Selective D3 Antagonist, Added to CBT and NRT for Smoking Cessation and Relapse Prevention
NCT01191190
Ofatumumab and High-dose Methylprednisolone in Patients With Chronic Lymphocytic Leukemia (CLL)
NCT01194167
Study of Eltrombopag in Platelet Refractory Thrombocytopenia
NCT01105936
Assess the Blood-Oxygen-Level-Dependent (BOLD) Signal Changes in the Brain by Paracetamol as Measured by Functional Magnetic Resonance Imaging (fMRI) in Subjects With Osteoarthritis (OA)
Start: Sep 1, 2010
Completion: Aug 1, 2011
NCT01181895
Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma
Completion: Aug 26, 2011
NCT01536574
Open-Label Extension Study With REQUIP PR for Subjects From Study ROP111528
Start: Sep 2, 2010
Completion: Mar 28, 2012
NCT01147484
A Study of Foretinib in Patients With Recurrent/Metastatic Breast Cancer
NCT01160224
Oral GW766944 (Oral CCR3 Antagonist)
Start: Sep 8, 2010
NCT01254071
A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry.
Start: Sep 10, 2010
Completion: Dec 21, 2010
NCT01192165
Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrexed + Cisplatin, or Nab-Paclitaxel
Start: Sep 14, 2010
Completion: Oct 7, 2013
NCT01218204
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin
Completion: Jun 29, 2011
NCT01195974
A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects.
Completion: Feb 9, 2011
NCT01196026
Immunogenicity and Safety Study of Fluarix™ Vaccine in Children Who Have Previously Been Vaccinated With Pandemrix™
Start: Sep 15, 2010
Completion: May 26, 2011
NCT01357850
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
NCT01407562
Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors
Start: Sep 17, 2010
Completion: Mar 29, 2016
NCT01204658
Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants
Start: Sep 27, 2010
NCT01153932
Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular Dystrophy
Start: Sep 30, 2010
NCT01156792
Safety and Efficacy Study of Adding GSK2190915 to Low Dose Inhaled Corticosteroid Treatment for Asthma Subjects > or = 12 Years of Age
NCT01165203
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Completion: May 14, 2013
NCT01187927
Drug Use Investigation for Cervarix®
NCT01195779
Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children
NCT01195792
A 35 Day Study to Investigate the Effects of GSK1521498 on Bodyweight in Obese Subjects With Over-Eating Behaviours.
NCT01202201
A Retrospective Survey of the Burden of Rotavirus Gastroenteritis (RV GE) and Nosocomial RV GE in Japan
NCT01205230
VEG113971: An Open-Label Study of the Effects of Ketoconazole or Esomeprazole on Pazopanib PK
NCT01205451
A Multicenter, Open-label, Single Dose Study of the Safety and Efficacy of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Focal Upper Limb Spasticity
NCT01227928
Efficacy and Safety of Pazopanib Monotherapy After First-line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Asian Women
NCT01318980
A Single Dose Study to Assess the Regional Absorption and Bioavailability of 100mg GSK2190915A
Completion: Mar 11, 2011
NCT01337323
Prospective Observational Study of Concomitant Allergic Rhinitis Treatment Patterns Among Patients Starting on Fluticasone Furoate Nasal Spray in a Retail Pharmacy Setting
NCT01381458
Risk of Re-Hospitalization in Patients With Chronic Obstructive Pulmonary Disease (COPD) Post Exacerbation
NCT01466361
Evaluation of the Nicotine Lozenge in Relief of Provoked Acute Craving
NCT01587339
Systematic Review: Retigabine for Adjunctive Therapy in Partial Epilepsy
NCT01721135
A Study to Evaluate the Effect of Two Different Repeat Doses of GSK2190915 on the QTc Interval.
NCT00864994
Multiorgan Pathology in Chronic Obstructive Pulmonary Disease (COPD)
Completion: Apr 30, 2015
NCT01090050
Treximet in the Treatment of Chronic Migraine
NCT01110694
Prospective Observation of Fibrosis in the Lung Clinical Endpoints Study
Completion: Sep 30, 2018
NCT01180621
Evaluation of Seasonal Influenza Vaccine for 2010-2011 in Young Children
NCT01209065
GSK1349572 Drug Interaction Study With Fosamprenavir/Ritonavir
NCT01209117
A Study to Assess the Relative Bioavailability of Tablet Formulations of GSK2248761 in Healthy Adult Subjects. SGN114435
NCT01756131
A Single Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Intramuscular and Subcutaneous Long Acting GSK1265744 in Healthy Subjects
NCT01178073
A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)
Start: Oct 1, 2010
NCT01196975
Completion: Jun 24, 2011
NCT01198756
A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Children
Completion: Jul 1, 2011
NCT01357876
Effect of Metformin on Gut Peptides , Bile Acids and Lipid Profiles in Type 2 Diabetics
NCT01153893
Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria
Start: Oct 4, 2010
Completion: Feb 16, 2011
NCT01190215
Immunogenicity and Safety Study of FluarixTM Vaccine in Children Who Have Previously Been Vaccinated With PandemrixTM
NCT01196988
Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine When Administered in Children
Completion: Jun 15, 2011
NCT01204671
Safety and Immunogenicity Study of GSK Biologicals' Seasonal Influenza Candidate Vaccine (GSK2321138A)
NCT01213849
Dose Proportionality Study: Blood Levels of Fluticasone Furoate (FF) and Vilanterol (VI) Following Different Doses of FF/VI Via an Inhaler
NCT01199731
Dose-finding Study of GSK2248761 in Antiretroviral Therapy-experienced Subjects With NNRTI-resistant HIV Infection
Start: Oct 5, 2010
NCT01262885
A Randomized, Single Blind, Placebo Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses and Repeat Escalating Oral Doses of GSK2251052 in Healthy Adult Subjects
Start: Oct 7, 2010
Completion: Aug 25, 2011
NCT01431937
Assessment of Repeat Ascending Doses of GSK2018682 in Healthy Volunteers
Start: Oct 10, 2010
Completion: Mar 29, 2011
NCT01200589
Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy
Start: Oct 11, 2010
NCT01160198
A Study to Demonstrate the Efficacy and Tolerability of Ferrous Bisglycinate Chelate in Iron Deficiency Anaemia and to Compare These With Those of Ferrous Ascorbate.
Start: Oct 13, 2010
NCT02135848
3 Month PHI PAD PoM Study
Start: Oct 15, 2010
Completion: Nov 1, 2011
NCT01266941
A Study to Assess the Effects of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Mild, Moderate or Severe Hepatic Impairment.
Start: Oct 18, 2010
Completion: Jul 15, 2011
NCT01227824
A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily
Start: Oct 19, 2010
Completion: Dec 27, 2016
NCT01231568
An Open Label Study to Examine the Effects of a High-Fat Meal and Particle Size on the Pharmacokinetics of Orally Administered GSK2118436 in Subjects With BRAF Mutation Positive Tumor
Start: Oct 21, 2010
Completion: May 13, 2011
NCT01449838
Phase I Study of Colistin Methanesulfonate Sodium
Start: Oct 23, 2010
NCT01494610
Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients.
Start: Oct 25, 2010
NCT03549117
A Pivotal Subjective Sleep Study of a Nasal Dilator (Breathe Right Tan)
NCT01031069
Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
Start: Oct 26, 2010
Completion: Apr 19, 2017
NCT01231516
A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults
Completion: Feb 2, 2021
NCT01138384
Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast Cancer
Start: Oct 27, 2010
NCT01231607
Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia
Start: Oct 28, 2010
Completion: Feb 28, 2012
NCT01037023
Regulatory Hycamtin(Oral) PMS
Start: Oct 31, 2010
NCT01153906
Post-marketing Safety Study of Autoimmune Diseases Following Cervarix® Vaccination
NCT01158209
An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus Types in Women in Egypt
NCT01205412
An Observational Study on the Prevalence of Human Papillomavirus Types in Women in the Kingdom of Bahrain
NCT01236066
Impact of Rotavirus Vaccination on Hospitalisations for Rotavirus Gastroenteritis in Children Aged <5 Years in Australia
NCT01277081
Effect of Paracetamol on the Common Cold
NCT01287065
A Study in Asthmatic Patients to Determine if There is Any Difference in Dosing With Fluticasone Furoate/Vilanterol Inhalation Powder in the Morning or Evening on Lung Function
NCT01337336
Chronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg Versus Anticholinergics in a COPD-Comorbid Depression/Anxiety Population
NCT01376258
Benefits of Adherence to 5-alpha Reductase Inhibitor Treatment in Men With Enlarged Prostate: An Assessment of Medicare and Medicaid Patients Using the MarketScan Database
NCT01381588
The Prevalence of Osteoporotic Vertebral Compression Fractures (OVCF) in Korean Post Menopausal Women
NCT01431911
Outcomes Associated With Early or Delayed Maintenance Treatment Post-Chronic Obstructive Pulmonary Disease Exacerbation
NCT01431924
Observed Outcomes Associated With Fluticasone Propionate/Salmeterol Xinafoate or Inhaled Corticosteroids in Asthma Patients
NCT01202812
A Randomized Trial of LOVAZA in Pediatric Sickle Cell Disease (SCD)
NCT01214993
A Phase 1, Open Label, Placebo-Controlled Study to Evaluate the Effect of GSK1349572 on Iohexol and Para-Aminohippurate Clearance in Healthy Subjects
NCT01238029
Dose Finding Study for Combination of Capecitabine, Lapatinib and Vinorelbine in Metastatic Breast Cancer
NCT01286285
Surveillance of Influenza in Paediatric Intensive Care Units in Bavaria
NCT01318876
Surveillance for Adverse Events Following Influenza Immunization
NCT01550679
Early Detection of COPD Patients in GOLD 0 (Smokers) Population
Completion: Apr 30, 2020
NCT01642173
Assessment of Coronary Plaque Composition Using Optical Coherence Tomography
Completion: Jun 30, 2015
NCT02284074
Nasal LPS Challenge in Healthy Volunteers
NCT01205243
ZIAGEN® Post-marketing Surveillance
Start: Nov 1, 2010
Completion: Feb 5, 2015
NCT01277692
A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients.
Start: Nov 3, 2010
Completion: May 9, 2011
NCT01168921
Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)
Completion: Mar 7, 2022
NCT01218126
Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-centre, Dose Ranging Study to Evaluate the Efficacy and Safety of Losmapimod Tablets Administered Twice Daily Compared With Placebo for 24 Weeks in Adult Subjects With Chronic Obstructive Pulmonary Disease (COPD).
Start: Nov 4, 2010
Completion: Dec 21, 2011
NCT03549130
A Pivotal Study to Assess the Effectiveness of Nasal Dilator (Breathe Right Nasal Strips)
NCT01267006
Blood Levels and Effects of GSK1325756 in Healthy Adult Volunteers Aged 40 to 80 Years Old
Start: Nov 5, 2010
Completion: Jan 27, 2011
NCT01218113
Efficacy and Safety of GSK Biologicals HIV Vaccine in Antiretroviral Therapy (ART)-naïve HIV-1 Infected Persons
Start: Nov 8, 2010
Completion: Nov 5, 2012
NCT01376232
Study to Assess the Pharmacokinetics of GSK1278863A Coadministered With a High Fat Meal or an Inhibitor of CYP2C8 (Gemfibrozil)
NCT01198769
Immunogenicity and Safety Study of Rotarix TM in Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth.
Start: Nov 11, 2010
Completion: Apr 18, 2011
NCT01235949
Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A and Prophylactic Antipyretic Treatment
Start: Nov 12, 2010
Completion: Dec 8, 2012
NCT01323673
Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis.
Start: Nov 15, 2010
NCT01266980
A Study to Assess the Effects of Repeat Doses of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Severe Impairment.
Start: Nov 18, 2010
NCT01428466
Japanese Phase 1 Study of GSK2585823
Completion: Feb 15, 2011
NCT01231555
Dose-finding Study of GSK2248761 in Antiretroviral Therapy-Naive Subjects (SIGNET)
NCT01231529
GSK1349572 Hepatic Impairment Study
Start: Nov 19, 2010
Completion: Jun 4, 2011
NCT01222078
Investigating Re-Dosing With Otelixizumab in Adults With Newly-Diagnosed Type 1 Diabetes Mellitus
Start: Nov 22, 2010
Completion: May 19, 2011
NCT01245062
GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma
Completion: Dec 16, 2016
NCT01592799
Study on the Burden of Influenza-related Hospitalizations and Emergency Room (ER) Visits in Children in Spain
Start: Nov 23, 2010
Completion: May 23, 2011
NCT01015625
Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer
Start: Nov 24, 2010
Completion: Jul 31, 2022
NCT01236040
Immunogenicity and Safety of Pandemic Influenza Vaccines in Adults Aged 18 - 49 Years Old
Start: Nov 29, 2010
Completion: Aug 20, 2012
NCT01294566
FTIH to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of GSK1322888 in Healthy Caucasian and Japanese Volunteers
Completion: Mar 23, 2011
NCT01235975
Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine Given as One Dose to Healthy Subjects Above 56 Years
Start: Nov 30, 2010
Completion: Aug 3, 2011
NCT01286844
GSK2190915 Pediatric Study
NCT01328106
Efficacy and Safety Study of GSK1120212, a MEK Inhibitor, in Subjects With Uveal Melanoma
NCT01381523
A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data
NCT01439321
Outcomes Comparison of Chronic Immune Thrombocytopenic Purpura (ITP) Patients Switched to Eltrombopag and Romiplostim
NCT01615783
Clinical and Economic Burden of Patients With Chronic Obstructive Pulmonary Disease in a Medicaid Population
NCT00958633
Mood Stabilizer (MS)+ Antidepressant vs MS + Placebo in Maintenance of Bipolar Disorder.
Completion: May 20, 2020
NCT01216982
Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders
NCT01246011
Significance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft Occlusion
NCT01252290
Breast Cancer Risk Biomarkers in Postmenopausal Women
NCT01477931
Interventional Study of Wellbutrin XL in Major Depressive Disorder With Atypical Features
NCT01299610
A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo
Start: Dec 1, 2010
NCT01424514
SB705498 Proof of Concept Chamber Challenge in Subjects With Non Allergic Rhinitis
NCT01254019
A Clinical Study to Assess the Efficacy and Safety of GSK2402968 in Subjects With Duchenne Muscular Dystrophy
Start: Dec 2, 2010
Completion: Jun 28, 2013
NCT01853956
Bioequivalence Trial of Alprazolam 0.25 mg Tablets
Completion: Dec 10, 2010
NCT01094171
Study to Evaluate the Safety of Co-administration of GSK Biologicals' Poliorix and Infanrix in Healthy Children in Russia
Start: Dec 3, 2010
Completion: Oct 27, 2012
NCT01248858
Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK2126458 and GSK1120212 Combination Therapy in Subjects With Advanced Solid Tumors.
Completion: Apr 23, 2015
NCT01745562
Bioequivalence Trial of Alprazolam 0.5 mg Tablets
Start: Dec 7, 2010
Completion: Dec 17, 2010
NCT01218308
A Study to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine in Children
Start: Dec 9, 2010
Completion: Jan 9, 2012
NCT01248884
Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)
Completion: Jan 5, 2012
NCT01251744
Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus
Completion: Jun 17, 2015
NCT01406327
Drug Use Investigation for VOLIBRIS® (Ambrisentan) (Pulmonary Arterial Hypertension)
Start: Dec 14, 2010
Completion: Feb 28, 2020
NCT01258530
A Study to Evaluate the Bioequivalence of Over-encapsulated Oseltamivir Capsules to Marketed Oseltamivir Capsules in Healthy Volunteers
Start: Dec 20, 2010
Completion: Feb 3, 2011
NCT01277666
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Completion: Jul 11, 2013
NCT01294592
Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement
Start: Dec 22, 2010
NCT01466322
A Study to Assess the Relative Bioavailability of Different Formulations of GSK2018682, a Sphingosine-1-phosphate Receptor Subtype 1 Agonist, in Healthy Volunteers.
NCT01227889
A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) Melanoma
Start: Dec 23, 2010
Completion: Sep 16, 2016
NCT01205217
Lapatinib or Trastuzumab Given Prior to Surgery With Chemotherapy in Patients With Early Breast Cancer
Start: Dec 31, 2010
NCT01245426
A Study in Asthmatics to Determine the Efficacy and Dose Response of Repeat Doses of GW870086X on Forced Expiratory Volume in 1 Second (FEV1)
NCT01248975
Safety and Efficacy Study Adding GSK2190915 to Mid-dose Inhaled Corticosteroid/Long Acting Beta Agonist Combination Treatment for Asthma
NCT01248988
Post Marketing Surveillance of Synflorix Vaccine Safety Among Infants in Korea
NCT01319019
A 4-week Dose-Ranging, Dose-Interval, Efficacy, Safety and Tolerability Study of GSK961081 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT01376284
Drug Use Investigation for AVOLVE(BPH)
NCT01420822
Special Drug Use Investigation for ALLERMIST (Long Term)
NCT01424527
Korean Chronic Obstructive Pulmonary Disease(COPD) Assessment Test Validation Study
NCT01446224
Cardiovascular and Torsades de Pointes Monitoring for Pazopanib
NCT01449825
Hepatic Monitoring for Pazopanib
NCT01462552
Physician Liver Function Test (LFT) Monitoring for Tykerb Pts
NCT01239394
Ofatumumab for Initial Systemic Treatment of Indolent B-cell Lymphoma
NCT01260389
Pharmaceutical Care for Chronic Obstructive Pulmonary Disease (COPD) Study.
NCT01262820
Pazopanib In Stage IIIB/IV NSCLC Lung Cancer After Progression on First Line Therapy Containing Bevacizumab
NCT01263340
Characterisation of People With COPD
NCT01273077
Evaluation of Universal Rotavirus Vaccination Program
NCT01300546
Treximet Trademark (TM) in the Prevention and Modification of Disease Progression in Migraine
NCT01488565
A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia
NCT02714335
The Correlation Between MAGE-A3, PRAME Polymorphism and Expression Levels of MAGE-A3 and PRAME in NSCLC Patients
NCT03243110
The Economic Burden of Asthma in Canada
Completion: Jun 30, 2017
NCT01316887
A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Start: Jan 1, 2011
Completion: Jul 21, 2012
NCT01266993
Persistence and Booster Study of GSK Biologicals' Meningococcal Vaccine (GSK134612) in Healthy Children
Start: Jan 3, 2011
Completion: May 17, 2014
NCT01332331
Efficacy and Safety of Ambrisentan in Children 8-18yrs
Start: Jan 4, 2011
Completion: Nov 12, 2013
NCT01323985
SAP Depleter Dose Escalation Study in Healthy Volunteers
Start: Jan 6, 2011
NCT01411111
A Repeat Dose Study to Investigate the Interaction of GSK2190915 on the Pharmacokinetics of Rosuvastatin
NCT01428479
Phase1 Study of GR121167, Single and Multiple Dose Study in Healthy Japanese Males
Start: Jan 7, 2011
Completion: Apr 4, 2011
NCT01267968
An Open-label, Randomized, Single Period, Parallel-Cohort Study To Evaluate Serum and Pulmonary Pharmacokinetics Following Single and Multiple Dose Administration of Intravenous GSK2251052 in Healthy Adult Subjects
Start: Jan 11, 2011
Completion: Mar 16, 2011
NCT01231503
Safety and Immunogenicity of GSK Biologicals' Malaria Vaccine 257049 When Administered on 7 Schedules to African Infants
Start: Jan 13, 2011
Completion: Dec 23, 2014
NCT01332552
A First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2485852 in Chronically Infected Hepatitis C Subjects
Start: Jan 14, 2011
NCT01738893
Bioequivalence Study of 300 mg Gabapentin
Completion: Jan 22, 2011
NCT01231620
A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza
Start: Jan 15, 2011
Completion: Mar 18, 2015
NCT01262976
Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Human Immunodeficiency Virus (HIV)-Positive Adults
Start: Jan 17, 2011
Completion: Jun 4, 2015
NCT01249365
The Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study
Start: Jan 24, 2011
Completion: Jan 10, 2017
NCT01324258
Trial of GSK1120212 and GSK1120212 in Combination With GEM in Japanese Subjects With Solid Tumors
Completion: Jul 8, 2013
NCT01313676
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
Start: Jan 25, 2011
Completion: Jul 15, 2015
NCT01262963
An Absorption, Distribution, Metabolism and Excretion (ADME) Study of Single Oral Dose [14C] GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Start: Jan 26, 2011
Completion: Apr 8, 2011
NCT01767532
Bioequivalence Study of Cephalexin Suspension 125
Start: Jan 30, 2011
NCT01767571
Bioequivalence Study of Cephalexin Suspension 250
NCT01039909
A Clinical Study to Assess the Effects of SRT2104 Upon Immobilization-Induced Skeletal Muscle Atrophy in Healthy Human Volunteers
Start: Jan 31, 2011
NCT01045564
Safety and Immunogenicity of Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure
NCT01213472
Evaluation of a New Anti-cancer Immunotherapy in Patients With Non-operable and Progressing Metastatic Cutaneous Melanoma
Completion: Apr 17, 2018
NCT01277679
Evaluation of MRI Measures of Lung Water With Posture Changes in Healthy Volunteers and in Patients With Cardiac Failure
NCT01107613
The Lung Attack Alert Study
NCT01184326
Expanded Phase I Pazopanib and Everolimus in Advanced Solid Tumors and Previously Treated Advanced Urothelial Cancer
NCT01191177
Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease
NCT01273103
A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK2248761 Administered as an Oral Suspension to Healthy Adult Subjects
NCT01578941
An Investigation of the Safety and Utility of Treximet in the Treatment of Menstrual Migraine
NCT01970189
The International ITP Registry
Completion: Dec 31, 2020
NCT02557165
Impact of COPD on Muscle Regeneration
Completion: Dec 31, 2015
NCT01342913
A Study to Evaluate the 24 Hour Spirometric Effect (FEV1) of Fluticasone Furoate/Vilanterol Inhalation Powder (100mcg Fluticasone Furoate (FF)/25mcg Vilanterol (VI)) Compared With Salmeterol/Fluticasone Propionate Inhalation Powder (50mcg Salmeterol/500mcg Fluticasone Propionate (FP))
Start: Feb 1, 2011
NCT01263015
A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial)
Completion: Dec 3, 2015
NCT01258608
Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma
Start: Feb 8, 2011
Completion: Nov 29, 2017
NCT01262872
Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & Infants
Start: Feb 9, 2011
NCT01332513
An Open Label, Randomised, Repeat Dose Study to Assess the Pharmacokinetic Performance of Five Ezogabine/Retigabine Modified Release (MR) Formulations at Steady State Compared to the Immediate Release (IR) Formulation.
Start: Feb 10, 2011
NCT01387204
Study to Investigate the Absorption, Distribution, Metabolism and Elimination of [14C]GSK1120212
Start: Feb 15, 2011
NCT01153841
Primary Vaccination Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Vietnam
Start: Feb 17, 2011
Completion: Jul 26, 2011
NCT01277042
Study to Assess Immune Responses and Safety of the GSK-580299 Vaccine in Healthy Women (26 to 45 Years)
NCT01262911
Effect of SRT2379 on Endotoxin-Induced Inflammation
Completion: Apr 26, 2011
NCT01336621
Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS)
Start: Feb 21, 2011
Completion: Sep 13, 2017
NCT01353742
Lamivudine and Adefovir Dipivoxil Fixed Dose Combination
NCT01266603
High-Dose Interleukin-2 (HDIL-2), Combined With recMAGE-A3 + AS15 ASCI
Start: Feb 22, 2011
Completion: Nov 1, 2018
NCT01772212
Bioequivalence Study for Terbinafine 250 mg
Start: Feb 24, 2011
Completion: Mar 15, 2011
NCT01319006
Relative Bioavailability Study for GSK1278863A
Start: Feb 25, 2011
NCT01266967
A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma to the Brain
Start: Feb 28, 2011
NCT01295320
Study of Long Term Immune Responses and Safety of the GSK Herpes Zoster Vaccine in Healthy Subjects
Completion: Jun 20, 2013
NCT01313663
A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population
NCT01366521
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
NCT01445262
Drug Use Investigation for XYZAL®
NCT01462656
Risk of Urinary Retention With Retigabine
NCT01466348
Effects of a Common Cold Treatment on Cognitive Function
NCT01264445
Safety and Immunogenicity Study of 2 Investigational Preventive HIV Vaccines
NCT01283789
Lapatinib and RAD-001 for HER2 Positive Metastatic Breast Cancer
Completion: Apr 30, 2017
NCT01321723
Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal Women
NCT01583530
Study of Belimumab Administered Subcutaneously to Healthy Subjects
NCT02247583
Investigating Patient Satisfaction With Oral Anti-Cancer Treatment
NCT01313637
A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD
Start: Mar 1, 2011
Completion: Apr 19, 2012
NCT01313650
A 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPD
Completion: Apr 5, 2012
NCT01316900
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
Completion: Apr 24, 2012
NCT01328444
An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444. Study A
Completion: Jun 14, 2012
NCT01309646
Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine
Start: Mar 4, 2011
Completion: Feb 24, 2012
NCT01336608
A 24-week Arterial Stiffness Study With Fluticasone Furoate/Vilanterol in COPD
Completion: Nov 4, 2014
NCT01310413
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Start: Mar 7, 2011
Completion: Jan 26, 2014
NCT01476046
Safety Study of GSK1995057 Given as Single and Repeat Intravenous Doses in Healthy Subjects.
Start: Mar 8, 2011
Completion: Jun 17, 2012
NCT01190202
Epidemiology Study of Malaria Transmission Intensity in Africa
Start: Mar 14, 2011
Completion: Dec 20, 2013
NCT01323660
An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444.Study B
Start: Mar 16, 2011
Completion: Jul 16, 2012
NCT01323621
Study Evaluating the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Start: Mar 18, 2011
Completion: Jan 24, 2012
NCT01323634
Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease
Completion: Dec 14, 2011
NCT01772238
Bioequivalence Study of an Amoxicillin-Clavulanic
Start: Mar 22, 2011
Completion: Mar 30, 2011
NCT01371812
GSK2239633 FTIH Study
Start: Mar 29, 2011
NCT01300234
Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB)
Start: Mar 30, 2011
Completion: Dec 6, 2016
NCT01416350
A Single and Repeat Dose PK/PD Study to Characterise Biomarker Response in Healthy Subjects Treated With Azithromycin
NCT01316913
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
Start: Mar 31, 2011
NCT01320137
Study in Allergic Adults to Support the Development of Immunological Assays
Completion: May 11, 2011
NCT01339221
Epidemiological, Observational and Post Marketing Study of Rotarix™ in Children With Severe Gastroenteritis in Belgium
NCT01381601
Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics)
NCT01381614
Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS)
NCT01390935
SUrvey of Guideline Adherence for Treatment of Systolic Heart Failure in Real World
NCT01395875
Outcomes for Chronic Obstructive Pulmonary Disease Moderate Exacerbators Initiating Treatment
NCT02348372
Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of GSK1278863A in Healthy Subjects
NCT01243190
Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Completion: Mar 28, 2023
NCT01283100
A Drug Interaction Study Evaluating Plasma GSK2248761 and GSK1349572 Pharmacokinetics in Healthy Adult Subjects.
NCT01296698
Study to Determine if a New Nicotine Replacement Therapy Can Safely Help Smokers to Quit Smoking
NCT01323400
Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST)
Completion: Feb 29, 2016
NCT01352884
Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-224 in Patients With Advanced Cancer
NCT01454479
A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma
NCT01647737
Green Tea Lozenges for the Management of Dry Mouth
NCT01190189
Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study
Start: Apr 1, 2011
Completion: Nov 23, 2017
NCT01245049
Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children
Completion: Apr 2, 2012
NCT01318993
Open-Label Extension Study of GSK1605786A
Completion: Oct 29, 2013
NCT01323959
Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults
Completion: Mar 1, 2012
NCT01286038
Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia
Start: Apr 6, 2011
Completion: Nov 3, 2018
NCT01220128
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Start: Apr 11, 2011
Completion: Nov 14, 2014
NCT01381445
A Study Assessing GW870086's Potential to Cause Skin Thinning
Start: Apr 14, 2011
NCT01424397
Intranasal SB-705498 in Allergic Rhinitis (AR) Patients
NCT01323946
Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in Children
Start: Apr 18, 2011
Completion: Nov 2, 2012
NCT01357902
Lamotrigine Bioequivalence Study to Compare Dispersible Tables With Compressed Tablets in China
NCT01273610
Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer
Start: Apr 20, 2011
Completion: May 19, 2026
NCT01475695
GSK2251052 Mass Balance in Healthy Adult Subjects
Start: Apr 21, 2011
NCT01323647
Immunogenicity and Safety of Booster Dose of PoliorixTM Vaccine in Previously Vaccinated Toddlers
Start: Apr 25, 2011
Completion: Sep 19, 2011
NCT01333813
Hepatitis B Antibody Persistence and Immune Response to Hepatitis B Vaccine Challenge in Previously Vaccinated Children
Start: Apr 26, 2011
Completion: Sep 28, 2011
NCT01362257
A Study to Determine the Excretion Balance and Pharmacokinetics of 14C-GSK573719
Start: Apr 29, 2011
Completion: Jun 22, 2011
NCT01376245
A 24-week Study of Fluticasone Furoate/Vilanterol Inhalation Powder in Subjects of Asian Ancestry With COPD
Start: Apr 30, 2011
NCT01476098
A Study to Investigate the Effect of SB-705498 on Chronic Cough
NCT01171378
Study of Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone (CHOP) With Ofatumumab in Patients With Richter's Syndrome
Completion: Apr 19, 2016
NCT01311024
Indirect Effects of Pneumococcal Vaccine on Nasopharyngeal Carriage
NCT01320228
Effect of Dietary Components on Gastrointestinal Side Effects Induced by Orlistat, a Lipase Inhibitor
NCT01330966
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma
NCT01332565
A Study to Investigate the Pharmacokinetics, Safety and Tolerability of GSK1349572 (Dolutegravir, DTG) in Healthy Japanese Subjects
NCT02412267
Study of Ofatumomab in Combination With ICE-chemotherapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL)
Completion: Mar 31, 2016
NCT01371487
GSK1120212 Food-effect Study
Start: May 2, 2011
NCT01262898
Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis
Start: May 3, 2011
Completion: Feb 26, 2013
NCT01160211
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Start: May 5, 2011
Completion: Jun 6, 2022
NCT01316939
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Start: May 9, 2011
Completion: Oct 23, 2013
NCT01577693
Study to Compare the Bioavailability of Dutasteride Novel Formulation Form to the Soft Gel Capsule Form in Healthy Male Subjects
Start: May 12, 2011
NCT01352286
Redirected Auto T Cells for Advanced Myeloma
Start: May 13, 2011
Completion: Jul 8, 2019
NCT01366573
GSK1521498 Alcohol Interaction Study
Completion: Sep 16, 2011
NCT01323972
Consistency of Immunogenicity and Non Inferiority of GSK Biologicals' Candidate Malaria Vaccine Lots in Children
Start: May 16, 2011
Completion: May 4, 2012
NCT01353729
A Study to Evaluate the Effect of Intravenous Zanamivir on Cardiac Conduction in Healthy Volunteers
Start: May 19, 2011
Completion: Aug 2, 2011
NCT01416363
Healthy Volunteer Study Using 3 Different Formulations of Firategrast
Start: May 20, 2011
NCT01345253
GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia
Start: May 23, 2011
Completion: Sep 21, 2018
NCT01352312
Combination of Pentostatin, Bendamustine and Ofatumumab for Treatment of Chronic Lymphocytic Leukemia and Lymphoma
Start: May 25, 2011
Completion: May 10, 2018
NCT01431989
Amoxicillin Bioequivalence Study Brazil - Fast
Start: May 27, 2011
Completion: Jun 11, 2011
NCT01358825
Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™
Start: May 30, 2011
NCT01480271
An Investigation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2245035 in Healthy Volunteers and Allergic Rhinitics.
NCT00920140
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Start: May 31, 2011
NCT01332539
An Observational Study to Assess the Burden of Drug-resistant Partial Epilepsy in Italy
NCT01332578
A Comparison of Solid and Soluble Forms of Cold and Influenza Remedies
NCT01458080
WEUSKOP5410: Observational Study in ENABLE Clinical Trials
NCT01231542
Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female Volunteers
NCT01328041
A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
NCT01329562
CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Menstrual Migraine Before and After Treximet
NCT01348880
Vardenafil ODT (Orally Disintegrating Tablet) - Nifedipine Interaction Study
NCT01380054
Pulmonary Hypertension, Quality of Life and Psychosocial Factors
Completion: May 20, 2016
NCT01393470
Evaluation of Long-term HPV Vaccine Efficacy
Completion: Dec 31, 2024
NCT01656421
Assessment of Risk in Chronic Airways Disease Evaluation
NCT01858792
A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies
NCT01175083
Immunization of Children Between 8 Weeks and 2 Years of Age With GSK Pneumococcal Vaccine GSK1024850A
Start: Jun 1, 2011
Completion: May 23, 2013
NCT01342926
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Completion: Apr 1, 2016
NCT01446237
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
Completion: Dec 15, 2011
NCT01248247
BATTLE-2 Program: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
Start: Jun 2, 2011
Completion: Nov 30, 2020
NCT01340833
Determination of the Absolute Bioavailability of GSK2118436 Following a Single Oral Dose Co-Administered With an Intravenous Radiolabelled Microtracer of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Start: Jun 8, 2011
Completion: Sep 12, 2011
NCT01382706
Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder
Start: Jun 13, 2011
Completion: Dec 15, 2017
NCT01416324
First Time in Human Study Using GSK2330672
Start: Jun 15, 2011
NCT01755611
Bioequivalence Minocycline Bioequivalence
Start: Jun 17, 2011
Completion: Jun 25, 2011
NCT01416337
Absolute Bioavialability of GSK1120212
Start: Jun 20, 2011
Completion: Dec 17, 2011
NCT01342952
Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529
Start: Jun 21, 2011
Completion: Jun 9, 2022
NCT01357915
Evaluation of the Long-term Persistence of GlaxoSmithKline (GSK) Biologicals' Candidate Cytomegalovirus (CMV) Vaccine
Start: Jun 24, 2011
Completion: Sep 13, 2012
NCT01381549
GSK2251052 in Complicated Urinary Tract Infection
Start: Jun 28, 2011
NCT01381575
Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls
Start: Jun 29, 2011
Completion: Nov 13, 2014
NCT01360398
Infectious Pathogens in Acute Respiratory Illness in Adults and Elderly
Start: Jun 30, 2011
Completion: Jun 27, 2014
NCT01365390
To Evaluate the Incidence of Acute Otitis Media in Children in Five East European Countries
NCT01395888
A Study to Compare the Impact of Fulticasone Furoate/Vilanterol vs. Tiotropium on Arterial Stiffness in COPD
Completion: Aug 6, 2012
NCT01471665
GSK2190915 Neutrophilic Asthma Study
NCT01471678
Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males.
Completion: Sep 7, 2011
NCT01521416
Cost of Illness Associated With Influenza in the UK
NCT01263418
Ofatumumab In Older Patients With Untreated Low Or Intermediate Risk Indolent B-Cell Lymphomas
Completion: Jan 31, 2018
NCT01308957
Fish Oil and Muscle Function
NCT01353716
Dolutegravir Renal Impairment Study
NCT01361113
Neoadjuvant Pazopanib in Renal Cell Carcinoma
Completion: Feb 15, 2017
NCT01361711
Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia
Completion: May 31, 2027
NCT01366547
Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination Tablets
NCT01377298
Pazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
NCT01382238
Relative Bioavailability Study of a Pediatric Granule Formulation of Dolutegravir
NCT01385228
Pazopanib, Docetaxel, Prednisone Prostate
NCT01394614
Risk of Narcolepsy Associated With Administration of H1N1 Vaccine
NCT01421251
H1N1 Vaccine Safety in Manitoba, Canada
NCT01425749
Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI
NCT01362322
Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old Adolescents
Start: Jul 1, 2011
Completion: Sep 3, 2012
NCT01372410
A Randomized, Double Blind, Placebo Controlled, Incomplete Block, Crossover, Dose Ranging Study to Evaluate the Dose Response of GSK573719 Administered Once or Twice Daily Over 7 Days in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Completion: Oct 27, 2011
NCT01387230
Evaluate the Efficacy and Safety of GSK573719 Delivered Via a Novel Dry Powder Inhaler in Subjects With COPD
Completion: Feb 13, 2012
NCT01406262
Albiglutide Thorough ECG Study in Healthy Volunteers
Start: Jul 6, 2011
Completion: Dec 29, 2011
NCT01258933
Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy
Completion: Oct 18, 2024
NCT01362348
12 Week Patient Study in Neovascular Age-related Macular Degeneration (AMD)
Start: Jul 7, 2011
Completion: Apr 16, 2012
NCT01439373
Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects
Completion: Dec 5, 2011
NCT01513187
Pazopanib in Combination With Interferon Alfa 2-A, in Patients With Advanced Renal Cell Carcinoma
Start: Jul 11, 2011
Completion: Feb 22, 2019
NCT01376323
A Study of GSK256073 in Subjects With Type 2 Diabetes Mellitus Who Are Being Treated With Metformin
Start: Jul 13, 2011
Completion: Sep 17, 2012
NCT01449799
An Investigation of the Pharmacokinetics of GSK961081 and Fluticasone Propionate in Healthy Volunteers
Completion: Sep 21, 2011
NCT01394211
Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer
Completion: Apr 12, 2012
NCT01400906
Inhalation of Corticosteroids in Smoking and Non-smoking Asthmatics.
Start: Jul 20, 2011
Completion: Dec 12, 2012
NCT01439438
Topiramate Bioequivalence Study Brazil - Fast
Start: Jul 22, 2011
Completion: Sep 11, 2011
NCT01462617
Study to Investigate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Single & Repeat Doses of GSK2269557
Start: Jul 24, 2011
Completion: Mar 26, 2012
NCT01928914
Tafenoquine Thorough QTc Study in Healthy Subjects
Start: Jul 26, 2011
Completion: Jun 4, 2012
NCT01379937
A Study to Evaluate the Safety and Immunogenicity of a Prime-boost Schedule of GSK Biologicals' Influenza Vaccine in Children
Start: Jul 28, 2011
Completion: Oct 5, 2012
NCT01458132
Drug Exposure Registry for GSK2248761, an Investigational NNRTI
Start: Jul 29, 2011
NCT01353768
Zanamivir Aqueous Solution Compassionate Use Program Retrospective Chart Review Study
Start: Jul 31, 2011
NCT01357889
Pharmacokinetics/Pharmacodynamics of Albiglutide
NCT01400932
Study STF115288, a Clinical Confirmation Study of GI148512 in the Treatment of Acne Vulgaris in Japanese Subjects
NCT01428505
[18F]PBR111 and Microglial Activation in Multiple Sclerosis
NCT01462487
Safety of Inhaled Zanamivir in Pregnancy
NCT01476085
Evaluating the Utility of the Apoptosis Imaging Biomarker 18F]ML10 in Patients With Non-Hodgkin's Lymphoma(NHL)
NCT01536704
Nicotine Lozenge Bioequivalence Study
NCT01389076
Trial of Low-Dose Methotrexate and I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma
NCT01391611
Pazopanib in Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors (GIST)
NCT01471327
Japanese Phase 1 Study of Mepolizumab
Start: Aug 9, 2011
Completion: Apr 27, 2012
NCT01366534
Safety, Immunogenicity and Efficacy Against of a Combined Malaria Vaccine in Healthy Malaria-naïve Adults
Start: Aug 10, 2011
Completion: Jul 3, 2012
NCT01424475
LRRK2 Mutation and Parkinson's Disease
Start: Aug 11, 2011
Completion: Jan 12, 2015
NCT01416571
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults
Start: Aug 12, 2011
Completion: Sep 28, 2012
NCT01449188
To Investigate the Effect of Intravenous Ondansetron on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult Subjects
Start: Aug 16, 2011
Completion: Dec 19, 2011
NCT01863615
Bioequivalence Study for an Isotretinoin
Start: Aug 26, 2011
Completion: Sep 23, 2011
NCT01406340
Assessment of the Pharmacokinetics of GSK1278863 and Metabolites in Normal Subjects and Subjects With Renal Impairment
Start: Aug 30, 2011
NCT01416376
Effect of Multiple Dose Levels of SRT2379 on Endotoxin-Induced Inflammation
Completion: Dec 12, 2011
NCT01376388
Long-term Safety Study for GSK573719/GW642444 in Japanese
Start: Aug 31, 2011
NCT01390922
Special Drug Use Investigation for Botox® (Botulinum) Spasticity (BOTOX is a Registered Trademark of Allergan, Inc.)
NCT01416597
A Systematic Review of Studies of the Effect of Influenza Vaccine Against Mismatched Strains
NCT01457989
Meta-Analysis Plan for Pooled Data for Studies VRX-RET-E22-303 and VRX-RET-E22-304
NCT01404806
GSK1349572 Exposure in Blood, Cervicovaginal Fluid, and Cervical and Vaginal Tissue in Healthy Female Subjects
NCT01426880
Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer
NCT01435356
Safety and Efficacy Study of MAGE-A3 + AS-15 in Patients With Muscle-invasive Bladder Cancer After Cystectomy
Completion: Apr 7, 2017
NCT02012400
Effects of Regular Exercise on Adult Asthma
NCT01424540
Cross-Over Study to Assess the Cardiovascular Effects of GSK2336805
Start: Sep 1, 2011
Completion: Oct 3, 2011
NCT01391819
Study to Evaluate the Incidence, Clinical Characteristics and Economic Burden of Dengue in Brazilian Children
Start: Sep 6, 2011
Completion: Jan 30, 2015
NCT01435993
Multiple Doses of Anti-NOGO A in Relapsing Forms of Multiple Sclerosis
Start: Sep 8, 2011
Completion: Jan 23, 2012
NCT01190176
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
Start: Sep 12, 2011
Completion: Sep 20, 2017
NCT01290354
Exploratory Lapatinib (Positron Emission Tomography) PET Study in Subjects With Breast Cancer
NCT01610388
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Oral and Intravenous GSK1322322 in Healthy Subjects
Start: Sep 13, 2011
Completion: Jan 26, 2012
NCT01489943
A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects
Start: Sep 19, 2011
Completion: Nov 10, 2011
NCT01290393
Post-marketing Study to Assess the Safety of CERVARIX When Used in the United States and in Canada
Start: Sep 26, 2011
Completion: Dec 20, 2012
NCT02202187
A Single Oral Escalating Dose Study of GSK2140944 in Healthy Volunteers
Completion: Feb 15, 2012
NCT01445301
Study STF115287, a Clinical Confirmation Study of GSK2585823 in the Treatment of Acne Vulgaris in Japanese Subjects
Start: Sep 27, 2011
NCT01458054
Effect of Omeprazole and Ritonavir on GSK2336805 Pharmacokinetics in Healthy Adults
Completion: Nov 28, 2011
NCT01362296
An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer
Start: Sep 30, 2011
NCT01431950
Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents
NCT01431963
Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy
NCT01431976
Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents
NCT01435967
Observational Study on Rotavirus Gastroenteritis Epidemiology, Impact of Lyophilised vs. Liquid Formulation of Rotarix™
NCT01436071
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
NCT01436110
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
NCT01440387
A Study of Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine FLU-Q-QIV in Adults Aged 18 Years and Older
Completion: Oct 22, 2011
NCT01453062
Phase IV Observational Study in Chronic Lymphocytic Leukemia
NCT01480245
Open Label Study of GSK2402968 in Subjects With Duchenne Muscular Dystrophy
NCT01494649
Pilot Study to Investigate the Efficacy of a Toothpaste in Providing Relief From Dentinal Hypersensitivity
NCT01506908
Provoked Craving Assessment
NCT01520935
Influenza Burden Assessment in the United Kingdom, 1996-2008
NCT01545856
Cardiovascular Events in Parkinson's Disease Patients
NCT01597661
Bupropion & Cardio Birth Defect (Slone)
NCT01380145
MAGE-A3 Protein + AS15 as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
NCT01425099
Drug Interaction Study Between Dolutegravir and Prednisone
NCT01437709
Ofatumumab With or Without Bendamustine for Patients With Mantle Cell Lymphoma Ineligible for Autologous Stem Cell Transplant
Completion: Sep 12, 2023
NCT01497626
Lapatinib and Bortezomib in Patients With Advanced Malignancies
NCT01681563
Trial of Pentostatin Plus Cyclophosphamide With Ofatumumab (PCO) in Older Patients With Chronic Lymphocytic Leukemia
NCT01428453
A Phase 2a Study to Evaluate the Effect of Rilapladib (SB-659032) in Alzheimer's Disease
Start: Oct 1, 2011
Completion: Feb 18, 2013
NCT01439360
An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children
NCT01449812
Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine
NCT01381562
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
Start: Oct 3, 2011
Completion: Mar 5, 2012
NCT01430572
Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients
Start: Oct 7, 2011
Completion: May 12, 2020
NCT01485185
Gabapentin and Donepezil Combination on Experimental Human Pain Models
Start: Oct 11, 2011
NCT01437605
Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC
Completion: Jul 18, 2018
NCT01453478
A Study to Look at How GSK1325756 is Taken up by the Body When Given by Mouth When Stomach Acid is Reduced
Start: Oct 12, 2011
NCT01521390
Assessment of Lung Function After Single Inhalations of a Bronchodilator From 2 Configurations a Dry Powder Inhaler.
Completion: Dec 16, 2011
NCT01406314
SAP Depleter Dose Assessment Study in Patients
Start: Oct 13, 2011
Completion: Nov 14, 2012
NCT01453998
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)
Start: Oct 14, 2011
Completion: Nov 12, 2012
NCT01494636
The Safety, Tolerability, PK and PD of GSK2339345 in Healthy Subjects
Start: Oct 17, 2011
Completion: Mar 15, 2012
NCT01702350
A Four Part Study to Investigate Relative Bioavailability, Safety and Tolerability of up to 5 Oral Formulation of GSK2251052 in Order to Identify a Formulation for Further Evaluation in a Future Later Phase Study
Start: Oct 21, 2011
NCT01462292
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
Start: Oct 26, 2011
Completion: Nov 4, 2013
NCT01476137
A Study of the Safety and Activity of the MEK Inhibitor Given Together With the AKT Inhibitor to Patients With Multiple Myeloma or Solid Tumor Cancers
NCT01466335
An Adaptive Phase I Study to Evaluate the Safety, Efficacy and Dose Responses of Ronacaleret in Healthy Human Volunteers
Start: Oct 27, 2011
NCT01137994
A Phase II, Randomized, Open-label Study of Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive and p95HER2-positive Metastatic Breast Cancer
Start: Oct 31, 2011
Completion: Mar 31, 2018
NCT01453023
Inhaled Fluticasone Furoate/Vilanterol Safety and Tolerability, PK and PD Study
NCT01485159
Airflow Limitation in Cardiac Diseases in Europe
NCT01636271
SB-480848 in Major Adverse Cardiovascular Events - Integrated Summary of Efficacy and Safety From the STABILITY Trial (LPL100601) and the SOLID-TIMI-52 Trial (SB-480848/033)
NCT00999804
Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy
Completion: Jan 31, 2026
NCT01397149
Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)
NCT01397591
Ofatumumab and Bortezomib in Subjects With Relapsed CD20+Diffuse Large B Cell, Follicular, or Mantle Cell Lymphoma
NCT01449929
Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects
Completion: Dec 26, 2016
NCT01453348
Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine
NCT01455051
Ofatumumab as Part of Reduced Intensity Conditioning (RIC) Regimen for Patients With High Risk Chronic Lymphocytic Leukemia (CLL) Undergoing Allogeneic Hematopoietic Cell Transplantation
Completion: Oct 31, 2017
NCT01481220
Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS)
NCT02343055
COPE With COPD Trial
NCT01457924
Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis
Start: Nov 1, 2011
Completion: Jun 10, 2015
NCT01462565
Study of a New Thermo Stable Formulation of Epoprostenol Sodium to Treat Pulmonary Arterial Hypertension (PAH)
Completion: Nov 8, 2012
NCT06035289
Register Schweres Asthma - German Asthma Net e.V.
Completion: Nov 1, 2026
NCT01495026
A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia
Start: Nov 6, 2011
Completion: Apr 3, 2012
NCT01545570
A Study to Determine the Safety, Tolerability, and Effects of GSK2374697 in Healthy Volunteers
Start: Nov 7, 2011
Completion: Dec 23, 2012
NCT01458366
Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide
Start: Nov 9, 2011
Completion: Jul 23, 2020
NCT01458067
A Phase I/IIa, First Time in Human, Study of GSK2636771 in Subjects With Advanced Solid Tumors With Phosphatase and Tensin Homolog (PTEN) Deficiency
Start: Nov 10, 2011
Completion: Feb 25, 2016
NCT01536418
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
Start: Nov 11, 2011
NCT01424501
Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease
Start: Nov 14, 2011
Completion: Apr 10, 2014
NCT01484496
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Start: Nov 16, 2011
Completion: Oct 1, 2015
NCT01345240
Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)
Start: Nov 17, 2011
Completion: Feb 9, 2017
NCT01462344
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
Completion: Nov 3, 2015
NCT01516528
Assessment of Comorbidities in Chronic Obstructive Pulmonary Disease (COPD) in European Symptomatic Subjects From Primary Care
Completion: Jun 12, 2015
NCT01475721
SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.
Start: Nov 18, 2011
Completion: Jun 23, 2015
NCT01462357
Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females
Start: Nov 21, 2011
Completion: Oct 27, 2015
NCT01602900
Healthy Volunteer Positron Emission Tomography (PET) Brain Occupancy Study of a Phosphodiesterase 4 (PDE4) Inhibitor in Huntington's Disease
Start: Nov 22, 2011
NCT01640990
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Intravenous Infusion of GW328267X in Healthy Volunteers
Completion: Dec 9, 2011
NCT01462604
Pilot Study of Patient's Adherence to TYKERB™/TYVERB™ + Capecitabine in Metastatic Breast Cancer
Start: Nov 23, 2011
Completion: Jan 24, 2013
NCT01573819
A Repeat Dose Study in Healthy Volunteers Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK356278
Start: Nov 24, 2011
NCT01484093
Sequential Chemo-Radioimmunotherapy Followed by Autologous Transplantation for Patients With Untreated Advanced Stage Mantle Cell Lymphoma
Start: Nov 29, 2011
Completion: Aug 11, 2023
NCT01395004
A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis
Start: Nov 30, 2011
NCT01428518
Special Drug Use Investigation for LAMICTAL Bipolar
Completion: Jan 31, 2016
NCT01445587
A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple Myeloma
NCT01457950
A Study in Korean Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab
NCT01476202
Provoked Craving Relief Study by NRT
NCT01479491
Study on the Incidence of Intussusception (IS) in Children Aged < 12 Months in Japan
NCT01480284
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue
NCT01480609
Effect of Haemodialysis on the Pharmacokinetics of Ezogabine/Retigabine and Its N-acetyl Metabolite
NCT01587729
IMI PROTECT(WP2): Antidepressants & Fractures
NCT01587742
IMI PROTECT (Work Package 2): Calcium Channel Blockers and Cancer
NCT01587768
WEUKBRE5555: IMI PROTECT(Work Package 2): Liver Injury & Antibiotics
NCT01587833
WEUKBRE5559: IMI PROTECT: Benzodiazepines & Fracture
NCT01597648
A Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivir™
NCT01657903
Evaluation of Efficacy of Experimental Gel to Foam Dentifrices in Dental Erosion
NCT01686646
Effects of Two Doses of a Common Cold Treatment on Alertness
NCT01453075
Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I)
NCT01456936
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
NCT01459315
GSK1349572 Exposure in Blood, Seminal Fluid, and Rectal Fluid and Tissue in Healthy Male Subjects
NCT01467583
Fondaparinux in Critically Ill Patients With Renal Failure
NCT01473030
Long-term Effects of Dutasteride on Architectural and Nuclear Morphometric Features of Benign Prostate Tissue
NCT01517191
Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults
NCT01480622
Pharmacokinetic (PK) Profiles of Tenofovir Disoproxil Fumarate (TDF) 300 mg in Healthy Chinese Subjects
Start: Dec 5, 2011
Completion: Dec 30, 2011
NCT01485406
Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine 2830930A Administered in Toddlers
Start: Dec 12, 2011
NCT01627587
A Two Cohort Study to Look at the Metabolites of GSK221149, the Metabolism of GSK221149 Administered With a High Fat Meal and With Ketoconazole
Completion: Feb 9, 2012
NCT01465659
Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
Completion: Jan 27, 2021
NCT01495065
A Study to Evaluate Single and Repeat Doses of IV GSK2251052 in Healthy Male Japanese and Caucasian Subjects and Repeat Doses of Supratherapeutic Doses of IV GSK2251052 in Healthy Volunteers
Start: Dec 19, 2011
Completion: Feb 17, 2012
NCT01521377
QTc Study GSK573719+GW642444
Completion: Jun 5, 2012
NCT01485445
Bioequivalence Study to Compare Fluticasone Furoate (FF) 1-strip Inhaler With FF 2-strip Inhaler and With FF/Vilanterol Combination
Start: Dec 21, 2011
Completion: Mar 12, 2012
NCT01516450
Japanese phase1 Study of Belimumab (IV vs SC)
Start: Dec 26, 2011
Completion: Apr 11, 2012
NCT01328054
A Study in Cancer Patients to Evaluate the Effect of Lapatinib on the QTc Interval
Start: Dec 31, 2011
NCT01475734
Albiglutide Glucose Clamp Study in Subjects With Type 2 Diabetes
NCT01475851
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs
NCT01476111
Evaluation of Specific Biomarkers in Primary Invasive Breast Cancer
NCT01495013
A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes Mellitus
NCT01602913
Type II Diabetes Mellitus in Patients Exposed to Pravastatin and Paroxetine
NCT01607333
WEUKBRE5557: IMI PROTECT(Work Package 2): Antiepileptics & Suicide
NCT01413113
Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery
NCT01465334
Ofatumumab With High Dose Methylprednisone Followed by Ofatumumab and Alemtuzumab in 17p CLL
Completion: Jan 31, 2017
NCT01467518
Methadone-Dolutegravir (DTG - GSK1349572) Drug Interaction Study.
NCT01485042
Dose Escalation Study of Pazopanib Plus TH-302
NCT01498861
Drug Interaction Study Between Dolutegravir and an Oral Contraceptive Containing Norgestimate and Ethinylestradiol
NCT01662778
The Clinical Effect of Monodisperse Fluticasone Propionate in Asthma
NCT01678430
A Trial Looking at Ofatumumab for People With Chronic Lymphocytic Leukaemia Who Cannot Have More Intensive Treatment
NCT01527110
A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection
Start: Jan 1, 2012
Completion: Mar 29, 2013
NCT01597700
Acotral® Versus Zetia® Ezetimibe Bioequivalance Study.
Start: Jan 13, 2012
Completion: Jan 30, 2012
NCT01540708
A Single Centre Study in Healthy Volunteers to Optimise the Rotacap Formulation and ROTAHALER Device for Delivery of Fluticasone Propionate/Salmeterol
Start: Jan 16, 2012
Completion: Sep 4, 2012
NCT01583036
An Open-label, Single-centre Study Evaluating the Pharmacokinetics of Digoxin Alone and When Administered at Various Doses of Ezogabine/Retigabine in Healthy Adults. The Pharmacokinetics of Ezogabine/Retigabine and the N-acetyl Metabolite of Ezogabine/Retigabine (NAMR) Will Also be Assessed
Completion: Apr 17, 2012
NCT01340898
Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and Toddlers
Start: Jan 27, 2012
Completion: Oct 19, 2015
NCT01561976
Evaluation of Food Effect on the Pharmacokinetics of Sustained Release Metformin in Healthy Indian Volunteers
Start: Jan 30, 2012
Completion: Feb 21, 2012
NCT01428531
Special Drug Use Investigation for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment
Start: Jan 31, 2012
NCT01435902
A Study of a New Asthma Medicine in Asthmatics Whose Asthma Worsens With Exercise
NCT01485172
A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release in Patients With Early Stage Parkinson's Disease
NCT01495000
A Study in Indian Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab
NCT01498653
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry
NCT01498679
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
NCT01536678
Bioequivalence of Two Levothyroxine Tablet Formulations in Healthy Indian Volunteers
NCT01467310
Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212
Completion: Mar 21, 2016
NCT01491802
Effect of a New Combination Bronchodilator on Exercise in GOLD Stage II Moderate COPD
NCT01498172
BCG Modulation of the recMAGE-A3 + AS15 ASCI Response in the Treatment of Non Muscle Invasive Bladder Cancer (NMIBC) Patients
NCT01499199
A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in the Central Nervous System in HIV-1 Infected ART-naive Subjects
NCT01520051
Mepolizumab Treatment for Rhinovirus-induced Asthma Exacerbations
NCT01516437
A Study to Assess Immunity to Specific Microbial Antigens in Healthy Smokers and Non-smokers and in Subjects With Stable COPD
Start: Feb 1, 2012
NCT01551771
GW824575 First Time in Human
NCT01506193
Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children
Start: Feb 6, 2012
NCT01563042
A Single Dose Pharmacokinetics (PK) Study of GSK2434735 in Healthy Male Volunteers
Start: Feb 13, 2012
Completion: May 23, 2012
NCT01453491
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
NCT01527123
A Study to Evaluate the Pharmacokinetics of Benzoic Acid and Hippuric Acid After Topical Administration of GSK2585823 in Japanese Subjects With Acne Vulgaris
Start: Feb 28, 2012
Completion: Jun 1, 2012
NCT01506895
A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema
Start: Feb 29, 2012
NCT01562548
Exploratory Efficacy Study of Guaifenesin in Upper Back Pain
NCT01584765
Rechallenge, Potential Drug Induced Liver Injury (Kaiser)
NCT01607411
A Clinical Study to Evaluate Experimental Children's Toothpastes in an In-Situ Caries Model
NCT01762982
Patch Test of Benzalkonium Chloride Disinfectant Spray
NCT01822665
Gastrointestinal Safety Evaluation of Two Over the Counter Analgesics
NCT01467037
Vaccine Effectiveness of RV1 in a Naïve Population
NCT01524848
Pazopanib in Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib
Completion: Nov 30, 2016
NCT01529086
For Cause Prostate Biopsy in REDUCE Population Trial
NCT01728428
A Multicenter, Observational Study to Evaluate Clinical Manifestation, Diagnosis and Treatment of Primary Hemifacial Spasm in Chinese Patients
NCT03072719
The Efficacy of a Dentifrice in Providing Relief From Immediate and Short Term Relief From Dentinal Hypersensitivity
Start: Mar 1, 2012
Completion: Jun 12, 2012
NCT01563328
A Study to Evaluate the Effect of Boceprevir and Telaprevir on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697).
Completion: May 1, 2012
NCT03315468
French Clinical Datbase of Melanoma Patients (RIC-Mel)
Completion: Mar 1, 2030
NCT01577680
A Study to Assess the Effects of GSK573719/VI Combination and GSK573719 Monotherapy in Subjects With Moderate Hepatic Impairment and Matched Healthy Volunteers
Start: Mar 5, 2012
Completion: Jun 29, 2012
NCT01562444
Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules
Start: Mar 8, 2012
Completion: Sep 30, 2016
NCT01551758
A Randomised Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in Chronic Obstructive Pulmonary Disease (COPD)
Start: Mar 13, 2012
Completion: Nov 24, 2015
NCT03285984
Ability of Four Toothpastes to Remove Plaque
Start: Mar 27, 2012
NCT01563029
A Dose-ranging Study of Fluticasone Furoate (FF)
Start: Mar 28, 2012
Completion: Sep 24, 2014
NCT01587703
A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers
Completion: Jul 29, 2019
NCT01587807
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Inhaled GSK1995057
Completion: Nov 19, 2012
NCT01571999
Study to Assess the Safety and PK of GSK573719 and GSK573719/GW642444(VI) Combination in Healthy Subjects and Subjects With Severe Renal Impairment
Start: Mar 29, 2012
Completion: Jun 22, 2012
NCT01428544
Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg)
Start: Mar 31, 2012
NCT01520909
Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.
NCT01521286
Study to Estimate the Burden of Herpes Zoster and Postherpetic Neuralgia in Spain
NCT01592864
The Efficacy of a Dentifrice in Providing Relief From the Pain of Dentinal Hypersensitivity
NCT01636726
WEUKBRE5554: IMI PROTECT(Work Package 2): Beta2 Agonists and Acute Myocardial Infarction
NCT01641237
Effect of Fluoride in a Dentifrice on Remineralization of Erosive Lesions
NCT01648179
A Study to Assess the Relative Bioavailability of Three Formulations and Food Effect on GSK1322322 in Healthy Subjects
NCT01702519
A Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers
NCT01437995
Long-acting Beta Agonist Step Down Study
NCT01627327
Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects With COPD Who Have or Are At Risk for Co-morbid Cardiovascular Disease
Start: Apr 1, 2012
NCT01494532
A Fixed Dose Study of Ropinirole Prolonged Release as Adjunctive Treatment in Patients With Advanced Parkinson's Disease
Start: Apr 2, 2012
Completion: Nov 18, 2014
NCT01573624
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
Start: Apr 3, 2012
Completion: Feb 4, 2013
NCT01602601
A Study to Test the Possibility of Cross Reaction Induced by the Idursulfase Drug to GSK2788723
Start: Apr 9, 2012
Completion: Jun 11, 2012
NCT01462669
Crossover Study to Evaluate the Pharmacokinetics of Ezogabine/Retigabine in Taiwanese Subjects
Start: Apr 10, 2012
NCT01956487
Bioequivalence of RYTHMOL SR® Manufactured at Two Different Sites
Start: Apr 11, 2012
NCT01353703
Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine
Start: Apr 16, 2012
Completion: Feb 25, 2013
NCT01568892
Study Assessing Dolutegravir in HIV-1 Infected Subjects With Virus Resistant to Raltegravir and/or Elivitegravir
Start: Apr 18, 2012
Completion: Dec 16, 2013
NCT01587716
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2339345.
Start: Apr 23, 2012
Completion: Jul 30, 2012
NCT01466972
Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib
Start: Apr 27, 2012
Completion: Oct 2, 2019
NCT01563055
A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic Leukemia
Start: Apr 30, 2012
NCT01563081
Safety Study of Levocetirizine Oral Solution for Japanese Pediatrics
NCT01573767
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
NCT01592851
Clinical Efficacy of a Toothpaste in Providing Relief From the Pain of Dentinal Hypersensitivity
NCT01607372
A Study to Investigate the Safety and Pharmacodynamics of Repeat Intranasal Administration of the TLR7 Agonist GSK2245035 in Subjects With Respiratory Allergies
NCT01616472
WEUKBRE5716: Steroid-related Damage in Systemic Lupus Erythematosus (Hopkins)
NCT01687309
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK2586184 and the Effect of Food and Gender
NCT01755637
Bioequivalence Study of Albendazole 400 mg Tablets in Chinese Population
NCT01858831
Single Oral Dose Study of Atovaquone/Proguanil Hydrochloride Combination Tablets and Atovaquone Suspension
NCT01457261
IPF Drug Deposition Study
NCT01491594
Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia
NCT01536067
Ofatumumab and Bortezomib in Treating Patients With Previously Untreated Waldenstrom Macroglobulinemia
NCT01563068
Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis
NCT01580995
Herpes Simplex Type 1 Suppression in Hepatitis C
NCT01622283
Pharmacokinetic Study of Levocetirizine Oral Solution
Start: May 2, 2012
Completion: Jun 10, 2012
NCT01602562
Valaciclovir Hydrochloride Phase III for Hematopoietic Stem Cell Transplantation Patients
Start: May 7, 2012
NCT01710527
BE Study of Metformin GSK 500mg
Start: May 9, 2012
Completion: May 18, 2012
NCT01582997
A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of of GSK2118436 in Japanese Subjects With BRAF Mutation Positive Solid Tumors
Start: May 11, 2012
Completion: Apr 16, 2015
NCT01673555
Effects of GSK1278863A on Pulmonary Artery Pressure in Healthy Volunteers
Start: May 15, 2012
NCT01587898
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
Start: May 17, 2012
NCT01607385
A Study to Evaluate the Safety, Tolerability, Pharmacokinetic a Single Day of Dosing With GSK1614235.
Start: May 18, 2012
Completion: Dec 3, 2012
NCT01545375
Evaluation of a Vaccine for Reducing Ear and Lung Infections in Children
Start: May 21, 2012
Completion: Jul 26, 2016
NCT01568060
Post-marketing Surveillance to Assess the Safety of Infanrix-IPV Vaccine Among Infants and Children in Korea
Completion: Dec 15, 2015
NCT01587924
4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
Start: May 23, 2012
Completion: May 27, 2013
NCT01555541
Intensive Consolidation and Stem Cell Mobilization Therapy Followed by Autologous Stem Cell Transplantation in High-risk Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Start: May 25, 2012
Completion: Jul 1, 2021
NCT01418937
Safety Evaluation of a Human Papillomavirus (HPV) Vaccine in Healthy Female Control Subjects From the GSK HPV 023 Study
Start: May 29, 2012
Completion: Jan 9, 2015
NCT01292213
A Study to Identify and Characterise Bacteria Causing Chronic Cough Among Children in United Kingdom
Start: May 31, 2012
NCT01584843
Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Patients With Strabismus
NCT01607398
ADOAIR250 Anti-inflammatory Effects in Japanese Subjects With Chronic Obstructive Pulmonary Disease
NCT01641692
A 3-period Crossover Study With GSK573719 as Monotherapy in Adult Subjects With Asthma
NCT01657864
WEUSKOP6166: Lamotrigine and Aseptic Meningitis
NCT01657877
Anti-caries Potential of a Sodium Monofluorophosphate and Calcium Sodium Phosphosilicate Dentifrice
NCT01499160
Letrozole and Lapatinib Followed by Everolimus in Women With Advanced Breast Cancer
NCT01550185
Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia
NCT01593046
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Repeat Dose Administration of Long-Acting GSK1265744 and Long-Acting TMC278 Intramuscular and Subcutaneous Injections in Healthy Adult Subjects
NCT01597492
A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)
Completion: Sep 24, 2015
NCT01600573
Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ)
NCT01615796
Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Repeat IV Doses
Start: Jun 4, 2012
Completion: Feb 21, 2014
NCT01597622
BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115
Start: Jun 11, 2012
Completion: Sep 13, 2018
NCT01536873
Dolutegravir Expanded Access Study
Start: Jun 14, 2012
Completion: Sep 23, 2016
NCT01597687
Pertussis Infection in Adolescents and Adults With Prolonged Cough
Start: Jun 20, 2012
Completion: May 2, 2013
NCT01621802
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age
Start: Jun 21, 2012
Completion: Nov 9, 2015
NCT01610427
Study to Optimize the Quality of Samples for Cell-mediated Immunity (CMI) in ART-naïve HIV-1-infected Subjects
Start: Jun 25, 2012
Completion: Oct 30, 2012
NCT01673490
Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia
Start: Jun 29, 2012
Completion: Mar 20, 2015
NCT01622231
Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis
Start: Jun 30, 2012
NCT01630135
Study FFR116364, a Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis
NCT01636193
Drug Use Investigation for ROTARIX®
NCT01669122
Pharmacokinetic Study of 4 mg Nicotine Lozenge.
NCT01541852
Losmapimod in Chronic Obstructive Pulmonary Disease Patients Stratified by Fibrinogen.
NCT01612351
Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
Completion: May 19, 2025
NCT01622491
Effectiveness of H1N1 Influenza Vaccines in Manitoba, Canada
NCT01622660
Gemcitabine and Pazopanib in Chemotherapy Naïve Patients With Advanced/Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Chemotherapy
NCT01622790
Evaluation of the Bioequivalence of a Combined Formulated Tablet
NCT01610492
A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy
Start: Jul 1, 2012
Completion: Sep 14, 2016
NCT01607112
A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/Influsplit SSW 2012/2013 in People Aged 18 Years and Above
Start: Jul 10, 2012
NCT01616459
Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants
Start: Jul 11, 2012
Completion: Jan 22, 2014
NCT01639339
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
Start: Jul 12, 2012
Completion: Mar 12, 2020
NCT01610414
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Start: Jul 13, 2012
Completion: Feb 1, 2017
NCT01532310
Belimumab (BENLYSTA®) Pregnancy Registry
Start: Jul 16, 2012
Completion: Nov 11, 2022
NCT01673529
Investigation of Topical SB705498 on Healthy Volunteers
Start: Jul 17, 2012
Completion: Oct 4, 2012
NCT01626820
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Fluviral® (2012/2013 Season) in Adults
Start: Jul 19, 2012
Completion: Aug 10, 2012
NCT01691482
A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and Ipratropium
Start: Jul 23, 2012
Completion: Oct 22, 2012
NCT01627340
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus
Start: Jul 24, 2012
Completion: Dec 18, 2013
NCT01648192
Phase I Study of GW856553 (Losmapimod)
Completion: Oct 26, 2012
NCT01494584
Study in Pediatric Subjects With Epilepsy
Start: Jul 25, 2012
Completion: Apr 29, 2013
NCT01647659
Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation
Start: Jul 30, 2012
NCT01536587
Effects of Salmeterol on Autonomic Nervous System
Start: Jul 31, 2012
NCT01599390
Influenza Burden Assessment in the United States, July1997 - up to April 2009
NCT01602549
A Study to Assess the Effect of Repeat Doses of GSK962040 on the Pharmacokinetics of L-DOPA in Subjects With Parkinson's Disease Exhibiting Delayed Gastric Emptying
NCT01636713
A 24-week Study to Evaluate the Efficacy and Safety of GSK573719/GW642444 125/25 mcg and 62.5/25mcg Inhalation Powder Compared With Placebo in Subjects With COPD
NCT01636739
Special Drug Use Investigation for ROTARIX®
NCT01636778
Japanese Phase II Study of SB-497115-GR in Hepatitis C Virus Infected Patients
NCT01653509
An Exploratory Study to Investigate the Inflammatory Response During a Cold Sore Episode
NCT01681979
WEUSRTP4850: Phase II: ICS/LABA Use in Pregnancy and Outcomes
NCT01710553
BE STUDY OF METFORMIN GSK 1000mg
NCT01763463
WEUSKOP6416: Evaluating Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) Subjects
NCT01534897
Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436
NCT01608009
[18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer
Completion: Apr 30, 2016
NCT01627223
Comparison Between Lamivudine and Entecavir Treatment in Spontaneous Severe Acute Exacerbation
NCT01656252
Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission
NCT02626923
Study of Maraviroc (MVC) and Epzicom (ABC/3TC) Once-Daily in ART-Naive & First Switch Patients
NCT01648140
Dose Ranging of GSK2336805 in Combination Therapy
Start: Aug 1, 2012
Completion: Jul 16, 2014
NCT01657552
Eltrombopag/Boceprevir and Eltrombopag/Telaprevir Drug-Drug Interaction Study In Healthy Adult Subjects
NCT01648231
Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Amlodipine and Losartan in Health Volunteers
Start: Aug 6, 2012
Completion: Sep 25, 2012
NCT01606761
A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T)
Completion: Jan 12, 2016
NCT01641809
Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus Rilpivirine
Completion: Jan 15, 2019
NCT01657526
Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Non-typeable Haemophilus Influenzae (NTHI) Vaccine
Start: Aug 8, 2012
Completion: Nov 25, 2013
NCT01663389
A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C -GSK1322322 After an Intravenous and an Oral Dose
Start: Aug 10, 2012
NCT01669070
A Four-way Crossover, Single and Repeat Dose Study to Determine the Dose Proportionality and Absolute Bioavailability of Fluticasone Furoate Inhalation Powder Administered by Novel Dry Powder Inhaler (NDPI)
Start: Aug 15, 2012
Completion: Nov 16, 2012
NCT01604343
A Study of CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND-D)
NCT01669083
Study to Evaluate the Pharmacokinetics, Safety and Tolerability of GSK557296 in Healthy Women Volunteers After Single and Repeat Dosing
Start: Aug 16, 2012
Completion: Mar 9, 2013
NCT01669096
Study in Healthy Adults to Evaluate Gene Activation After Vaccination With GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342
Start: Aug 21, 2012
NCT01659086
Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of Age
Start: Aug 22, 2012
Completion: Mar 19, 2014
NCT01657851
Bioequivalence - Duodart Against Avodart & Omnic
Start: Aug 23, 2012
Completion: Dec 5, 2012
NCT01648101
Assessment of the Efficacy and Safety of 2 Doses of Retigabine Immediate Release (900 mg/Day and 600 mg/Day) Used as Adjunctive Therapy in Adult Asian Subjects With Drug-resistant Partial-onset Seizures
Start: Aug 29, 2012
Completion: Dec 23, 2013
NCT01602510
Lamotrigine Phase III Study in Bipolar I Disorder
Start: Aug 31, 2012
NCT01648153
Investigate the Efficacy and Safety of GSK1070806 in Obese Subjects With T2DM
NCT01678677
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Non-typeable Haemophilus Influenzae (NTHi) Investigational Vaccine (GSK2838497A) in Current and Former Smokers
Completion: Jan 30, 2014
NCT01682005
Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotavirus (RV) Vaccination
NCT01691560
Exploratory Study to Evaluate an Occlusion Based Dentifrice in Relief of Dentinal Hypersensitivity
NCT01702363
Long-term Safety Study for GSK573719 in Japanese
NCT01710540
BE Study of Metformin GSK 850mg
NCT01301794
Lovaza Mechanisms of Action
NCT01542047
A Combination of Pazopanib and Carboplatin in Advanced Solid Malignancies
NCT02552472
A Study of Inhaler Use in the Community
NCT01597635
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Start: Sep 1, 2012
Completion: Oct 6, 2014
NCT01340846
A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Start: Sep 3, 2012
NCT01641133
Primary Vaccination With Either Synflorix™ or Prevenar 13™ or Both Vaccines and Booster Vaccination With Synflorix™
Start: Sep 4, 2012
Completion: May 7, 2014
NCT01668654
Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS
Completion: Jun 18, 2013
NCT01649765
Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy
Start: Sep 7, 2012
Completion: Apr 5, 2028
NCT01641042
Comparison of GlaxoSmithKline (GSK)134612 in Subjects With Increased Risk for Meningococcal Disease Versus Healthy Subjects
Start: Sep 10, 2012
Completion: Mar 3, 2015
NCT01658553
A Study to Look at the Electrical Activity of the Heart in Subjects With Solid Tumor Cancers, Before and After Receiving the Study Treatment, GSK1120212
Start: Sep 19, 2012
Completion: Apr 5, 2014
NCT01686633
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (mcg) , FF/VI 100/25 mcg, and FF 100 mcg in Adults and Adolescents With Persistent Asthma.
Start: Sep 20, 2012
Completion: Oct 15, 2013
NCT01696604
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2849466 in Healthy Male Subjects
Start: Sep 26, 2012
Completion: May 3, 2013
NCT01343043
A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma
Start: Sep 27, 2012
Completion: Jun 18, 2019
NCT01687283
Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma
Completion: Nov 7, 2013
NCT01725672
Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Extended Release Metformin and Extended Release Glimepiride in Health Volunteers
Completion: Aug 21, 2013
NCT01691859
MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects
Start: Sep 28, 2012
Completion: May 31, 2017
NCT01653483
Aura Adolescent PK Study GSK2829332
Start: Sep 30, 2012
NCT01702532
Nicotine Mouth Film for Craving Relief.
NCT01721213
Trobalt™ Products Risk Survey
NCT01767389
Glucagon-like Peptide (GLP) Utilization and Safety
NCT01619774
An Open-Label Phase II Study of the Combination of GSK2118436 and GSK1120212 in Patients With Metastatic Melanoma Which is Refractory or Resistant to BRAF Inhibitor
NCT01666652
A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults
Completion: Nov 30, 2017
NCT01694329
Impact of Introduction of PHiD-CV for Nunavik Children, Quebec, Canada
NCT01701869
Microbiology & Immunology of the Chronically-inflamed Airway
NCT01702376
This Study Will Investigate the Effect of Single Oral Doses of Retosiban on Cardiac Repolarization, With Moxifloxacin as a Positive Control in Healthy Volunteers.
Start: Oct 3, 2012
Completion: Jan 14, 2013
NCT01691820
A Study in Adolescent Females to Explore Cytomegalovirus Infection
Start: Oct 5, 2012
Completion: Apr 8, 2017
NCT01702454
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
Start: Oct 6, 2012
Completion: Jun 5, 2013
NCT01682876
Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.
Start: Oct 7, 2012
Completion: May 30, 2014
NCT01691521
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
Start: Oct 8, 2012
Completion: Jan 18, 2014
NCT01681992
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life
Start: Oct 10, 2012
Completion: Aug 18, 2015
NCT01691872
Pharmacokinetic Study of Retigabine Extended Release (XR) Formulation in Healthy Adult Japanese and Caucasian Subjects
Completion: Oct 18, 2012
NCT01627561
Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old
Start: Oct 15, 2012
Completion: Oct 6, 2016
NCT01706328
A Study to Assess the Efficacy of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25 mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50 mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Completion: Jun 17, 2013
NCT01706315
This Study Will Investigate the Safety, Tolerability and Pharmacokinetic Profile of Repeat Oral Doses of GSK2140944 in Healthy Adult Subjects
Start: Oct 17, 2012
Completion: Dec 13, 2013
NCT01702467
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single, Oral Escalating Doses of GSK2647544 in Healthy Volunteers
Start: Oct 19, 2012
Completion: May 15, 2013
NCT01711723
A Study to Assess the Pharmacokinetics, Safety and Tolerability of Repeat Oral Doses of Darapladib (SB-480848) in Subjects With Severe Renal Impairment
Start: Oct 29, 2012
Completion: Mar 25, 2013
NCT01160055
Study to Characterize and Identify Bacteria Causing Acute Otitis Media in Young Egyptian Children
Start: Oct 31, 2012
NCT01691495
ARIXTRA® Adherence in SVT Patients.
NCT01691508
Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
NCT01706302
Burden of Respiratory Syncytial Virus (RSV) in the United Kingdom From 1995 to 2009
NCT01715792
Assess the Risk of Solid Organ Transplant Rejection Following Vaccination With Pandemrix™ in UK
NCT01716520
Cross-Over Study in Subjects With COPD, Evaluating Lung Function Response After Treatment With Once Daily Umeclidinium 62.5mcg, Vilanterol 25mcg, and Umeclidinium/Vilanterol 62.5/25mcg
NCT01751178
An Efficacy Study of Chlorhexidine Mouthwashes
NCT01500538
A Pilot Study of Oral Vorinostat Plus Oral Eltrombopag Support in Patients With Lymphoma (VEIL)
NCT01621204
A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients
Completion: Aug 31, 2019
NCT01626352
Study of Bendamustine and Ofatumumab in Elderly Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy
NCT01706198
An Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in Asthma
Start: Nov 1, 2012
NCT01711736
Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children 6 to 35 Months of Age
Completion: Jun 19, 2013
NCT01802892
Study in Healthy Volunteers, to Evaluate the Safety, Efficacy and Dose Responses of SB-751689 (Ronacaleret)
Start: Nov 2, 2012
Completion: Apr 2, 2013
NCT01702480
Effects of Triglycerides on Age-Related Cognitive Function Decline in Older Subjects
Start: Nov 5, 2012
Completion: Jul 3, 2015
NCT01725685
To Investigate the Pharmacokinetics and Safety of Fluticasone Furoate (FF)/ Umeclidinium (UMEC) Combination Compared With FF and UMEC Monotherapies in Adult Healthy Volunteers Using a Dry Powder Inhaler (DPI)
Start: Nov 8, 2012
Completion: Jan 2, 2013
NCT01702428
Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age
Start: Nov 9, 2012
NCT01687296
Nebulized Fluticasone Propionate VS Oral Prednisone in Chinese Pediatric and Adolescent Subjects With an Acute Exacerbation of Asthma
Start: Nov 12, 2012
Completion: Jun 21, 2013
NCT01684397
Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer
Start: Nov 21, 2012
Completion: Jan 20, 2026
NCT01705977
Belimumab Assessment of Safety in SLE
Start: Nov 27, 2012
Completion: Aug 10, 2022
NCT01733862
Study to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis
Completion: Feb 8, 2017
NCT01031329
Study to Identify and Characterize Bacteria Causing Acute Otitis Media in Young Children in Turkey
Start: Nov 30, 2012
NCT01445600
ALTARGO(Retapamulin) PMS(Post-marketing Surveillance)
NCT01691885
RELOVAIR® Lung Deflation Study
NCT01706224
Sero-prevalence of Anti-pertussis Antibodies and Disease Awareness Among Spanish Healthcare Professionals
NCT01767363
WEUSKOP5723: Prostate Cancer Study
NCT01905462
Post-marketing Safety Study to Assess the Risk of Spontaneous Abortions in Women Exposed to Cervarix Residing in UK
NCT01689532
A Study of CNTO 136 (Sirukumab) Administered Subcutaneously in Japanese Patients With Active Rheumatoid Arthritis Unresponsive to Methotrexate or Sulfasalazine
NCT01700010
Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer
Completion: Jan 31, 2019
NCT01702857
A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico)
Completion: Mar 23, 2017
NCT01734434
Study to Identify Factors Influencing Access of Pregnant Women and Their Infants to Local Healthcare Systems
NCT01744106
A Multicenter Study of Pseudoephedrine for the Temporary Relief of Nasal Congestion in Children With the Common Cold
NCT01808313
Efficacy Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension (PAH)
Start: Dec 1, 2012
Completion: Aug 15, 2014
NCT01729949
The Acute and Chronic Effects of Fruit Polyphenols on Chronic Disease (PPF)
Completion: Jun 26, 2018
NCT01711463
Relovair PD PK in Chinese Healthy Subjects
Start: Dec 5, 2012
Completion: Jun 4, 2013
NCT01730378
Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old
NCT01591577
Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Multiforme
Start: Dec 7, 2012
Completion: May 7, 2024
NCT01577732
Safety of GSK Biologicals' Infanrix-IPV+HibTM Vaccine in Healthy Vietnamese Toddlers
Start: Dec 8, 2012
Completion: Apr 9, 2013
NCT01738867
To Evaluate the Influence of the A118G Polymorphism in the mu Opioid Receptor Gene (OPRM1) on Effects of GSK1521498 and Naltrexone on Physiological and Behavioural Markers of Brain Function in Healthy Social Drinkers
Start: Dec 12, 2012
Completion: May 27, 2014
NCT01691547
A Study to Assess the Systemic Exposure, Systemic Pharmacodynamics and Safety and Tolerability of FluticasoneFuroate, Umeclidinium and Vilanterol in Healthy Subjects
Start: Dec 17, 2012
Completion: Mar 8, 2013
NCT01751074
To Estimate the Potential Effects of Repeat Doses of Darapladib on the Pharmacokinetics (PK) of Rosuvastatin as Well as Evaluating Safety and Tolerability in Healthy Volunteers
Completion: Mar 14, 2013
NCT01721317
Dose-Optimization, Adjunctive Treatment Study of Ezogabine/Retigabine Immediate Release in Partial-onset Seizures
Start: Dec 19, 2012
NCT01753076
Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis
Start: Dec 20, 2012
Completion: Jan 22, 2015
NCT01733849
A Study to Estimate the Occurrence of Rotavirus Gastroenteritis in Children < 5 Years of Age, in Bulgaria and Latvia
Start: Dec 31, 2012
NCT01817790
Assessment of Fluticasone Propionate on Ocular Allergy Symptoms
NCT01693185
Remifentanil Only vs. Midazolam and Meperidine During Elective Colonoscopy
NCT01710059
Using Mobile Phones to Improve Adherence to Inhaled Steroids
NCT01762995
A Study to Evaluate the Effects of Calcium Carbonate and Ferrous Fumarate on Pharmacokinetics of Dolutegravir in Healthy Adult Subjects
NCT01772134
Efficacy and Safety of the Addition of Fluticanse Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide (62.5 or 125mcg) Once-daily Over 12 Weeks
Start: Jan 1, 2013
Completion: Jul 22, 2013
NCT01802931
GSK239512 DDI Study
Start: Jan 7, 2013
Completion: Apr 15, 2013
NCT01762878
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of the Dry Powder Formulation of GSK2269557 in Healthy Subjects
Start: Jan 9, 2013
Completion: Oct 21, 2013
NCT01756495
A Study to Evaluate the Effect of Losmapimod on Cardiac Conduction as Compared to Placebo and Moxifloxacin
Start: Jan 10, 2013
Completion: Apr 23, 2013
NCT01767376
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Conjugate Vaccine (GSK134612) When Co-administered With Boostrix® in Subjects Between 11 and 25 Years of Age
Completion: Jan 16, 2014
NCT01755689
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine With or Without Co-administration of Cervarix and Boostrix in Female Adolescents and Young Adults
Start: Jan 11, 2013
Completion: Apr 29, 2014
NCT01716208
Ofatumumab and Fresh Frozen Plasma in Patients With Chronic Lymphocytic Lymphoma
Start: Jan 14, 2013
Completion: Oct 1, 2020
NCT01793870
A Study in Healthy Volunteers to Evaluate the Application of Stable Isotope Approach to Reduce Number of Subjects Needed for PK Studies
Start: Jan 15, 2013
NCT01762774
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of GSK2256294 in Healthy Volunteers, and Single and Repeat Doses of GSK2256294 in Adult Male Moderately Obese Smokers
Start: Jan 16, 2013
Completion: May 1, 2014
NCT01738451
A Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors
Start: Jan 22, 2013
Completion: Nov 28, 2014
NCT01777334
The Purpose of This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotriopium 18 mcg Once Daily Over a 24-week Treatment Period in Subjects With COPD
Start: Jan 23, 2013
Completion: Sep 24, 2013
NCT01692496
Activity and Tolerability of Pazopanib in Advanced and/or Metastatic Liposarcoma. A Phase II Clinical Trial
Start: Jan 29, 2013
Completion: Mar 2, 2018
NCT01730391
Neisseria Meningitidis Burden of Disease Study
Start: Jan 31, 2013
NCT01738477
Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults
Completion: Apr 2, 2014
NCT01772147
Efficacy and Safety of the Addition of Fluticasone Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide Inhalation Powder (62.5 or 125mcg) Once-daily Over 12 Weeks.
NCT01831817
Exploratory Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in Relief of Dentinal Hypersensitivity
NCT02019732
Study to Assess the Burden of Mild Outcomes (Physician Office Visits) Due to Influenza in the United States
NCT02262702
Panadol Osteo Pharmaceuticals Benefit Scheme (PBS) Claims Cohort Study
NCT01754116
A Randomized Study to Assess the Relative Bioavailability of New Formulations of GSK1265744 Long Acting Parental (LAP) in Healthy Adult Subjects
NCT01866267
Switching Undetectables to Selzentry
NCT02070055
Dietary Correlates of the Maximal Capacity for Fat Oxidation
NCT02014480
A Cross-Over Study to Evaluate Lung Function Response After Treatment With Umeclidinium (UMEC) 62.5 Micrograms (mcg), Vilanterol (VI) 25 mcg, and Umeclidinium/Vilanterol (UMEC/VI) 62.5/25 mcg Once-Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Start: Feb 1, 2013
Completion: Jun 11, 2013
NCT01716533
Evaluation of the Immune Response to Clostridium Difficile in Adults With Clostridium Difficile Infection (CDI)
Start: Feb 2, 2013
Completion: Jun 1, 2015
NCT03292094
The African-PREDICT Study
Start: Feb 4, 2013
Completion: Dec 3, 2027
NCT01725100
A Study to Determine the Relative Bioavailability of the MEK Inhibitor, Trametinib, in Subjects With Solid Tumor Malignancies
Start: Feb 5, 2013
NCT02254460
Investigation of Iron Uptake From Micronutrient Fortified Powder Versus From Tailored Control in Milk
Start: Feb 6, 2013
NCT01725126
To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
Start: Feb 10, 2013
Completion: Sep 12, 2013
NCT01767454
Study of Dabrafenib +/- Trametinib in Combination With Ipilimumab for V600E/K Mutation Positive Metastatic or Unresectable Melanoma
Start: Feb 12, 2013
Completion: Sep 4, 2015
NCT01777269
Prospective Sexual Function Study for BPH Subjects
Start: Feb 18, 2013
Completion: Apr 5, 2016
NCT01802918
Single Dose Escalation Study of GSK2838232 in Healthy Subjects
Completion: Nov 21, 2013
NCT01632241
Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)
Start: Feb 19, 2013
Completion: Jan 28, 2019
NCT01729455
Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) Registry
Start: Feb 21, 2013
Completion: Feb 28, 2025
NCT01818024
A Study to Investigate the Safety Tolerability Pharmacokinetics, and Pharmacodynamics of Inhaled and Intravenous GSK2862277 in Healthy Volunteers
Start: Feb 22, 2013
Completion: Oct 25, 2013
NCT01910662
Characterisation of T-cell Response to Keyhole Limpet Hemocyanin (KLH) and Tuberculin Purified Protein Derivative (PPD)
Completion: Nov 26, 2013
NCT01777282
A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes Mellitus
Start: Feb 23, 2013
Completion: Jan 27, 2015
NCT01711749
Rosuvastatin Calcium Bioequivalence Study - Fast
Start: Feb 25, 2013
Completion: Mar 13, 2013
NCT01777295
Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System
Completion: Sep 13, 2016
NCT01772160
Study to Estimate the Burden of Herpes Zoster (HZ) and Post-herpetic Neuralgia (PHN) in Italy
Start: Feb 26, 2013
Completion: Oct 5, 2016
NCT01658605
A Study to Investigate the Efficacy and Safety of GSK1605786 for Treatment of Patients With Active Ulcerative Colitis
Start: Feb 28, 2013
NCT01733758
A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)
NCT01751113
A 3 Way Cross-over Study Evaluating the Effects of ADOAIR Twice Daily Plus Tiotropium Bromide Once Daily Compared With the Individual Treatments of Japanese Subjects
NCT01762800
Evaluating the Control of COPD Symptoms in Patients Treated With Tiotropium Bromide 18mcg Once Daily Alone, ADOAIR 50/250mcg Twice Daily Alone or ADOAIR 50/250mcg Plus Tiotropium Bromide 18mcg
NCT01772199
Study to Assess Whether GSK239512 Can Remyelinate Lesions in Subjects With Relapsing Remitting Multiple Sclerosis
NCT01827670
Investigating the Efficacy of a Dentifrice in Providing Long Term Relief From Dentinal Hypersensitivity
NCT01938560
REMS Retigabine Study
NCT01769508
Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer
NCT01771354
Training Study to Characterise Biomarkers to the Engerix B Vaccine
NCT01767467
Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers
Start: Mar 1, 2013
Completion: Jan 6, 2017
NCT01777256
An Adaptive Phase II Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of GSK2586184
NCT01782664
A Dose Ranging Study to Evaluate the Safety and Efficacy of GSK2586184 in Patients With Chronic Plaque Psoriasis
Completion: Mar 24, 2014
NCT01817764
A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol and Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT01798056
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy
Start: Mar 6, 2013
NCT01725139
A Proof of Mechanism Study With GSK2126458 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Start: Mar 8, 2013
Completion: Jul 12, 2016
NCT01751165
Safety and Immunogenicity of Different Dosing Schedules of GlaxoSmithkline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine in Adults 50 Years of Age or Older
Start: Mar 12, 2013
Completion: Apr 8, 2015
NCT01808482
A First Time in Human Study Exploring Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2618960 in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis (RRMS)
Start: Mar 13, 2013
Completion: Aug 6, 2013
NCT01842620
OXEMET™ 1000 mg Coated Tablets (Metformin Hydrochloride) Bioequivalence Study. OXEMET (TM) is a Trademark of the GlaxoSmithKline Group of Companies. GLAFORNIL(TM) is a Trademark of Merck.
Completion: May 4, 2013
NCT01766206
Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects From 2 Months to 55 Years of Age in the Republic of South Korea
Start: Mar 15, 2013
Completion: Jan 22, 2018
NCT01711658
TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer.
Completion: Sep 21, 2022
NCT01663623
Belimumab in Remission of VASculitis
Start: Mar 20, 2013
Completion: Feb 6, 2017
NCT02141217
AUGMENTIN™ in Dental Infections
Start: Mar 21, 2013
Completion: Dec 28, 2013
NCT01788228
Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure
Start: Mar 22, 2013
Completion: Feb 25, 2015
NCT01607346
An Open Label Study to Evaluate the Effects of Ezogabine/Retigabine Added to Existing Anti-epileptic Drug(s) on Urinary Voiding Function in Subjects With Partial Onset Seizures
Start: Mar 27, 2013
Completion: Nov 16, 2016
NCT01055600
Milk-only Lactation Study for Patients on Eltrombopag
Start: Mar 31, 2013
NCT01440361
A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.
NCT01788813
To Investigate the Safety, Pharmacodynamics and Effect on Allergic Reactivity of the Toll-like Receptor 7 (TLR7) Agonist GSK2245035 in Subjects With Respiratory Allergies
NCT01793857
Healthcare Seeking Behaviour of Primary Caregivers for Acute Otitis Media (AOM) in Children Aged 6 Months to Less Than 30 Months in Panama
NCT01808339
To Investigate the Effects of Altering the Time of Day of Dosing (Morning or Evening) With Fluticasone Furoate 100 Micrograms Once Daily Administered Via a Dry Powder Inhaler in Subjects With Asthma
NCT02020902
Post Marketing Surveillance for Contac Bien Z in Japan
NCT01285362
Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study
NCT01330147
HPV Prevalence in the Mouth and Oropharynx of the Tonsillectomy Population
Completion: Sep 28, 2015
NCT01813136
Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma
NCT01842633
Clinical Study to Evaluate Efficacy of New Paracetamol Formulation Compared to Ibuprofen in Headache
Start: Apr 1, 2013
NCT01822639
A Fixed Dose Combination Amlodipine + Enalapril Bioavailability Study
Start: Apr 3, 2013
NCT01822899
A Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Start: Apr 4, 2013
NCT01726738
LCCC 1128: Open Label Phase II Trial of the BRAF Inhibitor (Dabrafenib) and the MEK Inhibitor (Trametinib) in Unresectable Stage III and Stage IV BRAF Mutant Melanoma; Correlation of Resistance With the Kinome and Functional Mutations
Completion: Sep 17, 2020
NCT01803074
Study to Evaluate a HIV Drug for the Treatment of HIV Infection
Completion: Nov 29, 2014
NCT01777139
A Long-term, Safety, Tolerability, and Efficacy Study of Retigabine Immediate-release (IR) in Asian Adults With Partial Onset Seizures
Start: Apr 11, 2013
NCT01831791
A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia
Start: Apr 14, 2013
Completion: Jul 19, 2014
NCT01827644
Bioavailability and Food Effect of the Original Gelatin Formulation and Two New Formulations of Afuresertib in Normal Healthy Volunteers
Start: Apr 24, 2013
Completion: Jul 12, 2013
NCT01879423
The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 5mg×5 Compared With Lamotrigine Compressed Tablet 25mg in Chinese Healthy Male Subjects
Start: Apr 28, 2013
Completion: Jun 6, 2013
NCT01480596
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Start: Apr 30, 2013
NCT01551537
Post-marketing Surveillance of GSK Biologicals' Cervarix™ When Administered to Healthy Females in Sri Lanka
NCT01762852
Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy
NCT01803425
Post-marketing Safety Study of GlaxoSmithKline (GSK) Biologicals' Synflorix™ Vaccine, in Healthy Infants and Children in Sri Lanka
NCT01808326
A Phase II, Open Label, Single Arm, Multicenter Study of Chlorambucil in Japanese Previously Untreated Patients With Chronic Lymphocytic Leukemia
NCT01915732
A Efficacy and Safety of Duac™Compared With Clindamycin Phosphate Gel in the Treatment of Mild to Moderate Acne Vulgaris
NCT01920464
Place of Flixovate® in the Treatment Pathway and Its Conditions of Use in Infants Aged From 3 to 12 Months Between 2010 and 2012 by French GPs and Private Paediatricians
NCT01543802
Study of Preoperative Therapy With Pazopanib (Votrient®) to Treat High-risk Soft Tissue Sarcoma
Completion: Oct 31, 2016
NCT01582932
Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis
Completion: Aug 31, 2018
NCT01721603
Dabrafenib and Trametinib With Radiosurgery in Melanoma Brain Mets
NCT01821625
Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C
NCT01823159
Cortical Excitability Changes Induced by Retigabine: a Transcranial Magnetic Stimulation Study
NCT01827163
Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast Cancer
NCT01777308
Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine Administered 6 Years Post-MenC Primary Vaccination in Healthy Subjects Who Were 12-18 Months at Primary Vaccination
Start: May 3, 2013
Completion: Apr 20, 2016
NCT01777243
A Study to Evaluate the Safety of GSK2398852 When Co-administered With GSK2315698 in Patients With Systemic Amyloidosis
Start: May 13, 2013
Completion: Dec 22, 2015
NCT01847404
Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of ASA (Acetylsalicylic Acid) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fasting Conditions
Start: May 14, 2013
NCT01852565
Study to Determine the Effect of Repeated Administration of Diltiazem on the Pharmacokinetics of Darapladib (Sb-480848).
NCT01847417
Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of Acetylsalicylic Acid (ASA) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fed Conditions
Start: May 16, 2013
Completion: Jul 1, 2013
NCT01857895
Feasibility Study of Exenatide by Continuous Subcutaneous Infusion
NCT01743482
Pazopanib in Advanced and Cisplatin-resistant Germ Cell Tumors
Start: May 17, 2013
Completion: Jul 27, 2016
NCT01808261
Proof of Concept (POC) in Patients With Ischaemic Stroke
Start: May 18, 2013
Completion: Jul 28, 2014
NCT01857869
Efficacy, Safety and Immunogenicity Study of GlaxoSmithKline(GSK) Biologicals' Candidate Malaria Vaccine 257049 in the Sporozoite Challenge Model in Healthy Malaria-naïve Adults
Start: May 20, 2013
Completion: Dec 16, 2014
NCT01899638
Pharmacokinetics Of Umeclidinium and Vilanterol in Healthy Chinese, a Randomized, Open Label, 3 Crossover Study.
Completion: Jul 25, 2013
NCT01797926
Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting Conditions
Start: May 23, 2013
NCT01827631
Single and Repeat Dose Pharmacokinetic Study of GSK1605786 in Healthy Chinese Subjects
Start: May 27, 2013
NCT01842607
A Study to Determine Long-term Safety of Mepolizumab in Asthmatic Subjects
Completion: Mar 13, 2015
NCT01827657
Study to Evaluate the Pharmacokinetics and Safety of GSK2336805 in Subjects With Hepatic Impairment and Healthy Matched Control Subjects
Start: May 28, 2013
Completion: Mar 20, 2014
NCT04123665
A Phase 3 Clinical Study Investigating the Gingivitis Efficacy of a Test Dentifrice Containing Stannous Fluoride
Completion: Dec 11, 2013
NCT01817777
An Open Study to Evaluate Whether Pack Size Affects Compliance of Metformin Treatment in Subjects With Type II Diabetes
Start: May 31, 2013
NCT01847443
Comparison of Pharmacokinetic Profiles of Two Nicotine Gum Formulations
NCT01868009
DISKUS vs. ELLIPTA Device Preference Study in Chronic Obstructive Pulmonary Disease (COPD)
NCT01938508
Minocycline Bioequivalence Study
NCT02498288
A Study to Determine Bioequivalence of Isotretinoin in Healthy Male Subjects Under Fed Condition
NCT01848340
An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects
NCT01827839
Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster
Start: Jun 10, 2013
Completion: Nov 25, 2014
NCT01867996
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Retosiban (GSK221149) When Dosed With Efavirenz (EFZ)
Start: Jun 11, 2013
Completion: Sep 26, 2013
NCT01853878
A Study to Demonstrate the Benefit of a New Kind of Anti-cancer Treatment [PReferentially Expressed Antigen of MElanoma (PRAME) Immunotherapy] for Patients With Non-Small Cell Lung Cancer (NSCLC), After Removal of Their Tumor
Start: Jun 12, 2013
Completion: Aug 24, 2016
NCT01879410
A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol With Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Start: Jun 13, 2013
Completion: Jan 9, 2014
NCT01879462
A First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single & Repeat Escalating Doses of GSK2878175 in Healthy Subjects
Start: Jun 14, 2013
Completion: Jan 10, 2014
NCT01777321
Safety and Immunogenicity Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A When Administered Subcutaneously Intramuscularly in Adults Aged ≥50 Years
Start: Jun 17, 2013
Completion: Nov 11, 2014
NCT01831804
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863
Completion: Feb 10, 2017
NCT01746108
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection
Start: Jun 18, 2013
Completion: Jun 29, 2015
NCT01873339
Pharmacokinetic Interaction of Darapladib and CYP 3A4 in Healthy Subjects
Start: Jun 19, 2013
NCT01855724
Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree Cancer
Start: Jun 28, 2013
Completion: Sep 28, 2018
NCT01873365
A Study to Assess the Burden of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged Sixty Years and Above
Start: Jun 29, 2013
Completion: Feb 4, 2015
NCT01894919
Antibody Persistence, and Safety and Tolerability of a Booster Dose of the Meningococcal B Vaccine After the Completion of the Vaccination Course in Study V72_28
Start: Jun 30, 2013
NCT01884519
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine, Fluarix®/Influsplit SSW® (2013/2014 Season), in Adults 18 Years of Age and Older
Start: Jul 1, 2013
Completion: Aug 2, 2013
NCT01899755
A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability, Immunogenicity, and Pharmacodynamics (PD) of GSK2800528 in Healthy Subjects.
Start: Jul 10, 2013
Completion: Apr 3, 2014
NCT01878812
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine, Fluarix/Influsplit Tetra® (2013/2014 Season), in Adults 18 Years of Age and Older
Start: Jul 11, 2013
Completion: Aug 5, 2013
NCT01894386
Pharmacokinetic Study in Healthy Volunteers to Characterise the Exposure of Fluticasone Furoate (FF), Vilanterol (VI) and Umeclidinium (UMEC) at Two Different Doses
Start: Jul 15, 2013
NCT01878825
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Trivalent Split Virion Influenza Vaccine Fluviral™ (2013-2014 Season) in Adults Aged 18 Years and Older
Start: Jul 18, 2013
Completion: Aug 9, 2013
NCT01847430
Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder
Start: Jul 19, 2013
NCT01905215
Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccines
Start: Jul 22, 2013
Completion: Mar 16, 2015
NCT01890850
Study to Analyze the Risk Factors Associated With Pertussis/Whooping Cough Infection Among Infants
Start: Jul 31, 2013
NCT01848145
Rapid Infusion of Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia
NCT01916226
A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis
Start: Aug 1, 2013
NCT01929863
Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 in Type 2 Diabetes Patients Taking Metformin
NCT01808365
N. Meningitidis Carriage Study
Start: Aug 2, 2013
Completion: Mar 25, 2014
NCT01890863
ROTAHALER Device Optimization Study
Start: Aug 5, 2013
NCT02275364
Functional Magnetic Resonance Imaging (fMRI) Study of Nasal Strips in Nasal Congestion
Completion: Oct 30, 2013
NCT01875666
Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib
NCT01818011
A Three-part Study to Determine the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Volunteers and Healthy Male Japanese Subjects
Start: Aug 7, 2013
Completion: Oct 18, 2013
NCT01856309
Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003
Completion: Apr 30, 2018
NCT01934101
Phase 1 Dose Escalating Study to Assess Safety, Tolerability, Food Effect and PK of CHR-5154 in Healthy Male Volunteers
Start: Aug 12, 2013
Completion: May 28, 2014
NCT01928940
Japan PhI/II of GSK2118436 and GSK1120212 Combination in Subjects With BRAF V600E/K Mutation Positive Advanced Solid Tumors (Phase I Part) or Cutaneous Melanoma (Phase II Part)
Start: Aug 15, 2013
Completion: Jul 4, 2016
NCT01924858
A Positron Emission Tomography (PET) Study to Investigate the Brain Biodistribution of 18F GSK2647544 in Healthy Subjects to Determine Its Ability to Cross the Blood-brain-barrier.
Start: Aug 19, 2013
Completion: Mar 3, 2014
NCT01910402
A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)
Start: Aug 22, 2013
Completion: Aug 18, 2022
NCT01934127
Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age
Start: Aug 26, 2013
Completion: Oct 20, 2014
NCT01929317
A Study to Evaluate the Efficacy of 18 to 24mg/Day Ropinirole Controlled Release (CR) Tablets in Early and Advanced Parkinson's Disease (PD) Patients.
Start: Aug 28, 2013
Completion: Jun 9, 2015
NCT01934231
Study to Assess the Efficacy and Safety of Potassium Clavulanate/Amoxicillin in Children With Acute Bacterial Rhinosinusitis
Start: Aug 30, 2013
NCT01738841
Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines
Start: Aug 31, 2013
NCT01915888
Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotarix Vaccination
NCT01920568
A Study to Compare Denosumab With Zoledronic Acid in Subjects With Bone Metastases From Solid Tumors
NCT01911221
A Phase 3b, Single-Center, Open-label Study to Assess the Immunogenicity and Safety of Novartis Meningococcal B Recombinant Vaccine When Administered at a 0, 2-Month Schedule in Healthy At-Risk Adults Aged 18 to 65 Years Inclusive.
NCT01925222
Effects of Pneumococcal Vaccine on Nasopharyngeal Carriage
NCT01934153
Characterization of Exposure From Topical Administration of [14C] Umeclidinium to Axilla or Palm of Healthy Male Subjects
Start: Sep 2, 2013
Completion: Feb 19, 2014
NCT01750931
This Study is Randomised, Single Oral Dose Bioequivalence Study of Meloxicam GSK 15 MG Tablets.
Start: Sep 12, 2013
Completion: Oct 1, 2013
NCT03494985
A Clinical Study to Evaluate the Efficacy of Three Dry Mouth Relief Products Versus Water
Start: Sep 17, 2013
NCT01943864
A Phase IIa Study of the MEK Inhibitor Trametinib Monotherapy in the Treatment of Biliary Tract Cancers
Start: Sep 19, 2013
Completion: Feb 1, 2016
NCT01929291
Post-marketing Surveillance to Assess the Safety of Boostrix Vaccine Given According to Prescribing Information in Korea
Start: Sep 23, 2013
Completion: Jan 11, 2016
NCT01929330
Bioequivalence Study of Dutasteride Five 0.1 mg and One 0.5 mg Soft Gelatin Capsules in Healthy Male Volunteers
NCT02838407
Identification and Characterization of Bacteria in the Lungs of Children From 6 Months up to 6 Years Old, With Suspected Infection of the Lungs, in Spain.
Completion: Sep 23, 2015
NCT01934205
To Evaluate Plasma and Pulmonary Pharmacokinetics of GSK2140944
Start: Sep 25, 2013
Completion: Dec 21, 2013
NCT01949090
Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older
Completion: Oct 23, 2014
NCT01536379
A Study of Belimumab in the Prevention of Kidney Transplant Rejection
Start: Sep 30, 2013
NCT01772225
NSCLC Burden of Illness Study
NCT01884675
Ambrisentan for Inoperable Chronic Thromboembolic Pulmonary Hypertension.
NCT01962493
An Efficacy Study of Stain Control of a 67% Sodium Bicarbonate Containing Toothpaste on Chlorhexidine Tooth Staining
NCT02076269
Severe Chronic Obstructive Pulmonary Disease Inhalation Profiles Comparison
NCT02119325
The Effect of a Nutritional Supplement on Post Prandial Glucose and Lipids in an Adult Population
NCT01765413
Training Study to Characterize Biomarkers to Chickenpox and Yellow Fever Vaccines
NCT01891357
Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer
NCT01953510
Trial of Pneumococcal Vaccine Schedules in Ho Chi Minh City, Vietnam
Completion: Nov 8, 2021
NCT01949051
A Study to Assess Intranasal Repeat Dose Effect of Levocabastine in the Subjects With Allergic Rhinitis
Start: Oct 1, 2013
Completion: Feb 4, 2014
NCT01957163
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Completion: Apr 1, 2014
NCT01964924
Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Metastatic Triple-Negative Breast Cancer
Start: Oct 2, 2013
Completion: Apr 23, 2018
NCT01954251
Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older
Start: Oct 3, 2013
NCT01953835
A Two-part Study to Investigate the Interaction and Pharmacokinetics of GSK2586184
Start: Oct 4, 2013
Completion: Mar 10, 2014
NCT01902173
Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer
Start: Oct 8, 2013
Completion: Dec 23, 2023
NCT01868022
Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway Signaling
Start: Oct 9, 2013
Completion: Oct 24, 2017
NCT01962467
A Relative Bioavailability Study of Fluticasone Furoate and Levocabastine
Start: Oct 11, 2013
Completion: Feb 27, 2014
NCT01894360
A Study to Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Self-Administered Subcutaneously (SC) by Healthy Subjects
Start: Oct 14, 2013
Completion: May 13, 2014
NCT01984801
Study to Investigate the Irritation Potential of GSK1940029 Gel
Completion: Apr 10, 2015
NCT02275078
Innovations in Treating COPD Exacerbations: Pilot Project on Action Plans Using New Technology.
Start: Oct 15, 2013
NCT01954264
Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa
Start: Oct 19, 2013
NCT01837316
A Study to Assess the Bronchodilator Effect of a Single Dose of Fluticasone Furoate (FF)/ Vilanterol (VI) 100/25 Micrograms (mcg) Combination When Administered in Adult Patients With Asthma
Start: Oct 21, 2013
Completion: Aug 8, 2014
NCT01984086
Study to Evaluate the Pharmacokinetic Profile of Salbutamol Delivered by Unit Dose Dry Powder Inhaler (UD-DPI) Compared to the Diskus and Metered Dose Inhaler (MDI) in Healthy Volunteers.
Completion: May 26, 2014
NCT01974895
Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age
Start: Oct 23, 2013
Completion: Jul 3, 2014
NCT02000804
Darapladib China PK
Completion: Jan 4, 2014
NCT01957189
This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood Samples
Start: Oct 25, 2013
NCT01920594
Study of GSK1278863 to Reduce Ischemic Events in Patients Undergoing Thoracic Aortic Aneurysm Repair
Start: Oct 31, 2013
Completion: Oct 8, 2014
NCT01938456
Safety and Tolerability of Trametinib in Combination With Docetaxel in Japanese Subjects With Non-small Cell Lung Cancer
NCT01938482
Study to Evaluate the Safety, Tolerability and Pharmacokinetic of Single and 14 Day Repeat Topical Application of GSK1940029
Completion: Feb 17, 2015
NCT01953822
Study Assessing Risk of Autoimmune Diseases in Females (9 - 25 Years) Exposed to Cervarix® in United Kingdom
NCT01957202
A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR)
NCT01957215
Efficacy of Topical Indomethacin Patch Over Placebo in Ankle Sprain Pain Relief
NCT01977573
A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)
NCT02119286
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
NCT01893372
Eltrombopag With or Without Hypomethylating Agent After Hypomethylating Agent Failure For Patients With Myelodysplastic Syndrome (MDS)
Completion: Jan 6, 2019
NCT01940562
Eltrombopag for Enhancing Platelet Engraftment in Pediatric Patients Undergoing Cord Blood Transplantation
NCT01967771
Effect of Carbamazepine on Dolutegravir Pharmacokinetics in Healthy Adult Subjects
NCT02425241
Depletion of Serum Amyloid P Component to Enhance the Immune Response to DNA Vaccination
NCT01977482
Evaluation of Dose Response Relationship, Safety and Efficacy of GSK1278863 in Hemodialysis-dependent Subjects With Chronic Kidney Disease Associated Anemia
Start: Nov 1, 2013
Completion: Feb 6, 2015
NCT02100670
A Multicenter Efficacy Study of a Diclofenac+Menthol Gel in Subjects With Ankle Sprain
Completion: Mar 22, 2015
NCT02019719
Study to Evaluate the Safety, Efficacy and Pharmacokinetics of GSK1278863 in Japanese Hemodialysis-Dependent Subjects With Anemia Associated With Chronic Kidney Disease
Start: Nov 5, 2013
Completion: Aug 6, 2014
NCT01978119
A Non-inferiority Study to Evaluate the Efficacy, Safety, and Tolerability of Combination Dry Powder of Fluticasone Propionate and Salmeterol (FSC) 250/50 Microgram (mcg) Twice Daily (BID) in Adults and Adolescents With Asthma
Start: Nov 6, 2013
Completion: Jan 28, 2015
NCT02000765
A Study to Investigate the Recovery, Excretion and Pharmacokinetics of [14C]-GSK2140944 Administered as a Single Intravenous and Single Oral Dose to Healthy Adult Male Subjects
Start: Nov 8, 2013
NCT02314143
Phase II Biomarker Study Comparing the Combination of BRAF Inhibitor Dabrafenib With MEK Inhibitor Trametinib Versus the Combination After Monotherapy With Dabrafenib or Trametinib
Start: Nov 13, 2013
Completion: Jan 19, 2017
NCT01978145
A Non-inferiority Study to Evaluate the Efficacy, Safety, and Tolerability of Fluticasone Propionate/Salmeterol (FSC) 250/50 Microgram (mcg) Through a Capsule-Based Inhaler and a Multi-Dose Inhaler Administered Twice Daily (BID) in Adults With Chronic Obstructive Pulmonary Disease (COPD)
Start: Nov 14, 2013
NCT01938443
A Dose Escalation Study to Assess Safety of GSK2256098 (FAK Inhibitor) in Combination With Trametinib (MEK Inhibitor) in Subjects With Advanced Solid Tumors
Start: Nov 18, 2013
Completion: Jun 23, 2016
NCT01978327
GSK2647544 RD, DDI in Healthy Young and Elderly Volunteers
Start: Nov 22, 2013
NCT01999842
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3206641A and GSK3206640A Administered in Adults 18 to 64 Years of Age
Start: Nov 25, 2013
Completion: Jan 19, 2015
NCT01966445
Dose Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2849330 in Subjects With Advanced Her3-Positive Solid Tumors
Start: Nov 26, 2013
Completion: Sep 18, 2017
NCT01899768
GSK2339345 Hypertussive Challenge Study
Start: Nov 30, 2013
NCT02000466
FluLaval® Quadrivalent Pregnancy Registry
Completion: May 31, 2018
NCT02039960
PRJ2215: Assessment of Buproprion Misuse/Abuse 2004-2011
NCT02113449
Market Potential of Carbon Dioxide Nasal Spray
NCT02058654
A Clinical Study to Investigate the Effects of Creatine Supplementation on Muscle Energetics and Cognitive Function in Young Healthy Male Athletes and an Ageing Population
Start: Dec 1, 2013
Completion: Jun 24, 2014
NCT02058602
Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients
Start: Dec 3, 2013
Completion: Jul 11, 2016
NCT01888471
Feasibility Study for Identifying Anti Capsular Antibody Protection Against Invasive Group B Streptococcus (GBS) Disease in Newborns of 0-6 Days Age (Early Onset Disease [EOD]) as Well as Among Infants of 7-90 Days Age (Late Onset Disease [LOD])
Start: Dec 11, 2013
Completion: Jul 14, 2014
NCT02006589
Bioavailability Study of Candesartan Cilexetil 8mg Tablet Under Fasting Conditions
NCT01995175
A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From 0 to 2 Years of Age and Risk of Development of Wheeze and Asthma From 0 to 6 Years of Age
Start: Dec 12, 2013
Completion: Nov 3, 2021
NCT02006602
Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting Conditions
Start: Dec 13, 2013
NCT01954043
A Pharmacokinetics (PK) Study of the Effects Rabeprazole and Rifampin on Dabrafenib in Subjects With BRAF V600 Mutation Positive Tumors
Start: Dec 20, 2013
NCT02000453
Safety and Tolerability Study of GSK2586184 in Patients With Moderate to Severely Active Ulcerative Colitis.
NCT01915914
A Randomized, Open-label, Comparative Study to Evaluate an Intermittent Dosing Regimen of Fluticasone Propionate 0.05% Cream (Twice Per Week) in Reducing the Risk of Relapse When Added to Regular Daily Moisturization Using PHYSIOGEL Lotion in Paediatric Subjects With Stabilized Atopic Dermatitis
Start: Dec 23, 2013
Completion: Feb 15, 2015
NCT02014571
Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C.
Start: Dec 26, 2013
NCT01592838
Impact on Quality of Hospital Care During Pre- and Post- Rotavirus (RV) Vaccination Introduction in Belgium
Start: Dec 31, 2013
NCT02094781
Effect of Using Whey Protein and Creatine Supplements on Muscular Strength in Weight-training Adult Males
NCT01995981
Individualizing Pazopanib Therapy by exploRing the Role of Early Metabolic responsE and Drug Exposure as a preDICTor for Treatment Outcome in Patients With STS
Completion: Nov 10, 2017
NCT01984047
Single Dose Escalation Trial to Evaluate the Safety, Tolerability Pharmacokinetics and Pharmacodynamics of GSK3050002
Start: Jan 10, 2014
Completion: Feb 23, 2015
NCT02201303
Evaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface Expression
Start: Jan 13, 2014
Completion: Jul 2, 2015
NCT02014662
A Methodology Study to Assess Muscle Damage After Eccentric Exercise
Start: Jan 14, 2014
Completion: Jul 2, 2014
NCT02045940
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of GSK2881078 in Single and Repeat Doses
Start: Jan 20, 2014
Completion: Mar 26, 2015
NCT02033668
Pharmacokinetic (PK) Study of GSK933776 in Healthy Volunteers
Start: Jan 22, 2014
Completion: Jul 15, 2014
NCT01894022
A Open Label Study to Assess the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Start: Jan 23, 2014
Completion: Nov 18, 2015
NCT02052297
A Validation and Dosimetry Study of GSK2634673F PET Ligand
Start: Jan 24, 2014
Completion: Apr 21, 2016
NCT01957150
Study Evaluating the Effect of Fluticasone Furoate/ Vilanterol (FF/VI) Inhalation Powder Compared With Vilanterol (VI) Inhalation Powder on Bone Mineral Density (BMD) in Subjects With Chronic Obstructive Pulmonary Disease (COPD).
Start: Jan 28, 2014
Completion: Mar 26, 2018
NCT02045849
Relative Bioavailability, Safety, Tolerability, Pharmacokinetics (PK) and Food Effect Study of GSK2140944 in Healthy Subjects
Completion: Aug 21, 2014
NCT02058407
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Food Effect of Single or Repeat Doses of GSK2793660 in Healthy Subjects
NCT02045953
A Study to Assess the Systemic Exposure of FLIXOTIDE™ (Fluticasone Propionate) and SERETIDE™ (Fluticasone Propionate and Salmeterol) Given With VENTOLIN™ Mini-Spacer Compared to the Aerochamber Plus Spacer
Start: Jan 29, 2014
Completion: Mar 13, 2014
NCT01890798
Drisapersen Duchenne Muscular Dystrophy (DMD) Treatment Protocol
Start: Jan 31, 2014
NCT01916200
Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome Patients
NCT02006537
A Study to Investigate the Safety and Pharmacokinetics of a Single Dose of GSK2256294 in Healthy Young Males and Elderly Subjects
NCT02014467
Denosumab China Phase III Study
NCT02027454
Study to Evaluate the Effect of GSK1265744 on Cardiac Conduction
NCT01978093
Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age
Start: Feb 1, 2014
Completion: Mar 18, 2016
NCT02063360
DDI Study of BMS-663068 With Etravirine (ETR) and/or Darunavir (DVR) + Ritonavir (RTV)
NCT02201316
A Pilot Study to Determine the Relative Bioavailability of Mosapride 5mg From Two Candidate Formulations of GR107719B Relative to One 5mg Tablet of Reference Mosapride Citrate (GASMOTIN™) in Healthy Adult Human Subjects Under Fasting Conditions
Start: Feb 3, 2014
Completion: Mar 18, 2014
NCT02034123
Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung Carcinoma
Start: Feb 4, 2014
Completion: Apr 18, 2017
NCT02020889
A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis
Start: Feb 5, 2014
Completion: Sep 5, 2016
NCT02040480
Bioavailability and Food Effect Study of Gelatin Formulation and Immediate Release Tablet Formulation of Afuresertib
Completion: Apr 4, 2014
NCT02052596
Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) When Co-administered With GSK Biologicals' Diphtheria, Tetanus and Pertussis Vaccine (Boostrix®) in Adults Aged 50 Years and Older
Start: Feb 7, 2014
NCT02058368
Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia
Start: Feb 10, 2014
Completion: Mar 3, 2017
NCT02058576
Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin HCl Combination Capsule in Fed State
Start: Feb 11, 2014
Completion: Jan 2, 2015
NCT02130193
Investigation of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for Exacerbations
Start: Feb 13, 2014
Completion: Aug 29, 2016
NCT01751139
An Epidemiological Surveillance Study to Evaluate the Incidence of Dengue in Brazil
Start: Feb 18, 2014
Completion: Dec 20, 2018
NCT02052661
This Study Aims to Determine the Long-term Persistence of Antibodies Against Hepatitis B and to Evaluate the Immunogenicity and Safety of Hepatitis B Vaccine in Adolescents Vaccinated in Infancy With Infanrix™ Hexa
NCT02052713
Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin Hydrochloride (HCL) Combination Capsule in Fasted State
Start: Feb 19, 2014
Completion: Dec 29, 2014
NCT02064504
Study to Determine the Pharmacokinetics of GSK961081 and Fluticasone Furoate When Administered Alone or in Combination
Completion: May 20, 2014
NCT02058628
Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris
Start: Feb 21, 2014
Completion: Sep 8, 2014
NCT01988857
Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Healthy Vietnamese Children
Start: Feb 22, 2014
Completion: May 10, 2014
NCT02058641
Effect of Darapladib on Cantharidin-Induced Inflammatory Blisters in Subjects With Type 2 Diabetes Mellitus (T2DM)
Start: Feb 26, 2014
Completion: Aug 18, 2014
NCT02052752
A Five Day Clinical Study to Examine the Effects of a Benzoyl Peroxide Treatment on Facial Acne Lesions
Start: Feb 28, 2014
NCT02153333
Serologic Response to Porcine Circovirus Type 1 (PCV-1) in Infants Following Administration of Rotarix™
NCT02064374
Effect of Dolutegravir on Metformin Pharmacokinetics in Healthy Adult Subjects
NCT02076386
A Prospective, Non-interventional Study of the Use of Dolutegravir as Part of Combination Antiretroviral Therapy in Routine Daily Practice in Germany
Start: Mar 4, 2014
Completion: Jul 5, 2017
NCT02045836
Study to Evaluate Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A When Co-administered With Pneumovax 23™ in Adults Aged 50 Years and Older
Start: Mar 5, 2014
Completion: Jun 17, 2016
NCT01899703
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus
Start: Mar 10, 2014
Completion: Oct 7, 2015
NCT02000817
Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients
Start: Mar 12, 2014
Completion: Sep 27, 2018
NCT02064465
The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 100mg Compared With Compressed Tablet 100 mg
Start: Mar 15, 2014
Completion: Jul 8, 2014
NCT02046148
Safety and Immunogenicity of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women
Start: Mar 18, 2014
Completion: Mar 26, 2016
NCT02446483
A Bioequivalence Study of Idiazole 20mg DR Tabs and PARIET® 20 mg DR Tabs After a Single Oral Dose Administration Under Fasting Conditions in Healthy Adults
Start: Mar 19, 2014
Completion: Mar 26, 2014
NCT02058589
Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults 18 Years of Age or Older With Renal Transplant
Start: Mar 20, 2014
Completion: Apr 13, 2017
NCT02605395
Bioequivalence Study of Raperazole 20mg DR Tabs and PARIET® 20 mg DR Tabs Under Fed Conditions
Start: Mar 22, 2014
Completion: Mar 30, 2014
NCT02045797
Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections
Start: Mar 24, 2014
NCT02075619
Relative Bioavailability Study of One Amlodipine 10mg Tablet and One Rosuvastatin 20mg Tablet to Two Fixed Dose Combinations of Amlodipine (10mg) and Rosuvastatin (20mg) in Healthy Subjects Under Fasting Conditions
Completion: Jul 11, 2014
NCT02095886
Relative Bioavailability Study With BMS-955176
Start: Mar 25, 2014
Completion: Jul 7, 2014
NCT02094937
A Study to Compare the Efficacy and Safety of Fluticasone Furoate (FF) 100 mcg Once Daily With Fluticasone Propionate (FP) 250 mcg Twice Daily (BD) and FP 100 mcg BD in Well-controlled Asthmatic Japanese Subjects
Start: Mar 27, 2014
Completion: Aug 28, 2015
NCT02076178
Study to Evaluate the Safety Tolerability and Acceptability of Long Acting Injections of the Human Immunodeficiency Virus (HIV) Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR)
NCT02096276
Boostrix® Pregnancy Registry
Start: Mar 31, 2014
Completion: Aug 2, 2019
NCT02446496
A Bioequivalence Study of Cefadroxil Film Coated Tablets After A Single Oral Dose Administration to Healthy Subjects
Completion: Apr 8, 2014
NCT02010645
Eltrombopag With Decitabine in Advanced Myelodysplastic Syndrome (MDS)
Completion: Jan 2, 2019
NCT02079545
Bioavailability and Pharmacokinetics Study of Sirukumab in Healthy Male Participants
NCT02082808
Study to Evaluate the Drug Interaction Between Dolutegravir (DTG) and Daclatasvir (DCV) in Healthy Adult Subjects
NCT02477306
A Bioequivalence Study of Rabeprazole From Idiazole 20mg DR Tabs (GSK, Egypt) and PARIET 20 mg DR Tabs (JANSSEN, EGYPT)
NCT02479867
A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)
NCT02072525
A Protocol to Collect Human Serum Samples From Healthy Adults for Use as Quality Controls Samples in GlaxoSmithKline (GSK) Biologicals' Assays
Start: Apr 1, 2014
Completion: Jun 2, 2015
NCT02192203
A Safety Study to Investigate the Skin Sensitization Potential of MFC51123
NCT01812382
Retapamulin Microdialysis Feasibility Study
Start: Apr 2, 2014
NCT01934192
Nutritional Adequacy Therapeutic Enhancement in the Critically Ill. The NUTRIATE Study
Start: Apr 4, 2014
Completion: Jul 8, 2016
NCT02019472
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
Completion: Aug 17, 2016
NCT02105974
Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Start: Apr 7, 2014
Completion: Jul 8, 2015
NCT01978236
Dabrafenib/Trametinib, BRAF or BRAF AND MEK Pre-op With BRAF and MEK Post-op, Phase IIB, Melanoma With Brain Mets,Biomarkers and Metabolites
Start: Apr 8, 2014
Completion: Apr 26, 2017
NCT02100644
Valproate Dose Reduction and Its Clinical Evaluation by Introducing Lamotrigine in Japanese Women With Epilepsy - Single Arm, Multicenter, and Open-label Study
Start: Apr 12, 2014
Completion: May 11, 2015
NCT01978301
Study to Evaluate Fractional Collagen Synthesis Within Keloid Scars and Identify Biomarkers of Keloid Scars
Start: Apr 15, 2014
NCT02105948
Study to Evaluate Efficacy and Safety of Mepolizumab for Frequently Exacerbating Chronic Obstructive Pulmonary Disease (COPD) Patients
Completion: Jan 17, 2017
NCT02096263
Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants
Start: Apr 16, 2014
Completion: Nov 13, 2015
NCT02094924
A Relative Bioavailability Study of a Fixed Dose Combination (FDC) Tablets of GSK587323
Start: Apr 17, 2014
Completion: May 23, 2014
NCT02065063
A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Anti-Cancer Activity of Trametinib in Combination With Palbociclib in Subjects With Solid Tumors
Start: Apr 22, 2014
NCT01376167
Ph 2B/3 Tafenoquine (TFQ) Study in Prevention of Vivax Relapse
Start: Apr 24, 2014
Completion: Nov 18, 2016
NCT02014519
A Study to Determine the Seroprevalence of Bordetella Pertussis in Adults in Hungary
Completion: Apr 24, 2015
NCT02082977
A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK2816126 in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma, Transformed Follicular Lymphoma, Other Non-Hodgkin's Lymphomas, Solid Tumors and Multiple Myeloma
Completion: Jun 20, 2017
NCT02105961
Efficacy and Safety of Mepolizumab as an Add-on Treatment in Chronic Obstructive Pulmonary Disease (COPD)
Completion: Jan 16, 2017
NCT02120352
A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects
Start: Apr 28, 2014
Completion: Apr 20, 2023
NCT02034097
A Study to Evaluate Foretinib in Subjects With Non-Small-Cell Lung Cancer
Start: Apr 30, 2014
NCT02105987
A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen
NCT02116504
Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk of Immunization in Rheumatoid Arthritis Patients or Juvenile Idiopathic Arthritis Patients
NCT02113436
Efficacy and Safety of Fluticasone Propionate(FP)/ Salmeterol Xinafoate (SLM) Hydro Fluoro Alkane (HFA) Metered Dose Inhaler (MDI) in Pediatric Patients With Bronchial Asthma
Start: May 1, 2014
Completion: Oct 1, 2016
NCT01962454
A Study to Evaluate a Skeletal-muscle Microbiopsy Technique With Dynamic Proteomic Measurement in Healthy Male Volunteers
Start: May 5, 2014
NCT02119156
Belimumab Treatment Holiday and Treatment Re-start Study in Lupus Patients
Start: May 13, 2014
Completion: Dec 14, 2018
NCT01943851
A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD) and Clinical Activity of GSK525762 in Subjects With Relapsed, Refractory Hematologic Malignancies
Start: May 14, 2014
NCT02138084
Drug-drug Interaction (DDI) Rifabutin
Completion: Jul 24, 2014
NCT02124798
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
Start: May 20, 2014
Completion: Apr 13, 2015
NCT02135692
A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects
Start: May 29, 2014
Completion: Oct 5, 2017
NCT02106403
A Study to Evaluate the Cooling Sensation and Consumer Liking of a Skin Disinfectant Spray
Start: May 31, 2014
NCT01934894
Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases
NCT02114333
Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50-59 and 70-85 Year Olds
Completion: May 31, 2020
NCT02140762
Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents
NCT02075463
Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia
Start: Jun 1, 2014
Completion: Mar 16, 2016
NCT02148211
Fluarix/ FluLaval/ Fluarix Quadrivalent/ FluLaval Quadrivalent Vaccine Pregnancy Registry
Completion: May 31, 2019
NCT02169154
A Safety Study to Investigate the Skin Irritancy Potential of Diclofenac-Menthol Gel
NCT02157467
Study of Combined Oral Contraceptive Effects in Female Subjects
Start: Jun 2, 2014
Completion: Aug 25, 2014
NCT02145468
A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60)
Start: Jun 3, 2014
Completion: Dec 14, 2015
NCT02106390
Safety and Immunogenicity of GlaxoSmithKline Biologicals Meningococcal Group B Vaccine When Administered Concomitantly With GlaxoSmithKline Biologicals MenACWY Conjugate Vaccine to Healthy Infants
Start: Jun 5, 2014
Completion: Oct 14, 2016
NCT02119260
A First Time in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Healthy Subjects and Stable Heart Failure Patients
Start: Jun 9, 2014
Completion: Dec 25, 2016
NCT02169583
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Escalating Doses of GSK1325756 Solution for Infusion, and Absolute Bioavailability Relative of an Oral Dose, in Healthy Adult Subjects
Start: Jun 12, 2014
Completion: Aug 28, 2014
NCT02177942
A Clinical Trial to Study the Impact of a Nutritional Beverage on Tests of Memory in Healthy Preschool Age Children
Start: Jun 20, 2014
NCT02153346
Indirect Cost of Illness Study of Moderate and Severe Asthma in Quebec
Start: Jun 22, 2014
Completion: Apr 22, 2016
NCT02106000
A Non-investigational Product (IP) Study to Investigate Lung Function in Women in the Third Stage of Labour
Start: Jun 24, 2014
Completion: Dec 20, 2014
NCT02164045
Study to Evaluate the Effect of Food on the Pharmacokinetics of BMS-626529
NCT02135718
ELLIPTA™ vs. MDI Inhaler Preference Study, in Adult Subjects With Asthma
Start: Jun 30, 2014
NCT02164513
A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Completion: Jul 17, 2017
NCT02195583
The Effect of Experimental Dentifrices on Remineralization of Caries Lesions In-situ
NCT02135133
A Study of Idelalisib (GS1101, CAL101) + Ofatumumab in Previously Untreated CLL/SLL
Completion: Oct 6, 2020
NCT02000440
A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS)
Start: Jul 1, 2014
Completion: May 11, 2016
NCT02058563
Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older
Completion: Sep 17, 2015
NCT02164539
Evaluation of Umeclidinium Bromide in Combination With Fluticasone Furoate in COPD Subjects With an Asthmatic Component
Completion: Jul 18, 2015
NCT02290613
Early Treatment of Borderline Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (SSc-APAH)
NCT02014584
Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia
Start: Jul 2, 2014
Completion: Mar 19, 2016
NCT02075541
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithkline (GSK) Biologicals' Investigational Vaccine GSK2838504A When Administered to Chronic Obstructive Pulmonary Disease (COPD) Patients With Persistent Airflow Obstruction.
Start: Jul 8, 2014
NCT02184585
Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted States
Start: Jul 10, 2014
NCT02135640
China HVT Safety, PK, PD
Start: Jul 17, 2014
NCT02064387
Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Clinical Activity of GSK2857916
Start: Jul 29, 2014
Completion: Aug 1, 2019
NCT02135861
A Method Validation Study for Evaluation of Novel Treatments Limiting Pulmonary Oedema in Cardiac Failure
Start: Jul 30, 2014
Completion: Feb 22, 2017
NCT02195349
A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Intravenous (IV) Dose of GSK2831781 in Healthy Volunteers and Patients With Plaque Psoriasis
Completion: Mar 7, 2018
NCT02130635
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Dose-Response Relationship of Multiple Doses of GSK2269557 Administered as a Dry Powder to Chronic Obstructive Pulmonary Disease (COPD) Patients
Start: Jul 31, 2014
NCT02184637
A Study to Evaluate the Pharmacokinetics of a Single Dose of Tafenoquine Co-administered With Either Artemether + Lumefantrine or Dihydroartemisinin + Piperaquine Tetraphosphate
NCT02416245
Impact of Beverage Powder With Micronutrients and Brahmi Extract on Cognitive Variables in Indian School Children
NCT02185300
Bioavailability Study of a Dolutegravir Dispersible Tablet and Effect of Different Types of Water on the Dispersible Tablet in Healthy Volunteers
NCT02188238
Effect of Oral Health Ingredients on the Acquired Salivary Pellicle
NCT02250729
Allergy to Neuromuscular Blocking Agents and Pholcodine Exposure
Completion: Jul 31, 2020
NCT02546349
Exhaled NO Based Treatment of Chronic Obstructive Pulmonary Disease (COPD), ICS/LABA Versus LAMA
NCT02323178
A Study of Eltrombopag in Patients With CMML and Thrombocytopenia
Start: Aug 7, 2014
Completion: Apr 30, 2021
NCT02206711
Study of the Absorption, Metabolism, and Route of Elimination of a Novel Class of Anti-HIV 1 Drugs (BMS-955176) in Humans.
Start: Aug 8, 2014
Completion: Sep 9, 2014
NCT02058953
CNS and Extracranial Tumor Tissues, CSF, and Blood From Patients With Melanoma Brain Metastases
Start: Aug 12, 2014
Completion: Aug 19, 2019
NCT02075515
Consistency, Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults ≥ 50 Years of Age
Start: Aug 13, 2014
Completion: Apr 25, 2016
NCT02207413
A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Candidate Vaccine (GSK2321138A) Manufactured Using a New Process in Adults and Children
Start: Aug 18, 2014
Completion: Apr 18, 2015
NCT01755598
Study to Evaluate the Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine in Adults
Start: Aug 19, 2014
Completion: Nov 16, 2018
NCT02212457
Trial to Assess Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Meningococcal ABCWY Vaccine as Compared to Meningococcal B Vaccine in Adolescents
Start: Aug 21, 2014
Completion: Mar 3, 2016
NCT02184572
Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age
Start: Aug 25, 2014
NCT02207400
To Evaluate Efficacy and Tolerability of Sodium Bicarbonate Toothpaste and Its Effect on Opportunistic or Resistant Organisms
NCT02177812
A Phase I Dose Escalation Study of GSK2879552 in Subjects With Acute Myeloid Leukemia (AML)
Start: Aug 27, 2014
Completion: Dec 8, 2017
NCT02202161
A Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 Administered With Metformin to Type 2 Diabetes Patients
NCT02210000
A Study to Evaluate the Effect of Camicinal on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects With Gastroparesis
Completion: Aug 24, 2015
NCT02184624
Study of Inhaler Device Attributes Investigating Critical and Overall Errors, Ease of Use, and Preference Between a Number of Inhaler Devices
Start: Aug 28, 2014
NCT02213029
A Study to Evaluate Pharmacokinetics, Pharmacodynamics and Tissue Concentrations of Epelsiban
Completion: Feb 7, 2016
NCT02254434
A Pharmacokinetic Study of Eltrombopag 50 Milligram (mg) in Healthy Volunteers Under Fasting Conditions
NCT01782651
Treatment Options in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast Cancer Patients
Start: Aug 31, 2014
NCT01803399
A Study to Evaluate the Effect of GSK1322322 on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers
NCT01953809
A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult Women
NCT02207907
To Evaluate the Efficacy and Tolerability of Sodium Bicarbonate Toothpaste
NCT02097095
Substudy of Protocol TB-018 (NCT01755598): Collection and Storage of Biological Samples for Evaluation of Correlates of TB (C-041-972)
NCT02174978
Phase 1 Clinical Trial With Controlled Human Malaria Infection (CHMI) to Evaluate the Safety and Efficacy of the Plasmodium Falciparum Vaccine Candidate FMP012 Administered Intramuscularly With AS01B Adjuvant System in Healthy Malaria-Naïve Adults
NCT02367222
A Database Study to Estimate the Risk of Multiple Sclerosis Following Vaccination With Arepanrix™ in Manitoba, Canada
NCT02152605
A Phase IIIb Study to Evaluate the Efficacy of Umeclidinium/Vilanterol (UMEC/VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Start: Sep 1, 2014
Completion: Mar 5, 2015
NCT02207829
A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium Compared With Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease
NCT02226562
Clinical Study Investigating the Efficacy of a Mouthwash in Providing Long Term Relief From Dentinal Hypersensitivity
Start: Sep 2, 2014
NCT02158507
Pilot Study of Veliparib (ABT-888) and Lapatinib (Tykerb) in Patients With Metastatic, Triple Negative Breast Cancer
Start: Sep 4, 2014
Completion: Jul 22, 2021
NCT02234882
Study on Pharmacokinetics
Start: Sep 5, 2014
NCT02173704
Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Meningococcal B Recombinant Vaccine When Administered Concomitantly With Routine Vaccines to Healthy Infants of 2 Months of Age and Older, in Taiwan.
Start: Sep 11, 2014
NCT01899742
The Purpose of the This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotropium 18mcg Once Daily Over a a 12-week Treatment Period in Subjects With COPD Who Continue to Have Symptoms on Tiotropium
Start: Sep 15, 2014
Completion: Jul 22, 2015
NCT02207816
An Extension to Study MALARIA-055 PRI (NCT00866619) to Evaluate the Long-term Efficacy, Safety and Immunogenicity of GSK Biologicals' Candidate Malaria Vaccine in Infants and Children in Africa
Start: Sep 18, 2014
NCT01990196
Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer
Start: Sep 23, 2014
Completion: Sep 30, 2026
NCT02236611
A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Start: Sep 26, 2014
NCT02371616
Clinical Study to Evaluate the Efficacy of Two Dentifrices for Dentine Hypersensitivity
Start: Sep 29, 2014
Completion: Dec 18, 2014
NCT02223637
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Start: Sep 30, 2014
NCT02257372
A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT02349841
Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Meropenem Plus Amoxycillin/CA and Faropenem Plus Amoxycillin/CA in Adult Patients With Newly Diagnosed Pulmonary Tuberculosis
NCT03327740
PRJ2203: Dolutegravir Post Authorization Safety Study (PASS)
NCT02201225
A Methodology Study to Evaluate a Sitting Knee Measuring Device in Assessing Growth in Indian Children.
Start: Oct 1, 2014
NCT02201238
Pharmacokinetics Study Comparing Topical Diclofenac/Menthol Gels With Voltaren Gel and Oral Diclofenac Sodium
Completion: Nov 21, 2014
NCT02218697
Evaluation of the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine Influsplit™ Tetra (Fluarix™ Tetra) (GSK2321138A) When Co-administered With Pneumovax™ 23 in Adults 50 Years of Age and Older
Completion: May 4, 2015
NCT02242643
Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age
NCT02523287
Placebo Controlled Study to Generate Data Characterising Clinical Events, Physiological Responses and Immune Responses
Start: Oct 2, 2014
Completion: Aug 1, 2016
NCT02257398
Placebo and Moxifloxacin Controlled Cardiac Conduction Study of GSK2140944 in Healthy Volunteers
Start: Oct 6, 2014
Completion: Mar 2, 2015
NCT02230553
Lapatinib Plus Trametinib in KRAS Mutant NSCLC
Start: Oct 7, 2014
Completion: Aug 6, 2019
NCT02284009
Albiglutide Versus Placebo in Insulin-treated Subjects With New-onset Type 1 Diabetes Mellitus
Start: Oct 10, 2014
Completion: Oct 18, 2017
NCT02257385
Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus Tiotropium
Start: Oct 15, 2014
NCT02251704
Start: Oct 22, 2014
Completion: Jul 6, 2024
NCT02273947
Food Effect Study With BMS-955176
Start: Oct 23, 2014
Completion: Aug 15, 2016
NCT02243306
Study to Assess the Pharmacokinetics of GSK1278863 in Subjects With End Stage Renal Disease Undergoing Peritoneal Dialysis
Start: Oct 24, 2014
Completion: May 10, 2017
NCT02218723
Pharmacokinetic Profile of Four Formulations of Fluticasone Furoate (FF) Using Unit Dose Dry Powder Inhaler (UD-DPI) Compared With FF ELLIPTA® Presentation
Start: Oct 28, 2014
Completion: Dec 19, 2014
NCT02218762
A Study in Patients With Moderate Asthma to Compare Pharmacokinetics and Pharmacodynamic Effects of Fluticasone Propionate and Salmeterol Delivered Via the ROTAHALER® Inhaler Relative to the DISKUS® Inhaler
Start: Oct 31, 2014
NCT02324218
This Study Aims to Determine the Incidence, of Hepatitis B Diagnosis Among Diabetes Mellitus Patients of 0-80 Years of Age
NCT02345187
fMRI Study to Investigate Hemodynamic Changes in Brain Resulting From Supplementation of Bacopa Monnieri Extract and Multiple Micronutrient Supplementation.
NCT02519751
New Method Using Deuterium Labelled Creatine to Measure Total Body Skeletal Muscle Mass
NCT02270970
Evaluation of Belimumab Impact on a BLyS Activity Signature Test in the Absence of Confounding Polypharmacy
NCT02289027
A Clinical Trial on the Candidate Vaccine cAd3-EBOZ in Healthy Adults in Switzerland
NCT02362217
A Study to Assess the Safety of HIV and Hep C Vaccine Candidates When Given Separately or in Combination
NCT03587428
Effect of Two Toothpastes on Bacteria in Saliva
Start: Nov 4, 2014
Completion: Nov 27, 2014
NCT02281370
Drug-drug Interaction Study of Eltrombopag and Cyclosporine in Healthy Subjects
Start: Nov 5, 2014
Completion: Dec 24, 2014
NCT02277600
A Phase 1 Antiretroviral Drug-Drug Interaction Study in Healthy Volunteers (DDI)
NCT02293161
Single Ascending Doses Study of Anti- Interleukin-7 Receptor α Monoclonal Antibody (GSK2618960) in Healthy Volunteers
Start: Nov 11, 2014
Completion: Sep 1, 2015
NCT02215096
Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate Cancer
Start: Nov 13, 2014
Completion: Oct 3, 2019
NCT02233803
A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma
Start: Nov 14, 2014
Completion: Dec 11, 2015
NCT02289482
A Single Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects
Start: Nov 17, 2014
Completion: Mar 10, 2015
NCT02293148
Single Dose, Pharmacokinetic, Safety, Tolerability and QTc Study of GSK1278863 in Healthy Volunteers
NCT02424799
Study to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK2646264
NCT02289495
A Repeat Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects
Start: Nov 18, 2014
Completion: Jun 27, 2015
NCT02270944
Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine
Start: Nov 20, 2014
Completion: Sep 22, 2015
NCT02229227
Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus
Start: Nov 21, 2014
Completion: Jul 24, 2017
NCT02195284
To Study Device Attributes by Investigating Errors Made in Use, Ease of Use and Preference Among Different Inhalers in Subjects With Asthma
Start: Nov 30, 2014
NCT02285777
Assessing the Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents
Start: Dec 1, 2014
Completion: Jun 11, 2015
NCT02287688
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Infant Study
NCT02254447
Relative Bioavailability Study of Candesartan Cilexetil Under Fasting Conditions
Start: Dec 2, 2014
Completion: Jan 8, 2015
NCT02299375
Safety and Efficacy Study of Losmapimod (GW856553) in Frequently Exacerbating Participants With Chronic Obstructive Pulmonary Disease (COPD)
Start: Dec 9, 2014
NCT02112890
Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in Mexico
Start: Dec 10, 2014
Completion: May 2, 2016
NCT02281318
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control
Start: Dec 11, 2014
Completion: Jun 10, 2016
NCT02227238
Comparative Efficacy and Safety Study of Dolutegravir and Lopinavir/Ritonavir in Second-line Treatment
Completion: Feb 14, 2022
NCT02075593
ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus Infection
Start: Dec 17, 2014
Completion: Sep 15, 2021
NCT02257359
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Epelsiban in Healthy Female Volunteers
Start: Dec 18, 2014
Completion: Jan 29, 2015
NCT02298179
A Study to Evaluate the Safety and Ability of the Vaccine to Induce Antibodies Against the Respiratory Syncytial Virus in Healthy Adults
Start: Dec 19, 2014
Completion: Mar 27, 2017
NCT02110355
A Phase 1b/2a Study Evaluating AMG 232 in Metastatic Melanoma
Completion: Dec 27, 2018
NCT01978223
Effectiveness of RotarixTM Vaccine in Children Aged Between 12 Weeks to < 5 Years, Hospitalised for Severe Gastroenteritis
Start: Dec 31, 2014
NCT02293265
Cross-sectional Study for Identification and Description of Severe Asthma Patients
NCT02302417
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
Start: Jan 1, 2015
Completion: May 28, 2015
NCT02302404
A Safety and Tolerability Study of GSK2982772, in Single (in Both Fed and Fasted States) and Repeat Oral Doses in Healthy Male Subjects
Start: Jan 6, 2015
Completion: Mar 5, 2016
NCT02262689
To Evaluate Effects of GSK2256294 on Pulmonary Artery Pressure in Healthy Volunteers Under Normoxic and Hypoxic Conditions
Start: Jan 8, 2015
NCT02231190
GSK1278863 Effects on Eccentric Exercise-Induced Muscle Damage
Start: Jan 15, 2015
NCT02275052
A Study to Evaluate the Effect of the Combination of Umeclidinium (UMEC) and Vilanterol (VI) on Exercise Endurance Time (EET) in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Start: Jan 23, 2015
Completion: Jun 2, 2016
NCT02345161
A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Completion: Apr 7, 2016
NCT02178592
Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection
Completion: Mar 6, 2020
NCT02467335
Single-dose Pharmacokinetics of BMS-626529, Administered as BMS-663068, in Subjects With Hepatic Impairment Compared to Healthy Subjects
Start: Jan 29, 2015
Completion: Oct 3, 2015
NCT01890447
Assessing Contacts' Decision Making on Reducing the Risk of Pertussis Transmission to Newborns Through Immunisation
Start: Jan 31, 2015
NCT02100618
Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study
NCT02246166
The Effect of Paracetamol, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide and Chlorpheniramine Maleate Tablets Compared to Placebo in Subjects Suffering From the Common Cold or Influenza.
NCT02311881
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
NCT02323217
I2PETHV - Imidazoline2 Binding Site in Healthy Volunteers
NCT02347891
Belimumab in Idiopathic Inflammatory Myositis
NCT02355665
Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement Therapy
Completion: Feb 10, 2016
NCT02319668
Antimicrobial Agent for Reducing Bacteria in Aerosols and Oral Cavity
Start: Feb 1, 2015
NCT02404311
A Safety and Immune Response Study of 2 Experimental HIV Vaccines
Start: Feb 2, 2015
Completion: Aug 7, 2018
NCT02191397
Study to Evaluate the Efficacy, Safety and Tolerability of Bupropion Hydrochloride Extended-release Tablet, and Escitalopram Oxalate Capsule in Subjects With Major Depressive Disorder
Start: Feb 10, 2015
Completion: Oct 25, 2016
NCT02371603
Drug-drug Interaction Study of GSK1278863 With Pioglitazone, Rosuvastatin and Trimethoprim in Healthy Adult Volunteers
Start: Feb 11, 2015
Completion: Aug 12, 2015
NCT02082665
Effects of Dabrafenib on the Single Dose Pharmacokinetics (PK) of Rosuvastatin and Midazolam
Start: Feb 19, 2015
NCT02342769
Prospective Non-Interventional Observational Study of Use of TRIUMEQ and Corresponding Monitoring Measures in Clinical Practice in Germany
Completion: Oct 28, 2018
NCT02322671
Relative Bioavailability Study of Two Montelukast Sodium (GW483100) 5 Milligrams (mg) Chewable Tablets and One Reference Montelukast Sodium 5 mg Chewable Tablet in Healthy Adult Subjects
Start: Feb 23, 2015
Completion: Apr 20, 2015
NCT02339155
Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed
Start: Feb 24, 2015
Completion: Jun 6, 2017
NCT02204371
Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
Start: Feb 25, 2015
NCT02082639
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus Vaccine (Cervarix™) When Co-administered With GSK Biologicals' Hepatitis A Vaccine (Havrix®) in Healthy Female Adolescents Aged 9-14 Years
Start: Feb 28, 2015
NCT02447978
Duration of Protection: GSK DTaP Vaccines
NCT01991899
Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.
NCT02373930
Relative Oral Bioavailability Study of Different Fixed Dose Combinations of Dolutegravir and Rilpivirine in Healthy Subjects
NCT02301975
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma
Start: Mar 1, 2015
Completion: Nov 25, 2016
NCT02403999
A Tolerability Assessment Study of Three Wash Products in Infants
Completion: Apr 27, 2015
NCT02377414
Study to Investigate the Pharmacokinetics (PK), Safety and Tolerability of Retosiban in Healthy Japanese Women
Start: Mar 2, 2015
Completion: Apr 17, 2015
NCT02439411
Retrospective Analysis of Dabrafenib +/- Trametinib Compassionate Use Experience in Spain
Start: Mar 3, 2015
NCT02292771
A Randomized Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban for Women in Spontaneous Preterm Labour
Start: Mar 16, 2015
Completion: Aug 25, 2017
NCT02551614
Neutrophil Imaging in Healthy Subjects Following Lipopolysaccharide or Saline Challenge and in Subjects With Chronic Obstructive Pulmonary Disease
Start: Mar 17, 2015
Completion: May 24, 2016
NCT02195518
Tenofovir Disoproxil Fumarate (TDF) 300mg 3 Years RD Therapy Chinese Chronic Hepatitis B (CHN) CHB Multiple Nucleos(t)Ide Analogues (NAs) Failure Points Pts PH4 PMS Study
Start: Mar 18, 2015
Completion: Aug 14, 2018
NCT02345174
Immuno Positron Emission Tomography Study of GSK2849330 in Subjects With Human Epidermal Growth Factor Receptor 3-Positive Solid Tumors
Start: Mar 19, 2015
NCT02360475
Safety, Reactogenicity and Immunogenicity Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Women
Start: Mar 20, 2015
Completion: Jun 21, 2016
NCT02357810
Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas
Start: Mar 21, 2015
Completion: Oct 12, 2021
NCT02224456
Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis
Start: Mar 25, 2015
Completion: Dec 4, 2020
NCT02397915
Patient Preference Study of Fluticasone Furoate and Mometasone Furoate Nasal Sprays
Start: Mar 26, 2015
Completion: Jun 8, 2015
NCT01563159
Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2010-2011
Start: Mar 31, 2015
NCT02294734
An Efficacy Study of GSK2269557 Added to Standard Care in Subjects With an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
NCT02378142
Pazopanib for Treating Uterine Leiomyosarcoma
NCT02568592
Exercise Substrate Utilisation and Endurance Performance Following Short-term Manipulation of Dietary Fat Intake
NCT03298061
Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921
Start: Apr 14, 2015
Completion: Feb 16, 2023
NCT02429791
Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-1)
Completion: May 30, 2023
NCT02294682
A Dose-Ranging Study Evaluating the Efficacy, Safety, and Tolerability of GSK2140944 in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae
Start: Apr 15, 2015
NCT02386436
A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of GSK2330811 in Healthy Subjects
Start: Apr 21, 2015
Completion: Apr 11, 2016
NCT02422797
Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2)
Completion: May 25, 2023
NCT02221037
Study of GSK2862277 in Subjects Undergoing Oesophagectomy Surgery
Start: Apr 28, 2015
Completion: Jun 28, 2017
NCT02377401
Pharmacokinetics of Zanamivir After Single and Repeated Dose Infusion Administration in Healthy Chinese Adults
Completion: Jun 19, 2015
NCT02369341
Immunogenicity and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 Season Southern Hemisphere) in Adults 18 Years of Age and Above
Start: Apr 29, 2015
Completion: Jun 3, 2015
NCT02216123
Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria
Start: Apr 30, 2015
NCT02399163
Evaluation of Oral Hygiene Products in an In Situ Caries Model
NCT02383290
The Implementation of Pharmacogenomics Into Primary Care in British Columbia
NCT02428127
Efficacy of a Carbohydrate Drink on Speed, Agility and Power in School Going Children
Start: May 1, 2015
Completion: May 30, 2015
NCT02415595
Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults
Start: May 12, 2015
Completion: Aug 21, 2017
NCT02453022
A 5-Period, Single Dose, Phase 1 Study in Healthy Elderly Subjects to Assess Relative Bioavailability and Food Effect of Two Oral Formulations of GSK1325756 (Free Base vs HBr Salt) and Food Effect on the HBr Formulation When Given With Omeprazole
Start: May 18, 2015
NCT02428699
Study Comparing Blood Levels of Fatty Acids After Consuming Two Forms of Cod Liver Oil
Start: May 20, 2015
NCT02466152
Pharmacokinetic Study of Topical GSK2894512 Cream
Start: May 28, 2015
NCT02124785
Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix®
Start: May 31, 2015
Completion: Jul 31, 2019
NCT02135666
Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084)
Completion: Oct 31, 2019
NCT02424565
Effect of Topical Application of Iodex® Balm on Local Surface Temperature
NCT02003703
Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV .
NCT02292784
Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies
Start: Jun 1, 2015
Completion: Sep 2, 2019
NCT02469298
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
NCT02447432
A Study to Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants
Start: Jun 11, 2015
Completion: May 22, 2016
NCT02496221
A Study Evaluating the Effect of Albiglutide on Gallbladder Emptying in Healthy Subjects
Completion: Oct 13, 2015
NCT02478632
Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen
Start: Jun 12, 2015
Completion: Aug 17, 2018
NCT02416180
Study to Evaluate Handling Errors in Usage of SERETIDE® Metered Dose Inhaler (MDI) (EVOHALER®) by Adult Subjects Currently Using the SERETIDE DISKUS® Inhaler
Start: Jun 18, 2015
Completion: Aug 20, 2015
NCT02446613
Follow-up Study to Investigate the Effect of GSK2245035 on Nasal Allergic Reactivity in Subjects Completing Treatment in Study TL7116958
Start: Jun 22, 2015
Completion: Aug 10, 2015
NCT02354950
A Study to Evaluate Pharmacokinetic (PK) and Safety of GSK1265744 in Subjects With Hepatic Impairment and Control Healthy Volunteers
NCT02367651
Study of Pazopanib Versus Placebo as Maintenance Therapy for Advanced Soft Tissue Sarcoma
Start: Jun 30, 2015
NCT02447952
Exploratory Study of Biotelemetry in Amyotrophic Lateral Sclerosis
Completion: Jun 1, 2017
NCT02451514
A Study to Evaluate 4-year Antibody Persistence and Booster Response Following MenABCWY Vaccination in Healthy Adolescents and Young Adults Who Previously Participated in Studies V102_02 (NCT01210885) and V102_02E1 (NCT01367158)
Completion: Dec 10, 2015
NCT02458599
Efficacy Study of Protein Supplementation in Attenuating the Decline in Performance After Strenuous Concurrent Exercise
NCT02792595
In Vivo Sun Protection Factor Determination
NCT02331498
Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Completion: Aug 31, 2030
NCT02450552
Clinical Trial of Ezogabine (Retigabine) in ALS Subjects
NCT02459756
Anthocyanin-rich Blackcurrant and Vascular Function
NCT02500251
Belimumab Impacting Transplant Eligibility
NCT02752178
Peripheral Immunomarker Validation in Treatment-resistant Depression
NCT02465515
Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus
Start: Jul 1, 2015
Completion: Mar 14, 2018
NCT02480881
A Drug-drug Interaction Study Between BMS-663068 and Oral Contraceptives in Healthy Female Volunteers (DDI)
Start: Jul 7, 2015
NCT02480894
A Open-label, Drug-Drug Interaction With Maraviroc (DDI)
Completion: Sep 21, 2015
NCT02386098
Strategy-confirming Study of BMS-955176 to Treat HIV-1 Infected Treatment-experienced Adults
Start: Jul 8, 2015
Completion: Jun 7, 2017
NCT02446418
A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent Asthma
Start: Jul 9, 2015
Completion: Jul 20, 2017
NCT02703181
Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Epelsiban Administered in Repeat Doses in Healthy Women Volunteers
Completion: Sep 10, 2015
NCT02446691
Evaluation of Antibody Persistence Following 4 MenACWY Vaccinations
Start: Jul 13, 2015
Completion: Dec 28, 2017
NCT02485301
A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Adults
Start: Jul 15, 2015
Completion: Dec 23, 2016
NCT02568332
A Study to Assess the Safety of Hep C Vaccine Candidates in HIV Seropositive Individuals
Start: Jul 21, 2015
NCT02491463
A Study to Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' RSV Investigational Vaccine (ChAd155-RSV) (GSK3389245A) in Healthy Adults
Start: Jul 23, 2015
Completion: Jan 26, 2017
NCT02504671
Study to Evaluate the Efficacy and Safety of GSK3196165 Plus Methotrexate in Subjects With Active Moderate-Severe Rheumatoid Arthritis
Completion: Dec 29, 2017
NCT02509104
Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects
Start: Jul 30, 2015
Completion: Oct 10, 2015
NCT02411435
Effect of Rifampin (RIF) on the Pharmacokinetics (PK) of Oral Cabotegravir (CAB) in Healthy Subjects
Start: Jul 31, 2015
NCT02929043
Psychophysical Characterization and Brain Correlates of Dentine Hypersensitivity
NCT02504775
Bioequivalence Study for Mejoral 500 Product
Start: Aug 1, 2015
Completion: Aug 19, 2015
NCT02508064
Bioavailability of BMS-626529 in Healthy Subjects From Prototype Low Dose Extended Release Formulations (Part 1) and Prototype Extended Release Multi-particulate Formulations (Part 2) of BMS-663068 Relative to 600 mg Extended Release Tablet
Start: Aug 3, 2015
Completion: Nov 5, 2015
NCT02350426
A Study to Assess Inflammation in Rheumatoid Arthritis Using Molecular Imaging Techniques
Start: Aug 12, 2015
Completion: Oct 26, 2016
NCT02658422
Bioequivalence of GW483100 10 Milligram (mg) Tablets in Healthy Subjects Under Fasting Conditions
Start: Aug 18, 2015
NCT02555540
Placebo Controlled Study to Generate Data Characterising Safety Parameters and Immune Responses
Start: Aug 24, 2015
Completion: Dec 15, 2016
NCT02377427
Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children
Start: Aug 25, 2015
NCT02229240
Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus
Start: Aug 31, 2015
NCT02547974
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults.
NCT02421367
Study of Varying Injection Schedules of TDENV-PIV Vaccine With AS03B Adjuvant and Placebo in Healthy US Adults
NCT02502812
Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects
Start: Sep 4, 2015
NCT02513654
Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects
Start: Sep 6, 2015
Completion: Nov 11, 2015
NCT02502734
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
Start: Sep 7, 2015
NCT02753075
A Study in Dentinal Hypersensitivity (DH) Participants to Assess the Efficacy of an Occluding Dentifrice.
Start: Sep 8, 2015
Completion: Dec 18, 2015
NCT02578953
Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male Subjects
Start: Sep 9, 2015
NCT02528357
GSK3174998 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors (ENGAGE-1)
Start: Sep 11, 2015
Completion: Apr 29, 2020
NCT02542813
Safety, Tolerability and Pharmacokinetics (PK) Study of Oxytocin (GR121619) Administered Via an Inhaled Route in Healthy Female Volunteers
Start: Sep 14, 2015
Completion: Dec 16, 2015
NCT03841344
Repeatability and Sensitivity to Change of Non-invasive Endpoints in PAH
Start: Sep 15, 2015
Completion: May 20, 2019
NCT02619357
Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & Asthma
Start: Sep 21, 2015
NCT02523014
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Start: Sep 28, 2015
Completion: Jan 31, 2028
NCT02424539
A Study to Compare the Efficacy and Safety of Fluticasone Furoate Nasal Sprays (FFNS) 55 Microgram (mcg) and 110 mcg in Chinese Pediatric Subjects With Allergic Rhinitis (AR)
Start: Sep 30, 2015
Completion: Oct 25, 2017
NCT02542943
Efficacy of Two Experimental Oral Rinses in Providing Long Term Relief From Dentinal Hypersensitivity
NCT02548156
Intra Oral Kinetics of Fluoride Containing Dentifrices
NCT02567773
Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic Study of GSK2881078 and Study to Evaluate the Effect of CYP3A4 Inhibition on PK of GSK2881078
NCT02750189
The Economic Burden of Chronic Obstructive Pulmonary Disease(COPD) in South Korea
NCT02533466
In Vivo Investigation of Initial Stages of Enamel Erosion
Start: Oct 1, 2015
Completion: Nov 6, 2015
NCT02567708
A Study to Investigate the Efficacy, Safety, and Tolerability of Repeat Doses of Inhaled GSK2269557 in Adults With Persistent, Uncontrolled Asthma
Completion: Sep 28, 2016
NCT02567747
Vaccination Impact Against Pneumococcal Disease on Acute Otitis Media Morbidity in Colombian Children < 5 Years of Age
Completion: Feb 23, 2018
NCT02569879
Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.
Completion: Apr 14, 2018
NCT02586493
Ease of Use and Correct Use Study of Placebo ELLIPTA® Inhaler in COPD Subjects
Completion: Mar 15, 2016
NCT02586506
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
Completion: Feb 4, 2016
NCT02374450
A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine
Start: Oct 5, 2015
Completion: Aug 2, 2022
NCT02545517
A Phase 3 Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vaccine in Adults Following Primary Series of Pre/Exposure Prophylaxis.
Completion: Dec 23, 2022
NCT02557399
DUAC® Early Onset Efficacy Study in Japanese Subjects
Start: Oct 7, 2015
Completion: Feb 17, 2016
NCT02483975
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Start: Oct 9, 2015
NCT03197597
EUpertstrain 4 Study of Bordetella Pertussis Isolates
Start: Oct 12, 2015
NCT02377349
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women
Start: Oct 14, 2015
NCT02531633
Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis
Start: Oct 16, 2015
Completion: Mar 21, 2018
NCT02576119
A Study to Determine the Effect of Multiple Doses of BMS-955176 on the Electrocardiograph of Healthy Subjects
Start: Oct 19, 2015
NCT02548052
Study of Safety and Efficacy of Topical GSK2981278 Ointment in Plaque Psoriasis
Start: Oct 22, 2015
Completion: Feb 19, 2016
NCT02415842
A Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 Hemagglutinin (HA) Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GlaxoSmithKline (GSK) Biologicals' Pandemic Influenza Vaccines
Start: Oct 26, 2015
Completion: Feb 16, 2018
NCT02637206
Skin Irritation Study of GSK2894512 Cream
Start: Oct 27, 2015
Completion: Dec 2, 2015
NCT02380313
Dose-Finding Study of Afuresertib Administered in Combination With Either Enzalutamide or Aibraterone
Start: Oct 31, 2015
NCT02567721
Post-authorisation Safety Study (PASS) of Influenza Vaccine in United Kingdom (UK)
NCT02539576
Pharmacokinetics, Safety and Tolerability Study of Abacavir/ Dolutegravir/ Lamivudine Fixed-dose Combination Tablets in Healthy Japanese Subjects
NCT03141814
Asthma Origins and Remission Study
Completion: Oct 31, 2018
NCT02612064
The Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity
Start: Nov 1, 2015
Completion: Jun 3, 2016
NCT02750943
Potential of Stannous Fluoride Toothpaste to Reduce Gum Disease
Completion: Mar 4, 2016
NCT03271593
Impact of Rotavirus Vaccination on Hospital Pressures at a Large Paediatric Hospital in the UK: an Ecological Study
Start: Nov 2, 2015
NCT02522299
A Study to Evaluate the Safety, Efficacy and Changes in Induced Sputum and Blood Biomarkers Following Daily Repeat Doses of Inhaled GSK2269557 in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Acute Exacerbation
Start: Nov 4, 2015
Completion: Jun 22, 2018
NCT02570165
Dose-Finding Study of Batefenterol (GSK961081) Via Dry Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Start: Nov 6, 2015
Completion: Jul 6, 2016
NCT02548078
A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Children
Start: Nov 9, 2015
Completion: May 15, 2017
NCT02856880
A Study to Investigate the Antimicrobial Activity of 2 Test Toothpastes
NCT02570126
A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.
Start: Nov 13, 2015
NCT02446743
Combined Study - Phase 3b MenB Long Term Persistence in Adolescents
Start: Nov 17, 2015
NCT02551653
Positron Emission Tomography (PET) Study to Evaluate Biodistribution of [11C]-GSK2256098 in Healthy Subjects and Idiopathic Pulmonary Arterial Hypertension (PAH) Patients
Completion: Mar 14, 2017
NCT02594332
Effects of Mepolizumab Compared to Placebo on Airway Physiology in Patients With Eosinophilic Asthma: MEMORY Study
Completion: May 22, 2017
NCT02563899
Pharmacokinetic, Safety, Tolerability, and Clinical Effect of Topical Umeclidinium in Primary Axillary Hyperhidrosis
Start: Nov 23, 2015
NCT02564042
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
NCT02727283
A Phase 1, Randomized, Placebo-Controlled, Ascending Cohort, Dose Escalation Study in Normal Healthy Volunteers
Start: Nov 26, 2015
NCT02564055
A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD)
Start: Dec 1, 2015
Completion: Jan 12, 2017
NCT02573870
Batefenterol/Fluticasone Furoate in Treatment of Chronic Obstructive Pulmonary Disease
Completion: Jul 5, 2016
NCT02612051
First Time in Human (FTIH) Study of GSK3008348 in Healthy Volunteers and Idiopathic Pulmonary Fibrosis Patients
Start: Dec 4, 2015
NCT02581410
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 65 Years of Age With and Without Zostavax® Vaccination at Least 5 Years Earlier
Start: Dec 15, 2015
Completion: Aug 1, 2017
NCT02647281
First Time in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of GSK3389404 in Healthy Subjects
Start: Dec 17, 2015
Completion: Jan 3, 2017
NCT02613910
Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris
Start: Dec 23, 2015
Completion: Mar 23, 2016
NCT02141230
Risk Management Plan (RMP) Survey for Purchasers of Alli® (60 mg Orlistat) in the European Union.
Start: Dec 31, 2015
NCT02436473
Clinical Efficacy of Fluoride Toothpastes Using an In Situ Caries Model
NCT01528865
Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma
NCT02300935
Study of Trametinib and Nab-paclitaxel in Patients With Melanoma
Completion: Jan 20, 2016
NCT02622581
Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
NCT02773758
Study to Investigate the Efficacy of an Occluding Dentifrice in Providing Relief From Dentine Hypersensitivity
Start: Jan 1, 2016
Completion: Mar 11, 2016
NCT03083509
A Physiological Profile of Recovery From Resistance, Endurance, and Mixed Exercise Types
Completion: Jul 29, 2016
NCT02634073
A Phase IV, Open Label, 4-period Cross-over Study to Investigate a Drug Interaction Between Lamivudine and Sorbitol Oral Solutions in Healthy Volunteers
NCT02651467
A Study to Investigate Efficacy of Two Experimental Oral Rinses in Providing Long Term Relief From Pain Derived From Exposed Dentine in Response to Chemical, Thermal, Tactile, or Osmotic Stimuli.
Start: Jan 4, 2016
NCT02555371
Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients
Start: Jan 7, 2016
Completion: Jul 24, 2019
NCT02666001
A Study to Assess the Drug-drug Interaction of BMS 663068 With Methadone and Also With Buprenorphine/Naloxone
Start: Jan 12, 2016
Completion: Jun 29, 2016
NCT02487472
Burden of Herpes Zoster and Post-herpetic Neuralgia Among People ≥ 50 Years Old in France
Start: Jan 19, 2016
Completion: Aug 28, 2017
NCT02422264
Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery
Start: Jan 22, 2016
NCT02666287
GSK961081 Alone and With Fluticasone Furoate (FF), Phase 1 (Ph1), Single Dose Regimen (SD), Repeat Dose Regimen (RD), Pharmacokinetic (PK) Study in Healthy Volunteer (HV)
Start: Jan 27, 2016
NCT02666053
A Study to Assess the Effect of High Fat Meal and Increased Gastric pH on the Bioavailability of an Extended Release Formulation of BMS-663068 in Healthy Subjects
Completion: Feb 22, 2016
NCT02640677
Safety of 4CMenB Exposure During Pregnancy
Start: Jan 31, 2016
Completion: Nov 30, 2019
NCT02616289
Emollient Therapy for Severe Acute Malnutrition
NCT02627820
The Effect of an Antisense Oligonucleotide to Lower Transthyretin (TTR) Levels on the Progression of -Wild-type TTR Involving the Heart
NCT03110952
TDENV PIV and LAV Dengue Prime-boost Strategy Using AS03B Adjuvant
NCT04184336
Enhanced Population-based Core Surveillance of Meningococcal Invasive Infections at Participating Centers Across Canada
NCT01563146
Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2006-2007
Start: Feb 1, 2016
NCT02588612
Letetresgene Autoleucel Engineered T Cells in NY-ESO -1 Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
Completion: Aug 10, 2020
NCT02751320
Efficacy of Three Toothpastes Using an in Situ Caries Model
Completion: Aug 11, 2016
NCT02751450
The Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity(DH)
NCT02658435
Assessment of Any Potential Retinal Effects of Tafenoquine (TQ)
Start: Feb 2, 2016
Completion: Sep 14, 2017
NCT02663089
A Phase 1 (Ph1), Single Dose (SD), GSK961081 Absorption, Distribution, Metabolism, and Excretion (ADME) Study in Healthy Subjects
Start: Feb 8, 2016
Completion: Mar 17, 2016
NCT03243760
Dose Escalating Study of CCI15106 Inhalation Capsules in Healthy Subjects and Moderate Chronic Obstructive Pulmonary Disease (COPD) Patients
Start: Feb 10, 2016
Completion: Aug 20, 2016
NCT02856282
Drug Utilization Study for Pirinase Hayfever Relief
Start: Feb 15, 2016
NCT02631538
Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's Syndrome
Start: Feb 17, 2016
Completion: Jun 23, 2020
NCT02689206
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Three-times Weekly Dosing of GSK1278863 in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease Who Are Switched From a Stable Dose of an Erythropoiesis-stimulating Agent
Completion: Jan 25, 2017
NCT02688361
A Bioequivalence Study of an Acetylcysteine 2% Oral Solution Versus a Reference Fluimucil 2% Oral Solution
Start: Feb 22, 2016
Completion: Apr 13, 2016
NCT02674581
A Study of the Pharmacokinetics and Safety of BMS-663068 Administered in Subjects With Normal Renal Function and With Mild, Moderate, Severe and End Stage Renal Dysfunction (ESRD)
Start: Feb 26, 2016
NCT02292732
A Pharmacokinetics (PK) and Safety Study to Determine the Effect of Repeat Dosing of Trametinib on Combined Oral Contraceptive (Norethindrone Plus Ethinyl Estradiol) in Female Subjects With Solid Tumors
Start: Feb 29, 2016
NCT02377466
A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm Labor
NCT02660736
Bioequivalence Study of Two Albiglutide Drug Products in Healthy Adult Subjects
NCT02822287
Warming Sensation and Tolerability Study of Acetylcysteine 2% Oral Solution for Productive Cough
NCT02400320
Local Skin Safety Study of a Topical Pain Relief Spray Containing a Combination of Diclofenac, Methyl Salicylate, and Menthol
Start: Mar 1, 2016
NCT02639351
Safety and Immunogenicity of an Aluminium Hydroxide/LHD153R Adjuvanted Meningococcal C-CRM197 Conjugate Vaccine
Completion: Aug 31, 2017
NCT02705716
Study Investigating Efficacy of an Occluding Dentifrice for Dentine Hypersensitivity
NCT02832375
Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity
Completion: May 12, 2016
NCT02673619
A Study to Evaluate Clinical Effect, Pharmacokinetics , Safety, and Tolerability of Umeclidinium in Palmar Hyperhidrosis Subjects
Start: Mar 7, 2016
Completion: Dec 8, 2016
NCT02641912
Potential of an Experimental Mouthwash Formulation to Reduce Dry Mouth Symptoms
Start: Mar 9, 2016
Completion: Apr 15, 2016
NCT02688374
A Bioequivalence Study of Three, 2 mg Nicotine Chewing Gums (Two Tests and One Reference) in Healthy Adult Smokers
Start: Mar 11, 2016
Completion: Jun 12, 2016
NCT02860169
Motivation, Brain Function and Mood in Individuals With Cold and/or Flu
Completion: Nov 24, 2016
NCT02691325
Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK2269557 Administered Via the ELLIPTA Dry Powder Inhaler to Healthy Subjects
Start: Mar 14, 2016
Completion: Jun 5, 2016
NCT02742766
Safety, Tolerability and Preliminary Pharmacokinetics (PK) and Pharmacodynamics (PD) of Single and Repeat Oral Doses of GSK3008356 in Healthy and Obese Subjects
Completion: Jun 16, 2017
NCT02805556
Absolute Bioavailability of BMS-626529 After Oral and Intravenous Dosing
Start: Mar 15, 2016
Completion: May 5, 2016
NCT02683746
Safety and Efficacy Study of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus
Start: Mar 16, 2016
NCT02690207
Cross-vaccination Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) Studies.
Completion: Mar 15, 2019
NCT02654145
Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients
Start: Mar 17, 2016
NCT02683785
A Study to Investigate the Efficacy and Safety of GSK3196165 in Inflammatory Hand Osteoarthritis
NCT02688387
A Phase 1 Relative Bioavailability Study of Ambrisentan and Tadalfil Fixed Dose Combination Tablets in Healthy Subjects
Start: Mar 18, 2016
Completion: Aug 4, 2017
NCT02690181
Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-Pregnant Subjects.
Start: Mar 29, 2016
Completion: Nov 2, 2016
NCT02177734
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3277510A and GSK3277509A in Adults 18 to 60 Years of Age
Start: Mar 31, 2016
NCT02795754
Single and Repeated Dose Escalation Study of GSK2838232
NCT02731833
Short Term Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity
Start: Apr 1, 2016
NCT02753413
Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A) in Healthy Women
Completion: Jun 28, 2016
NCT02735915
Study to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2 Additional Doses at 10 Years After Initial Vaccination, in Healthy Subjects Aged 60 Years of Age(YOA) and Older
Start: Apr 11, 2016
Completion: Oct 8, 2018
NCT02497937
A Study to Evaluate the Effect of the Transient Receptor Potential Vanilloid 4 (TRPV4) Channel Blocker, GSK2798745, on Pulmonary Gas Transfer and Respiration in Patients With Congestive Heart Failure
Start: Apr 13, 2016
NCT02723773
A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older Adults
Start: Apr 16, 2016
Completion: Jun 28, 2023
NCT02737007
A Microdose Study in Healthy Subjects to Describe Intravenous Pharmacokinetics of GSK3191607
Start: Apr 18, 2016
NCT02630251
Dose Escalation Study of GSK2820151 in Subjects With Advanced or Recurrent Solid Tumors
Start: Apr 25, 2016
Completion: Dec 13, 2018
NCT02712047
A Phase IIA FF/VI Study to Measure FeNO in Asthmatic Patients.
Start: Apr 29, 2016
Completion: Feb 21, 2017
NCT02428270
A Study of GSK2256098 and Trametinib in Advanced Pancreatic Cancer
Start: Apr 30, 2016
Completion: Oct 27, 2022
NCT02715479
A Study to Evaluate the Effect of BMS-955176 on Pharmacokinetics of Dolutegravir and the Effect of Dolutegravir on the Pharmacokinetics of BMS-955176
Completion: May 31, 2016
NCT02706535
A Cross-over Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics (PK) of GSK525762 in Healthy Female Subjects of Non Child Bearing Potential
Start: May 5, 2016
NCT02184611
A 24 Week Efficacy Study of Inhaled Umeclidinium (UMEC) in Patients of Chronic Obstructive Pulmonary Disease (COPD) Using a Novel Dry Powder Inhaler (NDPI)
Start: May 9, 2016
Completion: Nov 8, 2017
NCT02741557
Bioequivalence Study of a Fixed-dose Combination (FDC) of Dolutegravir (DTG) and Rilpivirine (RPV)
Start: May 11, 2016
Completion: Oct 24, 2016
NCT02603172
A Safety Study of GSK3039294 in Healthy Volunteers and Patients With Systemic Amyloidosis
Start: May 12, 2016
NCT02757963
Benign Prostatic Hyperplasia (BPH) Screening Tool Case Finding Study in Subjects >=50 Years
Completion: Feb 27, 2017
NCT02839135
A Comparative Bioavailability and Adhesion Performance Study, Comparing a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants.
Start: May 13, 2016
Completion: Aug 10, 2016
NCT03293641
Zinc Supplementation in Children With Sickle Cell Disease in Western Kenya
Start: May 20, 2016
NCT02698553
A Study to Evaluate Pharmacokinetics, Safety and Tolerability of Extended-release Bupropion Hydrochloride Tablets in Chinese Healthy Volunteers
Start: May 23, 2016
NCT02752958
Impact of Long Term Management of Dentine Hypersensitivity (DH) With a Daily Use Anti-sensitivity Toothpaste on the Quality of Life Related to Oral Health
Completion: Feb 3, 2017
NCT02730351
Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)
Start: May 25, 2016
NCT02705807
Evaluation of a New Thermostable Formulation of FLOLAN in Japanese Subjects
Start: May 31, 2016
NCT02751294
A Study to Assess the Effects of Dissolution Profile on the Pharmacokinetics of Single Oral Doses of Tafenoquine Tablets and Tafenoquine Stable Isotope Labelled Solution
NCT02738931
Relative Bio-availability Study of Dolutegravir and Lamivudine Fixed Dose Combinations
NCT02551627
A Study to Investigate the Impact of a Multiple Micronutrient (MMN) Beverage Powder on Vaccine Response in School Children
Start: Jun 1, 2016
Completion: Oct 1, 2017
NCT02570152
A Cohort Study to Determine the Incidence of Dengue Fever and to Build Capacity for Dengue Vaccine Trials in Dengue-endemic Regions of South Asia
Completion: Jun 28, 2019
NCT02712359
This Study Will Evaluate the Persistence of Hepatitis A Antibodies, 8 Years and 10 Years Later, in Children Who Had Received Havrix at Selected Health Centres of Panama
Completion: Aug 22, 2018
NCT02791763
Phase III Study of GSK1278863 in Japanese Non-dialysis (ND) and Peritoneal Dialysis (PD) Subjects With Renal Anemia
Start: Jun 6, 2016
Completion: Oct 26, 2018
NCT02832362
Local Nasal Tolerability and Safety Study of 1146A in Healthy Adult Participants
Start: Jun 11, 2016
NCT02751424
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Intravenous Single Dose and Repeat Dose of GSK3342830
Start: Jun 13, 2016
Completion: Feb 2, 2017
NCT02799472
Mechanistic Study of GSK3196165 Plus Methotrexate (MTX) in Subjects With Active Rheumatoid Arthritis
Start: Jun 15, 2016
Completion: Oct 30, 2017
NCT02742753
Impact of Pneumococcal Conjugate Vaccines on Otitis Media and Acute Otitis Media in Swedish Children
Start: Jun 16, 2016
NCT02780661
Frequency of Denture Cleanser Use and Denture Cleanliness
Start: Jun 20, 2016
Completion: Nov 15, 2016
NCT02786927
Preference Attributes of ELLIPTA Dry Powder Inhaler (DPI) and HANDIHALER DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Start: Jun 21, 2016
Completion: Oct 4, 2016
NCT02723955
Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)
Start: Jun 23, 2016
Completion: Jul 5, 2023
NCT02729038
Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function
Start: Jun 29, 2016
NCT02729051
Comparative Study of Fluticasone Furoate(FF)/Umeclidinium Bromide (UMEC)/ Vilanterol (VI) Closed Therapy Versus FF/VI Plus UMEC Open Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Completion: May 23, 2017
NCT02731846
A Study Comparing the Closed Triple Therapy, Open Triple Therapy and a Dual Therapy for Effect on Lung Function in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Start: Jun 30, 2016
NCT02798991
A Phase I, Randomized, Placebo-controlled, Double Blind, Repeat Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Gastrointestinal Transit Time and Pharmacodynamic Biomarkers of GSK3179106 in Normal Subjects
NCT02801981
Dose-escalation Study of GSK2330672 in Japanese Healthy Male Volunteers
NCT02800655
Digital Health Feedback System for Longitudinal Measurement of Medication Adherence During Anti-Retroviral (ARV)Therapy
Completion: Dec 31, 2023
NCT02768194
Dentine Tubule Occlusion Assessment in a Modified in Situ Model
Start: Jul 6, 2016
Completion: Sep 21, 2016
NCT02719743
A Dose Ranging Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of Age
Start: Jul 7, 2016
Completion: Feb 13, 2018
NCT02757950
A Post-marketing, Observational, Retrospective Study to Assess the Safety of RefortrixTM (Tdap) When Administered During Pregnancy in a Maternal Immunization Program in Brazil.
Start: Jul 14, 2016
NCT02766088
This Study Will Describe the Burden of DENgue Fever Virus (DENV) Illness Among Household Members Aged 6 Months to 50 Years of Selected Communities in Latin America and Southeast Asia
NCT02799784
An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD Patients
Completion: Apr 27, 2017
NCT02831764
An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2)
Start: Jul 18, 2016
Completion: Jun 29, 2022
NCT02831673
An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1)
Start: Jul 21, 2016
Completion: Aug 15, 2022
NCT02593539
Safety, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Repeat Doses of Inhaled Nemiralisib in Patients With APDS/PASLI
Start: Jul 22, 2016
Completion: Jun 4, 2020
NCT02801942
Immune Profile in Subjects With New Onset Type 1 Diabetes
Start: Jul 25, 2016
Completion: Dec 21, 2017
NCT02928380
Evaluation of a Experimental Denture Adhesive to Prevent Food Ingress
NCT02794467
Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis
Start: Jul 31, 2016
NCT02874820
I2PETPG - Imidazoline2 Binding Sites in a Group of Participants Diagnosed With AD
Completion: Jul 31, 2017
NCT02853435
To Assess Bioavailability, Food Effect and Pharmacokinetics of Gepotidacin Tablets: A Phase I, Single-Dose, 2 Part Study in Healthy Subjects.
Start: Aug 4, 2016
Completion: Oct 17, 2017
NCT02676895
A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults
Start: Aug 8, 2016
Completion: Mar 10, 2017
NCT02829320
Efficacy and Safety Study of GSK1278863 in Japanese Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Taking Erythropoiesis Stimulating Agents
NCT02820844
Efficacy and Safety of GSK1358820 in Subjects With Overactive Bladder
Start: Aug 10, 2016
Completion: Nov 12, 2018
NCT02794480
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
Start: Aug 22, 2016
NCT02798952
A Study to Evaluate Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of Engerix™-B Kinder Challenge Dose, in Adolescents Vaccinated With Four Doses of Infanrix™ Hexa During Infancy
Start: Aug 23, 2016
NCT02829307
A Positron Emission Tomography (PET) Imaging Study to Investigate the Biodistribution and Clearance of an Albumin Binding Domain Antibody (AlbudAb) GSK3128349 in Healthy Male Subjects
Completion: Jan 27, 2017
NCT02868281
Asthma Control Test Guided Treatment in Chinese Subjects
Start: Aug 26, 2016
Completion: Aug 9, 2019
NCT02723786
Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of GSK1070806 for the Prevention of Delayed Graft Function (DGF) in Adult Subjects After Renal Transplantation
Start: Aug 27, 2016
Completion: Mar 6, 2018
NCT02776033
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Repeat Doses of GSK2982772 in Subjects With Psoriasis
Start: Aug 30, 2016
Completion: Jan 4, 2018
NCT02783300
An Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK3326595 in Participants With Solid Tumors and Non-Hodgkin's Lymphoma
Completion: Aug 30, 2023
NCT03005041
Consumer Perception of an Experimental Mouthwash After a Single Use in Dry Mouth Subjects
Start: Aug 31, 2016
Completion: Oct 19, 2016
NCT02348398
Phase II Study of Pazopanib and Topotecan in Cervical Cancer
NCT02925234
The Drug Rediscovery Protocol (DRUP Trial)
NCT02985450
A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in Canada
Completion: Jan 31, 2021
NCT02893878
Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines
Start: Sep 12, 2016
NCT02858440
A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia
Start: Sep 13, 2016
Completion: Nov 13, 2018
NCT02907216
Evaluation of Immunogenicity and Safety of the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) Vaccine Squarekids Co-administered With GSK Biologicals' Human Rotavirus (HRV) Vaccine Rotarix (GSK444563) in Healthy Infants
Start: Sep 16, 2016
Completion: May 29, 2017
NCT02853929
Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery
Start: Sep 19, 2016
Completion: Mar 19, 2019
NCT02802514
A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy Subjects
Start: Sep 20, 2016
Completion: Sep 7, 2017
NCT02861664
Assessment of the Efficacy of an Experimental Occlusion Technology Dentifrice in Dentinal Hypersensitivity
Start: Sep 21, 2016
Completion: Dec 24, 2016
NCT02794519
A Phase 2a Study to Evaluate the Effects of Sirukumab in Subjects With Severe Poorly Controlled Asthma
Start: Sep 23, 2016
NCT02793154
An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects
Start: Sep 26, 2016
Completion: Mar 16, 2017
NCT02876835
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Start: Sep 27, 2016
Completion: Apr 19, 2021
NCT02879305
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)
Start: Sep 28, 2016
Completion: Nov 9, 2020
NCT02837380
A Phase I Pharmacokinetic Study of Fluticasone Furoate /Umeclidinium Bromide/Vilanterol (100/62.5/25 Microgram [mcg]) After Single and Repeat Dose Administration From a Dry Powder Inhaler in Healthy Chinese Subjects
Start: Sep 30, 2016
NCT02750930
Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus Subjects
Start: Oct 7, 2016
Completion: Mar 21, 2017
NCT03001440
A 7-year Assessment on Subject Understanding of ZYBAN/ WELLBUTRIN Associated Risks
Completion: Dec 28, 2016
NCT03478644
Oral and Dermal Tolerability Clinical Study of an Experimental Denture Wipe
Start: Oct 10, 2016
NCT02849418
Efficacy and Safety Study of GSK1358820 in Japanese Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity
Start: Oct 11, 2016
NCT02901951
Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine (HBV), Engerix-B
Completion: May 1, 2017
NCT02923895
To Investigate the Efficacy of an Occluding Dentifrice in Dentinal Hypersensitivity (DH)
NCT02924688
A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma
Start: Oct 13, 2016
NCT02858492
Safety and Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy of Repeat Doses of GSK2982772 in Subjects With Moderate to Severe Rheumatoid Arthritis (RA)
Start: Oct 17, 2016
Completion: Oct 22, 2018
NCT02663102
Evaluation of Safety of GlaxoSmithKline (GSK) Vaccines' Quadrivalent Seasonal Influenza Vaccine, Fluarix Tetra When Administered According to the Approved Prescribing Information (PI) in Korea.
Start: Oct 20, 2016
Completion: Feb 5, 2021
NCT02968849
Pivotal Phase 2b/3 ALVAC/Bivalent gp120/MF59 HIV Vaccine Prevention Safety and Efficacy Study in South Africa
Start: Oct 26, 2016
Completion: Nov 16, 2021
NCT02914184
Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks
Start: Oct 27, 2016
Completion: Nov 26, 2018
NCT02938520
Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants
Completion: Dec 31, 2025
NCT02951052
Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults
Start: Oct 28, 2016
NCT02925546
A Phase I Study to Assess the Pharmacokinetics of GSK2798745 Tablets
Start: Oct 31, 2016
NCT02972905
Study to Evaluate Safety, Tolerability and Pharmacokinetics of GSK2269557 to Japanese Healthy Subjects
NCT02974114
Exploratory Study to Investigate Cognition Function and Mobility in Individuals With Pain
NCT02924350
The Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity (DH)
Start: Nov 7, 2016
Completion: Mar 17, 2017
NCT02956837
A Study to Rank Different Dosages of Antigen of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A), Based on Their Immune Response and Safety, When Administered to Healthy Adult Women
Start: Nov 10, 2016
Completion: Feb 5, 2018
NCT02903966
GSK2982772 Study in Subjects With Ulcerative Colitis
Start: Nov 15, 2016
Completion: Jun 17, 2019
NCT02946385
Study to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in Adolescents
NCT02899377
A PH I Pilot Imaging Study to Evaluate Molecular Imaging Methods in HVs and pSS Pts
Start: Nov 18, 2016
Completion: Jul 12, 2018
NCT02937623
To Evaluate the Efficacy of an Experimental Dissolvable Strip in Rapidly Relieving Dentinal Hypersensitivity (DH)
Start: Nov 21, 2016
NCT02969655
A Study to Evaluate Efficacy and Safety of Daprodustat Compared to Darbepoetin Alfa in Japanese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD)
Completion: Jul 2, 2018
NCT02999100
Comparison of Inhaled Oxytocin (IH) With Intramuscular (IM) Oxytocin in Pregnant Women and With Intravenous (IV) Oxytocin in Healthy Non-pregnant Women
Start: Nov 23, 2016
Completion: Mar 4, 2019
NCT02953808
Phase 1 Study of GSK2315698 in Healthy Japanese Subjects
Start: Nov 30, 2016
NCT02833974
Effect of the GSK2245035 on the Allergen-induced Asthmatic Response
Start: Dec 5, 2016
Completion: May 4, 2018
NCT02992743
Letetresgene Autoleucel Engineered T Cells in NY-ESO-1 Positive Participants With Advanced Myxoid/ Round Cell Liposarcoma
Start: Dec 6, 2016
Completion: Mar 22, 2022
NCT02986854
Study to Assess the Safety and Immunogenicity of a Single Dose of GlaxoSmithKline's (GSK) Meningococcal MenACWY-CRM Vaccine (Menveo), Administered to Subjects 15 Through 55 Years of Age, Approximately 4-6 Years After Primary ACWY Vaccination
Start: Dec 8, 2016
Completion: Dec 7, 2017
NCT02991872
A Study to Evaluate Persistence of Immune Responses After Post-exposure Prophylaxis of Rabipur® (Purified Chicken-embryo Cell Rabies Vaccine) in Chinese Children
Start: Dec 16, 2016
Completion: Mar 12, 2017
NCT02992691
Efficacy of Three Experimental Toothpastes to Remove Plaque
Start: Dec 19, 2016
NCT02965599
Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK3117391 in Subjects With Rheumatoid Arthritis
Start: Dec 27, 2016
Completion: Nov 14, 2017
NCT03005067
To Evaluate the Efficacy and Safety of 1146A Nasal Spray in Adult Participants With Symptoms of Common Cold
Start: Dec 29, 2016
NCT02982187
A Clinical Study Assessing Critical Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA® Dry Powder Inhaler, in Comparison to Combinations of Dry Powder Inhalers Used to Provide Triple Therapy, in Patients With Chronic Obstructive Pulmonary Disease
Start: Dec 30, 2016
Completion: Jun 19, 2017
NCT02977078
Improving Asthma Treatment Using Inhaler Technology
Start: Dec 31, 2016
NCT02986984
Transformative Research in Diabetic Nephropathy
Completion: Jun 30, 2027
NCT03014674
A Study to Compare the Pharmacokinetics of Mepolizumab as a Liquid Drug in a Safety Syringe or an Autoinjector Versus Lyophilised Drug
Start: Jan 6, 2017
Completion: Aug 11, 2017
NCT02798978
A Phase I, 2-part (Part 1 Being a Single Dose Escalation and Part 2, a Parallel Group) Study of Toll-like Receptor (TLR4) Agonist (GSK1795091) in Healthy Subjects
Start: Jan 10, 2017
Completion: Oct 13, 2017
NCT03178968
Can Surface Roughness Predict Progression of Tooth Wear?
NCT02927873
A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants
Start: Jan 11, 2017
Completion: Nov 26, 2020
NCT02966834
Dose Response Study of GSK2330672 for the Treatment of Pruritus in Participants With Primary Biliary Cholangitis
Completion: Apr 15, 2020
NCT03028480
Long Term Special Drug Use Investigation of Mepolizumab
Completion: Nov 22, 2023
NCT02927457
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus Erythematosus Subjects
Start: Jan 13, 2017
Completion: Jun 12, 2018
NCT02979639
Study to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GlaxoSmithKline (GSK) Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 50 Years of Age
Start: Jan 16, 2017
NCT02927431
Study to Evaluate the Efficacy and Safety of Danirixin Co-administered With Oseltamivir in the Treatment of Adults Hospitalized With Influenza
Start: Jan 19, 2017
Completion: May 24, 2017
NCT02880852
Belimumab Phase I Study in Chinese Subjects With Systemic Lupus Erythematosus
Start: Jan 23, 2017
Completion: Sep 8, 2017
NCT03408678
Determinants of Type 2 Diabetes Risk in Middle-aged Black South African Men and Women
Completion: Jul 31, 2018
NCT03028467
Evaluation of Pharmacokinetics and Safety of GSK3196165 in Combination With Methotrexate in Japanese Subjects With Rheumatoid Arthritis
Start: Jan 24, 2017
Completion: Dec 20, 2017
NCT03012061
Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With Asthma
Start: Jan 25, 2017
Completion: May 30, 2018
NCT02979626
Evaluation of Moderate to Severe Influenza Outcomes in Children
Start: Jan 30, 2017
Completion: May 5, 2018
NCT02678234
An Efficacy and Safety Study of Theraflu Day Powder as Oral Solution for Cold and Flu
Start: Feb 1, 2017
Completion: Apr 1, 2017
NCT02730364
An Efficacy and Safety Study of Theraflu Night Powder as Oral Solution for Cold and Flu
NCT03021304
Study of Mepolizumab Safety Syringe in Asthmatics
Completion: Aug 8, 2017
NCT02563496
A Pharmacokinetics, Safety and Efficacy Study of Tafenoquine (TQ) in Pediatric Subjects With Plasmodium Vivax (P. Vivax) Malaria
Start: Feb 6, 2017
Completion: Feb 17, 2020
NCT03045887
Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of GSK2292767 in Healthy Participants Who Smoke Cigarettes
Completion: Aug 16, 2017
NCT02991859
Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects
Start: Feb 9, 2017
NCT03348774
Scrutinizing the Heterogeneity of SLE: Defining Phenotypes
Completion: Jul 30, 2018
NCT03004846
A Study of GSK2981278 Ointment in Subjects With Plaque Psoriasis
Start: Feb 13, 2017
Completion: May 5, 2017
NCT03037307
A Clinical Bite Force Study of Two Marketed Adhesives Against no Adhesive
Completion: May 4, 2017
NCT03020745
A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3389404 in Chronic Hepatitis B (CHB) Subjects
Start: Feb 14, 2017
Completion: Nov 6, 2019
NCT02868970
Pharmacists as Immunizers to Improve Coverage and Provider/Recipient Satisfaction
Start: Feb 15, 2017
Completion: Jul 5, 2021
NCT03046069
FF/UMEC/VI Inhaler: Qualitative Analysis and Subject Preference Survey
Start: Feb 20, 2017
NCT02987465
Evaluating the Effect of Standard-of-care Erythropoiesis-stimulating Agents on Forearm Blood Flow in Nondialysis-dependent Subjects With Anaemia Associated With Chronic Kidney Disease.
Completion: May 21, 2018
NCT03216265
A Proof of Concept Clinical Study to Investigate the Effects of an Experimental Cosmetic Moisturiser on the Barrier Function of Human Skin on the Face and Forearm
Start: Feb 23, 2017
Completion: Apr 24, 2017
NCT02981602
Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HBV Infection
Start: Feb 24, 2017
Completion: Dec 26, 2019
NCT03076164
A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib
Start: Mar 1, 2017
Completion: Dec 18, 2020
NCT02836496
Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)
Start: Mar 7, 2017
Completion: Aug 8, 2019
NCT02937870
A Bite Force Study Comparing Two New Test Adhesives With Currently Marketed Denture Adhesive
Completion: Apr 5, 2017
NCT03028207
A Cross-sectional Study on COPD Prevalence
Start: Mar 9, 2017
Completion: Mar 1, 2019
NCT03089879
A Study to Evaluate Safety and Immunogenicity of 1 Booster Dose of 1790GAHB Vaccine in Healthy Adults Primed With 3 Doses of 1790GAHB Vaccine in Study H03_01TP Compared to 1 Vaccination of 1790GAHB in Either Subjects Who Received Placebo in the Same Study or naïve Subjects Not Part of H03_01TP Study
Start: Mar 16, 2017
NCT03031496
Bioequivalence Study Between GSK3542503 Hydrochlorothiazide + Amiloride Hydrochloride 50 mg: 5 mg Tablets and Reference Product in Healthy Adult Participants Under Fasting Conditions
Start: Mar 17, 2017
Completion: Apr 10, 2017
NCT03045861
Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus (HIV)-1 Infected Adults
NCT03180645
Proof of Concept Anti-ageing Clinical Study in Healthy Subjects
Start: Mar 20, 2017
Completion: Apr 21, 2017
NCT03055195
Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis
Start: Mar 21, 2017
Completion: Dec 6, 2017
NCT03175562
To Assess the Cutaneous Irritation and Sensitization Potential of a Cosmetic Facial Product Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Participants
Start: Mar 27, 2017
Completion: May 19, 2017
NCT03183518
To Assess the Photosensitisation and Photoallergy Potential of a Cosmetic Facial Product in Healthy Participants
NCT03078556
Bioequivalence Study of Fixed Dose Versus Single Entities of Dolutegravir and Lamivudine
Completion: Aug 18, 2017
NCT03075410
First Time in Human (FTIH) Safety and Pharmacokinetics (PK) Study of GSK3036656 in Healthy Subjects
Start: Apr 2, 2017
NCT03093181
A Study to Evaluate of Cosmetic Benefit of a Moisturising Cream in People With Blemish Prone Skin
Start: Apr 4, 2017
NCT03034967
Danirixin Dose Ranging Study in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Start: Apr 25, 2017
Completion: Oct 5, 2018
NCT03095638
Bioavailability Study of 10 Milligram (mg) and 5 mg Tablets Versus Conventional Tablets of Dolutegravir
Start: May 3, 2017
Completion: Jun 23, 2017
NCT03099096
Study of Mepolizumab Autoinjector in Asthmatics
Start: May 4, 2017
NCT03146754
A Study to Evaluate Lung Ultrasound as a Method to Measure Changes in Extravascular Lung Water Induced by Positional Changes (LUPE)
Completion: Jan 1, 2023
NCT03119688
To Assess the Mildness of a Cosmetic Cleanser in Healthy Participants Using the Forearm-Controlled Application Technique (FCAT)
Start: May 8, 2017
Completion: May 26, 2017
NCT02699099
Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.
Start: May 10, 2017
Completion: Oct 7, 2020
NCT03103906
Evaluation of the Cosmetic Benefit of a Skin Cream in Healthy Females With Mild to Advanced Photo-damaged Facial Skin Who Have Undergone a Glycolic Acid Facial Peel Procedure
Completion: Jul 19, 2017
NCT03136380
Study of Danirixin in Japanese Healthy Elderly Male Subjects
NCT03029208
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID)
Start: May 11, 2017
Completion: Sep 24, 2020
NCT03000686
Study of GSK2586881 on Acute Hypoxia and Exercise
Start: May 17, 2017
Completion: Jan 4, 2019
NCT03154086
A Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Volunteers
Completion: Mar 5, 2018
NCT03233009
To Investigate Primary Irritation Potential of Four Skin Serum Products on Human Subjects Assessed by 24 Hour Patch Test
Start: May 22, 2017
NCT03162614
Efficacy, Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Evaluating Different Dose Schedules in a Sporozoite Challenge Model in Healthy Malaria-naïve Adults
Start: May 24, 2017
Completion: Sep 24, 2018
NCT03085797
Effect of Mepolizumab in Severe Bilateral Nasal Polyps
Start: May 25, 2017
Completion: Dec 11, 2019
NCT03155269
To Investigate the Impact of a Nutritional Supplement on Bone Turnover Markers in Indian Healthy Premenopausal Women (25- 45 Years) After 6 Months of Intervention
Completion: Jan 16, 2018
NCT03136107
Determination of the Sun Protection Factor (SPF) of a Cosmetic Daily De-fence Skin Cream
Start: May 30, 2017
NCT02447939
Pharmacokinetics of Repeat Oral Doses of Dabrafenib and the Combination of Dabrafenib and Trametinib in Chinese Subjects With Melanoma
Start: May 31, 2017
NCT02939846
Pharmacokinetics of Single and Repeat Oral Doses of Trametinib in Chinese Subjects With Solid Tumours
NCT03161587
Patient Characteristics and Treatment Modalities in COPD Patients in China
NCT03041025
Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis
Start: Jun 5, 2017
Completion: Jul 7, 2020
NCT02778204
Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection
Completion: Nov 20, 2019
NCT03149848
Effect of Rifabutin on the Pharmacokinetics of Oral Cabotegravir in Healthy Subjects
Start: Jun 6, 2017
NCT03114969
Comparative Study of Error Rates Between ELLIPTA® Dry Powder Inhaler (DPI) and Other DPIs
Start: Jun 8, 2017
Completion: Mar 9, 2018
NCT03172364
To Investigate the Cutaneous and Ocular Local Tolerance of Two Cosmetic Facial Cleanser in Healthy Females With Sensitive Skin
Start: Jun 12, 2017
Completion: Jul 13, 2017
NCT03069989
Single Doses of GSK3008348 in Idiopathic Pulmonary Fibrosis (IPF) Participants Using Positron Emission Tomography (PET) Imaging
Start: Jun 13, 2017
NCT03189589
Safety, Tolerability and Pharmacokinetics (PK) Study of GSK2269557 in Healthy Subjects
Start: Jun 15, 2017
NCT03034915
A 24-week Study to Compare Umeclidinium/Vilanterol (UMEC/VI), UMEC and Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Start: Jun 16, 2017
Completion: Jun 18, 2018
NCT03235401
The PAH Disability and Bothersomeness Questionnaire
NCT03284710
Safety and Immunogenicity of Clade C ALVAC and gp120 HIV Vaccine
Start: Jun 19, 2017
Completion: Dec 12, 2019
NCT03157583
A Study to Measure the Sun Protection Factor (SPF) and Ultraviolet-A Protection Factor (UVAPF) of Four Developmental Sunscreen Formulations
Start: Jun 21, 2017
NCT03184987
A Long-term Safety Study of Fixed Dose Combination Therapy Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate in Japanese Subjects With Asthma
Start: Jun 22, 2017
Completion: Jun 25, 2019
NCT03201211
A Long Term Follow-up Study up to 4 Years After Study Vaccination to Assess Immunogenicity and Safety of the Investigational Vaccine in Adults
Completion: Mar 19, 2020
NCT04471493
Pediatric and Ambulatory Research in Infectious Diseases
Start: Jun 26, 2017
Completion: Aug 2, 2030
NCT03271203
Subject Insights to Understand the Hand Osteoarthritis (HOA)
Start: Jul 3, 2017
NCT03285191
Subject Insights to Understand Rheumatoid Arthritis (RA)
Completion: Aug 17, 2017
NCT02889809
Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a Year
Start: Jul 10, 2017
Completion: Jun 4, 2021
NCT03044353
Multiple Treatment Session Study to Assess GSK2398852 Administered Following and Along With GSK2315698
Completion: Jan 3, 2019
NCT03160703
Study to Investigate the Stain Control of Two Stannous Fluoride Dentifrices
NCT03191383
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the GlaxoSmithKline (GSK) Biologicals' Respiratory Syncytial Virus (RSV) Investigational Vaccine (GSK3003891A) in Healthy Pregnant Women and Infants Born to Vaccinated Mothers
Start: Jul 11, 2017
Completion: Jul 14, 2017
NCT03144063
Improving the Assessment of SLE Disease Activity
NCT03235726
Study of Safety and Drug Levels of CCI15106 Inhalation Powder in Healthy Adults and Adults With Moderate Chronic Obstructive Pulmonary Disease. Study of CCI15106 Levels in People Standing Near the Person Inhaling the Drug
Start: Jul 13, 2017
Completion: Jun 19, 2018
NCT03197883
Assessment of the Cosmetic Benefit of a Skin Cream in Healthy Females With Mild to Advanced Photo-damaged Facial Skin Who Have Undergone a Glycolic Acid Facial Peel Procedure
Start: Jul 17, 2017
NCT03131908
Study of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN Loss
NCT03150056
Dose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy in Participants With Castrate-resistant Prostate Cancer
Start: Jul 18, 2017
Completion: Jun 22, 2021
NCT02542865
A Study to Investigate the Impact of Fortified Malt Based on Immunity Outcomes in School Children
Start: Jul 24, 2017
Completion: Jul 6, 2018
NCT03223337
Daprodustat Hepatic Impairment Study
Completion: Aug 20, 2018
NCT03029247
Anemia Study in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Blood Pressure (ASCEND-BP)
Start: Jul 27, 2017
Completion: Jul 9, 2020
NCT02929498
Safety, Clinical Activity, Pharmacokinetics (PK) and Pharmacodynamics Study of GSK2879552, Alone or With Azacitidine, in Subjects With High Risk Myelodysplastic Syndromes (MDS)
Start: Jul 31, 2017
NCT03221192
Qualitative Analysis of Subject Experience of Nasal Polyps
NCT03150082
Bioequivalence Study Between GR37547 500 Milligrams (mg) Tablet Versus Ciprofloxacin 500 mg Tablet Reference Product in Healthy Adult Subjects
Start: Aug 1, 2017
NCT03125616
Babies Born Early Antibody Response to Men B Vaccination: BEAR Men B
Completion: Aug 28, 2020
NCT03234036
A Two-part Study to Compare a Tablet and Capsule Formulation of GSK2838232 With and Without Food, and to Assess the Safety and Drug Levels of Repeated Once-daily Doses of GSK2838232 Without Ritonavir
Start: Aug 2, 2017
NCT03261167
A Phase III Study to Evaluate the Efficacy and Safety of GSK1358820 in Subjects With Post-stroke Upper Limb Spasticity
Completion: Jan 10, 2019
NCT03238352
A Study to Assess Efficacy of an Experimental Oral Rinse in Providing Long Term Relief From Dentinal Hypersensitivity
Start: Aug 7, 2017
Completion: Oct 27, 2017
NCT03250832
Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid Tumors
Start: Aug 8, 2017
Completion: Feb 13, 2023
NCT03153007
Study of Subjects With Diabetic Foot Ulcer (DFU)
Start: Aug 11, 2017
NCT03306589
Lipopolysaccharide (LPS) or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Challenge Study on Healthy Subjects
Completion: Jun 20, 2018
NCT03015519
A Study to Evaluate Pharmacokinetics, Safety and Efficacy of Albiglutide in Pediatric Subjects With Type 2 Diabetes Mellitus
Start: Aug 14, 2017
Completion: Apr 20, 2020
NCT03168438
Letetresgene Autoleucel Engineered T Cells Alone and in Combination With Pembrolizumab in NY-ESO-1 Positive Multiple Myeloma
Start: Aug 18, 2017
Completion: Nov 5, 2020
NCT03184480
Arnuity® Ellipta® Drug Use Investigation
Start: Aug 19, 2017
Completion: Mar 17, 2021
NCT03245619
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Investigation of GSK3335065 Intravenous (IV) Infusion in Healthy Adults
Start: Aug 22, 2017
Completion: May 19, 2018
NCT03151395
Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease, in Asia Pacific
Start: Aug 25, 2017
Completion: Apr 6, 2020
NCT03219255
RELVAR® 100 ELLIPTA® Special Drug Use Investigation (COPD, Long-term)
Start: Aug 30, 2017
Completion: Mar 30, 2021
NCT03275389
A Study to Evaluate the Reactogenicity, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Supra-seasonal Universal Influenza Vaccines - Inactivated (SUIVs) (GSK3816302A) in Healthy Adults Aged 18 to 39 Years
Start: Sep 8, 2017
Completion: Mar 26, 2020
NCT02885246
Prevalence, Strain Circulation and Disease Burden Study of Seasonal Influenza A and B in Panama, Selected Countries of Central America and the Caribbean From the Year 2010 to 2015
Start: Sep 11, 2017
Completion: Sep 17, 2018
NCT03278067
Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England
Start: Sep 12, 2017
NCT03207243
Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma
Start: Sep 14, 2017
Completion: May 15, 2019
NCT03207750
This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine
NCT02937636
To Investigate the Gingivitis Efficacy of a Stannous Fluoride Dentifrice in a Chinese Population
Start: Sep 19, 2017
Completion: Dec 22, 2017
NCT03239600
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Proof of Mechanism of GSK2618960 in Primary Sjögren's Syndrome (pSS)
Completion: Oct 12, 2017
NCT03231943
GSK3640254 First Time in Human (FTIH) Study in Healthy Volunteers
Completion: Sep 9, 2018
NCT03227445
Comparative Study of ELLIPTA Dry Powder Inhaler (DPI) Versus DISKUS DPI Used With HandiHaler DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Start: Sep 20, 2017
NCT03258762
Phase I Study of Pyrimethamine in Healthy Japanese and Caucasian Subjects
Start: Sep 25, 2017
Completion: Nov 19, 2017
NCT03267511
A Study to Investigate the Stain and Plaque Removal Capability of Two Experimental Potassium Nitrate Dentifrices
Completion: Dec 2, 2017
NCT03266172
A Study to Compare the Pharmacokinetics (PK) of GSK2982772 Following Administration of Different Modified Release (MR) Formulations in Capsule and MR Tablet Formulations Relative to an Immediate Release (IR) Tablet Formulation and to Check the PK of MR Formulation in Capsule Following Repeat Doses
Start: Sep 27, 2017
Completion: Nov 21, 2018
NCT03276962
Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age
Start: Sep 28, 2017
Completion: Nov 14, 2022
NCT03258710
A Study of Switching From Entecavir to Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B
Start: Oct 2, 2017
Completion: Nov 25, 2019
NCT03294135
The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine
Start: Oct 5, 2017
Completion: Oct 25, 2021
NCT05491902
Pilot PET Study of Regional Cerebral Protein Synthesis in Alzheimer's
Start: Oct 9, 2017
Completion: Oct 15, 2020
NCT03239522
Absorption and Elimination of Radiolabeled Daprodustat
Start: Oct 10, 2017
Completion: Nov 28, 2017
NCT03300050
Safety and Immunogenicity of a Live-attenuated Universal Flu Vaccine Followed by an Inactivated Universal Flu Vaccine
NCT03305419
A Safety and Pharmacokinetic (PK) Study of GSK2982772 in Healthy Subjects
Start: Oct 11, 2017
Completion: Oct 15, 2018
NCT03170232
A Pilot Study of Danirixin for Disease Progression in Chronic Obstructive Pulmonary Disease (COPD)
Start: Oct 16, 2017
Completion: Nov 15, 2018
NCT03287310
First Time in Human (FTIH) Study to Evaluate Safety, Tolerability, Immunogenicity, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3511294 Administered Subcutaneously (SC) in Subjects With Mild to Moderate Asthma
Start: Oct 17, 2017
NCT03315572
Pediatric Ease of Use ELLIPTA Items
Completion: Dec 1, 2017
NCT03248128
Safety and Efficacy Study of Fluticasone Furoate/Vilanterol (FF/VI) Fixed Dose Combination (FDC) Compared to FF Alone in Subjects With Asthma
Start: Oct 20, 2017
Completion: Mar 21, 2022
NCT02130661
Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy Volunteers
Start: Oct 31, 2017
NCT03292588
A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children
Start: Nov 7, 2017
Completion: Apr 20, 2021
NCT03296072
In Situ Erosion Study to Investigate the Effectiveness of an Experimental Toothpaste
Start: Nov 13, 2017
NCT03306043
A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622
Completion: Dec 30, 2019
NCT03315559
Absorption & Elimination of Radiolabelled GSK2269557
Start: Nov 14, 2017
NCT03250689
Randomized Study Evaluating the Effect of Danirixin on Neutrophil Extracellular Traps (NETs) in Chronic Obstructive Pulmonary Disease (COPD)
Start: Nov 15, 2017
NCT03310268
A Clinical Study to Evaluate a Stannous Fluoride Toothpaste for the Relief of Dentinal Hypersensitivity
Start: Nov 18, 2017
Completion: Feb 2, 2018
NCT03345108
A Study to Investigate a Method to Measure Food Occlusion by Denture Adhesives in Denture Wearers
Start: Nov 20, 2017
NCT03136120
Cryobiopsy Study to Assess Drug Distribution in Subjects With Suspected Interstitial Lung Disease
Start: Nov 21, 2017
NCT03137043
Prevalence of Severe Asthma in Spanish Hospitals
Start: Nov 22, 2017
Completion: Jun 2, 2020
NCT03304548
Qualitative Research to Explore Treatment Preference in Pulmonary Arterial Hypertension (PAH) Subjects
Completion: Apr 10, 2018
NCT03266159
A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Clinical Activity of GSK525762 Plus Trametinib in Subjects With Solid Tumors
Start: Nov 27, 2017
Completion: Aug 19, 2020
NCT03281876
A Study to Test if the Vaccine is Working Well in Chronic Obstructive Pulmonary Disease (COPD) Patients Aged 40 to 80 Years Old to Reduce Episodes of Worsening Symptoms and to Gather Further Information on Safety and Immune Response.
NCT03345407
Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)
Start: Nov 28, 2017
NCT03128489
Evaluation of Immunogenicity and Safety of DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) Administered at 6, 10 and 14 Weeks in Healthy Indian Infants
Start: Dec 1, 2017
Completion: Aug 1, 2018
NCT03344406
A Study to Evaluate Conceptual Saturation of Evaluating Respiratory Symptoms (E-RS) in Subjects With Asthma
Completion: Sep 10, 2018
NCT03336567
Perceptions of Cell and Gene Therapies (CGT) for the Treatment of Cancer
Start: Dec 4, 2017
NCT03688061
Class II Invariant Chain HCV Vaccine Study
Completion: Aug 4, 2022
NCT03436511
Burden of Disease Among Subjects With Eosinophilic Chronic Obstructive Pulmonary Disease (COPD)
Start: Dec 5, 2017
Completion: Dec 10, 2018
NCT03201978
A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult Subjects
Start: Dec 14, 2017
Completion: May 15, 2018
NCT03368053
Long-term Immunogenicity of the HIV gp120-NefTat/AS01B Vaccine (GSK SB732461)
NCT03383783
Evaluation of the Fluoride Dose Response of a Modified In Situ Caries Model
Start: Dec 19, 2017
Completion: May 2, 2018
NCT03351140
Patient-Reported Outcome Measurement Information System (PROMIS) Physical Function
Start: Dec 20, 2017
Completion: May 8, 2020
NCT03273946
Post-marketing Safety Monitoring Program of Fluticasone Propionate (FP) in Chinese Subjects With Asthma Aged 1 to <4 Years
Start: Jan 9, 2018
NCT03329547
A Bioequivalence Study of SKF101804 Cefixime Versus Cefixime Reference Formulation in Healthy Adults Under Fasting Conditions
Start: Jan 11, 2018
NCT03358407
GSK2983559 First Time in Human Study
Completion: Feb 19, 2019
NCT03370263
BENLYSTA® Special Drug Use Investigation
Start: Jan 15, 2018
Completion: Jun 26, 2025
NCT03122223
Evaluating the Safety and Immunogenicity of ALVAC-HIV and MF59®- or AS01B-adjuvanted Bivalent Subtype C gp120 in Healthy, HIV-uninfected Adult Participants
Start: Jan 16, 2018
Completion: Jul 30, 2020
NCT03398421
A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics (PK) of Nemiralisib
Start: Jan 17, 2018
Completion: Mar 12, 2018
NCT03446573
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Start: Jan 18, 2018
Completion: May 3, 2022
NCT03883568
A 2-year, European Multicentre Study to Describe, Validate, and Predict Phenotypes of Knee Osteoarthritis
Start: Jan 19, 2018
Completion: Dec 1, 2021
NCT03202004
GSK2894512 Vehicle-Controlled Study for Adult Plaque Psoriasis
Start: Jan 22, 2018
NCT03312712
Validation of the Analysis Methodology Behind the Use of Quantitative 18F-FDG PET/CT to Assess Lung Inflammation
Start: Jan 23, 2018
Completion: Jan 31, 2022
NCT03399461
Targeted Literature Review and Subject Interviews in Wiskott-Aldrich Syndrome (WAS)
Start: Jan 24, 2018
Completion: Sep 14, 2018
NCT03311659
Evaluation of Immunogenicity, Safety and Reactogenicity of GSK Biologicals' Boostrix Vaccine Administered as a Booster Dose in Healthy Russian Subjects
Start: Jan 26, 2018
NCT03170999
Accurate Recognition of Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)
Start: Jan 29, 2018
Completion: May 29, 2020
NCT03242434
Investigation of Thermal Injury on Intestinal Permeability in Both Thermal Injury and Healthy Participants
NCT03380429
A Clinical Study to Evaluate the Effect of the Connected Inhaler System (CIS) on Adherence to Maintenance Therapy in Poorly Controlled Asthmatic Subjects
Start: Jan 31, 2018
Completion: Jan 24, 2019
NCT03404960
Niraparib + Ipilimumab or Nivolumab in Progression Free Pancreatic Adenocarcinoma After Platinum-Based Chemotherapy
Completion: Oct 9, 2024
NCT03408392
Bioequivalence Study Between SKF101804 Cefixime 200 Milligram (mg)/5 Milliliter (mL) Suspension Versus Cefixime 200 mg/5 mL Suspension Reference Product in Healthy Adult Subjects Under Fasting Conditions
Start: Feb 6, 2018
Completion: Mar 13, 2018
NCT03192371
A Study to Evaluate the One Year Long-term Persistence of Immune Responses Following Two Different Rabies Vaccine Post-exposure Regimens in Chinese Children
Start: Feb 15, 2018
Completion: May 12, 2019
NCT03177603
A Dose-escalation Study in Subjects With Pulmonary Arterial Hypertension (PAH)
Start: Feb 21, 2018
Completion: May 7, 2019
NCT03441984
To Assess the Relative Bioavailability (BA) of TRIUMEQ® and Dolutegravir and Lamivudine (DTG/3TC) Pediatric Dispersible Tablet Formulations in Healthy Volunteers
Start: Feb 26, 2018
Completion: Apr 28, 2018
NCT03355820
A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study
Start: Feb 28, 2018
Completion: Jun 29, 2018
NCT03359473
Study to Evaluate the Safety and Efficacy of 13 Weeks of the Selective Androgen Receptor Modulator (SARM) GSK2881078 in Chronic Obstructive Pulmonary Disease (COPD)
Completion: Nov 19, 2019
NCT03312907
A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE
Start: Mar 1, 2018
Completion: Jul 7, 2021
NCT03415243
To Investigate the Gastrointestinal Behaviour of Two Triple Combination Products in Healthy Male Volunteers
Completion: Mar 29, 2018
NCT03409107
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)
Start: Mar 5, 2018
NCT03363191
The Efficacy of Fluticasone Furoate/Vilanterol Versus (vs) Fluticasone Furoate on Asthma
Start: Mar 7, 2018
Completion: May 29, 2019
NCT03457727
GSK1325756 Relative Bioavailability Study in Healthy Elderly Subjects
Completion: Jul 25, 2018
NCT03493919
A Sourcing Study to Collect Human Blood Samples From Healthy Adults
Start: Mar 8, 2018
Completion: May 27, 2022
NCT03426995
First-time-in-Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single (in Both Fed and Fasted States) or Repeat Doses of GSK3358699
Start: Mar 13, 2018
Completion: May 2, 2019
NCT02899026
Efficacy and Safety Study of Sirukumab in Subjects With Polymyalgia Rheumatica
Start: Mar 15, 2018
Completion: Aug 26, 2021
NCT03443427
A Study to Test if a Third Dose of the Vaccine is Safe in Current and Former Smokers Aged 40 to 80 Years Old and to Gather Information on the Immune Response Following the Third Dose of the Vaccine
Start: Mar 20, 2018
Completion: Sep 23, 2020
NCT03447314
Study of a Combination of GSK1795091 and Immunotherapies in Subjects With Advanced Solid Tumors
Start: Mar 26, 2018
Completion: Mar 11, 2022
NCT03474081
A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Start: Mar 29, 2018
Completion: Jul 17, 2019
NCT03372603
A Study to Assess the Effectiveness and Side Effects of GSK2798745 in Participants With Chronic Cough
Start: Apr 5, 2018
NCT03417830
Biodistribution of 89Zirconium-labelled GSK2398852 Using PET Imaging
Start: Apr 6, 2018
Completion: Jul 20, 2018
NCT02802501
Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) Malaria
Start: Apr 8, 2018
NCT03409419
PET Imaging of the Immune System Using Analog Probes
Start: Apr 10, 2018
Completion: Nov 10, 2020
NCT03467425
INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice Design
Start: Apr 11, 2018
Completion: Oct 10, 2019
NCT03439657
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and Older
Start: Apr 12, 2018
Completion: Mar 3, 2020
NCT03463577
The Safety of Boostrix Following Routine Immunization of Pregnant Women
Start: Apr 13, 2018
Completion: Aug 4, 2020
NCT03152669
"The Extended Salford Lung Study (Ex-SLS) Data Access Project"
Start: Apr 15, 2018
Completion: Apr 30, 2028
NCT03393806
Repeat Dose Study of GSK3772847 in Participants With Moderate to Severe Asthma With Allergic Fungal Airway Disease (AFAD)
Start: Apr 18, 2018
Completion: Jan 6, 2020
NCT03465332
Use of Diagnostic Measures in Chronic Obstructive Pulmonary Disease (COPD) in Routine Practice and Their Impact on Treatment Decisions
Start: Apr 19, 2018
Completion: Aug 30, 2018
NCT03493386
Daprodustat Bioequivalence and Food Effect Study
Start: Apr 24, 2018
Completion: Jun 9, 2018
NCT03318783
Subarachnoid Hemorrhage and Soluble Epoxide Hydrolase Inhibition Trial
Start: May 2, 2018
Completion: Jan 9, 2020
NCT03441113
Extended Access of Momelotinib in Adults With Myelofibrosis
Start: May 3, 2018
Completion: Dec 31, 2026
NCT03183492
Immunogenicity and Persistence of GlaxoSmithKline (GSK) Biologicals' Havrix® in Healthy Adult Subjects Vaccinated at Infancy Under the Hepatitis A Universal Mass Vaccination (UMV) Program in Israel
Start: May 7, 2018
NCT03207958
Belimumab for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation
Start: May 16, 2018
Completion: Feb 9, 2024
NCT03485365
A Safety, Tolerability, Pharmacokinetics (PK) and Target Engagement (TE) Study of GSK3858279 in Healthy Participants and Evaluation of the Efficacy of Repeat Doses in Participants With Osteoarthritis (OA)
Start: May 17, 2018
Completion: Sep 12, 2022
NCT03555890
Bioequivalence Study Between Levocetirizine Oral Disintegrating Tablet (ODT) and Levocetirizine Immediate Release Tablet (IRT)
Start: May 18, 2018
NCT03188458
Immunogenicity of a Single Dose of GSK Biologicals' Boostrix™ in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, Colombia
Start: May 29, 2018
NCT03329573
Bioequivalence Study of Paroxetine Immediate Release (IR) Tablets Manufactured in GlaxoSmithKline Tianjin (GSKT) and Mississauga Sites in Healthy Chinese Subjects
Start: May 30, 2018
Completion: Aug 3, 2018
NCT03438006
A Post Marketing Surveillance (PMS) Study to Monitor the Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Female Chinese Subjects
Start: May 31, 2018
Completion: Dec 3, 2020
NCT03543176
Chronic Obstructive Pulmonary Disease (COPD) Dual Therapy Burden of Illness
Completion: Aug 21, 2019
NCT02671188
A Study to Evaluate the Safety, Mode of Action and Clinical Efficacy of GSK3050002 in Subjects With Psoriatic Arthritis
Start: Jun 1, 2018
NCT03563183
A Study to Assess Frailty of Subjects During ZOSTER-006 and ZOSTER-022
Start: Jun 5, 2018
NCT03518242
Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast Cancer
Start: Jun 6, 2018
Completion: May 4, 2022
NCT03212690
Study of Renin-angiotensin System in Mechanically Ventilated Subjects
Start: Jun 11, 2018
NCT03503474
COMBACTE-CDI Understanding the Burden of C. Difficile Infection
Completion: Sep 30, 2019
NCT03501420
Adelphi Primary Sjogren's Syndrome (pSS) Disease Specific Programme (DSP)
Start: Jun 13, 2018
Completion: Oct 30, 2018
NCT03562117
Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function
Start: Jun 14, 2018
Completion: Dec 26, 2018
NCT03478657
An Open-label Study to Evaluate Correct Use and Ease of Use of the ELLIPTA DPI in Pediatric Subjects With Asthma
Start: Jun 18, 2018
Completion: Dec 7, 2018
NCT03525678
A Study to Investigate the Efficacy and Safety of Two Doses of GSK2857916 in Participants With Multiple Myeloma Who Have Failed Prior Treatment With an Anti-CD38 Antibody
Completion: Sep 12, 2024
NCT03541044
A Bioequivalence Study of Two Nicotine Lozenges in Fasting Conditions in Healthy Smokers
Completion: Mar 24, 2019
NCT03543137
To Assess the Bioequivalence of the 4mg Prototype Mini Nicotine Lozenge to the Reference Product (Nicorette) in Healthy Smokers
NCT03478683
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Start: Jun 25, 2018
Completion: Mar 14, 2019
NCT03478696
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Completion: Mar 18, 2019
NCT03511105
Effects of GSK2798745 on Alveolar Barrier Disruption in a Segmental Lipopolysaccharide (LPS) Challenge Model
Completion: Dec 18, 2018
NCT03557060
NUCALA® Special Drug Use Investigation (EGPA, Long-term)
Completion: May 31, 2024
NCT03004807
Role of Centrum® Silver® in Improving Micronutrient Status in Older Men
Start: Jul 1, 2018
Completion: Dec 31, 2021
NCT03587207
Study to Assess Potential Immune Interference When GlaxoSmithKline (GSK) Biologicals' MenABCWY Vaccine is Administered to Healthy Subjects Aged 10-25 Years
Start: Jul 9, 2018
Completion: Dec 19, 2018
NCT03567499
Pro-arrhythmic Potential of GSK3039294 in Healthy Subjects
Start: Jul 12, 2018
Completion: May 3, 2019
NCT03497039
A Study to Characterize Diclofenac's Plasma and Knee Exposure After Application of Diclofenac Gel to the Knee of Subjects With Osteoarthritis That Have a Scheduled Arthroplasty
Start: Jul 19, 2018
NCT03590613
Phase I Study of GSK2982772 in Japanese Healthy Male Participants
Completion: Sep 26, 2018
NCT03543150
BOTOX® Drug Use Investigation (Spasmodic Dysphonia)
Start: Jul 20, 2018
Completion: Feb 28, 2022
NCT03357341
Sensor and Electronic Health Records (EHR) Integration Pilot Study
Start: Jul 23, 2018
Completion: Sep 27, 2019
NCT03568942
Pharmacokinetic Study of Oral Gepotidacin (GSK2140944) in Subjects With Uncomplicated Urinary Tract Infection (Acute Cystitis)
Completion: Jan 7, 2019
NCT03621670
Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants
Start: Jul 27, 2018
Completion: Dec 27, 2024
NCT03244059
Belimumab Treatment of Emphysema Patients With Anti-GRP78 Autoantibodies
Start: Aug 9, 2018
Completion: Apr 1, 2022
NCT03207347
A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)
Start: Aug 13, 2018
Completion: Aug 30, 2022
NCT03629886
Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study
Start: Aug 22, 2018
NCT03527173
A Study to Evaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection With Shigella Sonnei in Healthy Adults
Start: Aug 29, 2018
Completion: Nov 11, 2019
NCT03562195
A Safety and Efficacy Study of Mepolizumab in Subjects With Severe Asthma
Completion: Sep 7, 2022
NCT03433482
A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age
Start: Aug 30, 2018
Completion: Dec 17, 2019
NCT03627494
First Time in Human (FTIH) Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single and Repeat Doses of GSK3439171A in Healthy Subjects and to Assess Food Effect
Completion: Aug 26, 2019
NCT03400033
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD)
Start: Sep 5, 2018
Completion: Jun 19, 2020
NCT03652610
A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adults 18 to 40 Years of Age
Start: Sep 7, 2018
Completion: Jun 11, 2019
NCT03544281
To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
Start: Sep 20, 2018
Completion: Feb 28, 2024
NCT03595930
Post-marketing Surveillance (PMS) Study to Observe the Safety and Effectiveness of ARNUITY in Asthma Subjects in a Real World Setting
Start: Sep 21, 2018
Completion: Jul 22, 2020
NCT02588326
Sensitivity of Pharmacokinetics to Differences in Particle Size Distribution of Suspension-based Nasal Sprays
Completion: Apr 16, 2021
NCT03649412
A Study to Investigate the Pharmacokinetics (PK) of Modified Release (MR) Prototype Coated Tablet Formulations of GSK2982772
Start: Sep 26, 2018
NCT03361774
A Clinical Method Development Study to Characterise The Efficacy of a Dentifrice For The Relief Of Dentin Hypersensitivity
Start: Oct 1, 2018
Completion: Dec 3, 2018
NCT03747159
Synergetic B-cell Immunomodulation in SLE - 2nd Study.
Completion: Jun 7, 2026
NCT03671369
A Post-marketing Surveillance Study to Assess the Safety of Cervarix (GlaxoSmithKline [GSK] Biologicals' Human Papillomavirus [HPV] -16/18 Vaccine), When Administered According to the Approved Prescribing Information (PI) in Korea
Start: Oct 2, 2018
Completion: Dec 1, 2020
NCT03816189
Role of Eosinophil in Fibrogenesis of Systemic Sclerosis
Start: Oct 3, 2018
NCT03688620
Enhanced Safety Surveillance of GlaxoSmithKline's (GSK's) Quadrivalent Seasonal Influenza Vaccines During the 2018/19 Influenza Season
Start: Oct 5, 2018
NCT03640832
A Clinical Study to Investigate the Dermal and Ocular Tolerance of a Developmental Cosmetic Facial Serum Formulation in Healthy Females With Sensitive Skin
Start: Oct 15, 2018
NCT03614728
Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
Start: Oct 16, 2018
Completion: Jan 11, 2022
NCT03666988
First Time in Humans (FTIH) Study of GSK3368715 in Participants With Solid Tumors and Diffuse Large B-cell Lymphoma (DLBCL)
Start: Oct 22, 2018
Completion: Mar 4, 2021
NCT03674177
A Study to Evaluate Different Dose Levels of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3888550A), Based on the Vaccine Safety and the Antibodies (Body Defences) Produced Following Vaccine Administration, When Given to Healthy Non-pregnant Women
Start: Oct 30, 2018
NCT04585997
"Comparing Treatment Efficacy With Mepolizumab and Omalizumab in Severe Asthma - Choosebetweenamab."
Start: Nov 3, 2018
NCT03681951
First-time-in-human (FTIH) Study of GSK3145095 Alone and in Combination With Other Anticancer Agents in Adults With Advanced Solid Tumors
Start: Nov 16, 2018
Completion: Aug 13, 2019
NCT03281291
Study to Assess the Vaccine Efficacy Against Malaria Infection, in Children Immunized With the Primary and Yearly Booster of the RTS,S/AS01E Vaccine, as Part of Their Participation in the Malaria-094 (204889/NCT03276962) Study.
Start: Nov 19, 2018
Completion: Oct 23, 2023
NCT03598270
Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer
Start: Nov 21, 2018
Completion: Aug 5, 2024
NCT03693612
GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors
Start: Nov 26, 2018
Completion: Sep 16, 2021
NCT03715478
Multi-Center Study of GSK2857916 in Combination With Pomalidomide and Dex
NCT03699241
A Randomized, Double-blinded, Placebo-controlled, Dose-escalation Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV Envelope Protein BG505 SOSIP.664 gp140 Vaccine, Adjuvanted, in Healthy, HIV-1 Uninfected Adults
Start: Dec 3, 2018
Completion: Jul 11, 2023
NCT03709706
Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab
Start: Dec 31, 2018
Completion: Nov 4, 2022
NCT03709810
A Study to Investigate Food Occlusion Efficacy of a Denture Adhesive in Denture Wearers
Start: Jan 7, 2019
NCT03446612
Anemia Study in Chronic Kidney Disease (CKD) : Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat -Forearm Blood Flow (ASCEND-FBF)
Start: Jan 10, 2019
NCT03376932
Effectiveness of Fluticasone Furoate/ Umeclidinium/ Vilanterol (FF/UMEC/VI) Using the Connected Inhaler System (CIS) as Compared With Fluticasone Proprionate/ Salmeterol (FP/SAL) Plus Tiotropium (TIO) in Inadequately Controlled Asthma
Start: Jan 18, 2019
Completion: Feb 3, 2021
NCT03707678
A Safety and Efficacy Study of Intranasal GSK2245035 in Adults With Allergic Asthma
Start: Jan 21, 2019
Completion: Dec 23, 2019
NCT03814590
A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults
NCT03804710
To Evaluate the Effect of Moisturizing Creams on Skin Barrier Function
Start: Jan 22, 2019
Completion: Apr 16, 2019
NCT03739710
Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC)
Start: Jan 24, 2019
Completion: May 2, 2024
NCT03803202
A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal Vaccine
Completion: Sep 28, 2020
NCT05553808
Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 1
Completion: Sep 23, 2021
NCT03654833
Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma
Start: Jan 28, 2019
Completion: Oct 31, 2023
NCT03771157
Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors
Start: Feb 1, 2019
Completion: Aug 3, 2022
NCT03967925
Rituximab and Belimumab Combination Therapy in PR3 Vasculitis
Completion: Nov 30, 2023
NCT03807700
To Evaluate Oral Health and Quality of Life Associated With Use of a Denture Adhesive
Start: Feb 4, 2019
Completion: May 4, 2019
NCT03824236
A Study to Evaluate the Efficacy, Immunogenicity and Safety in a Sporozoite Challenge Model of a Fractional Booster Dose of GSK Biologicals' Candidate Malaria Vaccine Administered to Previously Vaccinated Healthy Malaria-naïve Adults
Start: Feb 5, 2019
Completion: Sep 26, 2019
NCT03973905
Effectiveness of Maternal Immunization With Boostrix at Preventing Pertussis Among Infants <2 Months Old in the United States
Start: Feb 15, 2019
NCT03782753
Molecular Pathology and Neuronal Networks in LRRK2 Parkinson's Disease
Completion: Jun 23, 2023
NCT02141204
Immunogenicity, Reactogenicity and Safety Study of Two Different Formulations of GSK Biologicals' Human Rotavirus Vaccine, Rotarix, in Healthy Infants
Start: Feb 20, 2019
Completion: Dec 28, 2019
NCT03681067
A Clinical Trial of Antibody GSK1070806 in the Treatment of Patients With Moderate to Severe Crohn's Disease
NCT03697824
Clinical Trial of Safety, Tolerability and Antitumor Activity of Genetically Engineered T Cells in Combination With Anti-Cancer Agents in Relapsed and Refractory Synovial Sarcoma Expressing New York Esophageal Antigen-1 (NY-ESO-1) and/or LAGE-1a
Start: Feb 25, 2019
Completion: Jul 18, 2022
NCT03843359
A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors
Start: Mar 12, 2019
Completion: Mar 31, 2025
NCT03919591
RSV Study in Adults 60 to 75 Years of Age
Completion: Jul 11, 2019
NCT03828292
An Open-label, Dose Escalation Study in Japanese Participants With Relapsed/Refractory Multiple Myeloma Who Have Failed Prior Anti Myeloma Treatments
Start: Mar 14, 2019
Completion: Sep 5, 2024
NCT03848845
Study Evaluating Safety, Tolerability and Clinical Activity of GSK2857916 in Combination With Pembrolizumab in Subjects With Relapsed/Refractory Multiple Myeloma (RRMM)
Completion: Jun 14, 2023
NCT03656380
Mepo for Eosinophilic Esophagitis (EoE) Study
Start: Mar 20, 2019
Completion: Dec 9, 2022
NCT03855995
A Study Assessing the Safety, Efficacy, and Impact of GlaxoSmithKline Biologicals' RTS, S/AS01E Malaria Vaccine in Young Children Across Sub-Saharan Africa
Start: Mar 21, 2019
Completion: Aug 11, 2025
NCT03557281
An Early Bactericidal Activity, Safety and Tolerability of GSK3036656 in Subjects With Drug-sensitive Pulmonary Tuberculosis
Start: Mar 22, 2019
Completion: Dec 14, 2021
NCT03866187
Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection
Start: Mar 28, 2019
Completion: Oct 7, 2024
NCT03732703
Myeloma-Developing Regimens Using Genomics (MyDRUG)
Start: Apr 1, 2019
NCT03889054
Effect of Education and Respiratory Rehabilitation on Quality of Life in COPD Patients
Completion: May 1, 2020
NCT03636906
Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV
Start: Apr 8, 2019
NCT03826108
ARTHR-IS (Arthroplasties' Infections Due to Staphylococcus Aureus)
Start: Apr 16, 2019
NCT03703245
Pooled Analysis of Clinical Data From Six GSK Studies to Investigate the Efficacy of a Dentifrice Containing 67% Weight by Weight (w/w) Sodium Bicarbonate on Gingivitis and Plaque Accumulation
Start: Apr 17, 2019
NCT03894969
Study to Assess the Immunogenicity and Safety of GSK's Investigational Vaccine (GSK3277511A) When Given to Healthy Smokers and Ex-smokers After Administration of Shingrix Vaccine
Start: Apr 23, 2019
Completion: Aug 13, 2021
NCT03797404
Airway Remodeling During Mepolizumab Treatment
Start: Apr 24, 2019
Completion: Jun 21, 2022
NCT03874234
Safety, Tolerability and Pharmacokinetics (PKs) Investigation of GSK3186899 in Healthy Subjects
Start: Apr 30, 2019
Completion: Oct 17, 2019
NCT03893565
Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative Colitis
Start: May 6, 2019
Completion: May 17, 2021
NCT03943095
Study to Characterize the Efficacy of a Dual Active Dentifrice for the Relief of Dentin Hypersensitivity
Start: May 13, 2019
Completion: Aug 28, 2019
NCT03984253
Swiss Severe Asthma Register
Completion: Feb 28, 2034
NCT03591380
CAMPath and BELimumab for Transplant Tolerance in Sensitized Kidney Transplant Recipients
Start: May 14, 2019
Completion: Dec 3, 2021
NCT03980483
Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Start: May 16, 2019
Completion: Aug 16, 2022
NCT03614676
A Study of Outcomes and Events of Interest in Pregnant Women, Neonates and Infants and of RSV Surveillance
Start: May 30, 2019
Completion: Jul 27, 2021
NCT03018808
Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and Eosinophilia Among Primary Care Patients
Start: Jun 3, 2019
Completion: Oct 4, 2021
NCT03970837
Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)
Start: Jun 5, 2019
Completion: Jan 18, 2023
NCT03965533
Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2831781 After an Intravenous (IV) Dose in Healthy Japanese and Caucasian Subjects, and a Subcutaneous (SC) Dose in Healthy Caucasian Subjects
Start: Jun 10, 2019
Completion: Dec 10, 2019
NCT03957577
Etiology of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) in Japan
Start: Jun 13, 2019
Completion: Jun 30, 2022
NCT04063306
Quality of Life of Taiwan People Living With HIV
Start: Jun 20, 2019
Completion: Dec 20, 2020
NCT03949842
Legend: TRELEGY Real World Chronic Obstructive Pulmonary Disease (COPD) Effectiveness Study
Start: Jun 27, 2019
Completion: Nov 30, 2022
NCT05779384
The COPD Attack Study
Start: Jul 7, 2019
NCT03809910
Dental Plaque Removal Ability of Prototype Power Toothbrush Versus a Manual Toothbrush in Healthy Participants
Start: Jul 8, 2019
NCT03992014
Pharmacokinetics (PKs) and Metabolism of Radiolabelled Linerixibat
NCT03840967
A Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma
Start: Jul 9, 2019
Completion: Feb 22, 2023
NCT03644342
Study of Niraparib With Radiotherapy for Treatment of Metastatic Invasive Carcinoma of the Cervix
Start: Jul 15, 2019
Completion: Sep 27, 2023
NCT03954743
Safety Study of 2 Formulations of GSK's Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks
Start: Jul 19, 2019
NCT03844061
Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis
Start: Jul 29, 2019
Completion: Jun 30, 2026
NCT03457701
Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe)
Start: Jul 30, 2019
Completion: Jul 5, 2022
NCT03494881
Mepolizumab for the Treatment of Chronic Spontaneous Urticaria
Completion: Feb 25, 2025
NCT04650503
Follow-up of Mild Eosinophilic Asthma
Start: Aug 1, 2019
NCT04026009
Safety and Immunogenicity Study of GSK's Clostridium Difficile Vaccine 2904545A When Administered in Healthy Adults Aged 18-45 Years and 50-70 Years
Start: Aug 5, 2019
Completion: May 10, 2022
NCT04062669
A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Experimental Rabies Vaccine in Healthy Adults
Start: Aug 13, 2019
Completion: Jul 1, 2022
NCT04053023
Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Subjects
Start: Aug 27, 2019
NCT04006795
A Photoxicity and Photoallergy Study of a Developmental Face Cream, Serum and Lotion
Start: Aug 28, 2019
Completion: Oct 11, 2019
NCT04007159
To Evaluate Skin Irritation and Skin Sensitisation of Developmental Cosmetic Facial Products
Start: Aug 30, 2019
Completion: Nov 29, 2019
NCT04079790
Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents Subjects
Start: Sep 4, 2019
NCT03750734
Target Validation and Discovery in Idiopathic Bronchiectasis
Start: Sep 10, 2019
Completion: Aug 9, 2021
NCT04091451
Safety and Immunogenicity Study of GlaxoSmithKline's Herpes Zoster Subunit Vaccine (HZ/su) When Given on a Two-dose Schedule to Adults at Least 50 Years of Age (YOA) With a Prior Episode of Herpes Zoster
Start: Sep 17, 2019
Completion: Feb 15, 2024
NCT04090658
A Study to Test GlaxoSmithKline's (GSK) Respiratory Syncytial Virus RSV Candidate Vaccine's Safety and Immune Response in Japanese Older Adults
Start: Sep 25, 2019
Completion: Dec 11, 2020
NCT02964507
Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer
Start: Sep 26, 2019
Completion: Jul 19, 2021
NCT03987295
A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2)
Start: Sep 27, 2019
Completion: Jun 5, 2024
NCT04025684
Efficacy of Manual Toothbrushes in Removing Dental Plaque
Start: Sep 30, 2019
NCT04095286
Relative Bioavailability Study of Marketed and Lower Dose Ambrisentan in Healthy Adult Participants
NCT04050722
A Clinical Study Investigating the Efficacy of a Stannous Fluoride Dentifrice in Improving Gingival Health After Twice Daily Use for 3 Weeks
Start: Oct 7, 2019
Completion: Nov 13, 2019
NCT04126200
Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
Completion: Feb 12, 2029
NCT06160609
Platform Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With aOX40 (GSK3174998) in Participants With RRMM
Completion: Jan 9, 2023
NCT03425201
Niraparib in Combination with Cabozantinib (XL184) in Patients with Advanced Urothelial Cancer (NICARAGUA)
Start: Oct 14, 2019
Completion: Jul 31, 2024
NCT04114656
Effects of Intravenous GSK3858279 on a Battery of Evoked Pain Tests in Healthy Volunteers
Start: Oct 15, 2019
NCT03983993
Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer
Completion: Oct 31, 2025
NCT04020341
A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI)
Start: Oct 17, 2019
NCT04010539
A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea
Start: Oct 21, 2019
Completion: Oct 10, 2023
NCT04052620
Voltaren Emulgel 2% Acute Ankle Sprain Non Inferiority Study
Start: Oct 24, 2019
Completion: Nov 12, 2020
NCT04006808
A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant
Start: Oct 25, 2019
Completion: Mar 31, 2027
NCT04136145
Single Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy Subjects
Start: Oct 28, 2019
Completion: Jan 14, 2020
NCT04133909
Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level
Start: Oct 30, 2019
Completion: Aug 8, 2024
NCT04134728
Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors
Start: Oct 31, 2019
Completion: Feb 1, 2022
NCT04126213
Study of Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline's (GSK)Respiratory Syncytial Virus (RSV)Maternal Unadjuvanted Vaccine in Healthy Pregnant Women (Aged 18 to 40 Years) and Their Infants
Start: Nov 5, 2019
Completion: May 14, 2021
NCT04138056
A Study of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Diphtheria, Pertussis and Tetanus (Tdap) Viruses Followed by a 2nd Dose of the RSV Vaccine to Healthy Non-Pregnant Women
Completion: Nov 22, 2021
NCT04021290
Regimen Switch to Dolutegravir/Lamivudine Fixed Dose Combination From Current Antiretroviral Regimen in HIV-1 Infected and Virologically Suppressed Adults (SALSA)
Start: Nov 11, 2019
Completion: Sep 9, 2022
NCT04128696
Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 (PD-L1) Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Start: Nov 21, 2019
Completion: Jun 20, 2023
NCT07217119
Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Feladilimab (GSK3359609) in Participants With RRMM
Start: Nov 26, 2019
Completion: Mar 11, 2027
NCT04179032
Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)
Start: Nov 28, 2019
Completion: Apr 26, 2027
NCT04138043
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of GSK2330811 in Healthy Japanese Participants
Start: Dec 5, 2019
Completion: May 28, 2020
NCT04176939
A Study to Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the Vaccine Are Safe and Able to Generate an Immune Response
Start: Dec 9, 2019
Completion: Jun 27, 2024
NCT04177823
A Study of Belantamab Mafodotin to Investigate Safety, Tolerability, Pharmacokinetics, Immunogenicity and Clinical Activity in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
Completion: Dec 30, 2021
NCT04091126
Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma
Start: Dec 18, 2019
NCT03680508
TSR-022 (anti-TIM-3 Antibody) and TSR-042 (anti-PD-1 Antibody) in Patients with Liver Cancer
Start: Dec 19, 2019
Completion: Oct 31, 2027
NCT04318535
Bioequivalence (BE) Study of Test Griseofulvin 500 Milligram (mg) Tablets Versus Reference and Dose Proportionality Study of Test Griseofulvin 250 mg and 500 mg Tablets Under Fed Conditions
Start: Jan 13, 2020
Completion: Feb 6, 2020
NCT04237896
Compliance With Clinical Guidelines and Effect on Patient Outcome of Treatment of Hospitalised Exacerbations of COPD
Start: Jan 27, 2020
Completion: Aug 30, 2020
NCT04295733
Safety, Tolerability and Immunogenicity of 4CMenB Vaccine(2 Doses) in Adults With an Immunodeficiency
Start: Feb 6, 2020
Completion: Jan 11, 2024
NCT03984799
Interleukin-5 Receptor Expression in COPD
Start: Feb 21, 2020
Completion: Apr 30, 2022
NCT04267939
ATR Inhibitor Elimusertib (BAY1895344) Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer
Start: Feb 26, 2020
Completion: Dec 1, 2023
NCT03949855
Belimumab With Rituximab for Primary Membranous Nephropathy
Start: Mar 6, 2020
NCT04162210
Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
Start: Apr 2, 2020
Completion: Jul 1, 2026
NCT04853225
Investigation of Chronic Obstructive Pulmonary Disease (COPD) Phenotypes and Endotypes in China
Start: Apr 22, 2020
Completion: Jun 25, 2024
NCT04187144
Comparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicated Urinary Tract Infection (UTI)
Start: Apr 23, 2020
Completion: Dec 1, 2022
NCT04512521
Functional Lung MRI for Early Treatment Response Assessment for Patients With Eosinophilic Asthma
Start: May 4, 2020
Completion: Aug 31, 2025
NCT04246047
Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Start: May 7, 2020
Completion: Jun 19, 2026
NCT04333147
Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA)
Start: May 12, 2020
Completion: Feb 24, 2023
NCT04376684
Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease
Start: May 28, 2020
Completion: Aug 16, 2021
NCT07084896
Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat in Participants With RRMM
Start: Jun 8, 2020
NCT04240106
Niraparib Plus Aromatase Inhibitors for Luminal-like(HER2-,ER+) and gBRCA or HDR+ Metastatic Breast Cancer (LUZERN)
Start: Jun 15, 2020
Completion: Nov 17, 2023
NCT04446351
Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid Tumors
Start: Jun 25, 2020
NCT04449419
Mitoquines in COPD
Start: Jul 1, 2020
Completion: Jun 1, 2021
NCT04617470
Niraparib as Maintenance Treatment in Platinum Responsive Ovarian Cancer Patients: a Real Life Study
Start: Jul 8, 2020
Completion: Jan 1, 2022
NCT04167358
Linerixibat Long-term Safety, and Tolerability Study
Start: Jul 14, 2020
Completion: Aug 31, 2027
NCT04366349
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Melrilimab (GSK3772847) in Healthy Participants
Start: Jul 21, 2020
Completion: Dec 21, 2020
NCT04374136
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)
Start: Jul 23, 2020
Completion: Aug 3, 2027
NCT04449029
A Study of GSK3228836 in Participants With Chronic Hepatitis B (CHB)
Start: Jul 27, 2020
Completion: Mar 18, 2022
NCT04224701
A Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Protein BG505 SOSIP.GT1.1 Gp140 Vaccine, Adjuvanted in Healthy, HIV-uninfected Adults
Start: Aug 1, 2020
Completion: Aug 2, 2023
NCT04501978
ACTIV-3: Therapeutics for Inpatients With COVID-19
Start: Aug 4, 2020
Completion: Jul 14, 2023
NCT04428333
Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Start: Aug 12, 2020
Completion: Sep 19, 2023
NCT04493931
Drug-drug Interaction Study of Gepotidacin
Start: Aug 14, 2020
NCT04502693
Effectiveness of GlaxoSmithKline Biologicals S.A's Meningococcal Group B and Combined ABCWY Vaccines in Healthy Adolescents and Young Adults
Completion: Sep 13, 2022
NCT04488770
Safety, Tolerability and Pharmacokinetic Investigation of GSK3882347 in Healthy Participants.
Start: Aug 24, 2020
NCT04341181
ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling
Completion: Apr 30, 2030
NCT04502602
Niraparib and Neratinib in Advanced Solid Tumors With Expansion Cohort in Advanced Ovarian Cancer
Completion: May 31, 2029
NCT04318548
Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine When Administered Concomitantly With GSK Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age
Start: Aug 25, 2020
Completion: Nov 21, 2023
NCT04545060
VIR-7831 for the Early Treatment of COVID-19 in Outpatients
Start: Aug 27, 2020
Completion: Sep 2, 2021
NCT04537208
Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older
Start: Sep 3, 2020
Completion: Nov 19, 2021
NCT04292912
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema
Start: Sep 7, 2020
Completion: Apr 11, 2022
NCT04075331
Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic Trial
Completion: Jun 21, 2024
NCT03543839
Trial of Belimumab in Early Lupus
Start: Sep 15, 2020
NCT04371380
Pharmacokinetic Study of Cabotegravir and Rilpivirine Long-acting Intramuscular Injections in Healthy Adult Participants
Start: Sep 16, 2020
Completion: Dec 26, 2021
NCT04316585
A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants
Start: Sep 28, 2020
NCT04504435
Safety, Tolerability and Pharmacokinetics (PK) Investigation of GSK3494245 in Healthy Participants
Start: Sep 29, 2020
NCT04484623
Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma
Start: Oct 1, 2020
Completion: Oct 25, 2029
NCT06811155
Non-Interventional Study to Describe the Clinical Management in Asthmatic Patients (NICMA)
Completion: Sep 30, 2021
NCT04473521
A Clinical Study to Assess Force Required to Dislodge Upper Denture With and Without Use of a Novel Denture Adhesive
Start: Oct 4, 2020
Completion: Jan 10, 2021
NCT04544956
A Mechanistic Study of GSK3228836 With Fine Needle Aspiration (FNA) in Participants With Chronic Hepatitis B
Start: Oct 6, 2020
NCT04398745
A Study of Belantamab Mafodotin Monotherapy in Multiple Myeloma Participants With Normal and Varying Degree of Impaired Renal Function
Start: Oct 9, 2020
NCT04557371
A Study to Assess the Local Cutaneous and Ocular Tolerance of Three Developmental Facial Skin-care Formulations.
Start: Oct 12, 2020
Completion: Dec 22, 2020
NCT04585009
Safety, Tolerability and Pharmacokinetics of GSK3923868 Inhalation Powder in Healthy Participants and Stable Asthmatics
Completion: Jun 16, 2022
NCT04349280
A Study to Evaluate the Efficacy and Safety of Bintrafusp Alfa (M7824) Monotherapy in Metastatic or Locally Advanced Urothelial Cancer
Start: Oct 15, 2020
NCT04475939
Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-Small Cell Lung Cancer
Start: Oct 26, 2020
Completion: Feb 6, 2026
NCT04634409
A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness
Start: Oct 29, 2020
Completion: Oct 18, 2021
NCT04472897
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of GSK2556286 in Healthy Adult Participants
Start: Oct 30, 2020
Completion: Nov 6, 2024
NCT04604795
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GSK3915393 in Healthy Participants and to Evaluate the Interaction Between GSK3915393 and Grapefruit Juice and Itraconazole
Start: Nov 4, 2020
Completion: Jun 29, 2021
NCT04313504
Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Recurrent/Metastatic HNSCC
Completion: Jun 1, 2025
NCT04661579
Study of Malaria Vaccine RTS,S/AS01E in Plasmodium Falciparum-infected and Uninfected Adults Pre-treated With Anti-malarial Therapy
Start: Nov 6, 2020
Completion: Aug 17, 2022
NCT04581824
Efficacy Comparison of Dostarlimab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Participants With Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)
Start: Nov 19, 2020
Completion: Sep 10, 2024
NCT04605159
A Phase III, Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated Mothers
Start: Nov 20, 2020
NCT04679064
Trial on NIraparib-TSR-042 (Dostarlimab) vs Physician's Choice CHEmotherapy in Recurrent, Ovarian, Fallopian Tube or Primary Peritoneal Cancer Patients Not Candidate for Platinum Retreatment
Start: Dec 1, 2020
Completion: Jan 1, 2025
NCT04606394
Peak Inspiratory Flow and Dry Powder Inhaler Performance in COPD
Start: Dec 2, 2020
Completion: Dec 15, 2021
NCT04655976
Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed on Prior Anti-PD-(L)1 Therapy and Chemotherapy
Start: Dec 8, 2020
Completion: Mar 30, 2027
NCT04311463
Bioequivalence Study of Paroxetine and PAXIL Under Fasting Conditions in Healthy Mexican Participants
Start: Dec 9, 2020
Completion: Jan 2, 2021
NCT04657198
Extension Study to Evaluate the Safety and Immunogenicity of a Revaccination Dose of the RSVPreF3 OA Investigational Vaccine in Adults 60 Years and Older Who Participated in the RSV OA=ADJ-002 Study
NCT04551989
Mepolizumab Long-term Study to Assess Real World Safety and Effectiveness of Eosinophilic Granulomatosis With Polyangiitis (EGPA) in Japan
Start: Dec 11, 2020
Completion: Apr 27, 2023
NCT04570306
Transcriptional and Immune Parameters of Response to Belimumab
Start: Dec 16, 2020
Completion: Dec 16, 2023
NCT05780281
VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
Completion: Oct 4, 2022
NCT04640311
Comparison of Daprodustat Formulations Produced by Two Methods of Manufacture for Bioequivalence and Dissolution in Healthy Participants
Start: Dec 18, 2020
Completion: May 18, 2021
NCT04584255
Niraparib + Dostarlimab In BRCA Mutated Breast Cancer
Completion: Jul 17, 2029
NCT04549363
Characterization of Corneal Epithelial Changes in Participants Treated With Belantamab Mafodotin
Start: Dec 21, 2020
Completion: Nov 21, 2022
NCT04260282
Microbiome and Exacerbations in Neutrophilic Asthma
Start: Jan 1, 2021
NCT05441059
Use of Nucala in Severe Asthma
Completion: May 1, 2022
NCT04657211
Triple Therapy in Chronic Obstructive Pulmonary Disease (COPD) Participants
Start: Jan 14, 2021
Completion: Jul 1, 2024
NCT04727294
MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey
Start: Jan 22, 2021
NCT04707391
Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine
Start: Jan 25, 2021
Completion: Sep 29, 2023
NCT04718389
A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype
Start: Jan 26, 2021
Completion: Sep 14, 2025
NCT04676724
Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB)
Start: Jan 28, 2021
Completion: Feb 17, 2023
NCT04750343
Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With or Without AS03 (COVID-19)
Start: Feb 3, 2021
NCT04718103
A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype
Start: Feb 4, 2021
Completion: Apr 11, 2024
NCT04732650
Real World Difference After Changing Medication From Nonselective to Selective Endothelin Receptor Antagonist in Stable Eisenmenger Syndrome
NCT04737538
A Proof-of-principle Clinical Study Investigating the Efficacy of an Experimental Dentifrice Containing Sodium Bicarbonate and Sodium Hyaluronate on Gingivitis
Start: Feb 10, 2021
Completion: Jul 28, 2021
NCT04732871
Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above
Start: Feb 15, 2021
Completion: May 25, 2026
NCT04758962
A Study of the Safety of and Immune Response to Varying Doses of a Vaccine Against COVID-19 in Healthy Adults
Completion: Apr 19, 2022
NCT06239441
Effectiveness of Anti-IL-5/IL5R Inhibitors
Start: Feb 16, 2021
Completion: Nov 29, 2023
NCT04779879
Safety, Tolerability and Pharmacokinetics of Second Generation VIR-7831 Material in Non-hospitalized Participants With Mild to Moderate COVID-19
Start: Feb 18, 2021
Completion: Apr 6, 2022
NCT04870333
PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V
Start: Feb 19, 2021
Completion: Apr 16, 2025
NCT03960255
Effect of Adiposity and Associated Local Microbial Factors on Healing and Progression of Diabetic Foot Ulcers
Start: Feb 20, 2021
Completion: May 20, 2023
NCT04808037
Blmf, Lenalidomide and Dexamethasone in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
Start: Feb 22, 2021
Completion: Nov 8, 2028
NCT04762680
Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and Older
Start: Feb 24, 2021
Completion: Jun 29, 2023
NCT04617925
A Study of Belantamab Mafodotin in Patients With Relapsed or Refractory AL Amyloidosis
Start: Feb 26, 2021
Completion: Jul 17, 2025
NCT04676763
Substance P Challenge in Healthy Participants
Start: Mar 2, 2021
Completion: Jul 21, 2021
NCT04762511
A Study on the Reactogenicity, Safety and Immune Response of a Vaccine Against Herpes Simplex Virus (HSV)-2 in Healthy Participants Aged 18-40 Years
Completion: May 26, 2021
NCT04749459
Sun Protection Factor (SPF) Determination of Two Sunscreen-Containing Lip Balms
Start: Mar 3, 2021
Completion: Mar 31, 2021
NCT06790303
Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 2
Start: Mar 4, 2021
NCT06655818
Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Dostarlimab (GSK4057190) in Participants With RRMM
Start: Mar 9, 2021
Completion: Feb 14, 2024
NCT04789577
A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine GSK3206641A Administered in Adults 18 to 64 Years of Age and 65 Years of Age and Older
Start: Mar 16, 2021
NCT05001087
"A Physician & Patient-powered Cohort Registry (MY MYELOMA)"
NCT04719832
Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype
Start: Mar 17, 2021
NCT04670627
Biomarkers in Nasal Samples of Seasonal Allergic Rhinitics
Start: Mar 22, 2021
NCT04641741
Effect of Mepolizumab on Severe Eosinophilic Asthma
Start: Apr 1, 2021
Completion: Mar 1, 2025
NCT04151225
Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease
Start: Apr 5, 2021
Completion: May 26, 2025
NCT04802356
Belantamab Mafodotin in Newly Diagnosed Transplant Eligible Multiple Myeloma Patients
Start: Apr 7, 2021
Completion: Jul 31, 2025
NCT04813354
A Comparison of Critical Errors, Overall Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA Versus BREEZHALER Dry Powder Inhalers (DPIs) in Adult Participants With Asthma
Start: Apr 14, 2021
Completion: Jul 8, 2021
NCT04641247
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Start: Apr 16, 2021
Completion: Nov 13, 2026
NCT04398680
A Study of Belantamab Mafodotin in Multiple Myeloma Participants With Normal and Impaired Hepatic Function
Start: Apr 20, 2021
Completion: Oct 13, 2025
NCT04607005
Efficacy and Safety of Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)/ Eosinophilic Chronic Rhinosinusitis (ECRS)
Start: Apr 22, 2021
Completion: Apr 12, 2023
NCT04841577
A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 60 Years and Above
Start: Apr 27, 2021
Completion: Feb 8, 2022
NCT04853238
Chronic Obstructive Pulmonary Disease (COPD) Maintenance Treatment Patterns in China
Completion: Feb 6, 2023
NCT03975361
Autoreactivity Threshold Analysis in Lupus and Immune Thrombocytopenia (Checkpoints ITP and SLE)
Start: Apr 29, 2021
Completion: Apr 29, 2022
NCT04714567
Portuguese Severe Asthma Registry: Getting Answers for Severe Asthma Patients
Start: May 1, 2021
NCT04869982
Efficacy, Immunogenicity and Safety Study of GSKs Recombinant Zoster Vaccine Shingrix (GSK1437173A) in Chinese Adults Aged ≥50 Years
Start: May 14, 2021
NCT04723446
Efficacy of Mouthwashes in Reducing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Saliva
Start: May 19, 2021
NCT04822337
Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma
Completion: Nov 30, 2032
NCT04655508
Efficacy of Fluticasone Propionate Associated With Salmeterol Using Inhalation Chamber Versus Placebo to Improve the Respiratory Function in Children Over Six Years of Age Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation With a Decline of FEV1 ≥10% From Pre Transplantation
Start: May 21, 2021
NCT04772053
Molecular Disease Characterization Initiative (MDCI)
Start: May 25, 2021
Completion: Nov 15, 2022
NCT04886596
Efficacy Study of GSK's Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above
NCT04535037
A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers
Start: May 26, 2021
Completion: Jul 25, 2022
NCT04680468
Study of Belantamab Mafodotin as Pre- and Post-autologous Stem Cell Transplant and Maintenance for Multiple Myeloma
Start: Jun 2, 2021
Completion: Jul 11, 2026
NCT04481113
Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer
Start: Jun 7, 2021
Completion: Dec 30, 2025
NCT04676516
A Phase II Window of Opportunity Trial of PRMT5 Inhibitor, GSK3326595, in Early Stage Breast Cancer
Start: Jun 8, 2021
NCT04950712
An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.
Start: Jun 9, 2021
Completion: Mar 14, 2024
NCT04913675
Intramuscular and Intravenous VIR-7831 (Sotrovimab) for Mild/Moderate COVID-19.
Start: Jun 10, 2021
Completion: Mar 24, 2023
NCT04886154
A Study on the Safety, Effectiveness and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Adolescents and Adults
Start: Jun 14, 2021
Completion: Feb 2, 2024
NCT04915755
Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease
Start: Jun 28, 2021
NCT04276233
Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Greater Than or Equal to (>=) 18 Years With Severe Eosinophilic Asthma
Start: Jun 29, 2021
Completion: Oct 28, 2023
NCT04676360
Belantamab Mafodotin In Plasmablastic Lymphoma & ALK+ Large B-Cell Lymphoma
Start: Jul 1, 2021
Completion: Nov 26, 2024
NCT04808973
DTG Plus 3TC for Prophylaxis of Mother-to-child Transmission of HIV Infection in Pregnant Women
Completion: Sep 10, 2023
NCT04959344
Safety and Immunogenicity of a Klebsiella Pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V)
Start: Jul 5, 2021
Completion: Sep 26, 2022
NCT04578171
Residual Exacerbations With Mepolizumab
Start: Jul 6, 2021
NCT04988152
A Study to Investigate the PK, Safety, and Tolerability of Sotrovimab vs Placebo Administered IV or IM in Japanese and Caucasian Participants
Completion: Dec 7, 2021
NCT04544995
Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP)
Start: Jul 19, 2021
Completion: Apr 23, 2025
NCT06868654
China Subpopulation: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Start: Jul 28, 2021
NCT06868667
Japan Expansion Cohort: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
NCT04937387
Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With Inadequately Controlled Asthma
Start: Jul 29, 2021
NCT07217184
Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Isatuximab in Participants With RRMM
NCT04924478
Evaluation of Volatile Organic Compounds in Mepolizumab Therapy
Start: Jul 31, 2021
NCT04961060
Drivers of Eosinophilic COPD Exacerbations
Completion: Jan 31, 2025
NCT04980391
A Study on the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers
Start: Aug 3, 2021
NCT04950127
Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)
Start: Aug 27, 2021
Completion: Dec 20, 2024
NCT05007951
Immunogenicity and Safety Study of SK SARS-CoV-2 Recombinant Nanoparticle Vaccine (GBP510) Adjuvanted With AS03 (COVID-19)
Start: Aug 30, 2021
Completion: Oct 2, 2023
NCT05060432
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
Start: Sep 6, 2021
NCT04971928
Phase 1 Study of GSK3228836 Pharmacokinetics in Participants With Hepatic Impairment
Start: Sep 7, 2021
Completion: May 12, 2022
NCT04971590
Study to Assess Demographic, Pharmacologic, Biomarker, Clinical Features and Quality of Life (QoL) of Participants With Lupus Nephritis
Start: Sep 14, 2021
Completion: Oct 31, 2024
NCT05044325
A First Time in Human (FTIH) Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK3884464 in Healthy Participants
Start: Sep 20, 2021
Completion: Aug 5, 2022
NCT05082688
Age Differences in Influenza and Herpes Zoster Vaccine Responses (INFLUENZA-SHINGRIX)
Completion: May 17, 2023
NCT04914078
Severe Asthma Exacerbations and Mepolizumab Treatment
Start: Sep 21, 2021
NCT05059301
A Study of 3 Lots of an Investigational Vaccine Against Respiratory Syncytial Virus (RSV) in Adults Aged 60 Years and Above
Start: Oct 1, 2021
NCT04767698
Addition of Belimumab to B-cell Depletion in Relapsing-remitting Multiple Sclerosis
NCT05073003
A Study on the Safety and Immune Responses to the GVGH altSonflex1-2-3 Vaccine Against Shigellosis in Adults, Children, and Infants
Start: Oct 6, 2021
Completion: Jul 4, 2025
NCT05047770
A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine
Start: Oct 7, 2021
Completion: Aug 31, 2022
NCT04895046
Maintenance Niraparib and Dostarlimab in Advanced Cholangiocarcinoma
Start: Oct 11, 2021
Completion: Sep 30, 2023
NCT05089630
A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults
Start: Oct 14, 2021
Completion: Apr 2, 2025
NCT04673448
Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer
Start: Oct 18, 2021
NCT04908865
Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE)
Start: Oct 21, 2021
Completion: Aug 13, 2024
NCT05045144
A Phase III Study to Assess the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response and Safety of RSV Maternal Vaccine When Given Alone or Co-administered With GSK's Influenza D-QIV Vaccine in Healthy Non-pregnant Women.
Start: Oct 26, 2021
NCT05076513
Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma
Start: Oct 29, 2021
Completion: Sep 30, 2025
NCT05131971
A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics (PD) of GSK3888130B in Healthy Participants
Start: Nov 1, 2021
Completion: Oct 12, 2023
NCT05091385
Efficacy of Mepolizumab in Polish Patients With Severe Eosinophilic Asthma
NCT04447053
Sequential Belimumab and T-cell Based Therapy in SLE
Start: Nov 8, 2021
Completion: May 20, 2025
NCT04975438
Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis
Start: Nov 18, 2021
Completion: Mar 13, 2023
NCT05087056
Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents
Completion: Feb 5, 2027
NCT05133830
Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Adult Participants
Start: Nov 23, 2021
Completion: May 31, 2022
NCT05082285
A Study on the Safety, Tolerability and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Infants
Start: Nov 29, 2021
NCT05169554
Beta-Lactam Containing Regimen for the Shortening of Buruli Ulcer Disease Therapy
Start: Dec 1, 2021
Completion: May 31, 2026
NCT05140200
Study of GSK3511294 in Healthy Chinese Participants
Start: Dec 10, 2021
NCT04954859
Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)
Start: Dec 14, 2021
Completion: Feb 8, 2029
NCT05100316
Screening Protocol for Preliminary Eligibility Determination for Adoptive Cell Therapy Trials
Start: Dec 16, 2021
NCT05124210
Pharmacokinetics, Pharmacodynamics, and Safety of Single-dose Sotrovimab in High-risk Pediatric Participants With Mild to Moderate COVID-19
NCT06926673
Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 3
Start: Dec 23, 2021
NCT05069051
Belimumab in Patients with Chronic Lymphocytic Leukemia
Start: Jan 19, 2022
Completion: Jul 14, 2027
NCT05169905
A Study to Evaluate the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine in Healthy Non-pregnant Females From 9 to 49 Years of Age
Start: Feb 2, 2022
NCT05219253
A Study on the Immune Response and Safety of a Vaccine Against Herpes Zoster in Adults Aged 50 Years and Older in India
Completion: Dec 12, 2022
NCT05084508
A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age
Start: Feb 3, 2022
Completion: Jun 13, 2024
NCT05210101
A Safety and Tolerability Study of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 in Immunocompromised Individuals
Start: Feb 7, 2022
Completion: Feb 28, 2023
NCT05252338
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVSQIV in Healthy Adults
Completion: Sep 27, 2022
NCT06956170
All Japanese Population: Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma
Start: Feb 10, 2022
Completion: Nov 30, 2029
NCT04878315
Bioequivalence Study Between Capoten Versus Captopril Reference Product in Healthy Adult Participants Under Fasting Conditions
Start: Feb 13, 2022
Completion: Mar 25, 2022
NCT05174013
Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK3858279 in Healthy Caucasian, Chinese and Japanese Participants
Start: Feb 14, 2022
Completion: Apr 17, 2023
NCT05002816
Novel Combination of Belantamab Mafodotin and Elotuzumab to Enhance Therapeutic Efficacy in Multiple Myeloma
Start: Feb 21, 2022
NCT05243680
An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)
Start: Mar 1, 2022
NCT05271799
A Study to Evaluate Pharmacokinetic, Safety, Tolerability and Relative Bioavailability of Gepotidacin in Healthy Adult Male and Female Participants
Completion: Apr 22, 2022
NCT05064358
Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refractory Multiple Myeloma
Start: Mar 3, 2022
Completion: Jan 30, 2026
NCT05298254
A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes
Start: Mar 7, 2022
Completion: Jun 12, 2025
NCT05229068
A Study of Safety, Reactogenicity and Immune Response of the Repeat Vaccination Against RSV When Given to Female Participants of 18-49 Years of Age During Their Subsequent Uncomplicated Pregnancy
Start: Mar 11, 2022
Completion: Oct 24, 2024
NCT05169437
Niraparib in the Treatment of Patients with Advanced PALB2 Mutated Tumors
Start: Mar 15, 2022
Completion: Aug 27, 2024
NCT05276297
A Study on the Safety, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide Against Chronic Hepatitis B (CHB) and Chronic Hepatitis B Targeted Immunotherapy (CHB-TI) in CHB Patients Receiving Nucleos(t)Ide Analogue (NA) Therapy
Start: Mar 22, 2022
Completion: Aug 5, 2025
NCT05277051
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
Completion: Sep 12, 2028
NCT05260437
Safety, Reactogenicity, and Immunogenicity Trial of CV2CoV mRNA Vaccine Against SARS-CoV-2 in Seropositive Adult Participants
Start: Mar 24, 2022
Completion: Mar 7, 2023
NCT05297240
Retrospective Study of the Use of Belantamab Mafodotin (Blenrep®) in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) in Spain.
NCT05280717
Relative Bioavailability, Safety, and Tolerability of Single-dose Sotrovimab Injection in Adults (COSMIC)
Start: Mar 28, 2022
Completion: Nov 6, 2023
NCT04992013
Niraparib in Tumors Metastatic to the CNS
Start: Apr 5, 2022
Completion: Jun 1, 2027
NCT05280275
A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant Ineligible
Start: Apr 13, 2022
Completion: Mar 15, 2026
NCT05330455
Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection
Start: Apr 14, 2022
Completion: Apr 3, 2026
NCT05201547
Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line
Start: Apr 15, 2022
Completion: Oct 31, 2029
NCT05281523
Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps (ANCHOR-2)
Start: Apr 18, 2022
Completion: Aug 6, 2024
NCT04964050
A Bioequivalence Study Between Capozide Versus ACE-Hemmer-ratiopharm in Healthy Adult Participants Under Fasting Conditions
Start: Apr 21, 2022
Completion: May 26, 2022
NCT05388448
EBA, Safety and Tolerability of Sanfetrinem Cilexetil
Completion: Aug 19, 2024
NCT05274750
Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps
Start: Apr 22, 2022
NCT05289492
Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma
Start: May 1, 2022
NCT04600752
Study to Evaluate the Safety and Clinical Efficacy of Augmentin® Extra Strength-600 in Children With Acute Otitis Media in India
Start: May 7, 2022
Completion: Nov 12, 2022
NCT05357274
A System to Classify Treatable Traits in Primary Care
Start: May 16, 2022
NCT05138822
Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract Infections
Start: May 18, 2022
Completion: Dec 3, 2024
NCT05398198
Efficacy and Safety of GSK3923868 Inhalation Powder, During Experimental Human Rhinovirus Infection in Participants With Mild Asthma
Start: Jun 9, 2022
Completion: Apr 9, 2024
NCT05297864
PARP Inhibition for Gliomas (PI-4G or π4g)
Completion: Feb 6, 2024
NCT05418868
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
Start: Jun 14, 2022
Completion: Nov 2, 2027
NCT05412030
A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infants
Start: Jun 16, 2022
Completion: Sep 18, 2025
NCT05349227
Comprehensive Outcomes for After Cancer Health
Start: Jun 23, 2022
NCT05305651
Study to Monitor the Occurrence of Viral Variants in Patients With Compromised Immune Systems Being Treated for COVID-19
Start: Jul 1, 2022
Completion: Jul 17, 2023
NCT04926324
A Safety Study Adding Niraparib and Dostarlimab to Radiation Therapy for Rectal Cancers
Start: Jul 7, 2022
Completion: Dec 26, 2024
NCT04965636
Study in Pediatrics With HypEREosinophilic Syndrome (SPHERE)
Start: Jul 11, 2022
Completion: Oct 9, 2025
NCT05263934
Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)
Start: Jul 14, 2022
Completion: Nov 24, 2026
NCT05393076
Phase I Study of Linerixibat in Adults With Moderate Hepatic Impairment and Healthy Controls
Start: Jul 19, 2022
Completion: Dec 6, 2022
NCT07150091
Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat, Lenalidomide, and Dexamethasone in Participants With RRMM
NCT05208307
Belantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma
Start: Jul 21, 2022
Completion: Oct 21, 2027
NCT05382312
Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis
Start: Jul 26, 2022
Completion: May 27, 2025
NCT05507970
First-in-Human Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV367
Start: Jul 29, 2022
Completion: Jan 25, 2023
NCT05341284
Impact of HPV Vaccination on HPV Infection and Cervical Related Disease Burden in Real-World Settings (HPV-RWS)
Start: Aug 1, 2022
Completion: Aug 1, 2022
NCT04651777
Evaluation of Triple Therapy Using Magnetic Resonance Imaging in Asthma
Start: Aug 8, 2022
NCT05446740
A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults
Start: Aug 9, 2022
Completion: Mar 26, 2024
NCT05371080
A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults
Start: Aug 10, 2022
Completion: Aug 23, 2027
NCT05435170
Food Effect Study of Linerixibat Tablets in Healthy Adult Participants
Start: Aug 11, 2022
Completion: Oct 10, 2022
NCT05477186
Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old
Start: Aug 12, 2022
Completion: Aug 18, 2023
NCT05121974
Tebipenem Trial in Children With Shigellosis
Start: Aug 18, 2022
Completion: Aug 17, 2026
NCT05496231
A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age
Start: Aug 22, 2022
Completion: Feb 25, 2024
NCT05515575
A Study of Niraparib in People With Soft Tissue Sarcoma Who Have Changes in Their Tumor DNA
Start: Aug 23, 2022
Completion: Aug 31, 2026
NCT07150104
Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM
Start: Aug 31, 2022
NCT05334368
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
Start: Sep 6, 2022
Completion: Nov 30, 2026
NCT05480800
A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella and Typhoid Fever
Start: Sep 13, 2022
Completion: Dec 18, 2024
NCT05424380
A Phase 1, Open Label Study of Intravenous GSK3745417 to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Determine RP2D & Schedule in Participants With Relapsed or Refractory Myeloid Malignancies Including AML and HR MDS
Start: Sep 20, 2022
Completion: Mar 4, 2024
NCT05561673
A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years
Start: Oct 4, 2022
Completion: Nov 29, 2024
NCT05535972
To Evaluate Real-World Effectiveness of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol (FF/UMEC/VI) in a Single Inhaler (Trelegy Ellipta) in Participants With Symptomatic COPD
Start: Oct 14, 2022
Completion: Sep 25, 2023
NCT05565378
A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer
Completion: Feb 26, 2027
NCT05568797
A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone or Co-administered With an Adjuvanted Vaccine Against Influenza in Adults Aged 65 Years and Above
NCT05559476
A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and Above
Start: Oct 20, 2022
Completion: Aug 15, 2023
NCT05581875
A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide Refractory
Completion: Oct 31, 2026
NCT05008081
The CATALINA Study
Start: Oct 25, 2022
NCT05590403
A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 50-59 Years of Age, Including Adults at Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease, Compared to Older Adults 60 Years of Age and Above
Start: Oct 28, 2022
Completion: Feb 12, 2024
NCT05442749
Niraparib As First Line Therapy with Metastatic Homologous Repair-deficient Pancreatic Cancer
Completion: Sep 15, 2026
NCT05590338
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic of GSK1070806 After a Single Intravenous Dose in Healthy Male and Female Caucasian, Chinese and Japanese Participants Aged 18 to 65 Years of Age Inclusive
Start: Nov 4, 2022
Completion: Dec 28, 2023
NCT05896748
Study to Assess the Effects of Cabotegravir (CAB) and Rilpivirine (RPV) Long-Acting (LA) Injections Following Sub-cutaneous (SC) Administration Compared With Intramuscular (IM) Administration in Adult Participants Living With Human Immunodeficiency Virus (HIV-1) Infection in the FLAIR Study
Start: Nov 8, 2022
Completion: Sep 14, 2023
NCT05338190
Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia
Start: Nov 14, 2022
Completion: Nov 14, 2027
NCT04420221
Safety, Immunogenicity and Efficacy of GSK S. Aureus Candidate Vaccine (GSK3878858A) When Administered to Healthy Adults (Dose-escalation) and to Adults 18 to 64 Years of Age With a Recent S. Aureus Skin and Soft Tissue Infection (SSTI)
Start: Nov 16, 2022
Completion: Mar 12, 2024
NCT04494412
An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection
Start: Nov 21, 2022
Completion: Apr 30, 2026
NCT05613205
Safety and Immunogenicity of a Novel Conjugate Vaccine Against Salmonella Typhi and Salmonella Paratyphi A in Healthy Adults
Start: Nov 28, 2022
Completion: Apr 2, 2024
NCT05630859
Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age.
Completion: May 22, 2025
NCT05630820
Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2)
Start: Dec 6, 2022
Completion: May 8, 2026
NCT05473195
A Phase 2 Trial to Evaluate the EBA, Safety and Tolerability of Eto Alone and in Combination With BVL-GSK098
Completion: Apr 16, 2024
NCT05630807
Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1)
Start: Dec 7, 2022
NCT05501522
Immunogenicity and Safety Study of Heterologous Booster Vaccination of a SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine(GBP510) Adjuvanted with AS03 in Adults Aged 18 Years and Older
Start: Dec 9, 2022
Completion: Aug 17, 2024
NCT05602025
A Study to Compare the Pharmacokinetics (PK) of Depemokimab When Delivered With a Safety Syringe Device (SSD) or an Autoinjector in Healthy Adult Participants
Start: Dec 13, 2022
NCT05630846
A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age
Start: Dec 14, 2022
Completion: Oct 14, 2024
NCT05526989
Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma
Start: Dec 28, 2022
Completion: Nov 30, 2027
NCT05583344
Phase 2b Study of GSK4532990 in Adults With NASH
Start: Jan 2, 2023
Completion: Apr 5, 2027
NCT05630833
A Study to Investigate the Efficacy and Safety With Gepotidacin in Japanese Female Participants With Uncomplicated Urinary Tract Infection (Acute Cystitis)
Start: Jan 11, 2023
NCT05677347
Phase 1, Single and Repeat Dose Study to Assess Safety, Tolerability, and Pharmacokinetics (PK) of GSK3923868 in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Start: Jan 23, 2023
Completion: Jul 20, 2023
NCT05404763
Mepolizumab and Physical Activity in Severe Asthma
Start: Feb 2, 2023
Completion: Jul 2, 2025
NCT05705440
A Follow-up Study to Describe the Safety of Study Participants Who Received RSVPreF3 Maternal Vaccination (Any Dose) or Controls From Previous RSV MAT Studies During Any Pregnancy Conceived Post Vaccination/Control
Start: Feb 7, 2023
Completion: Jan 15, 2025
NCT05304130
A Study in Healthy Japanese Participants to Evaluate the Safety and Pharmacokinetics of Otilimab
Start: Feb 8, 2023
Completion: May 4, 2023
NCT05523440
Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation
Start: Feb 15, 2023
Completion: Jan 8, 2025
NCT05065021
Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor
Start: Feb 23, 2023
Completion: Jun 6, 2025
NCT04305678
Mepolizumab for Eosinophilic Fasciitis
Start: Feb 28, 2023
Completion: Feb 15, 2023
NCT05405192
Dostarlimab in Chemoresistant Gestational Trophoblastic Neoplasia
Start: Mar 1, 2023
Completion: Dec 1, 2028
NCT05673083
Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma
Completion: Mar 31, 2026
NCT05626777
Symptoms Control and adhErenCe Assessment During Treatment With MepolizUmab New pREfilled Devices
Start: Mar 9, 2023
Completion: Jul 31, 2026
NCT05721365
The Use and Development of Patient Reported Outcome Measures (PROMs) in the Adoptive Cell Therapy (ACT) Setting
Start: Mar 28, 2023
NCT05519670
A Phase 1b/2 Trial Evaluating Safety and Efficacy of CAPecitabine in Combination With Ni-rapaRIb in HER2-negative Advanced Breast canCEr
Start: Mar 31, 2023
NCT05723562
A Study of Dostarlimab in Untreated dMMR/MSI-H Locally Advanced Rectal Cancer
Start: Apr 3, 2023
Completion: Oct 11, 2029
NCT05791565
Green (Sustainable) VENTOLIN - Pharmacokinetics (PK) Study in Healthy Participants
Completion: May 21, 2023
NCT05811754
Safety of Herpes Zoster Subunit (HZ/su) Vaccine During Pregnancy in Adult Women With Immunocompromised Conditions
Completion: Apr 30, 2029
NCT05760261
Drug Interaction Assessment of GSK3882347 in Healthy Participants Aged 18 to 65 Years
Start: Apr 11, 2023
NCT05807399
PanACEA - STEP2C -01
Start: Apr 14, 2023
Completion: Dec 30, 2027
NCT05757102
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
Start: Apr 25, 2023
Completion: Jan 15, 2027
NCT05823974
A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults
Start: Apr 27, 2023
NCT05320939
Immunological Basis for Mepolizumab Activity in COPD
Start: Apr 30, 2023
Completion: May 31, 2025
NCT05762861
Exploring Clinical Predictors of COPD Exacerbation in a Community Cohort
Completion: Apr 30, 2025
NCT06389058
Using NLP and Neural Networks to Autonomously Identify Severe Asthma and Determine Study Eligibility in a Large Healthcare System
Start: May 1, 2023
NCT05406700
Niraparib In Recurrent IDH 1/2 Gliomas
Start: May 18, 2023
Completion: Feb 28, 2026
NCT05694715
Combination Therapy in Cancers With Mutations in DNA Repair Genes
Start: May 23, 2023
NCT05879419
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
Completion: Dec 1, 2027
NCT05879107
Study to Assess the Immune Response, the Safety and the Reactogenicity of Respiratory Syncytial Virus (RSV) Prefusion Protein 3 Older Adult (OA) (RSVPreF3 OA) Investigational Vaccine When co Administered With PCV20 in Older Adults
Start: May 26, 2023
NCT05789303
Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma
Start: May 30, 2023
Completion: Jul 1, 2028
NCT06348173
Response and Remission to Treatment With Anti-IL5/IL5R Antagonists
Start: Jun 1, 2023
NCT04923347
A Study to Evaluate the Safety and Efficacy of Fluticasone Furoate (FF)/Umeclidinium(UMEC)/Vilanterol (VI) in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Start: Jun 6, 2023
NCT05714839
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Start: Jun 14, 2023
Completion: Dec 3, 2029
NCT05913700
Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)
Start: Jul 1, 2023
NCT05951192
A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease
NCT05917288
A Study of Belimumab in Chinese Pediatric Participants With Systemic Lupus Erythematosus
Start: Jul 7, 2023
Completion: Oct 30, 2024
NCT05573802
A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma
Start: Jul 14, 2023
NCT05819892
Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer
Start: Jul 17, 2023
Completion: Mar 1, 2028
NCT05857397
A Collaborative Trial of Niraparib to Evaluate Patients With Ovarian Cancer in the Expanded Access Program in Latin America
Start: Jul 21, 2023
NCT05855811
PREventing Second Cancers With DOSTARlimab
Start: Jul 26, 2023
Completion: Mar 26, 2029
NCT05921903
A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant and Are at an Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease and Compared to Healthy Adults 50 Years of Age and Above
Start: Jul 28, 2023
Completion: May 16, 2025
NCT05966090
A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults
Completion: Jul 29, 2024
NCT05917509
A Study to Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy
Completion: Sep 3, 2026
NCT05855200
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Start: Aug 1, 2023
Completion: Mar 27, 2031
NCT05960097
A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults
Completion: Aug 30, 2024
NCT05979207
Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. Falciparum
Completion: Oct 30, 2023
NCT05975840
Safety and Immunogenicity of Different Formulations of Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine With AS03 Adjuvant System in Medically Stable Adults
Start: Aug 3, 2023
Completion: Sep 19, 2024
NCT05972993
A Safety and Immune Response Study to Evaluate Varying Doses of an mRNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Healthy Adults
Start: Aug 7, 2023
NCT05989672
A Study on the Reactogenicity, Safety and Immune Response of a Targeted Immunotherapy Against HSV in Healthy Japanese Participants Aged 18-40 Years
Start: Aug 8, 2023
Completion: Apr 24, 2024
NCT05980416
Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2
Start: Aug 10, 2023
Completion: Jun 2, 2025
NCT06201559
Bioequivalence Study Between Two Albendazole 400 mg Tablets in Healthy Adult Participants Under Fed Conditions
Start: Aug 21, 2023
NCT05961124
Alternative Dosing Of Niraparib To Decrease Dose Interruption In First Line Maintenance Treatment For Ovarian Cancer
Completion: Sep 30, 2027
NCT05660265
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years
Start: Aug 26, 2023
Completion: Feb 27, 2026
NCT06025695
Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix Porcine Circovirus (PCV)-Free Liquid Compared to Rotarix Liquid Given in 2-doses in Healthy Chinese Infants Starting at Age 6-16 Weeks
Start: Sep 1, 2023
Completion: Oct 23, 2024
NCT06327724
Belimumab in SLE Synovial Inflammation and Lymph Nodes
NCT05895929
The Role of IL5 in Epithelial Cell Integrity
Start: Sep 5, 2023
NCT05682326
Anemia Studies in CKD: Erythropoiesis Via a Novel PHI Daprodustat - Pediatric (ASCEND-P)
Start: Sep 6, 2023
Completion: Mar 17, 2025
NCT05838742
A Dose-Finding Study to Evaluate the Efficacy and Safety of GSK3858279 in Adults With Knee Osteoarthritis (OA) Pain
Start: Sep 13, 2023
NCT05878717
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Completion: Jul 12, 2027
NCT05956457
PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma
Start: Sep 15, 2023
NCT05986682
Real-World Analysis of Belantamab Mafodotin Care Patterns in Patients With Relapsed and/or Refractory Multiple Myeloma
Start: Sep 18, 2023
Completion: Nov 7, 2023
NCT05838755
A Study to Evaluate Efficacy and Safety of GSK3858279 in Diabetic Peripheral Neuropathic Pain
Start: Sep 20, 2023
Completion: Feb 17, 2025
NCT06065735
Concentration-QT Study of Paroxetine in Healthy Adults
Start: Oct 2, 2023
Completion: Jan 8, 2024
NCT06058390
A Study to Evaluate the Relative Bioavailability of Subcutaneous Bepirovirsen When Delivered From a Vial or Prefilled Syringe Fitted With a Safety Syringe Device in Healthy Adult Participants
Start: Oct 4, 2023
Completion: May 3, 2024
NCT05666349
Reirradiation and Niraparib in Patients With Recurrent Glioblastoma
Start: Oct 13, 2023
Completion: Oct 13, 2023
NCT05340257
A Pharmacokinetics and Safety Study of Augmentin ES-600 in Children With CAP and ABRS
Start: Oct 14, 2023
Completion: Jul 8, 2024
NCT06079190
Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease
Start: Oct 20, 2023
Completion: Nov 23, 2026
NCT06077877
A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid Tumors
Start: Oct 24, 2023
Completion: Jun 29, 2027
NCT05775718
Shingrix In Recipients of Allogeneic Transplants
Completion: Dec 1, 2030
NCT05952271
Herpes Zoster Hospitalizations in Italy
Start: Oct 26, 2023
Completion: Jul 30, 2025
NCT05999708
A First Time in Human Study to Evaluate the Safety and Tolerability of GSK4381406 in Healthy Participants
Start: Oct 31, 2023
Completion: Dec 5, 2024
NCT05126342
Study to Estimate Efficacy of Combining Dostarlimab and Niraparib in Relapsed EOC After Treatment With PARPi
Start: Nov 1, 2023
NCT05784012
Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma
Start: Nov 8, 2023
Completion: Mar 31, 2029
NCT06113198
A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age
Start: Nov 10, 2023
Completion: Jul 30, 2027
NCT06062420
A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202
Start: Nov 14, 2023
Completion: Jul 27, 2027
NCT05999799
A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis
Start: Nov 16, 2023
Completion: Jul 24, 2025
NCT06154837
A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease
Start: Nov 27, 2023
NCT06014580
Molecular and Epidemiological Characteristics of Endometrial Cancer in Brazil
NCT06190509
Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study
Start: Dec 6, 2023
NCT06171113
A Study to Investigate the Safety of GSK4024484 in Healthy Adult Participants
Start: Dec 12, 2023
Completion: Aug 14, 2025
NCT05648357
A Study to Assess the Safety and Immune Response of Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) in Participants Aged 65 Years and Older in India
Start: Dec 14, 2023
Completion: Feb 26, 2024
NCT05718323
Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC
Start: Dec 20, 2023
NCT06059846
A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
Start: Dec 21, 2023
Completion: Feb 6, 2025
NCT06147206
Exacerbantes Study
Start: Dec 31, 2023
NCT06272123
Endotypic Stability in CRS
Start: Jan 1, 2024
NCT06114628
Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
Start: Jan 9, 2024
Completion: Aug 11, 2027
NCT06188507
A First Time in Human Study to Evaluate the Safety and Tolerability of GSK3996401 Following Dosing With GSK4347859 in Healthy Participants
Start: Jan 12, 2024
Completion: Jul 14, 2026
NCT06213506
A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and Infants
Start: Jan 15, 2024
Completion: Apr 27, 2026
NCT06104319
Dose Exploration Study of GSK4532990 in. Participants With NASH or Suspected NASH
Start: Jan 22, 2024
Completion: Sep 23, 2025
NCT06023862
A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)
Completion: Dec 31, 2029
NCT06188065
Eosinopenia in Severe COPD Exacerbation
NCT06161493
ZEN003694 Combined With Niraparib in Patients With Metastatic or Recurrent Solid Tumors
Start: Jan 23, 2024
NCT04274023
Study on TSR-042 in Advanced Clear Cell Sarcoma
Start: Jan 29, 2024
Completion: Jan 29, 2024
NCT06214052
VH4524184 Proof-of-Concept in Treatment-Naïve Adults Living With HIV-1
Start: Feb 7, 2024
Completion: Jun 12, 2024
NCT06298448
eGPA and Local Inflammation Within the Ear, Nose and Throat Area
Start: Feb 14, 2024
NCT05145816
Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
Start: Feb 15, 2024
Completion: Sep 1, 2026
NCT06282861
ANTES B+ Clinical Trial
Start: Feb 29, 2024
Completion: Jan 23, 2025
NCT06206083
Molecular Classification in Mexican Patients With Endometrial Cancer and Its Impact on Prognosis
Start: Mar 1, 2024
Completion: Feb 1, 2027
NCT05659381
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Start: Mar 8, 2024
Completion: Aug 1, 2034
NCT06238635
Dostarlimab and Cobolimab in Advanced Cervical Cancer
Start: Mar 11, 2024
Completion: Jul 15, 2027
NCT06041386
REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study
Start: Mar 20, 2024
Completion: Jun 14, 2028
NCT06256588
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
Start: Mar 21, 2024
Completion: Oct 26, 2029
NCT06310551
First Time in Human Study of Long Acting VH4524184 Formulations
Completion: Jan 21, 2028
NCT06331156
A Study on the Immune Response and Safety of Inactivated Poliovirus Vaccine (IPV) When Co-administered With Human Rotavirus (HRV) Porcine Circovirus (PCV)-Free Vaccine in Healthy Chinese Infants
Start: Mar 22, 2024
Completion: Oct 22, 2024
NCT06317285
A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Start: Apr 4, 2024
Completion: Oct 1, 2025
NCT06354257
A Study to Investigate the Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With GSK3036656 in Female Participants of Non-childbearing Potential Aged 18 to 65 Years of Age
Start: Apr 5, 2024
NCT06372496
Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma
Start: Apr 16, 2024
Completion: Jan 22, 2026
NCT06382311
A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults
Start: Apr 18, 2024
Completion: Jan 16, 2026
NCT06374394
A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a COVID-19 mRNA Vaccine in Adults Aged 50 Years and Above
Start: Apr 29, 2024
NCT06389487
A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus (RSV) Given to Adults 18 to 49 Years of Age at Increased Risk for Respiratory Syncytial Virus Disease, Compared to Older Adults 60 Years of Age and Above
Completion: Mar 18, 2025
NCT06317311
A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Japanese Participants With Primary Advanced or Recurrent Endometrial Cancer
Start: May 7, 2024
NCT06235801
A Phase I/II Study of Gilteritinib and Momelotinib for Patients With Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia
Start: May 22, 2024
Completion: Oct 1, 2029
NCT06431607
A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adults
Start: May 23, 2024
Completion: Jun 4, 2025
NCT06134362
Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)
Start: May 24, 2024
Completion: Sep 29, 2028
NCT06261957
A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma
Start: May 31, 2024
Completion: Sep 5, 2025
NCT06413511
A Study to Investigate the Safety and Pharmacological Effect of a Single Intravenous Infusion of Belantamab in Male and Female Participants Aged 18 to 75 With Autoimmune Disease
Start: Jun 3, 2024
Completion: Jul 8, 2025
NCT06433908
A Study to Compare the Pharmacokinetics (PK) of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152A (Test) or HFA-134A (Reference) in Healthy Participants Aged 18 to 55 Inclusive
Start: Jun 4, 2024
NCT06447506
Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis.
Start: Jun 5, 2024
Completion: Jul 29, 2025
NCT06411249
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
Start: Jun 6, 2024
Completion: May 29, 2029
NCT06472076
A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)
Start: Jun 10, 2024
Completion: Feb 2, 2027
NCT05922501
Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma
Start: Jun 18, 2024
Completion: Dec 1, 2026
NCT06388733
A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma
Start: Jun 19, 2024
Completion: Mar 31, 2028
NCT06488703
Retrospective Analysis of Systemic Glucocorticoid Mediated Long-term Effects, Patient Pathways and Economic Burden Across Multiple Indications
Start: Jul 1, 2024
NCT06431594
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Participants With Advanced Solid Tumors
Start: Jul 2, 2024
Completion: Sep 20, 2027
NCT06422767
Study to Evaluate the Effect of Bepirovirsen on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers
Start: Jul 18, 2024
Completion: Apr 28, 2025
NCT06333314
Dostarlimab for Locally Advanced or Metastatic Cancer (non-colorectal/non-endometrial) with Tumor DMMR/MSI
Start: Jul 23, 2024
Completion: Sep 30, 2030
NCT06506266
Study of the Effect of HFA-152a and HFA-134a Propellants on Mucociliary Clearance in Healthy Participants
Start: Jul 29, 2024
NCT06534892
An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study
Start: Aug 1, 2024
NCT06278857
SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr)
Completion: Jun 30, 2028
NCT06551181
A Study on the Immune Response, Safety and the Occurrence of Respiratory Syncytial Virus (RSV)-Associated Respiratory Tract Illness After Administration of RSV OA Vaccine in Adults 60 Years and Older
Start: Aug 5, 2024
Completion: Sep 15, 2025
NCT06433921
A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive
Start: Aug 14, 2024
Completion: Aug 14, 2026
NCT04876248
Belantamab Mafodotin and Lenalidomide for the Treatment of Multiple Myeloma in Patients With Minimal Residual Disease Positive After Stem Cell Transplant
Start: Aug 19, 2024
NCT06576271
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants and Healthy Chinese and Japanese Participants
Start: Sep 2, 2024
NCT06577597
Safety, Tolerability and Blood Sampling of GSK3923868 Administered Via Dry Powder Inhaler to Healthy Participants of Chinese, Japanese and European Ancestry
Completion: Nov 1, 2024
NCT06572384
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Start: Sep 11, 2024
Completion: Dec 13, 2028
NCT06497504
Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus)
Start: Sep 17, 2024
Completion: Apr 27, 2027
NCT06597916
RSV Vaccination in Immunocompromised Patients.
Start: Sep 19, 2024
NCT06594679
A Study of Niraparib in Combination With Abemaciclib for Late Line Treatment of Ovarian Cancer (NICHOL TRIAL)
Start: Sep 26, 2024
Completion: Sep 18, 2027
NCT06613698
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 65 Years With Alcohol-related Liver Disease
Start: Sep 27, 2024
NCT06551142
A Study of GSK5764227 in Participants With Advanced Solid Tumors
Start: Sep 30, 2024
Completion: May 19, 2027
NCT06573281
A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in Healthy Adults Aged 18-45 Years
Completion: Apr 13, 2026
NCT06597500
A Study to Evaluate the Effect of Itraconazole on the Concentration of GSK3923868 in the Blood in Healthy Participants
Completion: Dec 23, 2024
NCT06258018
Niraparib and Temozolomide in Patients Glioblastoma
NCT06614725
A Study in India on the Immune Response and Safety of a Respiratory Syncytial Virus (RSV) Older Adults (OA) Vaccine When Given to Older Adults 60 Years of Age and Above and Adults 50-59 Years of Age at Increased Risk (AIR) of Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV-LRTD)
Start: Oct 1, 2024
Completion: Nov 24, 2025
NCT06597344
A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis)
Start: Oct 2, 2024
Completion: Mar 10, 2025
NCT06527872
Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN
Start: Oct 4, 2024
Completion: Mar 29, 2029
NCT06625489
A Study to Evaluate the Safety, Tolerability and Blood Levels of GSK3915393 Administered to Healthy Participants of Chinese, Japanese and European Ancestry and to Assess Effects of GSK3915393 on Nintedanib
Start: Oct 7, 2024
Completion: Nov 25, 2024
NCT06533813
Clinical Epidemiology in Contemporary Patients With Myelofibrosis.
Start: Oct 14, 2024
NCT06640049
A Study of Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China
Start: Oct 17, 2024
Completion: Apr 15, 2031
NCT06224270
Study of Response to Zoster Vaccine in Adults with Inflammatory Bowel Disease Treated with Medications
Start: Oct 31, 2024
NCT06537414
A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)
Start: Nov 11, 2024
NCT06680375
A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults
Completion: Jun 9, 2025
NCT06663436
A Study on the Immune Response and Safety of a Multicomponent Shigella Vaccine in Preventing Shigellosis in Infants
Start: Nov 13, 2024
Completion: Oct 16, 2025
NCT06666491
An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and Older
NCT06681181
A First-time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK4528287 in Healthy Participants
Start: Nov 18, 2024
Completion: Sep 9, 2026
NCT06702449
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
Start: Nov 19, 2024
NCT06727136
A Study to Characterize Single and Repeat Dose Pharmacokinetics of Tebipenem-Pivoxil-Hydrobromide (TBP-PI-HBr) and Its Major Metabolite (SPR1349) in Healthy Participants
Start: Nov 20, 2024
Completion: Apr 22, 2025
NCT06693895
A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age
Start: Nov 26, 2024
NCT06468995
Antiviral Long Acting Drugs Landing in People Living With HIV
Start: Dec 2, 2024
NCT06734234
A Study to Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease
Start: Dec 11, 2024
Completion: Sep 4, 2026
NCT06381453
Belimumab in Autoimmune Hepatitis
NCT06716606
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Start: Dec 12, 2024
Completion: Jan 8, 2030
NCT06710847
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
Start: Dec 13, 2024
Completion: Jun 16, 2028
NCT06763783
Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases
Start: Dec 17, 2024
Completion: Jun 30, 2034
NCT06679101
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Start: Dec 27, 2024
Completion: Apr 6, 2032
NCT06740630
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
Start: Jan 10, 2025
Completion: May 13, 2027
NCT06365970
Niraparib and Dostarlimab for Patients With MMR-D/MSI-H Colorectal Cancers
Start: Jan 31, 2025
NCT06748053
A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled Asthma
Start: Feb 10, 2025
Completion: Jan 14, 2027
NCT06567782
A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer
Start: Feb 17, 2025
Completion: Jun 15, 2028
NCT06757244
DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer
Start: Feb 18, 2025
Completion: Feb 18, 2028
NCT06517875
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
Start: Feb 28, 2025
NCT06702345
Clostridioides Difficile Controlled Human Infection Model
Start: Mar 1, 2025
NCT06796907
A Study of GSK5733584 in Combination With Anti-cancer Therapies for Advanced Solid Tumors
Start: Mar 4, 2025
NCT06521567
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
Start: Mar 6, 2025
Completion: Jan 2, 2032
NCT06702462
A Study to Assess the Potential for Airway Sensitivity Reactions With Propellants HFA-152a (Test) and HFA-134a (Reference) Administered Via Pressurized Inhalers in Adults With Mild Asthma
Start: Mar 11, 2025
NCT06920043
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Start: Apr 9, 2025
NCT06855160
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age
Start: Apr 17, 2025
Completion: Dec 24, 2026
NCT06887933
A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer
Start: Apr 22, 2025
Completion: Jul 8, 2026
NCT06911775
Eosinophil Subpopulations in Eosinophilic-associated Diseases
Start: Apr 30, 2025
NCT06747845
Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy
Start: May 7, 2025
Completion: Jan 30, 2029
NCT06806137
A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age
Start: May 15, 2025
Completion: Apr 2, 2027
NCT06979518
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GSK3862995B Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and European Ancestry
Start: May 20, 2025
NCT06979323
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
Start: Jun 3, 2025
Completion: Feb 11, 2028
NCT06847867
A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
Start: Jun 5, 2025
Completion: Mar 6, 2029
NCT06885034
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed
Start: Jun 11, 2025
Completion: Jun 23, 2028
NCT06990880
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
Start: Jun 12, 2025
Completion: Aug 9, 2028
NCT06959095
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
Start: Jun 20, 2025
Completion: Aug 20, 2029
NCT06961214
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Start: Jun 23, 2025
Completion: Aug 21, 2029
NCT06405230
Evaluation of Programmed Death Ligand 1 (PDL1) Response to Treatment in Extracellular Vesicles (EVs), Patient-derived Organoid (PDOs)s and Immune-marker Positron Emission Tomography (PET) Scanning in Non-small Cell Lung Cancer (NSCLC)
Start: Jun 27, 2025
Completion: Jun 27, 2029
NCT07017803
Molecular Epidemiology, Strains Genotyping of Multi-drug Resistant Tuberculosis Circulating in Central Africa Region
Start: Jul 1, 2025
NCT06995430
A Phase 3 Study to Assess the Immune Response And Safety Of Rmenb+Omv Nz In Primed Healthy Participants (10 To 20 Years Old)
Start: Jul 7, 2025
Completion: Dec 10, 2025
NCT06897527
A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)
Start: Jul 15, 2025
Completion: Jan 13, 2027
NCT07085702
A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of the GSK 4-component Strep A Vaccine With Aluminum Hydroxide (Alum) or AS37 in Healthy Young Adults
Start: Jul 31, 2025
NCT07036159
A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Months
Start: Aug 6, 2025
Completion: Apr 23, 2027
NCT07092865
A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant
Completion: Jul 16, 2027
NCT07099898
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)
Start: Aug 11, 2025
Completion: Sep 11, 2028
NCT07105722
A Trial to Evaluate the Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults 50 To 64 Years of Age
Start: Aug 12, 2025
Completion: Jun 18, 2026
NCT07105709
Open-label Extension Study in Participants With Early Alzheimer's Disease
Start: Aug 14, 2025
Completion: Nov 24, 2028
NCT07121192
A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older
Start: Aug 25, 2025
Completion: May 15, 2026
NCT07168356
A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease
Start: Sep 16, 2025
Completion: Aug 18, 2026
NCT07201051
A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
Start: Sep 26, 2025
Completion: Nov 8, 2027
NCT07115927
pReOperative Dostarlimab and Novel Therapies in EndOmetrial Cancer
Start: Sep 30, 2025
Completion: Jan 31, 2031
NCT07013851
Clinical Trial to Assess the Efficacy of Dostarlimab as Neoadjuvant Therapy in Patients With MMRd/MSI-H Stage II-III Endometrial Cancer
Start: Oct 1, 2025
NCT07204964
A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above
Start: Oct 10, 2025
Completion: Sep 18, 2026
NCT07213609
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
Completion: Oct 27, 2028
NCT07177339
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Start: Oct 20, 2025
Completion: Dec 14, 2029
NCT07218926
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
Start: Oct 30, 2025
Completion: Oct 28, 2030
NCT07220109
A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to 59 Years of Age at Increased Risk of Respiratory Syncytial Virus Disease
Start: Oct 31, 2025
Completion: Dec 14, 2026
NCT07098936
Momelotinib in VEXAS Syndrome
Completion: Oct 31, 2028
NCT07108270
A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Chinese Participants With Primary Advanced or Recurrent Endometrial Cancer (EC)
Start: Nov 30, 2025
Completion: Mar 31, 2030
NCT06412120
Study Evaluating Safety, Tolerability, and Metabolism of Niraparib
Start: Dec 1, 2025
Completion: Oct 1, 2030
NCT07050732
Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons
Start: Dec 31, 2025
NCT07104799
Momelotinib During and After HCT in Myelofibrosis
Start: Jan 31, 2026
Completion: Jan 31, 2030